0001213900-23-023646.txt : 20230328 0001213900-23-023646.hdr.sgml : 20230328 20230328153748 ACCESSION NUMBER: 0001213900-23-023646 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 54 CONFORMED PERIOD OF REPORT: 20221231 FILED AS OF DATE: 20230328 DATE AS OF CHANGE: 20230328 FILER: COMPANY DATA: COMPANY CONFORMED NAME: VS Trust CENTRAL INDEX KEY: 0001793497 STANDARD INDUSTRIAL CLASSIFICATION: [6221] IRS NUMBER: 846704517 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-41280 FILM NUMBER: 23769229 BUSINESS ADDRESS: STREET 1: 100 SOUTH BEDFORD ROAD, SUITE 340 CITY: MOUNT KISCO STATE: NY ZIP: 10549 BUSINESS PHONE: 2039986005 MAIL ADDRESS: STREET 1: 100 SOUTH BEDFORD ROAD, SUITE 340 CITY: MOUNT KISCO STATE: NY ZIP: 10549 10-K 1 f10k2022_vstrust.htm ANNUAL REPORT
 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

FORM 10-K

 

 

 

Annual report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended December 31, 2022.

 

or

 

Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from ________ to ________.

 

Commission file number: 001-41280

 

 

 

VS Trust

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   84-6704517
(State or other jurisdiction of   (I.R.S. Employer
incorporation or organization)   Identification No.)

 

c/o Volatility Shares LLC
2000 PGA Boulevard, Suite 4440
Palm Beach Gardens, FL 33408

(Address of principal executive offices) (Zip Code)

 

(866) 261-0273

(Registrant’s telephone number, including area code)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading Symbol(s)

 

Name of each exchange on which registered

-1x Short VIX Futures ETF   SVIX   Cboe BZX Exchange
2x Long VIX Futures ETF   UVIX   Cboe BZX Exchange

 

Securities registered pursuant to Section 12(g) of the Act: None

 

 

 

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes No

 

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes No

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes No

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such
files). Yes No

 

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (§229.405 of this chapter) is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K.

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer”, “accelerated filer”, “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large Accelerated Filer Accelerated Filer
Non-Accelerated Filer Smaller Reporting Company
Emerging Growth Company  

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. ☐

 

If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statement of the registrant included in the filing reflect the correction of an error to previously issued financial statements. ☐

 

Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b). ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act.). Yes No

 

As of February 28, 2023, the registrant had 7,570,000 shares of common stock, $0 par value per share, outstanding.

 

The aggregate market value of each Fund’s units held by non-affiliates as of June 30, 2022 and the number of outstanding units for each Fund as of February 28, 2023, are included in the table below.

 

Fund  Aggregate Market Value of the Fund's Units Held by Non-Affiliates as of June 30, 2022   Number of Outstanding Units as of February 28, 2023 
-1x Short VIX Futures ETF  $46,889,371    2,890,000 
2x Long VIX Futures ETF  $60,436,455    4,680,000 
Total  $107,325,826      

 

DOCUMENTS INCORPORATED BY REFERENCE:

 

None.

 

THE FINANCIAL STATEMENT SCHEDULES CONTAINED IN PART IV OF THIS ANNUAL REPORT ON FORM 10-K CONSTITUTE THE ANNUAL REPORT WITH RESPECT TO THE COMMODITY POOLS FOR PURPOSES OF COMMODITY FUTURES TRADING COMMISSION RULE 4.22(C)

 

 

 

 

 

 

VS Trust

 

Table of Contents

 

      Page
         
Part I.     1
         
Item 1.   Business   1
Item 1A.   Risk Factors   16
Item 1B.   Unresolved Staff Comments   16
Item 2.   Properties   16
Item 3.   Legal Proceedings   16
Item 4.   Mine Safety Disclosures   16
         
Part II.     17 
         
Item 5.   Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities   17
Item 6.   [Reserved]   17
Item 7.   Management’s Discussion and Analysis of Financial Condition and Results of Operations   17
Item 8.   Financial Statements and Supplementary Data   24
Item 9.   Changes in and Disagreements With Accountants on Accounting and Financial Disclosure   25
Item 9A.   Controls and Procedures   25
Item 9B.   Other Information   26
Item 9C.   Disclosure Regarding Jurisdictions that Prevent Inspections   26
         
Part III.     26
         
Item 10.   Directors, Executive Officers and Corporate Governance   26
Item 11.   Executive Compensation   30
Item 12.   Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters   30
Item 13.   Certain Relationships and Related Transactions, and Director Independence   30
Item 14.   Principal Accounting Fees and Services   30
         
Part IV.     31
         
Item 15.   Exhibits and Financial Statement Schedules   31
Item 16.   Form 10-K Summary   31

 

i

 

 

Part I.

 

Item 1. Business.

 

Summary

 

VS Trust (the “Trust”) is a Delaware statutory trust formed on October 24, 2019 and is currently organized into separate series (each, a “Fund” and collectively, the “Funds”). As of September 30, 2022, the following two series of the Trust have commenced investment operations: -1x Short VIX Futures ETF (“SVIX”) and 2x Long VIX Futures ETF (“UVIX”). Each of the Funds listed above issues common units of beneficial interest (“Shares”), which represent units of fractional undivided beneficial interest in and ownership of only that Fund. The Shares of each Fund are listed on the Cboe BZX Exchange (“Cboe BZX”).

 

The Funds’ inception of operation was March 28, 2022. Neither the Trust nor the Funds had any operations prior to March 28, 2022, other than matters relating to its date of organization and the registration of each series under the Securities Act of 1933.

 

Each Fund’s investment exposure to VIX futures contracts will cause each to be deemed a commodity pool, thereby subjecting each Fund to regulation under the Commodity Exchange Act of 1934 (“CEA”) and Commodity Futures Trading Commission (“CFTC”) rules. The Sponsor is registered as a Commodity Pool Operator (“CPO”) and the Fund will be operated in accordance with applicable CFTC rules. Registration as a CPO imposes additional compliance obligations on the Sponsor and the Funds related to additional laws, regulations and enforcement policies, which could increase compliance costs and may affect the operations and financial performance of the Funds.

 

Volatility Shares LLC (the “Sponsor”) is the sponsor of the Trust and the Funds. The Sponsor also will serve as the Trust’s commodity pool operator. The Funds are commodity pools, as defined under the Commodity Exchange Act (the “CEA”), and the applicable regulations of the CFTC and are operated by the Sponsor, which is registered as a commodity pool operator with the CFTC. The Trust is not an investment company registered under the Investment Company Act of 1940.

 

Penserra Capital (the “Commodity Sub-Adviser”) serves as the Funds’ sub-adviser (the “Commodity Sub-Adviser”) and provides sub-advisory services to each Fund pursuant to a commodity sub-advisory agreement (the “Commodity Sub-Advisory Agreement”). Prior to November 1, 2022, Milliman FRM served as the Funds’ commodity sub-adviser.

 

SVIX seeks daily investment results, before fees and expenses, that correspond to the performance of the Short VIX Futures Index (the “Short Index”) for a single day, not for any other period. UVIX seeks daily investment results, before fees and expenses, that correspond to twice the performance of the Long VIX Futures Index (the “Long Index”). A “single day” is measured from the time a Fund calculates its net asset value (“NAV”) to the time of the Fund’s next NAV calculation. The NAV calculation time for a Fund typically is 4:00 p.m. (Eastern Time). The Short Index measures the daily inverse (i.e., opposite) performance of a portfolio of first- and second-month futures contracts on the CBOE Volatility Index, commonly known as the “VIX.” The Long Index measures the performance of a portfolio of first- and second-month futures contracts on the VIX. Because the Funds’ portfolios are rebalanced daily to meet their leveraged (or inverse) investment objective, the Funds may not be suitable for investors who plan to hold them for periods longer than one day, particularly in volatile markets.

 

The Funds seek to achieve their investment objective through the appropriate amount of exposure to the VIX futures contracts included in their respective index. The Funds also have the ability to engage in options transactions, swaps, forward contracts and other instruments in order to achieve their investment objective, in the manner and to the extent described herein.

 

SVIX is not benchmarked to the inverse of, and UVIX is not benchmarked to twice, the widely referenced VIX. The Short Index and the inverse of the VIX are separate measurements and can be expected to perform very differently. The Long Index and twice the VIX also are separate measurements and can be expected to perform very differently. As such, SVIX can be expected to perform very differently from the inverse (-1x) of the performance of the VIX over any period, and UVIX can be expected to perform very differently from twice (2x) of the performance of the VIX over any period. The Funds continuously offer and redeem Shares in blocks of at least 10,000 Shares (each such block, a “Creation Unit”) at current per Share market prices. Only Authorized Participants (as defined herein) may purchase and redeem Shares from a Fund and then only in Creation Units. An Authorized Participant is an entity that has entered into an Authorized Participant Agreement with the Trust and Volatility Shares LLC (the “Sponsor”). Shares are offered on a continuous basis to Authorized Participants in Creation Units at NAV. Authorized Participants may then offer to the public, from time to time, Shares from any Creation Unit they create at a per-Share market price. The form of Authorized Participant Agreement and the related Authorized Participant Procedures Handbook set forth the terms and conditions under which an Authorized Participant may purchase or redeem a Creation Unit. Authorized Participants will not receive from a Fund, the Sponsor, or any of their affiliates, any fee or other compensation in connection with their sale of Shares to the public. An Authorized Participant may receive commissions or fees from investors who purchase Shares through their commission or fee-based brokerage accounts.

 

1

 

 

The Sponsor maintains a website at www.volatilityshares.com, through which monthly account statements and the Trust’s Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended (the “1934 Act”), can be accessed free of charge, as soon as reasonably practicable after such material is electronically file with, or furnished to, the U.S. Securities and Exchange Commission (the “SEC”). Additional information regarding the Trust may also be found on the SEC’s EDGAR database at www.sec.gov.

 

Investment Objectives and Principal Investment Strategies

 

Investment Objectives

 

SVIX

 

SVIX seeks daily investment results, before fees and expenses, that correspond to the performance of the Short Index for a single day. The Fund does not seek to achieve its stated objective over a period greater than a single day. A “single day” is measured from the time the Fund calculates its NAV to the time of the Fund’s next NAV calculation.

 

The Index measures the daily inverse performance of a portfolio of first and second month VIX futures contracts. This theoretical portfolio is rolled each day to maintain a consistent time to maturity of the futures contracts. The Index is calculated daily at 4:00 p.m. (Eastern time) and at a value calculated from the average price for the futures contracts between 3:45 p.m. (Eastern time) and 4:00 p.m. (Eastern time). Through this price averaging process — known as the Time Weighted Average Price (or TWAP). The Short Index inception date was November 22, 2019. Its ticker symbol is: SHORTVOL. 

 

If SVIX is successful in meeting its objective, its value on a given day, before fees and expenses, should gain approximately as much on a percentage basis as the level of the Short Index. Conversely, its value on a given day, before fees and expenses, should lose approximately as much on a percentage basis as the level of the Short Index. Although the Fund seeks to track the performance of the Short Index each day, the Fund may not perfectly track the Short Index’s performance over the same period, which is known as tracking error.

 

UVIX

 

UVIX seeks daily investment results, before fees and expenses, that correspond to twice (2x) the performance of the Long Index for a single day. The Fund does not seek to achieve its stated objective over a period greater than a single day. A “single day” is measured from the time the Fund calculates its NAV to the time of the Fund’s next NAV calculation.

 

The Long Index measures the daily performance of a portfolio of long positions in first and second month VIX futures contracts. This theoretical portfolio is rolled each day to maintain a consistent time to maturity of the futures contracts. The Index is calculated daily at 4:00 p.m. (Eastern time) and at a value calculated from the average price for the futures contracts between 3:45 p.m. (Eastern time) and 4:00 p.m. (Eastern time). Through this price averaging process — known as the Time Weighted Average Price (or TWAP). The Long Index inception date is October 8, 2021. Its ticker symbol is: LONGVOL. If the Fund is successful in meeting its objective, its value on a given day, before fees and expenses, should gain or lose approximately as much on a percentage basis as twice (2x) the level of the Index. Although the Fund seeks to track twice (2x) the performance of the Index each day, the Fund may not perfectly achieve its objective over the same period, which is known as tracking error. For more information, see Correlation Risk on page 10.

 

The Fund is not designed to meet its investment objective over periods longer than one day. Notwithstanding, the table below shows a performance example of the how compounding impacts a 2x daily rebalanced investment referencing an index over periods longer than one day. Areas shaded lighter represent those scenarios where a hypothetical fund that seeks 2x daily returns of an index will return the same or outperform (i.e., return more than) 2x of the index performance; conversely, areas shaded darker represent those scenarios where the hypothetical fund will underperform (i.e., return less than) 2x of the index performance.

 

2

 

 

Principal Investment Strategies

 

In seeking to achieve each Fund’s investment objective, the Commodity Sub-Adviser uses a mathematical approach to investing. Using this approach, the Commodity Sub-Adviser determines the type, quantity and mix of investment positions that it believes, in combination, should produce daily returns consistent with each Fund’s objective.

 

Each Fund intends to meet its investment objective by investing all or substantially all of its assets in positions in first and second month VIX futures contracts, though it may invest in any one of, or combinations of, Financial Instruments (e.g., futures contracts, options contracts and swap transactions), such that a Fund typically has exposure intended to approximate the Index at the time of its NAV calculation. Under normal market conditions, SVIX’s portfolio will comprise short positions, and UVIX’s portfolio will comprise long positions, on first- and second-month VIX futures contracts. The number and type of these contracts will naturally change day-to-day as each Fund takes a daily rolling position in such contracts.

 

In the event that accountability rules, price limits, position limits, margin limits or other exposure limits are reached with respect to VIX futures contracts, the Sponsor may cause a Fund to obtain exposure to the Index through the use of options contracts or swap transactions referencing the VIX futures contracts. Each Fund may also invest in swaps if the market for a specific futures contract experiences emergencies (e.g., natural disaster, terrorist attack or an act of God) or disruptions (e.g., a trading halt or a flash crash) or in situations where the Sponsor deems it impractical or inadvisable to buy or sell futures contracts (such as during periods of market volatility or illiquidity).

 

Each Fund also may hold cash or cash equivalents such as U.S. Treasury securities or other high credit quality, short-term fixed-income or similar securities (such as shares of money market funds) as collateral for Financial Instruments and pending investment in Financial Instruments.

 

Neither Fund is actively managed by traditional methods (e.g., by effecting changes in the composition of a portfolio on the basis of judgments relating to economic, financial and market conditions with a view toward obtaining positive results under all market conditions). Each Fund seeks to remain fully invested at all times in Financial Instruments and money market instruments that, in combination, provide exposure to the Index consistent with its investment objective without regard to market conditions, trends or direction.

 

Each Fund seeks to position its portfolio so that its exposure to its Benchmark is consistent with its investment objective. The time and manner in which the Fund rebalances its portfolio is defined by the Index methodology but may vary from day to day depending upon market conditions and other circumstances, deemed at the discretion of the Commodity Sub-Adviser, beneficial at tracking the Benchmark, or beneficial to the Fund holders.

 

The amount of exposure a Fund has to a specific combination of Financial Instruments may differ and may be changed without shareholder approval at any given time. Currently, SVIX seeks to be, under normal market conditions and absent any unforeseen circumstances, fully exposed to short positions in short-term VIX futures contracts, and UVIX seeks to be, under normal market conditions and absent any unforeseen circumstances, fully exposed to long positions in short-term VIX futures contracts. To the extent that any options or swap transaction entered into by a Fund are believed by the Fund to be “securities” under the Investment Company Act of 1940, the Fund will limit its investments in such transactions so that such investments, in combination, will not exceed 40 percent of the Fund’s assets (other than cash and government securities) and thereby avoid potentially being deemed an unregistered investment company.”

 

The amount of a Fund’s exposure should be expected to change from time to time at the discretion of the Sponsor based on market conditions and other factors.

 

In addition, the Sponsor has the power to change the Fund’s investment objective, Benchmark or investment strategy at any time, without shareholder approval, subject to applicable regulatory requirements.

 

Mitigating Price Impacts to VIX Futures Contract Prices at Times of Fund Rebalancing

 

The Sponsor will seek to minimize the market impact of rebalances across all exchange traded products based on VIX Futures Contracts that it sponsors (the “VIX ETPs”) on the price of VIX futures contracts by limiting VIX ETP participation, on any given day, in VIX futures contracts to no more than ten percent (10%) of the contracts traded on Cboe Futures Exchange, Inc. (“CFE”) during any “Rebalance Period,” defined as any fifteen minute period of continuous market trading. In the event that any VIX ETP (including each Fund) expects to hit the ten percent threshold during the primary Rebalance Period from 3:45 p.m. to 4:00 p.m. (Eastern time), the VIX ETPs would extend participation during periods of market illiquidity, the Sponsor, on any given day, may vary the manner and period over which all funds it sponsors are rebalanced, and as such, the manner and period over which a Fund is rebalanced.

 

3

 

   

The Short Index

 

The Short Index measures the daily inverse performance of a portfolio of first and second month VIX futures contracts. This theoretical portfolio is rolled each day to maintain a consistent time to maturity of the futures contracts.

 

The Short Index is calculated daily at 4:00 p.m. (Eastern time) from the average price of the VIX futures contracts between 3:45 p.m. and 4:00 p.m. (Eastern time).

 

The Short Index has an inception date of November 22, 2019.

 

The Long Index

 

The Long Index measures the daily performance of long positions in a portfolio of first and second month VIX futures contracts. This theoretical portfolio is rolled each day to maintain a consistent time to maturity of the futures contracts.

 

The Long Index is calculated daily at 4:00 p.m. (Eastern time) from the average price of the VIX futures contracts between 3:45 p.m. and 4:00 p.m. (Eastern time).

 

The Long Index has an inception date of October 8, 2021.

 

VIX Futures Contracts

 

Each Index is comprised of VIX futures contracts. VIX futures contracts were first launched for trading by the CBOE in 2004. VIX futures contracts allow investors to invest based on their view of the forward implied market volatility of the S&P 500. Investors that believe the forward implied market volatility of the S&P 500 will increase may buy VIX futures contracts. Conversely, investors that believe that the forward implied market volatility of the S&P 500 will decline may sell VIX futures contracts.

 

While the VIX represents a measure of the current expected volatility of the S&P 500 over the next 30 days, the prices of VIX futures contracts are based on the current expectation of the expected 30-day volatility of the S&P 500 on the expiration date of the futures contract. Since the VIX and VIX futures contracts are two distinctly different measures, the VIX and VIX futures contracts generally behave quite differently.

 

An important consequence of the spot/forward relationship between the VIX and VIX futures contracts (and therefore between the VIX and A Fund) that investors should understand is that the price of a VIX futures contract can be lower, equal to or higher than the VIX, depending on whether the market expects volatility to be lower, equal to or higher in the 30-day forward period covered by the VIX futures contract than in the 30-day spot period covered by the VIX. Therefore the performance of VIX Futures contracts should be expected to be very different than the performance of the VIX as there is no direct relationship between the two measures. As a result, since the performance of a Fund is linked to the performance of the VIX futures contracts included in the Index, a Fund should be expected to perform very differently from the VIX (or -1x or 2x thereof).

  

The VIX

 

The VIX is an index designed to measure the implied volatility of the S&P 500 over 30 days in the future. The VIX is calculated based on the prices of certain put and call options on the S&P 500. The VIX is reflective of the premium paid by investors for certain options linked to the level of the S&P 500.

 

During periods of rising investor uncertainty, including periods of market instability, the implied level of volatility of the S&P 500 typically increases and, consequently, the prices of options linked to the S&P 500 typically increase (assuming all other relevant factors remain constant or have negligible changes). This, in turn, causes the level of the VIX to increase.

 

During periods of declining investor uncertainty, the implied level of volatility of the S&P 500 typically decreases and, consequently, the prices of options linked to the S&P 500 typically decrease (assuming all other relevant factors remain constant or have negligible changes). This, in turn, causes the level of the VIX to decrease.

 

4

 

 

Volatility, and the level of the VIX, can increase (or decrease) without warning. The VIX was developed by the CBOE and is calculated, maintained and published by the CBOE. The CBOE may change the methodology used to determine the VIX and has no obligation to continue to publish, and may discontinue the publication of, the VIX. The VIX is reported by Bloomberg Finance L.P. under the ticker symbol “VIX.”

 

The S&P 500

 

The S&P 500 is an index that measures large-cap U.S. stock market performance. It is a float-adjusted market capitalization weighted index of 500 U.S. operating companies and real estate investment trusts selected by the S&P U.S. Index Committee through a non-mechanical process that factors in criteria such as liquidity, price, market capitalization and financial viability. Reconstitution occurs both on a quarterly and ongoing basis. S&P publishes the S&P 500. The daily calculation of the current value of the S&P 500 is based on the relative value of the aggregate market value of the common stocks of 500 companies as of a particular time compared to the aggregate average initial market value of the common stocks of 500 similar companies at the time of the inception of the S&P 500. The 500 companies are not the 500 largest publicly traded companies and not all 500 companies are listed on the Exchange. S&P chooses companies for inclusion in the S&P 500 with the objective of achieving a distribution by broad industry groupings that approximates the distribution of these groupings in the common stock population of the U.S. equity market. S&P may from time to time, in its sole discretion, add companies to, or delete companies from, the S&P 500 to achieve the objectives stated above. Relevant criteria employed by S&P include the viability of the particular company, the extent to which that company represents the industry group to which it is assigned, the extent to which the company’s common stock is widely held and the market value and trading activity of the common stock of that company.

 

Information about the Index Provider

 

EACH FUND IS NOT SPONSORED, ENDORSED, SOLD OR PROMOTED BY S&P AND ITS AFFILIATES OR CBOE. S&P AND CBOE MAKE NO REPRESENTATION, CONDITION OR WARRANTY, EXPRESS OR IMPLIED, TO THE OWNERS OF A FUND OR ANY MEMBER OF THE PUBLIC REGARDING THE ADVISABILITY OF INVESTING IN SECURITIES GENERALLY OR IN THE FUND PARTICULARLY OR THE ABILITY OF THE INDEX TO TRACK MARKET PERFORMANCE AND/OR OF GROUPS OF ASSETS OR ASSET CLASSES AND/OR TO ACHIEVE ITS STATED OBJECTIVE AND/OR TO FORM THE BASIS OF A SUCCESSFUL INVESTMENT STRATEGY, AS APPLICABLE. S&P’S AND CBOE’S ONLY RELATIONSHIP TO VS TRUST ON BEHALF OF ITS APPLICABLE SERIES AND VOLATILITY SHARES LLC IS THE LICENSING OF CERTAIN TRADEMARKS AND TRADE NAMES AND OF EACH INDEX WHICH ARE DETERMINED, COMPOSED AND CALCULATED BY S&P AND CBOE WITHOUT REGARD TO VS TRUST ON BEHALF OF ITS APPLICABLE SERIES AND VOLATILITY SHARES LLC OR THE FUNDS. S&P AND CBOE HAVE NO OBLIGATION TO TAKE THE NEEDS OF VS TRUST ON BEHALF OF ITS APPLICABLE SERIES AND VOLATILITY SHARES LLC OR THE OWNERS OF THE FUNDS INTO CONSIDERATION IN DETERMINING, COMPOSING OR CALCULATING THE INDEX. S&P AND CBOE ARE NOT ADVISORS TO THE FUNDS AND ARE NOT RESPONSIBLE FOR AND HAVE NOT PARTICIPATED IN THE DETERMINATION OF THE PRICES AND AMOUNT OF THE FUNDS OR THE TIMING OF THE ISSUANCE OR SALE OF A FUND OR IN THE DETERMINATION OR CALCULATION OF THE EQUATION BY WHICH FUND SHARES ARE TO BE CONVERTED INTO CASH. S&P AND CBOE HAVE NO OBLIGATION OR LIABILITY IN CONNECTION WITH THE ADMINISTRATION, MARKETING, OR TRADING OF THE FUNDS.

 

NEITHER S&P, ITS AFFILIATES NOR THIRD PARTY LICENSORS, INCLUDING CBOE, GUARANTEES THE ACCURACY AND/OR THE COMPLETENESS OF AN INDEX OR ANY DATA INCLUDED THEREIN AND S&P, ITS AFFILIATES AND THEIR THIRD PARTY LICENSORS, INCLUDING CBOE, SHALL HAVE NO LIABILITY FOR ANY ERRORS, OMISSIONS, OR INTERRUPTIONS THEREIN. S&P AND CBOE MAKE NO WARRANTY, CONDITION OR REPRESENTATION, EXPRESS OR IMPLIED, AS TO RESULTS TO BE OBTAINED BY VS TRUST ON BEHALF OF ITS APPLICABLE SERIES AND VOLATILITY SHARES LLC, SHAREHOLDERS OF THE FUNDS, OR ANY OTHER PERSON OR ENTITY FROM THE USE OF AN INDEX OR ANY DATA INCLUDED THEREIN. S&P AND CBOE MAKE NO EXPRESS OR IMPLIED WARRANTIES, REPRESENTATIONS OR CONDITIONS, AND EXPRESSLY DISCLAIM ALL WARRANTIES OR CONDITIONS OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE OR USE AND ANY OTHER EXPRESS OR IMPLIED WARRANTY OR CONDITION WITH RESPECT TO THE INDEX OR ANY DATA INCLUDED THEREIN. WITHOUT LIMITING ANY OF THE FOREGOING, IN NO EVENT SHALL S&P, ITS AFFILIATES OR THEIR THIRD PARTY LICENSORS, INCLUDING CBOE, HAVE ANY LIABILITY FOR ANY SPECIAL, PUNITIVE, INDIRECT, OR CONSEQUENTIAL DAMAGES (INCLUDING LOST PROFITS) RESULTING FROM THE USE OF THE INDEX OR ANY DATA INCLUDED THEREIN, EVEN IF NOTIFIED OF THE POSSIBILITY OF SUCH DAMAGES.

 

5

 

 

Information about Financial Instruments and Commodities Markets

 

Futures Contracts

 

A futures contract is a standardized contract traded on, or subject to the rules of, an exchange that calls for the future delivery of a specified quantity and type of a particular underlying asset at a specified time and place or alternatively may call for cash settlement. Futures contracts are traded on a wide variety of underlying assets, including bonds, interest rates, agricultural products, stock indexes, currencies, energy, metals, economic indicators and statistical measures. The notional size and calendar term futures contracts on a particular underlying asset are identical and are not subject to any negotiation, other than with respect to price and the number of contracts traded between the buyer and seller. A Fund generally deposits cash and/or securities with an FCM for its open positions in futures contracts, which may, in turn, transfer such deposits to the clearinghouse to protect the clearing house against non-payment by the Fund. The clearing house becomes substituted for each counterparty to a futures contract, and, in effect, guarantees performance. In addition, the FCM may require a Fund to deposit collateral in excess of the clearing house’s margin requirements for the FCM’s own protection.

 

Certain futures contracts, including stock index contracts, VIX futures contracts and certain commodity futures contracts settle in cash. The cash settlement amount reflects the difference between the contract purchase/sale price and the contract settlement price. The cash settlement mechanism avoids the potential for either side to have to deliver the underlying asset. For other futures contracts, the contractual obligations of a buyer or seller may generally be satisfied by taking or making physical delivery of the underlying asset or by making an offsetting sale or purchase of an identical futures contract on the same or linked exchange before the designated date of delivery. The difference between the price at which the futures contract is purchased or sold and the price paid for the offsetting sale or purchase, after allowance for brokerage commissions and exchange fees, constitutes the profit or loss to the trader.

 

Futures contracts involve, to varying degrees, elements of market risk and exposure to loss in excess of the amounts of variation margin, which are the amounts of cash that a Fund agrees to pay to or receive from FCMs equal to the daily fluctuation in the value of a futures contract. Additional risks associated with the use of futures contracts are imperfect correlation between movements in the price of the futures contracts and the level of the underlying benchmark and the possibility of an illiquid market for a futures contract. With futures contracts, there is minimal but some counterparty risk to a Fund since futures contracts are exchange traded and the exchange’s clearing house, as counterparty to all exchange-traded futures contracts, effectively guarantees futures contracts against default. Many futures exchanges and boards of trade limit the amount of fluctuation permitted in futures contract prices during a single trading day. Once the daily limit has been reached in a particular contract, no trades may be made that day at a price beyond that limit or trading may be suspended for specified times during the trading day. Futures contracts prices could move to the limit for several consecutive trading days with little or no trading, thereby preventing prompt liquidation of futures positions and potentially subjecting a Fund to substantial losses. If trading is not possible or if a Fund determines not to close a futures position in anticipation of adverse price movements, the Fund may be required to make daily cash payments of variation margin.

  

Futures Account Agreements

 

Each Fund has entered into a written agreement (each, a “Futures Account Agreement”) with one or more FCMs governing the terms of futures transactions of a Fund cleared by such FCM. Each FCM has its own agreement and other documentation used for establishing customer relationships. As such, the terms of the Futures Account Agreement and other documentation that a Fund has with a particular FCM may differ in material respects from that with another FCM.

 

Most Futures Account Agreements do not require the FCM to enter into new transactions or maintain existing transactions with a Fund. In general, each FCM is permitted to terminate its agreement with a Fund at any time in its sole discretion. In addition, an FCM generally will have the discretion to set margin requirements and/or position limits that would be in addition to any margin requirements and/or position limits required by applicable law, set by the exchange, or set by the clearing house that clears the futures contracts in which a Fund transacts. As a result, a Fund’s ability to engage in futures transactions or maintain open positions in such contracts will be dependent on the willingness of its FCMs to continue to accept or maintain such transactions on terms that are economically appropriate for a Fund’s investment strategy.

 

When a Fund has an open futures contract position, it is subject to at least daily variation margin calls by an FCM that could be substantial in the event of adverse price movements. Because futures contracts may require only a small initial investment in the form of a deposit or margin, they may involve a high degree of leverage. A Fund with open positions is subject to maintenance or variance margin on its open positions. If a Fund has insufficient cash to meet daily variation margin requirements, it may need to sell Financial Instruments at a time when such sales are disadvantageous. Futures markets are highly volatile and the use of or exposure to futures contracts may increase volatility of a Fund’s NAV.

 

6

 

 

Margin posted by a Fund to an FCM typically will be held by relevant exchange’s clearing house (in the case of clearing house-required margin) or the FCM (in the case of “house” margin requirements of the FCM). In the event that market movements favorable to a Fund result in the Fund having posted more margin than is required, the Fund typically would have a right to return of margin from the FCM. However, the timing of such return may be uncertain. As a result, it is possible that a Fund may face liquidity constraints including potential delays in its ability to pay redemption proceeds, where margin is not immediately returned by an FCM.

 

In the event that a Fund fails to comply with its obligations under a Futures Account Agreement (including, for example, failing to deliver the margin required by an FCM on a timely basis), the Futures Account Agreement typically will provide the FCM with broad discretion to take remedial action against the Fund. Among other things, the FCM typically will have the right, upon the occurrence of such a failure by a Fund, to terminate any or all futures contracts in the Fund’s account with that FCM, to sell the collateral posted as margin by the Fund, to close out any open positions of the Fund in whole or in part, and to cancel any or all pending transactions with the Fund. Futures Account Agreements typically provide that the Fund will remain liable for paying to the relevant FCM, on demand, the amount of any deficiency in a Fund’s account with that FCM.

 

The Futures Account Agreement between the Fund and an FCM generally requires the Fund to indemnify and hold harmless the FCM, its directors, officers, employees, agents and affiliates (collectively, “indemnified persons”) from and against all claims, damages, losses and costs (including reasonable attorneys’ fees) incurred by the indemnified persons, in connection with: (1) any failure by the Fund to perform its obligations under the Futures Account Agreement and the FCM’s exercise of its rights and remedies thereunder; (2) any failure by the Fund to comply with applicable law; (3) any action reasonably taken by the indemnified persons pursuant to the Futures Account Agreement to comply with applicable law; and (4) any actions taken by the FCM in reliance on instructions, notices and other communications that the FCM and its relevant personnel, as applicable, reasonably believes to originate from a person authorized to act on behalf of the Fund.

 

To the extent that the Fund trades in futures contracts on U.S. exchanges, the assets deposited by the Fund with the FCMs (or another eligible financial institution, as applicable) as margin must be segregated pursuant to the regulations of the CFTC. Such segregated funds may be invested only in a limited range of instruments — principally U.S. government obligations to margin futures and forward contract positions.

 

Each Fund currently uses each of the following firms as an FCM: ADM Investor Services, Inc. (“ADMIS”), Advantage Futures LLC (“Advantage”), Marex North America LLC (“Marex”), StoneX Financial Inc. — FCM, Straits Financial LLC, E D& F Man Capital Markets Inc. and RBC Capital Markets, LLC (“RBC Capital”). The FCMs used by a Fund may change from time to time. The above discussion relating to an FCM also would apply to other firms that serve as an FCM to a Fund in the future. Each FCM in its capacity as a registered FCM, serves as a clearing broker to the Trust and a Fund and certain other funds of the Trust and as such arranges for the execution and clearing of a Fund’s futures transactions. Each FCM acts as clearing broker for many other funds and individuals. A variety of executing brokers may execute futures transactions on behalf of the Funds. The executing brokers will give-up all such transactions to an FCM as applicable. Each FCM is registered as an FCM with the CFTC, is a member of the NFA and a clearing member of the CBOT, CME, NYMEX, or another major U.S. commodity exchange. No FCM is affiliated with or acts as a supervisor of the Trust, the Funds, the Sponsor, the Commodity Sub-Adviser, the Trustee, the Administrator, Sub-Administrator, Transfer Agent, or the Custodian. No FCM acts as an underwriter or sponsor of the offering of the Shares, or has passed upon the merits of participating in this offering or has passed upon the adequacy of this Prospectus or on the accuracy of the information contained herein. No FCM provides any commodity trading advice regarding a Fund’s trading activities. Investors should investors should also note that the Sponsor may select additional clearing brokers or replace any FCM as a Fund’s clearing broker.

  

Options

 

An option is a contract that gives the purchaser of the option, in return for the premium paid, the right to buy an underlying reference instrument, such as a specified security, currency, index, or other instrument, from the writer of the option (in the case of a call option), or to sell a specified reference instrument to the writer of the option (in the case of a put option) at a designated price during the term of the option. The premium paid by the buyer of an option will reflect, among other things, the relationship of the exercise price to the market price and the volatility of the underlying reference instrument, the remaining term of the option, supply, demand, interest rates and/or currency exchange rates. An American style put or call option may be exercised at any time during the option period while a European style put or call option may be exercised only upon expiration or during a fixed period prior thereto. Put and call options are traded on national securities exchanges and in the OTC market. Options traded on national securities exchanges are within the jurisdiction of the SEC or other appropriate national securities regulator, as are securities traded on such exchanges. As a result, many of the protections provided to traders on organized exchanges will be available with respect to such transactions. In particular, all option positions entered into on a national securities exchange in the United States are cleared and guaranteed by the Options Clearing Corporation, thereby reducing the risk of counterparty default. Furthermore, a liquid secondary market in options traded on a national securities exchange may be more readily available than in the OTC market, potentially permitting a Fund to liquidate open positions at a profit prior to exercise or expiration, or to limit losses in the event of adverse market movements. There is no assurance, however, that higher than anticipated trading activity or other unforeseen events might not temporarily render the capabilities of the Options Clearing Corporation inadequate, and thereby result in the exchange instituting special procedures which may interfere with the timely execution of a Fund’s orders to close out open options positions.

 

7

 

 

Swap Agreements

 

Swaps are contracts that have traditionally been entered into primarily by institutional investors in OTC markets for a specified period ranging from a day to many years. Certain types of swaps may be cleared, and certain types are, in fact, required to be cleared. The types of swaps that may be cleared are generally limited to only swaps where the most liquidity exists and a clearing organization is willing to clear the trade on standardized terms. Swaps with customized terms or those for which significant market liquidity does not exist are generally not able to be cleared.

 

In a standard swap transaction, the parties agree to exchange the returns on, among other things, a particular predetermined security, commodity, interest rate, or index for a fixed or floating rate of return (the “interest rate leg,” which will also include the cost of borrowing for short swaps) in respect of a predetermined notional amount. The notional amount of the swap reflects the extent of a Fund’s total investment exposure under the swap.

 

In the case of futures contracts-based indexes, such as those used by a Fund, the reference interest rate typically is zero, although a financing spread or fee is generally still applied. Transaction or commission costs are reflected in the benchmark level at which the transaction is entered into. The gross returns to be exchanged are calculated with respect to the notional amount and the benchmark returns to which the swap is linked. Swaps are usually closed out on a net basis, i.e., the two payment streams are netted out in a cash settlement on the payment date specified in the agreement, with the parties receiving or paying, as the case may be, only the net amount of the two payments. Thus, while the notional amount reflects a Fund’s total investment exposure under the swap (i.e., the entire face amount or principal of a swap), the net amount is the Fund’s current obligations (or rights) under the swap. That is the amount to be paid or received under the agreement based on the relative values of the positions held by each party to the agreement on any given termination date.

 

Swaps may also expose a Fund to liquidity risk. Although a Fund may have the ability to terminate a swap at any time, doing so may subject the Fund to certain early termination charges. In addition, there may not be a liquid market within which to dispose of an outstanding swap even if a permitted disposal might avoid an early termination charge. Uncleared swaps generally are not assignable except by agreement between the parties to the swap, and generally no party or purchaser has any obligation to permit such assignments.

 

Swaps involve, to varying degrees, elements of market risk and exposure to loss in excess of the amount which would be reflected on a Fund’s Statement of Financial Condition. In addition to market risk and other risks, the use of swaps also comes with counterparty credit risk — i.e., the inability of a counterparty to a swap to perform its obligations. A Fund that invests in swaps bears the risk of loss of the net amount, if any, expected to be received under a swap agreement in the event of the default or bankruptcy of a swap counterparty. A Fund enters or intends to enter into swaps only with major, global financial institutions. However, there are no limitations on the percentage of its assets a Fund may invest in swaps with a particular counterparty.

 

A Fund that invests in swaps may use various techniques to minimize counterparty credit risk. A Fund that invests in swaps generally enters into arrangements with its counterparties whereby both sides exchange collateral on a mark-to-market basis. In addition, the Fund may post “initial margin” or “independent amount” to counterparties in swaps. Such collateral serves as protection for the counterparty in the event of a failure by the Fund and is in addition to any mark-to-market collateral that (i.e., the Fund may post initial margin to the counterparty even where the counterparty would owe money to the Fund if the swap were to be terminated). The amount of initial margin posted by the Fund may vary depending on the risk profile of the swap. The collateral, whether for mark-to-market or for initial margin, generally consists of cash and/or securities.

 

Collateral posted by a Fund to a counterparty in connection with uncleared derivatives transactions is generally held for the benefit of the counterparty in a segregated tri-party account at a third-party custodian to protect the counterparty against non-payment by the Fund. In the event of a default by a Fund where the counterparty is owed money in the uncleared swap transaction, such counterparty will seek withdrawal of this collateral from the segregated account.

 

8

 

 

Collateral posted by the counterparty to a Fund is typically held for the benefit of the Fund in a segregated tri-party account at a third-party custodian. In the event of a default by the counterparty where the Fund is owed money in the uncleared swap transaction, the Fund will seek withdrawal of this collateral from the segregated account. The Fund may incur certain costs exercising its right with respect to the collateral.

 

Notwithstanding the use of collateral arrangements, to the extent any collateral provided to a Fund is insufficient or there are delays in accessing the collateral, a Fund will be exposed to counterparty risk as described above, including possible delays in recovering amounts as a result of bankruptcy proceedings.

 

Money Market Instruments

 

Money market instruments are short-term debt instruments that have a remaining maturity of 397 days or less and exhibit high quality credit profiles. Money market instruments may include U.S. government securities, securities issued by governments of other developed countries and repurchase agreements.

 

U.S. Derivatives Exchanges

 

Derivatives exchanges, including swap execution facilities that are required under the Dodd-Frank Act, provide centralized market facilities for trading derivatives in which multiple persons have the ability to execute or trade contracts by accepting bids and offers from multiple participants. Members of, and trades executed on, a particular exchange are subject to the rules of that exchange. Among the principal exchanges in the United States are the CBOE (which includes the CBOE Futures Exchange (the “CFE”)), the Chicago Mercantile Exchange (“CME”) (which includes, among others, the Chicago Board of Trade (“CBOT”) and the New York Mercantile Exchange (the “NYMEX”) and the Intercontinental Exchange (“ICE”)).

 

Each derivatives exchange in the United States has an associated “clearing house.” Clearing houses provide services designed to transfer credit risk and ensure the integrity of trades. Once trades between members of an exchange have been confirmed and/or cleared, the clearing house becomes substituted for each buyer and each seller of contracts traded on the exchange and, in effect, becomes the other party to each trader’s open position in the market. Thereafter, each party to a trade looks only to the clearing house for performance. The clearing house generally establishes some sort of security or guarantee fund to which all clearing members of the exchange must contribute. This fund acts as an emergency buffer which is intended to enable the clearing house to meet its obligations with regard to the other side of an insolvent clearing member’s contracts. Furthermore, clearing houses require margin deposits and continuously mark positions to market to provide some assurance that their members will be able to fulfil their contractual obligations. Thus, members effecting derivatives transactions on an organized exchange or clearing an OTC derivatives transaction through a clearing house do not bear the risk of the insolvency of the party on the opposite side of the trade; their credit risk is limited to the respective solvencies of their commodity broker and the clearing house. The clearing house “guarantee” of performance on open positions does not run to customers. If a member firm goes bankrupt, customers could lose money.

 

If a Fund decides to execute derivatives transactions through such derivatives exchanges — and especially if it decides to become a direct member of one or more exchanges or swap execution facilities — the Fund would be subject to the rules of the exchange or swap executive facility, which would bring additional risks and liabilities, and potential additional regulatory requirements.

 

Regulations

 

Derivatives exchanges in the United States are subject to regulation under the CEA, by the CFTC, the governmental agency having responsibility for regulation of derivatives exchanges and trading on those exchanges. Following the adoption of the Dodd-Frank Act, the CFTC also has authority to regulate OTC derivatives markets, including certain OTC foreign exchange markets.

 

9

 

 

The CFTC has exclusive authority to designate exchanges for the trading of specific futures contracts and to prescribe rules and regulations of the marketing of each. The CFTC also regulates the activities of “commodity pool operators” and the CFTC has adopted regulations with respect to certain of such persons’ activities. Pursuant to its authority, the CFTC requires a commodity pool operator, such as the Sponsor, to keep accurate, current and orderly records with respect to each pool it operates. The CFTC may suspend, modify or terminate the registration of any registrant for failure to comply with CFTC rules or regulations. Suspension, restriction or termination of the Sponsor’s registration as a commodity pool operator would prevent it, until such time (if any) as such registration were to be reinstated, from managing, and might result in the termination of the Fund. If the Sponsor were unable to provide services and/or advice to the Fund, the Fund would be unable to pursue its investment objective unless and until the Sponsor’s ability to provide services and advice to the Fund was reinstated or a replacement for the Sponsor as commodity pool operator could be found. Such an event could result in termination of the Fund.

 

The CEA requires all FCMs to meet and maintain specified fitness and financial requirements, segregate customer funds from proprietary funds and account separately for all customers’ funds and positions, and to maintain specified books and records open to inspection by the staff of the CFTC.

 

The CEA also gives the states certain powers to enforce its provisions and the regulations of the CFTC.

 

Under certain circumstances, the CEA grants shareholders the right to institute a reparations proceeding before the CFTC against the Sponsor (as a registered commodity pool operator), an FCM, as well as those of their respective employees who are required to be registered under the CEA. Shareholders may also be able to maintain a private right of action for certain violations of the CEA.

 

Pursuant to authority in the CEA, the NFA has been formed and registered with the CFTC as a registered futures association. At the present time, the NFA is the only self-regulatory organization for commodities professionals other than exchanges. As such, the NFA promulgates rules governing the conduct of commodity professionals and disciplines those professionals that do not comply with such standards. The CFTC has delegated to the NFA responsibility for the registration of commodity pool operators, FCMs, swap dealers, commodity trading advisors, introducing brokers and their respective associated persons and floor brokers. The Sponsor is a member of the NFA (each Fund itself is not required to become members of the NFA). As an NFA member, the Sponsor is subject to NFA standards relating to fair trade practices, financial condition, and consumer protection.

 

The CEA and CFTC regulations prohibit market abuse and generally require that all futures exchange-based trading be conducted in compliance with rules designed to ensure the integrity of market prices and without any intent to manipulate prices. CFTC regulations and futures exchange rules also impose limits on the size of the positions that a person may hold or control as well as standards for aggregating certain positions. The rules of the CFTC and the futures exchanges also authorize special emergency actions to halt, suspend or limit trading overall or to restrict, halt, suspend or limit the trading of an individual trader or to otherwise impose special reporting or margin requirements.

 

Each Fund’s investments in Financial Instruments will be subject to regulation under the CEA and traded pursuant to CFTC and applicable exchange regulations.

 

Daily Limits

 

Most U.S. futures exchanges (but generally not foreign exchanges or banks or dealers in the cases of swap agreements) limit the amount of fluctuation in some futures contract or options contract prices during a single day by regulations. These regulations specify what are referred to as “daily price fluctuation limits” or more commonly “daily limits.” Once the daily limit has been reached in a particular futures contract, no trades may be made at a price beyond that limit. Currently, CBOE limits daily VIX futures contracts to no more than 50,000 per entity.

 

10

 

 

Margin

 

“Initial” or “original” margin is the minimum dollar amount that a counterparty to a cleared derivatives contract must deposit with its commodity broker in order to establish an open position. “Maintenance” or “variation” margin is the amount (generally less than initial margin) to which a trader’s account may decline before he must deliver additional margin so as to maintain open positions. A margin deposit is like a cash performance bond. It helps assure the futures trader’s performance of the futures contracts he purchases or sells.

 

The minimum amount of margin required in connection with a particular futures contract is set by the exchange on which such contract is traded and is subject to change at any time during the term of the contract. Futures contracts are customarily bought and sold on margins that represent a percentage of the aggregate purchase or sales price of the contract.

 

Brokerage firms may require higher amounts of margin than exchange minimums. These requirements may change without warning.

 

Margin requirements are computed each day or intraday by a commodity broker and the relevant exchange. At the close of each trading day or intraday, each open futures contract is marked to market, that is, the gain or loss on the position is calculated from the prior day’s close. When the market value of a particular open futures contract position changes to a point where the margin on deposit does not satisfy maintenance margin requirements, a margin call is made by the commodity broker. If the margin call is not met within a reasonable time, the broker may close out the customer’s position.

 

Creation and Redemption of Shares

 

Each Fund creates and redeems Shares from time to time, but only in one or more Creation Units. A Creation Unit is a block of at least 10,000 Shares. Except when aggregated in Creation Units, the Shares are not redeemable securities.

 

The manner by which Creation Units are purchased and redeemed is governed by the terms of the Authorized Participant Agreement and Authorized Participant Procedures Handbook, and all such procedures are at the discretion of the Sponsor. By placing a purchase order, an Authorized Participant agrees to deposit cash or Financial Instruments with the Custodian of a Fund (unless as provided otherwise by this Prospectus). Purchases and redemptions made by Authorized Participants primarily in cash rather than through in-kind delivery of Financial Instruments, if not offset by a transaction fee (as described below), may cause a Fund to incur certain costs, including brokerage costs or taxable capital gains or losses, that may decrease the Fund’s net asset value.

 

If permitted by the Sponsor in its sole discretion with respect to a Fund, an Authorized Participant may also agree to enter into or arrange for an exchange of a futures contract for related position (“EFCRP”) or block trade with the Fund whereby the Authorized Participant would also transfer to the Fund a number and type of exchange-traded futures contracts at or near the closing settlement price for such contracts on the purchase order date. Similarly, the Sponsor in its sole discretion may agree with an Authorized Participant to use an EFCRP to effect an order to redeem Creation Units.

 

An EFCRP is a technique permitted by the rules of certain futures exchanges that, as utilized by a Fund in the Sponsor’s discretion, would allow the Fund to take a position in a futures contract from an Authorized Participant, or give futures contracts to an Authorized Participant, in the case of a redemption, rather than to enter the futures exchange markets to obtain such a position. An EFCRP by itself will not change either party’s net risk position materially. Because the futures position that a Fund would otherwise need to take in order to meet its investment objective can be obtained without unnecessarily impacting the financial or futures markets or their pricing, EFCRPs can generally be viewed as transactions beneficial to the Fund. A block trade is a technique that permits a Fund to obtain a futures position without going through the market auction system and can generally be viewed as a transaction beneficial to the Fund.

 

Authorized Participants pay a fixed transaction fee of up to $500 in connection with each order to create or redeem a Creation Unit in order to compensate the Administrator, Sub-Administrator, the Custodian and the Transfer Agent of a Fund and its Shares, for services in processing the creation and redemption of Creation Units and to offset the costs of increasing or decreasing derivative positions. Authorized Participants also may pay a variable transaction fee to the Fund of up to 0.20% of the value of the Creation Unit that is purchased or redeemed unless the transaction fee is waived or otherwise adjusted by the Sponsor. The Sponsor provides such Authorized Participant with prompt notice in advance of any such waiver or adjustment of the transaction fee. The Sponsor may waive a fixed or variable transaction fee for any number of reasons, including to maintain similar costs structures as competitive investment vehicles. Authorized Participants may sell the Shares included in the Creation Units they purchase from a Fund to other investors.

 

11

 

 

The form of Authorized Participant Agreement and the related Authorized Participant Procedures Handbook set forth the procedures for the creation and redemption of Creation Units and for the payment of cash or Financial Instruments required for such creations and redemptions. The Sponsor may delegate its duties and obligations under the form of Authorized Participant Agreement to the Administrator, Sub-Administrator, the Custodian and the Transfer Agent without consent from any shareholder or Authorized Participant. The form of Authorized Participant Agreement, the related procedures attached thereto and the Authorized Participant Procedures Handbook may be amended by the Sponsor without the consent of any shareholder or Authorized Participant. Authorized Participants who purchase Creation Units from a Fund receive no fees, commissions or other form of compensation or inducement of any kind from either the Sponsor or the Fund, and no such person has any obligation or responsibility to the Sponsor or the Fund to effect any sale or resale of Shares.

 

Each Authorized Participant must be registered as a broker-dealer under the 1934 Act and regulated by the Financial Industry Regulatory Authority, Inc. (“FINRA”), or exempt from being, or otherwise not required to be, so regulated or registered, and must be qualified to act as a broker or dealer in the states or other jurisdictions where the nature of its business so requires. Certain Authorized Participants may be regulated under federal and state banking laws and regulations. Each Authorized Participant must have its own set of rules and procedures, internal controls and information barriers as it determines is appropriate in light of its own regulatory regime.

 

Authorized Participants may act for their own accounts or as agents for broker-dealers, custodians and other securities market participants that wish to create or redeem Creation Units.

 

Persons interested in purchasing Creation Units should contact the Sponsor or the Administrator to obtain the contact information for the Authorized Participants. Shareholders who are not Authorized Participants are only able to redeem their Shares through an Authorized Participant.

 

Pursuant to the Authorized Participant Agreement, the Sponsor agreed to indemnify the Authorized Participants against certain liabilities, including liabilities under the 1933 Act, and to contribute to the payments the Authorized Participants may be required to make in respect of those liabilities.

 

The following description of the procedures for the creation and redemption of Creation Units is only a summary and an investor should refer to the relevant provisions of the Trust Agreement and the form of Authorized Participant Agreement for more detail. The Trust Agreement and the form of Authorized Participant Agreement are filed as exhibits to the Registration Statement of which this Prospectus is a part.

 

Creation Procedures

 

On any Business Day, an Authorized Participant may place an order with the Marketing Agent to create one or more Creation Units.

 

Purchase orders must be placed by 2:00 p.m. (Eastern time). The cut-off time may be earlier if, for example, the Exchange or other exchange material to the valuation or operation of the Fund closes before the cut-off time. If a purchase order is received prior to the applicable cut-off time, the day on which the Marketing Agent receives a valid purchase order is the purchase order date. If the purchase order is received after the applicable cut-off time, the purchase order date will be the next Business Day. Purchase orders are irrevocable. By placing a purchase order, and prior to delivery of such Creation Units, an Authorized Participant’s DTC account will be charged the non-refundable transaction fee due for the purchase order.

 

12

 

 

Determination of Required Payment

 

The total payment required to create each Creation Unit is the value of the Creation Unit on the purchase order date plus the applicable transaction fees.

 

Delivery of Cash

 

Cash required for settlement will typically be transferred to the Custodian through: (1) the Continuous Net Settlement (the “CNS”) clearing process of NSCC, as such processes have been enhanced to effect creations and redemptions of Creation Units; or (2) the facilities of DTC on a Delivery Versus Payment (“DVP”) basis, which is the procedure in which the buyer’s payment for securities is due at the time of delivery. Security delivery and payment are simultaneous. If the Custodian does not receive the cash by the market close on the first Business Day following the purchase order date (“T+1”), such order may be charged interest for delayed settlement or cancelled. The Sponsor reserves the right to extend the deadline for the Custodian to receive the cash required for settlement up to the second Business Day following the purchase order date (“T+2”). In the event a purchase order is cancelled, the Authorized Participant will be responsible for reimbursing a Fund for all costs associated with cancelling the order including costs for repositioning the portfolio. At its sole discretion, the Sponsor may agree to a delivery date other than T+2. Additional fees may apply for special settlement. The Creation Unit will be delivered to the Authorized Participant upon the Custodian’s receipt of the purchase amount.

 

Delivery of Exchange of Futures Contract for Related Position (“EFCRP”) Futures Contracts or Block Trades

 

In the event that the Sponsor shall have determined to permit the Authorized Participant to transfer futures contracts pursuant to an EFCRP or to engage in a block trade purchase of futures contracts from the Authorized Participant with respect to a Fund, as well as to deliver cash, in the creation process, futures contracts required for settlement must be transferred directly to the Fund’s account at its FCM. If the cash is not received by the market close on the second Business Day following the purchase order date (T+2); such order may be charged interest for delayed settlements or cancelled. In the event a purchase order is cancelled, the Authorized Participant will be responsible for reimbursing a Fund for all costs associated with cancelling the order including costs for repositioning the portfolio. At its sole discretion, the Sponsor may agree to a delivery date other than T+2. The Creation Unit will be delivered to the Authorized Participant upon the Custodian’s receipt of the cash purchase amount and the futures contracts.

 

Suspension or Rejection of Purchase Orders

 

The Sponsor may, in its discretion, suspend the right to purchase, or postpone the purchase settlement date: (1) for any period during which any of the Exchange, CBOE, CFE, CME (including CBOT and NYMEX) or ICE or other exchange material to the valuation or operation of a Fund is closed or when trading is suspended or restricted on such exchanges in any of the underlying VIX futures contracts; (2) for any period during which an emergency exists as a result of which the fulfilment of a purchase order is not reasonably practicable; or (3) for such other period as the Sponsor determines to be necessary for the protection of the shareholders. The Sponsor will not be liable to any person or in any way for any loss or damages that may result from any such suspension or postponement.

 

The Sponsor also may reject a purchase order if:

 

It determines that the purchase order is not in proper form;

 

The Sponsor believes that the purchase order would have adverse tax consequences to the Fund or its shareholders;

 

The order would be illegal; or

 

Circumstances outside the control of the Sponsor make it, for all practical purposes, not feasible to process creations of Creation Units.

 

None of the Sponsor, the Administrator, Sub-Administrator or the Custodian will be liable for the suspension or rejection of any purchase order.

 

Redemption Procedures

 

The procedures by which an Authorized Participant can redeem one or more Creation Units mirror the procedures for the creation of Creation Units. On any Business Day, an Authorized Participant may place an order with the Marketing Agent to redeem one or more Creation Units. Redemption orders must be received prior to 2:00 p.m. (Eastern time), or earlier if, for example, the Exchange or other exchange material to the valuation or operation of a Fund closes before the cut-off time. If a redemption order is received prior to the applicable cut-off time, the day on which the Marketing Agent receives a valid redemption order is the redemption order date. If the redemption order is received after the applicable cut-off time, the redemption order date will be the next day. Redemption orders are irrevocable. Individual shareholders may not redeem directly from the Fund.

 

13

 

 

By placing a redemption order, an Authorized Participant agrees to deliver the Creation Units to be redeemed through DTC’s book-entry system to the applicable Fund not later than noon (Eastern Time), on the first Business Day immediately following the redemption order date (T+1). The Sponsor reserves the right to extend the deadline for a Fund to receive the Creation Units required for settlement up to the second Business Day following the redemption order date (T+2). By placing a redemption order, and prior to receipt of the redemption proceeds, an Authorized Participant must wire to the Custodian the non-refundable transaction fee due for the redemption order or any proceeds due will be reduced by the amount of the fee payable. At its sole discretion, the Sponsor may agree to a delivery date other than T+2. Additional fees may apply for special settlement.

 

Upon request of an Authorized Participant made at the time of a redemption order, the Sponsor at its sole discretion may determine, in addition to delivering redemption proceeds, to transfer futures contracts to the Authorized Participant pursuant to an EFCRP or to a block trade sale of futures contracts to the Authorized Participant.

 

Determination of Redemption Proceeds

 

The redemption proceeds from a Fund consist of the cash redemption amount and, if permitted by the Sponsor in its sole discretion with respect to the Fund, an EFCRP or block trade with the Fund as described in “— Creation and Redemption of Shares” above. The cash redemption amount is equal to the NAV of the number of Creation Unit(s) of a Fund requested in the Authorized Participant’s redemption order as of the time of the calculation of the Fund’s NAV on the redemption order date, less transaction fees and any amounts attributable to any applicable EFCRP or block trade.

 

Delivery of Redemption Proceeds

 

The redemption proceeds due from a Fund are delivered to the Authorized Participant at noon (Eastern Time), on the second Business Day immediately following the redemption order date if, by such time on such Business Day immediately following the redemption order date, the Fund’s DTC account has been credited with the Creation Units to be redeemed. A Fund should be credited through: (1) the CNS clearing process of NSCC, as such processes have been enhanced to effect creations and redemptions of Creation Units; or (2) the facilities of DTC on a DVP basis. If a Fund’s DTC account has not been credited with all of the Creation Units to be redeemed by such time, the redemption distribution is delivered to the extent whole Creation Units are received. Any remainder of the redemption distribution is delivered on the next Business Day to the extent any remaining whole Creation Units are received if: (1) the Sponsor receives the fee applicable to the extension of the redemption distribution date which the Sponsor may, from time to time, determine, and (2) the remaining Creation Units to be redeemed are credited to a Fund’s DTC account by noon (Eastern Time), on such next Business Day. Any further outstanding amount of the redemption order may be cancelled. The Authorized Participant will be responsible for reimbursing a Fund for all costs associated with cancelling the order including costs for repositioning the portfolio.

 

The Sponsor is also authorized to deliver the redemption distribution notwithstanding that the Creation Units to be redeemed are not credited to a Fund’s DTC account by noon (Eastern Time), on the second Business Day immediately following the redemption order date if the Authorized Participant has collateralized its obligation to deliver the Creation Units through DTC’s book-entry system on such terms as the Sponsor may determine from time to time.

 

In the event that the Authorized Participant shall have requested, and the Sponsor shall have determined to permit the Authorized Participant to receive futures contracts pursuant to an EFCRP, as well as the cash redemption proceeds, in the redemption process, futures contracts required for settlement shall be transferred directly from a Fund’s account at its FCM to the account of the Authorized Participant at its FCM.

 

Suspension or Rejection of Redemption Orders

 

The Sponsor may, in its discretion, suspend the right of redemption, or postpone the redemption settlement date, (1) for any period during which any of the Exchange, CBOE, CFE, CME (including CBOT and NYMEX) or ICE or other exchange material to the valuation or operation of a Fund is closed or when trading is suspended or restricted on such exchanges in any of the underlying VIX futures contracts; (2) for any period during which an emergency exists as a result of which the redemption distribution is not reasonably practicable; or (3) for such other period as the Sponsor determines to be necessary for the protection of the shareholders. The Sponsor will not be liable to any person or in any way for any loss or damages that may result from any such suspension or postponement.

 

14

 

 

The Sponsor will reject a redemption order if the order is not in proper form as described in the form of Authorized Participant Agreement or if the fulfilment of the order might be unlawful.

 

Creation and Redemption Transaction Fee

 

To compensate Foreside Fund Services, LLC for services in processing the creation and redemption of Creation Units and to offset some or all of the transaction costs, an Authorized Participant may be required to pay a fixed transaction fee to Foreside Fund Services, LLC of up to $500 per order to create or redeem Creation Units and may pay a variable transaction fee to a Fund of up to 0.20% of the value of a Creation Unit. An order may include multiple Creation Units. The transaction fee(s) may be reduced, increased or otherwise changed by the Sponsor at its sole discretion.

 

Special Settlement

 

The Sponsor may allow for early settlement of purchase or redemption orders. Such arrangements may result in additional charges to the Authorized Participant.

 

Net Asset Value

 

The net asset value (“NAV”) in respect of a Fund means the total assets of the Fund including, but not limited to, all cash and cash equivalents or other debt securities less total liabilities of the Fund, consistently applied under the accrual method of accounting. In particular, the NAV includes any unrealized profit or loss on open futures contracts (and Financial Instruments, if any), and any other credit or debit accruing to the Fund but unpaid or not received by the Fund. The NAV per Share of a Fund is computed by dividing the value of the net assets of the Fund (i.e., the value of its total assets less total liabilities) by its total number of Shares outstanding. Expenses and fees are accrued daily and taken into account for purposes of determining the NAV. Each Fund’s NAV is calculated on each day other than a day when the Exchange is closed for regular trading. Each Fund computes its NAV only once each Business Day as of 4:00 p.m. (Eastern Time) (the “NAV Calculation Time”), or an earlier time as set forth on www.volatilityshares.com. For example, a Fund may calculate its NAV as of an earlier time if the Exchange or other exchange material to the valuation or operation of the Fund closes early. The Funds’ website at www.volatilityshares.com will display the end of day closing Index level, and NAV per Share for the Fund. The Fund will provide daily website disclosure, prior to market opening, of the Funds’ portfolio holdings. This website disclosure of the portfolio composition of the Fund will occur at the same time as the disclosure by the Fund of the portfolio composition to Authorized Participants so that all market participants are provided portfolio composition information at the same time.

 

In calculating the NAV of a Fund, the VIX futures contracts are valued using the Time Weighted Average Price (TWAP) of the futures during the last 15 minutes of NYSE’s regular trading session, rather than solely from the VIX futures’ settlement price. The value of a Fund’s non-exchange-traded Financial Instruments typically is determined by applying the then-current disseminated levels for the Index to the terms of the Fund’s non-exchange-traded Financial Instruments.

 

In certain circumstances (e.g., if the Sponsor believes market quotations do not accurately reflect the fair value of a Fund’s investment, or a trading halt closes an exchange or market early), the Sponsor may, in its sole discretion, choose to determine a fair value price as the basis for determining the market value of such investment for such day. Such fair value prices would generally be determined based on available inputs about the current value of the underlying VIX futures contract and would be based on principles that the Sponsor deems fair and equitable.

 

The Funds may use a variety of money market instruments. Money market instruments generally will be valued using market prices or at amortized cost.

 

Indicative Optimized Portfolio Value (“IOPV”)

 

The IOPV, which is also known as the intraday indicative value or IIV, is an indicator of the value of a Fund’s net assets at the time the IOPV is disseminated. The IOPV is calculated and disseminated every 15 seconds during a normal Business Day. A Business Day is defined as a day the United States equity markets are open for trading on the NYSE. The IOPV may cease calculating at an earlier time if the Exchange or other information material to the valuation or operation of a Fund closes early. The IOPV is generally calculated using the prior day’s closing net assets of a Fund as a base and updating throughout the Business Day changes in the value of the Financial Instruments held by the Fund. The IOPV should not be viewed as an actual real time update of the NAV because NAV is calculated only once at the end of each Business Day. The IOPV also should not be viewed as a precise value of the Shares. Because the market price per Share may differ from the IOPV, the price at which an investor may be able to sell Shares at any time, and especially in times of market volatility, may be significantly less than the IOPV at the time of sale. Neither a Fund nor the Sponsor is liable for any errors in the calculation of the IOPV or any failure to disseminate IOPV.

 

15

 

 

The Exchange disseminates the IOPV. In addition, the IOPV is published on the Exchange’s website and is available through on-line information services such as Bloomberg Finance L.P. and/or Reuters.

 

Fees and Expenses

 

Management Fee

 

SVIX pays the Sponsor a management fee (the “Management Fee”), monthly in arrears, in an amount equal to 1.35% per annum of its average daily net assets. UVIX pays the Sponsor a Management Fee, monthly in arrears, in an amount equal to 1.65% per annum of its average daily net assets. “Average daily net assets” is calculated by dividing the month-end net assets of each Fund by the number of calendar days in such month.

 

No other Management Fee is paid by the Funds. The Management Fee is paid in consideration of the Sponsor’s trading advisory services and the other services provided to the Fund that the Sponsor pays directly.

 

Licensing and Index Calculation Fee

 

Each Fund pays CBOE a fee to calculate and maintain the Index. Each Fund pays S&P a fee for the futures data that is based on the VIX and the use of third party licensor trademarks.

 

Recurring and Non-Recurring Fees and Expenses

 

Each Fund pays all of its fees and expenses, including recurring, non-recurring, routine and unusual fees and expenses.

 

Selling Commission

 

Retail investors may purchase and sell Shares through traditional brokerage accounts. Investors are expected to be charged a customary commission by their brokers in connection with purchases of Shares that will vary from investor to investor. Investors are encouraged to review the terms of their brokerage accounts for applicable charges. The price at which an Authorized Participant sells a Share may be higher or lower than the price paid by such Authorized Participant in connection with the creation of such Share in a Creation Unit.

 

Brokerage Commissions and Fees

 

Each Fund pays all of its respective brokerage commissions, including applicable exchange fees, NFA fees and give-up fees, pit brokerage fees and other transaction related fees and expenses charged in connection with trading activities for the Fund’s investments in CFTC regulated investments. On average, total charges paid to FCMs are expected to be less than $7.00 per round-turn trade, although brokerage commissions and trading fees are determined on a contract-by-contract basis. Each Fund bears other transaction costs including the effects of trading spreads and financing costs/fees, if any, associated with the use of Financial Instruments, and costs relating to the purchase of U.S. Treasury securities or similar high credit quality short-term fixed-income or similar securities (such as shares of money market funds).

 

Employees

 

The Trust has no employees.

 

Item 1A. Risk Factors.

 

As a smaller reporting company, the Trust is not required to provide the information required by this item.

 

Item 1B. Unresolved Staff Comments.

 

None.

 

Item 2. Properties.

 

Not applicable.

 

Item 3. Legal Proceedings.

 

None

 

Item 4. Mine Safety Disclosures.

 

Not applicable.

 

16

 

  

Part II.

 

Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.

 

a)The Shares of each Fund that has commenced investment operations are listed in the accompanying table. The dates the Shares of each Fund began trading, their symbols and their primary listing exchange are indicated below:

 

Fund  Commencement of Operations  Ticker Symbol  Name of each exchange on which registered
-1x Short VIX Futures ETF  28-Mar-22  SVIX  Cboe BZX Exchange
2x Long VIX Futures ETF  28-Mar-22  UVIX  Cboe BZX Exchange

 

The approximate number of holders of the Shares of each Fund as of December 31, 2022 was as follows:

 

Fund  Number of Holders 
-1x Short VIX Futures ETF   3,170,000 
2x Long VIX Futures ETF   21,450,000 
Combined Trust:   24,620,000 

 

The Funds made no distributions to Shareholders during the fiscal year ended December 31, 2022. The Funds have no obligation to make periodic distributions to Shareholders.

 

b)Not applicable.

 

Title of Securities Registered 

Amount Registered as of December 31,
2022

  Shares Sold For the Three
Months Ended December 31, 2022
   Sale Price of Shares Sold For the Three
Months Ended December 31, 2022
   Shares Sold For the Year
Ended December 31, 2022
   Sale Price of Shares Sold For the Year Ended December 31, 2022 
-1x Short VIX Futures ETF                       
Common Units of Beneficial Interest  An indeterminant amount of securities   1,720,000   $20,649,395    16,980,000   $189,786,132 
2x Long VIX Futures ETF                       
Common Units of Beneficial Interest  An indeterminant amount of securities   17,830,000    146,749,592    36,390,000    399,696,269 

 

c)From October 1, 2022 through December 31, 2022, the number of Shares redeemed and average price per Share for each Fund were as follows:

 

Fund  Total Number of Shares
Redeemed
   Average Price
Per Share
 
-1x Short VIX Futures ETF        
10/01/22 to 10/31/22   (1,700,000)  $11.48 
11/01/22 to 11/30/22   (1,280,000)   12.66 
12/01/22 to 12/31/22   (950,000)   14.47 
2x Long VIX Futures ETF          
10/01/22 to 10/31/22   (1,790,000)   13.01 
11/01/22 to 11/30/22   (250,000)   8.82 
12/01/22 to 12/31/22   (1,100,000)   6.51 

 

Item 6. [Reserved].

 

Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

 

This information should be read in conjunction with the financial statements and notes to the financial statements included with this Annual Report on Form 10-K. The discussion and analysis that follows may contain statements that relate to future events or future performance. In some cases, such forward-looking statements can be identified by terminology such as “will,” “may,” “should,” “expect,” “plan,” “anticipate,” “believe,” “estimate,” “predict,” “potential,” “intend,” “project,” “seek” or the negative of these terms or other comparable terminology. None of the Trust, the Sponsor, the Commodity Sub-Adviser, the Trustee, or the Administrator assumes responsibility for the accuracy or completeness of any forward-looking statements. Except as expressly required by federal securities laws, none of the Trust, the Sponsor, the Commodity Sub-Adviser, the Trustee, or the Administrator is under a duty to update any of the forward-looking statements to conform such statements to actual results or to a change in expectations or predictions.

 

17

 

 

Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risk and changes in circumstances that are difficult to predict and many of which are outside of the Funds’ control. The Funds’ forward-looking statements are not guarantees of future results and conditions and important factors, risks and uncertainties in the markets for financial instruments that the Funds trade, in the markets for related physical commodities, in the legal and regulatory regimes applicable to the Sponsor, the Funds, and the Funds’ service providers, and in the broader economy may cause the Funds’ actual results to differ materially from those expressed in forward-looking statements.

 

Liquidity and Capital Resources

 

In order to collateralize derivatives positions, a portion of the NAV of each Fund is held in cash and/or U.S. Treasury securities, agency securities, or other high credit quality short term fixed-income or similar securities (such as shares of money market funds, bank deposits, bank money market accounts, certain variable rate-demand notes and repurchase agreements collateralized by government securities). A portion of these investments may be posted as collateral in connection with swap agreements, futures, and/or forward contracts. The percentage that U.S. Treasury bills and other short-term fixed-income securities bear to the shareholders’ equity of each Fund varies from period to period as the market values of the underlying swaps, futures contracts and forward contracts change. During the year ended December 31, 2022, each of the Funds earned total income as follows:

 

Fund  Total Income
Year Ended
December 31,
2022
 
-1x Short VIX Futures ETF  $134,777 
2x Long VIX Futures ETF   306,187 

 

Each Fund’s underlying swaps, futures, options, forward contracts and foreign currency forward contracts, as applicable, may be subject to periods of illiquidity because of market conditions, regulatory considerations and other reasons. For example, swaps and forward contracts are not traded on an exchange, do not have uniform terms and conditions, and in general are not transferable without the consent of the counterparty. In the case of futures contracts, commodity exchanges may limit fluctuations in certain futures contract prices during a single day by regulations referred to as “daily limits.” During a single day, no futures trades may be executed at prices beyond the daily limit. Once the price of a futures contract has increased or decreased by an amount equal to the daily limit, positions in such futures contracts can neither be taken nor liquidated unless the traders are willing to effect trades at or within the limit. Futures contract prices have occasionally moved to the daily limit for several consecutive days with little or no trading. Such market conditions could prevent a Fund from promptly liquidating its futures positions.

 

In addition, the Sponsor will seek to minimize the market impact of rebalances across all exchange traded products based on VIX futures contracts (“VIX ETPs”) that it sponsors on the price of VIX futures contracts by limiting the Funds’ participation, on any given day, in VIX futures contracts to no more than 10% of the VIX futures contracts traded on Cboe Futures Exchange, Inc. (“CFE”) during any “Rebalance Period,” defined as any fifteen minute period of continuous market trading. To limit participation during periods of market illiquidity, the Sponsor, on any given day, may vary the manner and period over which all VIX ETPs it sponsors are rebalanced, and as such, the manner and period over which the Funds are rebalanced. The Sponsor believes that a Fund will enter an extended rebalance period most often during periods of extraordinary market conditions or illiquidity in VIX futures contracts. In the event that the Fund participates in an extended rebalance period, the Fund represents that it will notify the Exchange and the SEC of such participation as soon as practicable, but no later than 9:00 a.m. ET on the trading day following the event.

 

Entry into swap agreements or forward contracts may further impact liquidity because these contractual agreements are executed “off-exchange” between private parties and, therefore, the time required to offset or “unwind” these positions may be greater than that for exchange-traded instruments. This potential delay could be exacerbated to the extent a counterparty is not a United States person.

 

The large size of the positions in which a Fund may acquire increases the risk of illiquidity by both making their positions more difficult to liquidate and increasing the losses incurred while trying to do so. Any type of disruption or illiquidity will potentially be exacerbated due to the fact that the Funds will typically invest in Financial Investments related to one benchmark, which in many cases is highly concentrated.

 

Because each Fund may enter into swaps and may trade futures and forward contracts, its capital is at risk due to changes in the value of these contracts (market risk) or the inability of counterparties to perform under the terms of the contracts (credit risk).

 

18

 

 

Market Risk

 

Trading in derivatives contracts involves each Fund entering into contractual commitments to purchase or sell a commodity, currency or spot volatility product underlying such Fund’s benchmark at a specified date and price, should it hold such derivative contract into the deliverable period. Should a Fund enter into a contractual commitment to sell a physical commodity, currency or spot volatility product, it would be required to make delivery of that commodity, currency or spot volatility product at the contract price and then repurchase the contract at prevailing market prices or settle in cash. Since the repurchase price to which the value of a commodity, currency or spot volatility product can rise is unlimited, entering into commitments to sell commodities, currencies or spot volatility products would expose a Fund to theoretically unlimited risk.

 

For more information, see “Item 7A. Quantitative and Qualitative Disclosures About Market Risk” in this Annual Report on Form 10-K.

 

Credit Risk

 

When a Fund enters into swap agreements, futures contracts or forward contracts, the Fund is exposed to credit risk that the counterparty to the contract will not meet its obligations.

 

The counterparty for futures contracts traded on United States and most foreign futures exchanges as well as certain swaps is the clearing house associated with the particular exchange. In general, clearing houses are backed by their corporate members who may be required to share in the financial burden resulting from the nonperformance by one of their members and, as such, should significantly reduce this credit risk. In cases where the clearing house is not backed by the clearing members (i.e., some foreign exchanges, which may become applicable in the future), it may be backed by a consortium of banks or other financial institutions.

 

Certain swap and forward agreements are contracted for directly with counterparties. There can be no assurance that any counterparty, clearing member or clearing house will meet its obligations to a Fund.

 

Swap agreements do not generally involve the delivery of underlying assets either at the outset of a transaction or upon settlement. Accordingly, if the counterparty to an OTC swap agreement defaults, the Fund’s risk of loss typically consists of the net amount of payments that the Fund is contractually entitled to receive, if any. Swap counterparty risk is generally limited to the amount of any unrealized gains, although in the event of a counterparty bankruptcy, there could be delays and costs associated with the recovery of collateral posted in segregated tri-party accounts at the Fund’s custodian bank.

 

Forward agreements do not involve the delivery of assets at the onset of a transaction, but may be settled physically in the underlying asset if such contracts are held to expiration, particularly in the case of currency forwards. Thus, prior to settlement, if the counterparty to a forward contract defaults, a Fund’s risk of loss will generally consist of the net amount of payments that the Fund is contractually entitled to receive, if any. However, if physically settled forwards are held until expiration (presently, there is no plan to do this), at the time of settlement, a Fund may be at risk for the full notional value of the forward contracts depending on the type of settlement procedures used.

 

The Sponsor attempts to minimize certain of these market and credit risks by normally:

 

executing and clearing trades with creditworthy counterparties, as determined by the Sponsor;

 

limiting the outstanding amounts due from counterparties to the Funds;

 

requiring that the counterparty posts collateral in amounts approximately equal to that owed to the Funds, as marked to

 

market daily, subject to certain minimum thresholds;

 

limiting the amount of margin or premium posted at a FCM; and

 

ensuring that deliverable contracts are not held to such a date when delivery of the underlying asset could be called for.

 

19

 

 

Off-Balance Sheet Arrangements and Contractual Obligations

 

As of February 28, 2023, the Funds have not used, nor do they expect to use in the future, special purpose entities to facilitate off-balance sheet financing arrangements and have no loan guarantee arrangements or off-balance sheet arrangements of any kind other than agreements entered into in the normal course of business, which may include indemnification provisions related to certain risks service providers undertake in performing services which are in the best interests of the Funds. While each Fund’s exposure under such indemnification provisions cannot be estimated, these general business indemnifications are not expected to have a material impact on a Fund’s financial position.

 

Management fee payments made to the Sponsor are calculated as a fixed percentage of each Fund’s NAV. As such, the Sponsor cannot anticipate the payment amounts that will be required under these arrangements for future periods as NAVs are not known until a future date. The agreement with the Sponsor may be terminated by either party upon 30 days written notice to the other party.

 

Critical Accounting Policies

 

Preparation of the financial statements and related disclosures in compliance with accounting principles generally accepted in the United States of America requires the application of appropriate accounting rules and guidance, as well as the use of estimates. The Trust’s and the Funds’ application of these policies involves judgments and actual results may differ from the estimates used.

 

Each Fund has significant exposure to Financial Instruments. The Funds hold a significant portion of their assets in swaps, futures, forward contracts or foreign currency forward contracts, all of which are recorded on a trade date basis and at fair value in the financial statements, with changes in fair value reported in the Statements of Operations.

 

The use of fair value to measure Financial Instruments, with related unrealized gains or losses recognized in earnings in each period, is fundamental to the Trust’s and the Funds’ financial statements. The fair value of a Financial Instrument is the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (the exit price).

 

For financial reporting purposes, the Funds value investments based upon the closing price in their primary markets. Accordingly, the investment valuations in these financial statements may differ from those used in the calculation of certain Funds’ final creation/redemption NAV for the year ended December 31, 2022.

 

Short-term investments are valued at amortized cost which approximates fair value for daily NAV purposes. For financial reporting purposes, short-term investments are valued at their market price using information provided by a third-party pricing service or market quotations.

 

Derivatives (e.g., futures contracts, options, swap agreements, forward agreements and foreign currency forward contracts) are generally valued using independent sources and/or agreements with counterparties or other procedures as determined by the Sponsor. Futures contracts, except for those entered into by the Gold, Silver, Australian Dollar and Short Euro Funds, are generally valued at the last settled price on the applicable exchange on which that future trades. Futures contracts entered into by the Gold, Silver,

 

Fair value pricing may require subjective determinations about the value of an investment. While each Fund’s policy is intended to result in a calculation of the Fund’s NAV that fairly reflects investment values as of the time of pricing, the Funds cannot ensure that fair values determined by the Sponsor or persons acting at their direction would accurately reflect the price that the Fund could obtain for an investment if it were to dispose of that investment as of the time of pricing (for instance, in a forced or distressed sale).

 

The prices used by a Fund may differ from the value that would be realized if the investments were sold and the differences could be material to the financial statements.

 

The Funds disclose the fair value of their investments in a hierarchy that prioritizes the inputs to valuation techniques used to measure fair value.

 

Discounts on short-term securities purchased are amortized and reflected as Interest Income in the Statements of Operations.

 

Realized gains (losses) and changes in unrealized gain (loss) on open investments are determined on a specific identification basis and recognized in the Statements of Operations in the period in which the contract is closed or the changes occur, respectively.

 

Each Fund pays its respective brokerage commissions, including applicable exchange fees, NFA fees, give up fees, pit futures account fees and other transaction related fees and expenses charged in connection with trading activities for each Fund’s investment in U.S. Commodity Futures Trading Commission regulated investments. Brokerage commissions on futures contracts are recognized on a half-turn basis.

 

20

 

 

Results of Operations for the Year Ended December 31, 2022

 

-1x Short VIX Futures ETF

 

Fund Performance

 

The following table provides summary performance information for the Fund for the year ended December 31, 2022:

 

   Year Ended
December 31,
2022
 
NAV beginning of period  $- 
NAV end of period  $46,378,603 
Percentage change in NAV   100%
Shares outstanding beginning of period   - 
Shares outstanding end of period   3,170,000 
Percentage change in shares outstanding   100%
Shares created   16,980,000 
Shares redeemed   (13,810,000)
Per share NAV beginning of period  $15.00 
Per share NAV end of period  $14.63 
Percentage change in per share NAV   -2.5%
Percentage change in benchmark   5.86%
Benchmark annualized volatility   68.53%

 

The Fund’s inception of operation was March 28, 2022. Neither the Trust nor the Fund had any operations prior to March 28, 2022, other than matters relating to its organization and the registration of each series under the Securities Act of 1933.

 

During the year ended December 31, 2022, the increase in the Fund’s NAV resulted primarily from the increase of 3,170,000 outstanding Shares during the period. The increase in the Fund’s NAV also resulted in part from the cumulative effect of the Fund seeking daily investment results, before fees and expenses, that correspond to the performance of the Short Index.

 

Net Income/Loss

 

The following table provides summary income information for the Fund for the year ended December 31, 2022:

 

   Year Ended
December 31,
2022
 
Net investment income (loss)  $(737,456)
Management fee   489,398 
Brokerage commissions / Futures account fees   41,169 
Non-recurring fees and expenses   341,666 
Net realized gain (loss)   16,573,828 
Change in net unrealized appreciation (depreciation)   1,156,106 
Net income (loss)   16,992,478

 

The Fund’s net income was primarily due to a decrease in the value of the futures prices during the year ended December 31, 2022.

  

21

 

 

Futures Positions as of December 31, 2022(1)

 

Contract  Long or Short  Expiration  Contracts   Valuation Price   Contract Multiplier   Notional
Amount at
Value
 
CBOE VIX FUTURE   Jan23  Short  Jan-23   (1,150)  $23.16    1,000   $(26,634,000)
CBOE VIX FUTURE   Feb23  Short  Feb-23   (804)   24.57    1,000    (19,754,280)

 

(1)The Fund commenced operations on March 28, 2022.

  

The December 31, 2022 futures notional values are calculated by multiplying the number of contracts held times the valuation price times the contract multiplier. The notional values will increase (decrease) proportionally with increases (decreases) in the price of the futures contract. Additional gains (losses) associated with these contracts will be equal to any such subsequent increases (decreases) in notional values, before accounting for spreads or transaction or financing costs. The Fund will generally attempt to adjust its positions in Financial Instruments each day to match the performance of the Short Index. Future period returns, before fees and expenses, cannot be estimated simply by estimating the return of the Short Index.

 

2x Long VIX Futures ETF

 

Fund Performance

 

The following table provides summary performance information for the Fund for the year ended December 31, 2022:

 

   Year Ended
December 31,
2022
 
NAV beginning of period  $- 
NAV end of period  $125,488,766 
Percentage change in NAV   100.0%
Shares outstanding beginning of period   - 
Shares outstanding end of period   21,450,000 
Percentage change in shares outstanding   100%
Shares created   36,390,000 
Shares redeemed   (14,940,000)
Per share NAV beginning of period  $15.00 
Per share NAV end of period  $5.85 
Percentage change in per share NAV   -61.0%
Percentage change in benchmark   -30.1%
Benchmark annualized volatility   68.53%

 

The Fund’s inception of operation was March 28, 2022. Neither the Trust nor the Fund had any operations prior to March 28, 2022, other than matters relating to its organization and the registration of each series under the Securities Act of 1933.

 

During the year ended December 31, 2022, the increase in the Fund’s NAV resulted primarily from the increase of 21,450,000 outstanding Shares during the period. This increase was partially offset by the cumulative effect of the Fund seeking daily investment results, before fees and expenses, that correspond to the performance of the Long Index.

 

22

 

  

Net Income/Loss

 

The following table provides summary income information for the Fund for the year ended December 31, 2022:

 

   Year Ended
December 31,
2022
 
Net investment income (loss)  $(1,191,352)
Management fee   1,004,754 
Brokerage commissions / Futures account fees   43,638 
Non-recurring fees and expenses   449,147 
Net realized gain (loss)   (67,298,832)
Change in net unrealized appreciation (depreciation)   (9,203,522)
Net income (loss)   (77,693,706)

 

The Fund’s net loss was primarily due to a decrease in the value of the futures prices during the year ended December 31, 2022.

 

Futures Positions as of December 31, 2022 (1)
Contract  Long or
Short
  Expiration   Contracts   Valuation
Price
   Contract Multiplier   Notional 
Amount at
Value
 
CBOE VIX FUTURE   Jan23  Long   Jan-23    6,221   $23.16    1,000   $144,078,360 
CBOE VIX FUTURE   Feb23  Long   Feb-23    4,355    24.57    1,000    107,002,350 

 

(1)The Fund commenced operations on March 28, 2022.

  

The December 31, 2022 futures notional values are calculated by multiplying the number of contracts held times the valuation price times the contract multiplier. The notional values will increase (decrease) proportionally with increases (decreases) in the price of the futures contract. Additional gains (losses) associated with these contracts will be equal to any such subsequent increases (decreases) in notional values, before accounting for spreads or transaction or financing costs. The Fund will generally attempt to adjust its positions in Financial Instruments each day to match the performance of the Long Index. Future period returns, before fees and expenses, cannot be estimated simply by estimating the return of the Long Index.

 

Qualitative Disclosure

 

The primary market risks that the Funds are exposed to depend on each Fund’s investment objective and corresponding benchmark. For example, the primary market risk that SVIX and UVIX are exposed to are inverse and long exposure, respectively, to the price of certain VIX futures contracts as measured by the return of holding and periodically rolling such futures contracts.

 

23

 

 

Item 8. Financial Statements and Supplementary Data.

 

Statement of Operations for the three month periods ended March 31, 2022, June 30, 2022, September 30, 2022, and December 31, 2022 and the year ended December 31, 2022 for each Fund, as applicable.

 

-1x Short VIX Futures ETF

 

   Three Months Ended (Unaudited)   Year Ended 
   March 31, 
2022
   June 30,
2022
   September 30,
2022
   December 31,
2022
   December 31,
2022
 
Net investment income (loss)  $(1,793)  $(242,779)  $(230,841)  $(262,043)  $(737,456)
Net realized gain (loss)   (4,078)   (4,573,052)   8,077,788    13,073,170    16,573,828 
Net unrealized gain (loss)   (135,277)   835,808    (6,278,300)   6,733,875    1,156,106 
Net income (loss)  $(141,148)  $(3,980,023)  $1,568,647   $19,545,002   $16,992,478 
Net increase (decrease) in net asset value per share  $(0.84)  $(3.76)  $(0.06)  $4.29   $(0.37)

 

2x Long VIX Futures ETF

 

   Three Months Ended (Unaudited)   Year Ended 
   March 31,
2022
   June 30,
2022
   September 30,
2022
   December 31,
2022
   December 31,
2022
 
Net investment income (loss)  $(1,777)  $(180,611)  $(495,723)  $(513,241)  $(1,191,352)
Net realized gain (loss)   (454)   7,528,449    (22,686,414)   (52,140,413)   (67,298,832)
Net unrealized gain (loss)   276,202    (256,944)   20,574,735    (29,797,515)   (9,203,522)
Net income (loss)  $273,971   $7,090,894   $(2,607,402)  $(82,451,169)  $(77,693,706)
Net increase (decrease) in net asset value per share  $1.64   $0.48   $(3.25)  $(8.02)  $(9.15)

 

  

24

 

 

Item 9. Changes in and Disagreements With Accountants on Accounting and Financial Disclosure.

 

Not applicable.

 

Item 9A. Controls and Procedures.

 

Disclosure Controls and Procedures

 

Under the supervision and with the participation of the principal executive officer and principal financial officer of the Trust, Trust management has evaluated the effectiveness of the Trust’s and the Funds’ disclosure controls and procedures, and the principal executive officer and principal financial officer have concluded that the disclosure controls and procedures of the Trust and the Funds (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “1934 Act”)) were effective, as of December 31, 2022, to provide reasonable assurance that information required to be disclosed in the reports that the Trust files or submits under the 1934 Act on behalf of the Trust and the Funds is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to management, including the principal executive officer and principal financial officer, of the Trust as appropriate to allow timely decisions regarding required disclosure.

 

Management’s Annual Report on Internal Control Over Financial Reporting

 

The Trust’s management is responsible for establishing and maintaining adequate internal control over financial reporting of the Trust and the Funds, as defined in Rules 13a-15(f) and 15d-15(f) under the 1934 Act. The Trust’s and the Funds’ internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. Internal control over financial reporting includes those policies and procedures that: (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the Trust and the Funds; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that the Trust’s and the Funds’ receipts and expenditures are being made only in accordance with appropriate authorizations of management of the Trust on behalf of the Trust and the Funds; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the Trust’s or the Funds’ assets that could have a material effect on the Trust’s or the Funds’ financial statements.

 

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

 

Management, including the principal executive officer and principal financial officer of the Trust, assessed the effectiveness of the Trust’s and the Funds’ internal control over financial reporting as of December 31, 2022. Their assessment included an evaluation of the design of the Trust’s and the Funds’ internal control over financial reporting and testing of the operational effectiveness of their internal control over financial reporting. In making its assessment, the Trust’s management has utilized the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) in its report entitled Internal Control – Integrated Framework (2013). Based on their assessment and those criteria, management, including the principal executive officer and principal financial officer of the Trust, concluded that the Trust’s and the Funds’ internal control over financial reporting was effective as of December 31, 2022.

 

25

 

 

Changes in Internal Control over Financial Reporting

 

There were no changes in the Trust’s or the Funds’ internal control over financial reporting that occurred during the year ended December 31, 2022 that have materially affected, or are reasonably likely to materially affect, the Trust’s or the Funds’ internal control over financial reporting.

 

Certifications

 

The certifications by the Principal Executive Officer and Principal Financial Officer of the Trust required by Section 302 and Section 906 of the Sarbanes-Oxley Act of 2002, which are filed or furnished as exhibits to this Annual Report on Form 10-K, apply both to the Trust taken as a whole and each Fund, and the Principal Executive Officer and Principal Financial Officer of the Trust are certifying both as to the Trust taken as a whole and each Fund.

 

Item 9B. Other Information.

 

Not applicable.

 

Item 9C. Disclosure Regarding Jurisdictions that Prevent Inspections.

 

Not applicable.

 

Part III.

 

Item 10. Directors, Executive Officers and Corporate Governance.

 

The Sponsor

 

Volatility Shares LLC, is the Sponsor of the Trust and the Funds. As noted above, the Sponsor has exclusive management and control of all aspects of the business of the Funds. The Trustee has no duty or liability to supervise the performance of the Sponsor, nor will the Trustee have any liability for the acts or omissions of the Sponsor.

 

As of December 31, 2022, the Sponsor serves as the Trust’s commodity pool operator.

 

Specifically, with respect to the Trust, the Sponsor:

 

Manages and directs the Funds’ portfolio of Financial Instruments and other assets, including cash and cash equivalents;

 

selects the Funds’ service providers;

 

negotiates various agreements and fees;

 

performs such other services as the Sponsor believes that the Trust may require from time to time;

 

selects the FCM and Financial Instrument counterparties, if any; and

 

Oversees the Commodity Sub-Adviser’s management of the Funds’ portfolio of Financial Instruments and other assets, including cash equivalents.

 

The Shares are not deposits or other obligations of the Sponsor, the Trustee or any of their respective subsidiaries or affiliates or any other bank, are not guaranteed by the Sponsor, the Trustee or any of their respective subsidiaries or affiliates or any other bank and are not insured by the Federal Deposit Insurance Corporation (the “FDIC”) or any other governmental agency. An investment in the Shares of the Fund offered hereby is speculative and involves a high degree of risk.

 

The principal office of the Sponsor is located at 2000 PGA Boulevard, Suite 4440, Palm Beach Gardens, FL 33408. The telephone number of the Sponsor and the Trust is (866) 261-0273.

 

26

 

 

Background and Principals

 

As of December 31, 2022, Volatility Shares LLC, the Sponsor, is a limited liability company formed in Delaware on July 25, 2019. The Sponsor was formed for the purpose of sponsoring volatility-linked exchange-traded funds, of which the Funds are the first. Prior to its engagement as Sponsor of the Funds, the Sponsor had no operating history.

 

The Sponsor currently serves as the commodity pool operator of the Trust and the Funds. The Sponsor is registered as a commodity pool operator with the CFTC and is a member in good standing of the NFA. The Sponsor’s membership with the NFA was originally approved on October 14, 2019. Its membership with the NFA is currently effective. The Sponsor’s registration as a commodity pool operator was originally approved on October 14, 2019. Its registration as a commodity pool operator is currently effective. As a registered commodity pool operator, with respect to the Trust, the Sponsor must comply with various regulatory requirements under the CEA, and the rules and regulations of the CFTC and the NFA, including investor protection requirements, antifraud prohibitions, disclosure requirements, and reporting and recordkeeping requirements. The NFA approved the Sponsor as a Swaps Firm on October 14, 2019. The Sponsor is also subject to periodic examinations by the CFTC and NFA staff. Its principal place of business is 2000 PGA Boulevard, Suite 4440, Palm Beach Gardens, FL 33408. The telephone number of the Sponsor and the Trust is (866) 261-0273. The registration of the Sponsor with the CFTC and its membership in the NFA must not be taken as an indication that either the CFTC or the NFA has recommended or approved the Sponsor, the Trust and the Funds.

 

Executive Officers of the Trust and Principals and Significant Employees of the Sponsor

 

Name   Position
Justin Young*  

Principal of the Sponsor (since 10/4/2019)

Associated Person of the Sponsor (since 12/12/2019)

Principal Executive Officer (since 4/8/2021)

Principal Financial Officer (since 4/8/2021)

Principal Accounting Officer of the Trust (since 4/8/2021)

Stuart Barton*  

Principal of the Sponsor (since 10/2/2019)

Associated Person of the Sponsor (since 10/14/2019)

Chief Investment Officer (since 4/8/21)

Chang Kim*  

Principal of the Sponsor (since 1/26/2022)

Chief Compliance Officer (since 1/26/2022)

Manzone LLC   Principal of the Sponsor (since 2/11/2021)
     

 

*Denotes principal of the Sponsor who participates in making trading decisions for the Funds.

 

The following is a biographical summary of the business experience of the executive officers of the Trust and the principals and significant employees of the Sponsor. Of the Principals listed below, only Justin Young, Stuart Barton and Chang Kim participate in making trading or operational decisions for the Funds or supervise persons engaged in making trading or operational decisions for the Funds.

 

Justin Young holds a BA in American Studies from Georgetown University. Since April 2017, he has served as Managing Partner of Invest In Vol LLC (overseeing operations at an investment adviser); from August 2015 to April 2017, he was Vice President of Rex Shares LLC (overseeing product development at an ETF sponsor); from April 2011 to August 2015 he was Head of Capital Markets for Global X Management Company LLC (overseeing capital markets operations for an ETF sponsor); and from July 2009 to April 2011 he was an Associate of NYSE Euronext (working on a number of listing matters for a national securities exchange).

 

Stuart Barton holds a PhD in Economic History from the University of Cambridge, an MBA from the University of Surrey, and a B.Sc in engineering from the University of Cape Town. Since March 2017, he has served as Managing Partner of Invest In Vol LLC (overseeing operations at an investment adviser); from September 2016 to March 2017 he was Chief Investment Officer of Rex Shares (overseeing investments at an ETF sponsor); from September 2014 to September 2017 he was Managing Partner at Corpus Capital Partners LLC (overseeing operations at a commodity pool operator); from October 2010 to September 2014 he was a Ph.D. Candidate (completed Ph.D.) at the University of Cambridge, UK; from January 2008 to October 2010 he was unemployed and engaged in travel; from June 2007 to January 2008 he was Senior Equity Derivatives Trader at HSBC’s Hong Kong office (traded derivatives at an investment bank); from September 2004 to June 2007 he was Senior Equity Derivatives Trader at Barclays Capital PLC in New York (traded derivatives at a broker-dealer); and from August 2001 to September 2004 he was Equity Derivatives Trader at Barclays Capital PLC in London.

 

Chang Kim holds a BA in Film Studies from Yale University. From January 2021 to December 2021, he served as the CEO of The Library Shop, Inc. (overseeing operations at an e-commerce business); from September 2009 to December 2020, he served as a Portfolio Manager and the COO at Global X Management Company LLC (overseeing operations at an ETF sponsor).

 

Manzone LLC became a Principal of the Sponsor on February 11, 2021. Manzone LLC has a passive ownership interest in the Sponsor and exercises no management authority over the Funds.

 

27

 

 

Duties of the Sponsor and Indemnification

 

The general fiduciary duties which would otherwise be imposed on the Sponsor (which would make its operation of the Trust as described herein impracticable due to the strict prohibition imposed by such duties on, for example, conflicts of interest on behalf of a fiduciary in its dealings with its beneficiaries), are replaced by the terms of the Trust Agreement (to which terms all shareholders, by subscribing to the Shares, are deemed to consent).

 

The Trust Agreement provides that the Sponsor and its affiliates shall have no liability to the Trust or to any shareholder for any loss suffered by the Trust arising out of any action or inaction of the Sponsor or its affiliates or their respective directors, officers, shareholders, partners, members, managers or employees (the “Sponsor Related Parties”), if the Sponsor Related Parties, in good faith, determined that such course of conduct was in the best interests of the Funds and such course of conduct did not constitute gross negligence or willful misconduct by the Sponsor Related Parties. The Trust has agreed to indemnify the Sponsor Related Parties against claims, losses or liabilities based on their conduct relating to the Trust, provided that the conduct resulting in the claims, losses or liabilities for which indemnity is sought did not constitute gross negligence or willful misconduct and was done in good faith and in a manner reasonably believed to be in the best interests of the Funds.

 

Under Delaware law, a beneficial owner of a statutory trust (such as a shareholder of the Funds) may, under certain circumstances, institute legal action on behalf of himself and all other similarly situated beneficial owners (a “class action”) to recover damages for violations of fiduciary duties, or on behalf of a statutory trust (a “derivative action”) to recover damages from a third party where there has been a failure or refusal to institute proceedings to recover such damages. In addition, beneficial owners may have the right, subject to certain legal requirements, to bring class actions in federal court to enforce their rights under the federal securities laws and the rules and regulations promulgated thereunder by the SEC. Beneficial owners who have suffered losses in connection with the purchase or sale of their beneficial interests may be able to recover such losses from the Sponsor where the losses result from a violation by the Sponsor of the anti-fraud provisions of the federal securities laws.

 

Under certain circumstances, shareholders also have the right to institute a reparations proceeding before the CFTC against the Sponsor (a registered commodity pool operator), an FCM, as well as those of their respective employees who are required to be registered under the CEA, and the rules and regulations promulgated thereunder. Private rights of action are conferred by the CEA. Investors in futures and in commodity pools may, therefore, invoke the protections provided thereunder.

 

The foregoing summary describing in general terms the remedies available to shareholders under federal law is based on statutes, rules and decisions as of the date of this Prospectus. As this is a rapidly developing and changing area of the law, shareholders who believe that they may have a legal cause of action against any of the foregoing parties should consult their own counsel as to their evaluation of the status of the applicable law at such time.

 

Code of Ethics

 

The Trust has adopted a code of ethics (“Code of Ethics”) that applies to its Principal Executive Officer and Principal Financial Officer. A copy of the Code of Ethics can be obtained, without charge, upon written request to the Sponsor at the following address: VolatilityShares LLC, Attn: Chief Compliance Officer, 2000 PGA Boulevard, Suite 4440, Palm Beach Gardens, FL 33408.

 

28

 

 

The Commodity Sub-Adviser

 

Penserra Capital (the “Commodity Sub-Adviser”), with its principal office at 4 Orinda Way, suite 100-a, Orinda, CA. 94563, serves as the Funds’ Commodity Sub-Adviser pursuant to a commodity sub-advisory agreement (the “Commodity Sub-Advisory Agreement”). Prior to November 1, 2022, Milliman FRM served as the Funds’ commodity sub-adviser.

 

The Commodity Sub-Adviser formed in July 2009. It provides investment advisory services, specializing in ETF sub-advisory serves. The Commodity Sub-Adviser became an NFA member on September 20, 2022 and a registered commodity trading adviser on September 20, 2022. Previously, it was an NFA member from March 29, 2017 through May 19, 2018, when its membership was withdrawn, and was a commodity trading advisor from April 13, 2017 through May 19, 2018, when its registration was withdrawn.

 

The Commodity Sub-Adviser also provides services as an investment adviser or sub-adviser or CTA, to mutual funds, exchange-traded funds (“ETFs”), unit investment trusts (“UITs”), funds offered through bank collective investment trusts (“CITs”), and other exchange-traded products (“ETPs”). The strategy exercised for each product is designed to meet a particular investment goal. In the case of sub-advisory services, the primary adviser to the fund is usually responsible for the selection of underlying investments for the fund, and the Commodity Sub-Adviser manages strategies for the various funds’ assets based on the investment goals and objectives as outlined in each of the funds’ offering documents.

 

As of December 31, 2022, the Commodity Sub-Adviser manages 100% of the Funds’ assets. The Commodity Sub-Adviser will be paid by the Sponsor an annual sub-advisory fee of 0.20% based on each Fund’s average daily net assets (total assets of the Fund, minus the sum of its accrued liabilities). The Funds do not directly pay the Commodity Sub-Adviser.

 

The following is a biographical summary of the business experience of the principals of the Commodity Sub-Adviser. Each of the principals listed below participate in making trading or operational decisions for the Funds or supervise persons engaged in making trading or operational decisions for the Funds.

 

Anthony Castelli joined the Commodity Sub-Adviser in August 2011 and has served as Chief Compliance Officer since August 2011. In that role, he oversees compliance and risk operations for Commodity Sub-Adviser. Mr. Kelkar was approved as a principal on September 9, 2022.

 

Dustin Allen Lewellyn joined the Commodity Sub-Adviser in September 2014 as a Managing Director. In that role he oversees equity and commodity interest trading. Mr. Lewellyn was approved as a principal on September 9, 2022.

 

George Madrigal joined the Commodity Sub-Adviser in August 2009 as President and Chief Operating Officer. In that role, he manages and oversees the operations of the Commodity Sub-Adviser. He also has served as President of Penserra Securities LLC since December 2007. Mr. Madrigal was approved as a principal on September 9, 2022.

 

Lee Wilson Geiger joined the Commodity Sub-Adviser in September 2014 as a Managing Director. In that role, he oversees equity and commodity interest trading. Mr. Lewellyn was approved as a principal on August 29, 2022, became registered as an associated person on September 20, 2022, and was approved as an NFA associate member on September 20, 2022.

 

29

 

 

Item 11. Executive Compensation.

 

The Funds have no employees or directors and are managed by the Sponsor. None of the officers of the Trust, or the members or officers of the Sponsor receive compensation from the Funds.

 

SVIX pays the Sponsor a management fee (the “Management Fee”), monthly in arrears, in an amount equal to 1.35% per annum of its average daily net assets. UVIX pays the Sponsor a Management Fee, monthly in arrears, in an amount equal to 1.65% per annum of its average daily net assets. “Average daily net assets” is calculated by dividing the month-end net assets of each Fund by the number of calendar days in such month.

 

No other Management Fee is paid by the Funds. The Management Fee is paid in consideration of the Sponsor’s trading advisory services and the other services provided to the Fund that the Sponsor pays directly.

 

For the year ended December 31, 2022, the following represents Management Fees earned by the Sponsor:

 

Fund  Amount 
-1x Short VIX Futures ETF  $489,398 
2x Long VIX Futures ETF   1,004,754 

 

Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.

 

Not applicable.

 

Item 13. Certain Relationships and Related Transactions, and Director Independence.

 

Not applicable.

 

Item 14. Principal Accounting Fees and Services.

 

(1)to (4). Fees for services performed by Tait, Weller & Baker, LLP (“Tait Weller”) and PricewaterCoopers (PwC) for the year ended December 31, 2022 were as follows:

  

   Year Ended
December 31,
2022
 
SVIX    
Audit Fees  $17,962 
Audit-Related Fees   - 
Tax Fees  91,905 
All Other Fees   - 
   $109,867 
UVIX     
Audit Fees  $17,962 
Audit-Related Fees   - 
Tax Fees  169,470 
All Other Fees   - 
   $187,432 
      
Combined Trust:  $297,299 

 

Audit fees for the year ended December 31, 2022 consist of fees paid to Tait Weller for the audit of the Funds’ December 31, 2022 annual financial statements included in the Annual Report on Form 10-K for the year ended December 31, 2022, for the review of the financial statements included in each Form 10-Q, and for the audits of financial statements included with registration statements. Tax fees include certain tax compliance and reporting services provided by PricewaterhouseCoopers (“PwC”) to the Trust, including processing beneficial ownership information as it relates to the preparation of tax reporting packages and the subsequent delivery of related information to the IRS. Services also include assistance with tax reporting and related information using a web-based tax package product developed by PwC and a toll-free tax package support help line.

 

(5)The Sponsor approved all of the services provided by Tait Weller and PwC described above. The Sponsor pre-approves all audit and allowed non-audit services of the Trust’s independent registered public accounting firm, including all engagement fees and terms.

 

30

 

 

Part IV.

 

Item 15. Exhibits and Financial Statement Schedules.

 

Financial Statement Schedules

 

See the Index to Financial Statements for a list of the financial statements being filed as part of this Annual Report on Form 10-K. Schedules may have been omitted since they are either not required, not applicable, or the information has otherwise been included.

 

Exhibit No.

 

Description of Document

3.1*   Restated Certificate of Trust
4.1**   Trust Agreement
4.2**   Form of Authorized Participant Agreement
4.3****   Description of Shares
10.1**   Form of Sponsor Agreement
10.2**   Form of Transfer Agency Services Agreement
10.3**   Form of Custodian Agreement
10.4**   Form of Marketing Agent Agreement
10.5**   Form of Futures Account Agreement
10.6**   Form of Administration Servicing Agreement
10.7**   Form of Sub-Administration Servicing Agreement
10.8**   Form of Fund Accounting Servicing Agreement
10.9***   Commodity Sub-Advisory Agreement
31.1****   Certification by Principal Executive Officer of the Trust Pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934, as amended
31.2****   Certification by Principal Financial Officer of the Trust Pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934, as amended
32.1****   Certification by Principal Executive Officer of the Trust Pursuant to 18 U.S.C. Section 1350, As Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2****   Certification by Principal Financial Officer of the Trust Pursuant to 18 U.S.C. Section 1350, As Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS****   Inline XBRL Instance Document.
101.SCH****   Inline XBRL Taxonomy Extension Schema Document.
101.CAL****   Inline XBRL Taxonomy Extension Calculation Linkbase Document.
101.DEF****   Inline XBRL Taxonomy Extension Definition Linkbase Document.
101.LAB****   Inline XBRL Taxonomy Extension Label Linkbase Document.
101.PRE****   Inline XBRL Taxonomy Extension Presentation Linkbase Document.
104 ****   Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

 

*Incorporated by reference to the Trust’s Registration Statement, filed on January 6, 2022.

**Incorporated by reference to the Trust’s Registration Statement, filed on August 26, 2020
***Incorporated by reference to the Trust’s Registration Statement, filed on September, 26, 2022.
****Included herewith.

 

Item 16. Form 10-K Summary.

 

Not applicable.

 

31

 

 

Signatures

 

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this Annual Report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

VS TRUST  
     
/s/ Justin Young  
By: Justin Young  
Principal Executive Officer  
Date: March 28, 2023  
     
/s/ Justin Young  
By: Justin Young  
Principal Financial and Accounting Officer  
Date: March 28, 2023  

 

32

 

 

VS TRUST

 

Financial Statements as of December 31, 2022

 

Index

 

Documents   Page
Report of Independent Registered Public Accounting Firm (PCAOB number: 238)   F-2
Statements of Financial Condition, Schedule of Investments, Statements of Operations, Statements of Changes in Shareholders’ Equity and Statements of Cash Flows:    
-1x Short VIX Futures ETF   F-3
2x Long VIX Futures ETF   F-8
Notes to Financial Statements   F-17

 

F-1

 

 

 

taitweller.com

 

 

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

To Management of the Trust’s Sponsor of

VS Trust

 

Opinion on the Financial Statements

 

We have audited the accompanying combined statement of financial condition of VS Trust as of December 31, 2022, and the related combined statements of operations, changes in net assets, and cash flows for the period March 28, 2022 (commencement of operations) through December 31, 2022 and the related notes (collectively referred to as the “combined financial statements”). In our opinion, the combined financial statements present fairly, in all material respects, the combined financial position of the Trust as of December 31, 2022, and the results of their combined operations, combined changes in net assets, and combined cash flows for the period March 28, 2022 through December 31 2022, in conformity with accounting principles generally accepted in the United States of America

 

We have also audited the accompanying statements of financial condition of -1x Short VIX Futures ETF and 2x Long VIX Futures ETF (the “Funds”), each a series of VS Trust, including the schedules of investments as of December 31, 2022, and the related statements of operations, changes in net assets, cash flows and the financial highlights for the period March 28, 2022 (commencement of operations) through December 31, 2022 and the related notes (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Funds as of December 31, 2022, and the results of their operations, changes in net assets, cash flows and financial highlights for the period March 28, 2022 through December 31 2022, in conformity with accounting principles generally accepted in the United States of America

 

Basis for Opinion

 

These combined financial statements and financial statements are the responsibility of the management of the Trust’s sponsor. Our responsibility is to express an opinion on the Trust’s combined financial statements and the Funds’ financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (“PCAOB”) and are required to be independent with respect to the Trust and the Funds in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB. We have served as the auditor of the Trust and the Funds since 2022.

 

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the combined financial statements and financial statements are free of material misstatement, whether due to error or fraud. The Trust and the Funds are not required to have, nor were we engaged to perform, an audit of their internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting, but not for the purpose of expressing an opinion on the effectiveness of the Trust’s and Funds’ internal control over financial reporting. Accordingly, we express no such opinion.

 

Our audits included performing procedures to assess the risks of material misstatement of the combined financial statements and financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the combined financial statements and financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the combined financial statements and financial statements. Our procedures included confirmation of securities owned as of December 31, 2022 by correspondence with the custodian and brokers. We believe that our audits provide a reasonable basis for our opinion.

 

   
  TAIT, WELLER & BAKER LLP

 

Philadelphia, Pennsylvania

March 27, 2023

 

F-2

 

 

-1x SHORT VIX FUTURES ETF

STATEMENT OF FINANCIAL CONDITION

DECEMBER 31, 2022

 

ASSETS    
Cash  $504,600 
Interest receivable   12,909 
Prepaid expenses and other assets   10,295 
Deposit at Broker for Futures   48,144,554 
Other receivable   571 
Total Assets  $48,672,929 
      
LIABILITIES     
Variation margin payable  $187,030 
Fund shares redeemed   1,903,018 
Management fees payable   54,374 
Administrative, accounting and custodian fees payable   15,869 
Professional fees payable   125,274 
Licensing and registration fees payable   8,761 
Total Liabilities  2,294,326 
Net Assets  $46,378,603 
      
NET ASSETS CONSIST OF:     
Paid-in capital  $29,386,125 
Total distributable earnings (accumulated deficit)   16,992,478 
Net Assets  $46,378,603 
      
NET ASSET VALUE:     
Class I (unlimited shares authorized):     
Net Assets  $46,378,603 
Shares Outstanding^   3,170,000 
Net Asset Value, Offering and Redemption Price per Share  $14.63 
Market Value per Share (Note 2)  $14.66 

 

^No par value

 

See accompanying notes to financial statements.

 

F-3

 

 

-1x SHORT VIX FUTURES ETF

SCHEDULE OF INVESTMENTS

DECEMBER 31, 2022

 

Cash - 1.1% (a)  $504,600 
Other assets in excess of liabilities - 98.9% (a)   45,874,003 
TOTAL NET ASSETS - 100.0%  $46,378,603 

 

(a)$48,144,554 of cash is pledged as collateral for futures contracts.

 

-1x SHORT VIX FUTURES ETF

SHORT FUTURES CONTRACTS

DECEMBER 31, 2022  

 

Contract  Expiration Date  Number of Contracts   Notional Amount at Value   Unrealized Appreciation (Depreciation) 
CBOE VIX FUTURE Jan23  January 18, 2023   (1,150)  $(26,634,000)  $1,058,571 
CBOE VIX FUTURE Feb23  February 15, 2023   (804)   (19,754,280)   97,536 
       (1,954)  $(46,388,280)  $1,156,106 

 

See accompanying notes to financial statements.

 

F-4

 

 

-1x SHORT VIX FUTURES ETF

STATEMENT OF OPERATIONS

FOR THE PERIOD ENDED DECEMBER 31, 2022(1)

 

INVESTMENT INCOME    
Income:    
Dividends  $2 
Interest income   134,714 
Other income   61 
Total Income   134,777 
      
Expenses:     
Management fees   489,398 
Administrative, accounting and custodian fees   40,782 
Professional fees   240,079 
Licensing and registration fees   60,805 
Broker interest expense   41,169 
Total Expenses   872,233 
Net Investment loss   (737,456)
      
REALIZED AND UNREALIZED GAIN ON INVESTMENTS AND FUTURES CONTRACTS     
Net realized gain on:     
Short Term Investments   12 
Futures   16,573,816 
Net change in unrealized appreciation of:     
Short Term Investments   
-
 
Futures   1,156,106 
Net realized and unrealized gain on investments and futures contracts   17,729,934 
NET INCREASE IN NET ASSETS RESULTING FROM OPERATIONS  $16,992,478 

 

(1)The Fund commenced operations on March 28, 2022.

 

See accompanying notes to financial statements.

 

F-5

 

 

-1x SHORT VIX FUTURES ETF

STATEMENT OF CHANGES IN NET ASSETS

FOR THE PERIOD ENDED DECEMBER 31, 2022(1)

 

INCREASE (DECREASE) IN NET ASSETS:    
OPERATIONS    
Net investment loss  $(737,456)
Net realized gain on investments and futures contracts   16,573,828 
Net change in unrealized appreciation of investments and futures contracts   1,156,106 
Net increase in net assets resulting from operations   16,992,478 
      
CAPITAL SHARE TRANSACTIONS     
Shares sold   189,786,132 
Shares redeemed   (160,400,007)
Net increase in net assets from capital share transactions   29,386,125 
Total increase in net assets  46,378,603 
      
NET ASSETS     
Beginning of Period 
-
 
End of Period #  $46,378,603 

 

(1)The Fund commenced operations on March 28, 2022.

 

See accompanying notes to financial statements.

 

F-6

 

 

-1x SHORT VIX FUTURES ETF

STATEMENT OF CASH FLOWS

PERIOD ENDED DECEMBER 31, 2022(1)

 

CASH FLOW FROM OPERATING ACTIVITIES    
Net increase (decrease) in net assets resulting from operations  $16,992,478 
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities     
Purchase of investments   (224,609,285)
Proceeds from sales or maturities of investments held   224,609,285 
Decrease (Increase) in Deposits at broker for futures contracts   (48,144,554)
Decrease (Increase) in Prepaid expenses and other assets   (10,295)
Decrease (Increase) in interest receivable   (12,909)
Decrease (Increase) in other receivables   (571)
Increase (Decrease) in Variation margin payable   187,030 
Increase (Decrease) in Payable to Sponsor   54,374 
Increase (Decrease) in Administrative, accounting and custodian fees payable   15,869 
Increase (Decrease) in Professional fees payable   125,274 
Increase (Decrease) in Licensing and registration fees payable   8,761 
Net cash provided by (used in) operating activities   (30,784,543)
      
CASH FLOW FROM FINANCING ACTIVITIES     
Proceeds from shares sold, net of cost from shares purchased   189,786,132 
Cost of shares redeemed   (158,496,989)
Net cash provided by (used in) financing activities   31,289,143 
      
NET INCREASE IN CASH   504,600 
      
Beginning of Period   
-
 
End of Period #  $504,600 

 

(1)The Fund commenced operations on March 28, 2022.

 

See accompanying notes to financial statements.

 

F-7

 

 

2x LONG VIX FUTURES ETF

STATEMENT OF FINANCIAL CONDITION

DECEMBER 31, 2022

 

ASSETS    
Cash  $
-
 
Investments in securities, at value *   8,250,285 
Interest receivable   50,483 
Prepaid expenses and other assets   15,666 
Receivable for shares sold   1,931,028 
Deposit at Broker for Futures   114,821,272 
Variation margin receivable   830,840 
Other receivable   579 
Total Assets  $125,900,153 
      
LIABILITIES     
Management fees payable  $176,838 
Administrative, accounting and custodian fees payable   19,957 
Professional fees payable  203,411 
Licensing and registration fees payable   11,181 
Total Liabilities   411,387 
Net Assets  $125,488,766 
      
NET ASSETS CONSIST OF:     
Paid-in capital  $203,182,472 
Total distributable earnings (accumulated deficit)   (77,693,706)
Net Assets  $125,488,766 
      
NET ASSET VALUE:     
Class I (unlimited shares authorized):     
Net Assets  $125,488,766 
Shares Outstanding^   21,450,000 
Net Asset Value, Offering and Redemption Price per Share  $5.85 
Market Value per Share (Note 2)  $5.82 
      
*Investments in securities, at cost  $8,250,285 

 

^No par value

 

See accompanying notes to financial statements.

 

F-8

 

 

2x LONG VIX FUTURES ETF
SCHEDULE OF INVESTMENTS
DECEMBER 31, 2022

 

SHORT TERM INVESTMENT - 6.6%

Money Market Fund - 6.6%

 

 8,250,285   First American Government Obligations Fund, 4.11% (a)  $8,250,285 
     TOTAL SHORT TERM INVESTMENT (Cost $8,250,285)  8,250,285 
           
     TOTAL INVESTMENTS (Cost $8,250,285) - 6.6%  8,250,285 
     Other assets in excess of liabilities - 93.4% (b)   117,238,481 
     TOTAL NET ASSETS - 100.0%  $125,488,766 

 

Percentages are stated as a percent of net assets.

 

(a)Represents annualized seven-day yield at December 31, 2022.
(b)$114,821,272 of cash is pledged as collateral for futures contracts.

 

2x LONG VIX FUTURES ETF

LONG FUTURES CONTRACTS

DECEMBER 31, 2022

 

Contract  Expiration Date  Number of
Contracts
   Notional
Amount at
Value
   Unrealized
Appreciation
(Depreciation)
 
CBOE VIX FUTURES   Jan23  January 18, 2023   6,221   $144,078,360   $(8,416,975)
CBOE VIX FUTURES   Feb23  February 15, 2023   4,355    107,002,350    (786,547)
       10,576   $251,080,710   $(9,203,522)

 

See accompanying notes to financial statements.

 

F-9

 

 

2x LONG VIX FUTURES ETF

STATEMENT OF OPERATIONS

FOR THE PERIOD ENDED DECEMBER 31, 2022(1)

 

INVESTMENT INCOME    
Income:    
Dividends  $7 
Interest income   306,021 
Other income   159 
Total Income   306,187 
      
Expenses:     
Management fees   1,004,754 
Administrative, accounting and custodian fees   55,759 
Professional fees   318,741 
Licensing and registration fees   74,647 
Broker interest expense   43,638 
Total Expenses   1,497,539 
Net Investment loss   (1,191,352)
      
REALIZED AND UNREALIZED GAIN (LOSS) ON INVESTMENTS AND FUTURES CONTRACTS     
Net realized gain (loss) on:     
Short Term Investments   38 
Futures   (67,298,870)
Net change in unrealized appreciation (depreciation) of:     
Short Term Investments   
-
 
Futures   (9,203,522)
Net realized and unrealized gain (loss) on investments and futures contracts   (76,502,354)
NET DECREASE IN NET ASSETS RESULTING FROM OPERATIONS  $(77,693,706)

 

(1)The Fund commenced operations on March 28, 2022.

 

See accompanying notes to financial statements.

 

F-10

 

 

2x LONG VIX FUTURES ETF

STATEMENT OF CHANGES IN NET ASSETS

FOR THE PERIOD ENDED DECEMBER 31, 2022(1)

 

INCREASE (DECREASE) IN NET ASSETS:    
OPERATIONS    
Net investment loss  $(1,191,352)
Net realized gain (loss) on investments and futures contracts   (67,298,832)
Net change in unrealized appreciation  (depreciation) of investments and futures contracts   (9,203,522)
Net decrease in net assets resulting from operations   (77,693,706)
      
CAPITAL SHARE TRANSACTIONS     
Shares sold   399,696,269 
Shares redeemed   (196,513,797)
Net increase in net assets from capital share transactions   203,182,472 
Total increase in net assets  125,488,766 
      
NET ASSETS     
Beginning of Period 
-
 
End of Period #  $125,488,766 

 

(1)The Fund commenced operations on March 28, 2022.

 

See accompanying notes to financial statements.

 

F-11

 

 

2x LONG VIX FUTURES ETF

STATEMENT OF CASH FLOWS

PERIOD ENDED DECEMBER 31, 2022(1)

 

CASH FLOW FROM OPERATING ACTIVITIES    
Net increase (decrease) in net assets resulting from operations  $(77,693,706)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities     
Purchase of investments   (358,531,359)
Proceeds from sales or maturities of investments held   350,281,074 
Decrease (Increase) in Deposits at broker for futures contracts   (114,821,272)
Decrease (Increase) in Variation margin receivable   (830,840)
Decrease (Increase) in Prepaid expenses and other assets   (15,666)
Decrease (Increase) in interest receivable   (50,483)
Decrease (Increase) in other receivables   (579)
Increase (Decrease) in Payable to Sponsor   176,838 
Increase (Decrease) in Administrative, accounting and custodian fees payable   19,957 
Increase (Decrease) in Professional fees payable   203,411 
Increase (Decrease) in Licensing and registration fees payable   11,181 
Net cash provided by (used in) operating activities   (201,251,444)
      
CASH FLOW FROM FINANCING ACTIVITIES     
Proceeds from shares sold, net of cost from shares purchased   397,765,241 
Cost of shares redeemed   (196,513,797)
Net cash provided by (used in) financing activities   201,251,444 
      
NET INCREASE IN CASH   
-
 
      
Beginning of Period   
-
 
End of Period  $
-
 

 

(1)The Fund commenced operations on March 28, 2022.

 

See accompanying notes to financial statements.

 

F-12

 

 

VS TRUST

COMBINED STATEMENT OF FINANCIAL CONDITION(1)

DECEMBER 31, 2022

 

ASSETS    
Cash  $504,600 
Investments in securities, at value *   8,250,285 
Interest receivable   63,392 
Prepaid expenses and other assets   25,961 
Receivable for shares sold   1,931,028 
Deposit at Broker for Futures   162,965,826 
Variation margin receivable   830,840 
Other receivable   1,150 
Total Assets  $174,573,082 
      
LIABILITIES     
Variation margin payable  $187,030 
Fund shares redeemed   1,903,018 
Management fees payable   231,212 
Administrative, accounting and custodian fees payable   35,826 
Professional fees payable   328,685 
Licensing and registration fees payable   19,942 
Total Liabilities  2,705,713 
Net Assets  $171,867,369 
      
NET ASSETS CONSIST OF:     
Paid-in capital  $232,568,597 
Total distributable earnings (accumulated deficit)   (60,701,228)
Net Assets #  $171,867,369 
      
NET ASSET VALUE:     
Class I (unlimited shares authorized):     
Net Assets  $171,867,369 
Shares Outstanding^   24,620,000 
      
      
*Investments in securities, at cost  $8,250,285 

 

(1)The fund commenced operations on March 28, 2022
^No par value

 

See accompanying notes to financial statements.

 

F-13

 

 

VS TRUST

COMBINED STATEMENT OF OPERATIONS

FOR THE PERIOD ENDED DECEMBER 31, 2022(1)

 

INVESTMENT INCOME    
Income:    
Dividends  $9 
Interest income   440,735 
Other income   220 
Total Income   440,964 
      
Expenses:     
Management fees   1,494,152 
Administrative, accounting and custodian fees   96,541 
Professional fees   558,820 
Licensing and registration fees   135,452 
Broker interest expense   84,807 
Total Expenses   2,369,772 
Net Investment loss   (1,928,808)
      
REALIZED AND UNREALIZED GAIN (LOSS) ON INVESTMENTS AND FUTURES CONTRACTS     
Net realized gain (loss) on:     
Short Term Investments   50 
Futures   (50,725,054)
Net change in unrealized appreciation (depreciation) of:     
Short Term Investments   
-
 
Futures   (8,047,416)
Net realized and unrealized gain (loss) on investments and futures contracts   (58,772,420)
NET DECREASE IN NET ASSETS RESULTING FROM OPERATIONS  $(60,701,228)

 

(1)The Funds commenced operations on March 28, 2022.

 

See accompanying notes to financial statements.

 

F-14

 

 

VS TRUST

COMBINED STATEMENT OF CHANGES IN NET ASSETS

FOR THE PERIOD ENDED DECEMBER 31, 2022(1)

 

     
INCREASE (DECREASE) IN NET ASSETS:    
OPERATIONS    
Net investment loss  $(1,928,808)
Net realized gain (loss) on investments and futures contracts   (50,725,004)
Net change in unrealized appreciation  (depreciation) of investments and futures contracts   (8,047,416)
Net decrease in net assets resulting from operations   (60,701,228)
      
CAPITAL SHARE TRANSACTIONS     
Shares sold   589,482,401 
Shares redeemed   (356,913,804)
Net increase in net assets from capital share transactions   232,568,597 
Total increase in net assets  171,867,369 
      
NET ASSETS     
Beginning of Period 
-
 
End of Period  $171,867,369 

 

(1)The Funds commenced operations on March 28, 2022.

 

See accompanying notes to financial statements.

 

F-15

 

 

VS TRUST

COMBINED STATEMENTS OF CASH FLOWS

FOR THE PERIOD ENDED DECEMBER 31, 2022(1)

 

CASH FLOW FROM OPERATING ACTIVITIES    
Net increase (decrease) in net assets resulting from operations  $(60,701,228)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities     
Purchase of investments   (583,140,644)
Proceeds from sales or maturities of investments held   574,890,359 
Decrease (Increase) in Deposits at broker for futures contracts   (162,965,826)
Decrease (Increase) in Variation margin receivable   (830,840)
Decrease (Increase) in Prepaid expenses and other assets   (25,961)
Decrease (Increase) in interest receivable   (63,392)
Decrease (Increase) in other receivables   (1,150)
Increase (Decrease) in Variation margin payable   187,030 
Increase (Decrease) in Payable to Sponsor   231,212 
Increase (Decrease) in Administrative, accounting and custodian fees payable   35,826 
Increase (Decrease) in Professional fees payable   328,685 
Increase (Decrease) in Licensing and registration fees payable   19,942 
Net cash used in operating activities   (232,035,987)
      
CASH FLOW FROM FINANCING ACTIVITIES     
Proceeds from shares sold, net of cost from shares purchased   587,551,373 
Cost of shares redeemed   (355,010,786)
Net cash provided by financing activities   232,540,587 
      
NET INCREASE IN CASH  504,600 
      
Beginning of Period 
-
 
End of Period  $504,600 

 

(1)The Funds commenced operations on March 28, 2022.

 

See accompanying notes to financial statements.

 

F-16

 

 

VS Trust

NOTES TO FINANCIAL STATEMENTS

December 31, 2022

 

NOTE 1 – ORGANIZATION

 

VS Trust (the “Trust”) is a Delaware statutory trust formed on October 24, 2019 and is currently organized into separate series (each, a “Fund” and collectively, the “Funds”). As of December 31, 2022, the following two series of the Trust have commenced investment operations: -1x Short VIX Futures ETF (“SVIX”) and 2x Long VIX Futures ETF (“UVIX”). Each of the Funds listed above issues common units of beneficial interest (“Shares”), which represent units of fractional undivided beneficial interest in and ownership of only that Fund. The Shares of each Fund are listed on the Cboe BZX Exchange (“Cboe BZX”).

 

The Funds’ inception of operation was March 28, 2022. Neither the Trust nor the Funds had any operations prior to March 28, 2022, other than matters relating to its organization and the registration of each series under the Securities Act of 1933.

 

Each Fund’s investment exposure to VIX futures contracts will cause each to be deemed a commodity pool, thereby subjecting each Fund to regulation under the Commodity Exchange Act of 1934 (“CEA”) and Commodity Futures Trading Commission (“CFTC”) rules. The Sponsor is registered as a Commodity Pool Operator (“CPO”) and the Fund will be operated in accordance with applicable CFTC rules. Registration as a CPO imposes additional compliance obligations on the Sponsor and the Funds related to additional laws, regulations and enforcement policies, which could increase compliance costs and may affect the operations and financial performance of the Funds.

 

Volatility Shares LLC (the “Sponsor”) is the sponsor of the Trust and the Funds. The Sponsor also will serve as the Trust’s commodity pool operator. The Funds are commodity pools, as defined under the Commodity Exchange Act (the “CEA”), and the applicable regulations of the CFTC and are operated by the Sponsor, which is registered as a commodity pool operator with the CFTC. The Trust is not an investment company registered under the Investment Company Act of 1940.

 

NOTE 2 – SIGNIFICANT ACCOUNTING POLICIES

 

Each Fund is an investment company, as defined by Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 946 “Financial Services — Investment Companies.” As such, the Funds follow the investment company accounting and reporting guidance. The following is a summary of significant accounting policies followed by each Fund, as applicable, in preparation of its financial statements. These policies are in conformity with accounting principles generally accepted in the United States of America (“GAAP”).

 

The accompanying unaudited financial statements were prepared in accordance with GAAP for interim financial information and with the instructions for Form 10-K and the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”). In the opinion of management, all material adjustments, consisting only of normal recurring adjustments, considered necessary for a fair statement of the interim period financial statements have been made. Interim period results are not necessarily indicative of results for a full-year period.

 

Emerging growth company

 

The Trust is an “emerging growth company,” as defined in the Jumpstart Our Business Startups Act of 2012. It will remain an emerging growth company until the earlier of (1) the beginning of the first fiscal year following the fifth anniversary of its initial public offering, (2) the beginning of the first fiscal year after annual gross revenue is $1.07 billion (subject to adjustment for inflation) or more, (3) the date on which the Fund has, during the previous three-year period, issued more than $1.0 billion in non-convertible debt securities and (4) as of the end of any fiscal year in which the market value of common equity held by non-affiliates exceeded $700 million as of the end of the second quarter of that fiscal year.

 

For as long as the Trust remains an “emerging growth company,” it may take advantage of certain exemptions from the various reporting requirements that are applicable to public companies that are not “emerging growth companies” including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation and financial statements in our periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote to approve executive compensation and shareholder approval of any golden parachute payments not previously approved. The Trust will take advantage of these reporting exemptions until it is no longer an “emerging growth company.”

 

F-17

 

 

Use of Estimates & Indemnifications

 

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

 

In the normal course of business, the Trust enters into contracts that contain a variety of representations which provide general indemnifications. The Trust’s maximum exposure under these arrangements cannot be known; however, the Trust expects any risk of loss to be remote.

 

Basis of Presentation

 

Pursuant to rules and regulations of the SEC, these financial statements are presented for the Trust as a whole, as the SEC registrant, and for each Fund individually. The debts, liabilities, obligations and expenses incurred, contracted for or otherwise existing with respect to a particular Fund shall be enforceable only against the assets of such Fund and not against the assets of the Trust generally or any other Fund. Accordingly, the assets of each Fund of the Trust include only those funds and other assets that are paid to, held by or distributed to the Trust for the purchase of Shares in that Fund.

 

Statements of Cash Flows

 

The cash amount shown in the Statements of Cash Flows is the amount reported as cash in the Statements of Financial Condition dated December 31, 2022, and represents cash but does not include short-term investments.

 

Final Net Asset Value for Fiscal Period

 

The cut-off times and the times of the calculation of the Funds’ final net asset value for creation and redemption of fund Shares for the three months ended December 31, 2022 were typically as follows. All times are Eastern Standard Time:

 

    Create/Redeem   NAV Calculation   NAV
Fund   Cut-off*(EST)   Time (EST)   Calculation Date
-1x Short VIX Futures ETF and   2:00 p.m.   4:00 p.m.   December 31, 2022
2x Long VIX Futures ETF   2:00 p.m.   4:00 p.m.   December 31, 2022

  

* Although the Funds’ shares may continue to trade on secondary markets subsequent to the calculation of the final NAV, these times represent the final opportunity to transact in creation or redemption units for the three months ended December 31, 2022.

 

Market value per Share is determined at the close of Cboe BZX and may be later than when the Funds’ NAV per Share is calculated.

 

For financial reporting purposes, the Funds value transactions based upon the final closing price in their primary markets. Accordingly, the investment valuations in these financial statements may differ from those used in the calculation of certain of the Funds’ final creation/redemption NAV for the three months ended December 31, 2022.

 

Investment Valuation

 

Short-term investments are valued at amortized cost which approximates fair value for daily NAV purposes. For financial reporting purposes, short-term investments are valued at their market price using information provided by a third-party pricing service or market quotations. In each of these situations, valuations are typically categorized as Level I in the fair value hierarchy.

 

VIX futures contracts are valued using the Time Weighted Average Price (TWAP) of the futures during the last 15 minutes of NYSE’s regular trading session, rather than solely from the VIX futures’ settlement price. The value of a Fund’s non-exchange-traded Financial Instruments typically is determined by applying the then-current disseminated levels for the Index to the terms of the Fund’s non-exchange-traded Financial Instruments.

 

In certain circumstances (e.g., if the Sponsor believes market quotations do not accurately reflect the fair value of a Fund’s investment, or a trading halt closes an exchange or market early), the Sponsor may, in its sole discretion, choose to determine a fair value price as the basis for determining the market value of such investment for such day. Such fair value prices would generally be determined based on available inputs about the current value of the underlying VIX futures contract and would be based on principles that the Sponsor deems fair and equitable.

 

The Funds may use a variety of money market instruments. Money market instruments generally will be valued using market prices or at amortized cost.

 

F-18

 

 

Fair value pricing may require subjective determinations about the value of an investment. While the Funds’ policies are intended to result in a calculation of its respective Fund’s NAV that fairly reflects investment values as of the time of pricing, such Fund cannot ensure that fair values determined by the Sponsor or persons acting at their direction would accurately reflect the price that a Fund could obtain for an investment if it were to dispose of that investment as of the time of pricing (for instance, in a forced or distressed sale). The prices used by such Fund may differ from the value that would be realized if the investments were sold and the differences could be material to the financial statements.

 

Fair Value of Financial Instruments

 

The Funds disclose the fair value of their investments in a hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The disclosure requirements establish a fair value hierarchy that distinguishes between: (1) market participant assumptions developed based on market data obtained from sources independent of the Funds (observable inputs); and (2) the Funds’ own assumptions about market participant assumptions developed based on the best information available under the circumstances (unobservable inputs). The three levels defined by the disclosure requirements hierarchy are as follows:

 

Level I – Quoted prices (unadjusted) in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date.

 

Level II – Inputs other than quoted prices included within Level I that are observable for the asset or liability, either directly or indirectly. Level II assets include the following: quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the asset or liability, and inputs that are derived principally from or corroborated by observable market data by correlation or other means (market-corroborated inputs).

 

Level III – Unobservable pricing input at the measurement date for the asset or liability. Unobservable inputs shall be used to measure fair value to the extent that observable inputs are not available.

 

In some instances, the inputs used to measure fair value might fall in different levels of the fair value hierarchy. The level in the fair value hierarchy within which the fair value measurement in its entirety falls is determined based on the lowest input level that is significant to the fair value measurement in its entirety.

 

Fair value measurements also require additional disclosure when the volume and level of activity for the asset or liability have significantly decreased, as well as when circumstances indicate that a transaction is not orderly.

 

The following table summarizes the valuation of investments at December 31, 2022 using the fair value hierarchy:

 

   Level 1 - 
Quoted
Prices
   Level 2 -
Other
Significant
Observable
Inputs
     
Fund  Money
Market Fund
   Futures
Contracts*
   Total 
-1x Short VIX Futures ETF  $
-
   $1,156,106   $1,156,106 
2x Long VIX Futures ETF   8,250,285    (9,203,522)   (953,237)
Total Trust  $8,250,285   $(8,047,416)  $202,869 

 

*Includes cumulative appreciation (depreciation) of futures contracts as reported in the Schedule of Investments. Only current day’s variation margin is reported within the Statements of Financial Condition in receivable/payable on open futures.

 

The inputs or methodology used for valuing investments are not necessarily an indication of the risk associated with investing in those securities.

 

Investment Transactions and Related Income

 

Investment transactions are recorded on the trade date. All such transactions are recorded on the identified cost basis and marked to market daily. Unrealized appreciation (depreciation) on open contracts are reflected in the Statements of Financial Condition and changes in the unrealized appreciation (depreciation) between periods are reflected in the Statements of Operations.

 

Interest income is recognized on an accrual basis and includes, where applicable, the amortization of premium or discount, and is reflected as Interest Income in the Statement of Operations.

 

Brokerage Commissions and Futures Account Fees

 

Each Fund pays its respective brokerage commissions, including applicable exchange fees, National Futures Association (“NFA”) fees, give-up fees, pit brokerage fees and other transaction related fees and expenses charged in connection with trading activities for each Fund’s investment in U.S. Commodity Futures Trading Commission (“CFTC”) regulated investments. The effects of trading spreads, financing costs/fees associated with Financial Instruments, and costs relating to the purchase of U.S. Treasury securities or similar high credit quality short-term fixed-income would also be borne by the Funds. Brokerage commissions on futures contracts are recognized on a half-turn basis (e.g., the first half is recognized when the contract is purchased (opened) and the second half is recognized when the transaction is closed). The Sponsor is currently paying brokerage commissions on VIX futures contracts for the Funds that exceed variable create/redeem fees collected by more than 0.04% and 0.09%, for SVIX and UVIX, respectively, of each Fund’s average net assets annually.

 

F-19

 

 

Federal Income Tax

 

Each Fund is registered as a series of a Delaware statutory trust and is treated as a partnership for U.S. federal income tax purposes. Accordingly, no Fund expects to incur U.S. federal income tax liability; rather, each beneficial owner of a Fund’s Shares is required to take into account its allocable share of its Fund’s income, gain, loss, deductions and other items for its Fund’s taxable year ending with or within the beneficial owner’s taxable year.

 

Management of the Funds has reviewed all open tax years and major jurisdictions (i.e., the last four tax year ends and the interim tax period since then, as applicable) and concluded that there is no tax liability resulting from unrecognized tax benefits relating to uncertain income tax positions taken or expected to be taken in future tax returns. The Funds are also not aware of any tax positions for which it is reasonably possible that the total amounts of unrecognized tax benefits will significantly change in the next twelve months. On an ongoing basis, management monitors its tax positions taken under the interpretation to determine if adjustments to conclusions are necessary based on factors including, but not limited to, on-going analysis of tax law, regulation, and interpretations thereof.

 

NOTE 3 – INVESTMENTS

 

Short-Term Investments

 

The Funds may purchase U.S. Treasury Bills, agency securities, and other high-credit quality short-term fixed income or similar securities with original maturities of one year or less. A portion of these investments may be posted as collateral in connection with swap agreements, futures, and/or forward contracts.

 

Accounting for Derivative Instruments

 

In seeking to achieve each Fund’s investment objective, the Sponsor uses a mathematical approach to investing. Using this approach, the Sponsor determines the type, quantity and mix of investment positions, including derivative positions, which the Sponsor believes in combination, should produce returns consistent with a Fund’s objective.

 

All open derivative positions at period end are reflected on each respective Fund’s Schedule of Investments. Certain Funds utilized a varying level of derivative instruments in conjunction with investment securities in seeking to meet their investment objectives during the period. While the volume of open positions may vary on a daily basis as each Fund transacts derivatives contracts in order to achieve the appropriate exposure to meet its investment objective, the volume of these open positions relative to the net assets of each respective Fund at the date of this report is generally representative of open positions throughout the reporting period.

 

Following is a description of the derivative instruments used by the Funds during the reporting period, including the primary underlying risk exposures related to each instrument type.

 

Futures Contracts

 

The Funds may enter into futures contracts to gain exposure to changes in the value of, or as a substitute for investing directly in (or shorting), an underlying benchmark. A futures contract obligates the seller to deliver (and the purchaser to accept) the future delivery of a specified quantity and type of asset at a specified time and place. The contractual obligations of a buyer or seller may generally be satisfied by taking or making physical delivery of the underlying commodity, if applicable, or by making an offsetting sale or purchase of an identical futures contract on the same or linked exchange before the designated date of delivery, or by cash settlement at expiration of contract.

 

Upon entering into a futures contract, each Fund is required to deposit and maintain as collateral at least such initial margin as required by the exchange on which the transaction is affected. The initial margin is segregated as cash and/or securities balances with brokers for futures contracts, as disclosed in the Statements of Financial Condition, and is restricted as to its use. The Funds that enter into futures contracts maintain collateral at the broker in the form of cash and/or securities. Pursuant to the futures contract, each Fund generally agrees to receive from or pay to the broker(s) an amount of cash equal to the daily fluctuation in value of the futures contract. Such receipts or payments are known as variation margin and are recorded by each Fund as unrealized gains or losses. Each Fund will realize a gain or loss upon closing of a futures transaction.

 

F-20

 

 

Futures contracts involve, to varying degrees, elements of market risk (specifically exchange rate sensitivity, commodity price risk or equity market volatility risk) and exposure to loss in excess of the amount of variation margin. The face or contract amounts reflect the extent of the total exposure each Fund has in the particular classes of instruments. Additional risks associated with the use of futures contracts are imperfect correlation between movements in the price of the futures contracts and the market value of the underlying Index or commodity and the possibility of an illiquid market for a futures contract. With futures contracts, there is minimal but some counterparty risk to the Funds since futures contracts are exchange-traded and the credit risk resides with the Funds’ clearing broker or clearinghouse itself. Many futures exchanges and boards of trade limit the amount of fluctuation permitted in futures contract prices during a single trading day. Once the daily limit has been reached in a particular contract, no trades may be made that day at a price beyond that limit or trading may be suspended for specified times during the trading day. Futures contracts prices could move to the limit for several consecutive trading days with little or no trading, thereby preventing prompt liquidation of futures positions and potentially subjecting a Fund to substantial losses. If trading is not possible, or if a Fund determines not to close a futures position in anticipation of adverse price movements, the Fund will be required to make daily cash payments of variation margin. The risk the Fund will be unable to close out a futures position will be minimized by entering into such transactions on a national exchange with an active and liquid secondary market.

 

Option Contracts

 

An option is a contract that gives the buyer the right, but not the obligation, to buy or sell a specified quantity of a commodity or other instrument at a specific (or strike) price within a specified period of time, regardless of the market price of that instrument. There are two types of options: calls and puts. A call option conveys to the option buyer the right to purchase a particular futures contract at a stated price at any time during the life of the option. A put option conveys to the option buyer the right to sell a particular futures contract at a stated price at any time during the life of the option. Options written by a Fund may be wholly or partially covered (meaning that the Fund holds an offsetting position) or uncovered. In the case of the purchase of an option, the risk of loss of an investor’s entire investment (i.e., the premium paid plus transaction charges) reflects the nature of an option as a wasting asset that may become worthless when the option expires. Where an option is written or granted (i.e., sold) uncovered, the seller may be liable to pay substantial additional margin, and the risk of loss is unlimited, as the seller will be obligated to deliver, or take delivery of, an asset at a predetermined price which may, upon exercise of the option, be significantly different from the market value.

 

When a Fund writes a call or put, an amount equal to the premium received is recorded and subsequently marked to market to reflect the current value of the option written. Premiums received from writing options which expire are treated as realized gains. Premiums received from writing options which are exercised or closed are added to the proceeds or offset against amounts paid on the underlying futures, swap or security transaction to determine the realized gain (loss).

 

When a Fund purchases an option, the Fund pays a premium which is included as an asset on the Statement of Financial Condition and subsequently marked to market to reflect the current value of the option. Premiums paid for purchasing options which expire are treated as realized losses. The risk associated with purchasing put and call options is limited to the premium paid. Premiums paid for purchasing options which are exercised or closed are added to the amounts paid or offset against the proceeds on the underlying investment transaction to determine the realized gain (loss) when the underlying transaction is executed.

 

Certain options transactions may subject the writer (seller) to unlimited risk of loss in the event of an increase in the price of the contract to be purchased or delivered. The value of a Fund’s options transactions, if any, will be affected by, among other things, changes in the value of a Fund’s underlying benchmark relative to the strike price, changes in interest rates, changes in the actual and implied volatility of the Fund’s underlying benchmark, and the remaining time until the options expire, or any combination thereof. The value of the options should not be expected to increase or decrease at the same rate as the level of the Fund’s underlying benchmark, which may contribute to tracking error. Options may be less liquid than certain other securities. A Fund’s ability to trade options will be dependent on the willingness of counterparties to trade such options with the Fund. In a less liquid market for options, a Fund may have difficulty closing out certain option positions at desired times and prices. A Fund may experience substantial downside from specific option positions and certain option positions may expire worthless. Over-the-counter options generally are not assignable except by agreement between the parties concerned, and no party or purchaser has any obligation to permit such assignments. The over-the-counter market for options is relatively illiquid, particularly for relatively small transactions. The use of options transactions exposes a Fund to liquidity risk and counterparty credit risk, and in certain circumstances may expose the Fund to unlimited risk of loss. The Funds may buy and sell options on futures contracts, which may present even greater volatility and risk of loss.

 

F-21

 

 

Swap Agreements

 

The Funds may enter into swap agreements for purposes of pursuing their investment objectives or as a substitute for investing directly in (or shorting) an underlying Index or to create an economic hedge against a position. Swap agreements are two-party contracts that have traditionally been entered into primarily with institutional investors in over-the-counter (“OTC”) markets for a specified period, ranging from a day to more than one year. However, the Dodd-Frank Wall Street Reform and Consumer Protection Act (the “Dodd-Frank Act”) provides for significant reforms of the OTC derivative markets, including a requirement to execute certain swap transactions on a CFTC-regulated market and/or to clear such transactions through a CFTC-regulated central clearing organization. In a standard swap transaction, two parties agree to exchange the returns earned or realized on a particular predetermined investment, instrument or Index in exchange for a fixed or floating rate of return in respect of a predetermined notional amount. Transaction or commission costs are reflected in the benchmark level at which the transaction is entered into. The gross returns to be exchanged are calculated with respect to a notional amount and the benchmark returns to which the swap is linked. Swap agreements do not involve the delivery of underlying instruments.

 

Generally, swap agreements entered into by the Funds calculate and settle the obligations of the parties to the agreement on a “net basis” with a single payment. Consequently, each Fund’s current obligations (or rights) under a swap agreement will generally be equal only to the net amount to be paid or received under the agreement based on the relative values of such obligations (or rights) (the “net amount”). In a typical swap agreement entered into by UVIX, the would be entitled to settlement payments in the event the level of the benchmark increases and would be required to make payments to the swap counterparties in the event the level of the benchmark decreases, adjusted for any transaction costs or trading spreads on the notional amount the Funds may pay. In a typical swap agreement entered into by SVIX, the Fund would be required to make payments to the swap counterparties in the event the level of the benchmark increases and would be entitled to settlement payments in the event the level of the benchmark decreases, adjusted for any transaction costs or trading spreads on the notional amount the Funds may pay.

 

The net amount of the excess, if any, of each Fund’s obligations over its entitlements with respect to each OTC swap agreement is accrued on a daily basis and an amount of cash and/or securities having an aggregate value at least equal to such accrued excess is maintained for the benefit of the counterparty in a segregated account by the Funds’ Custodian. The net amount of the excess, if any, of each Fund’s entitlements over its obligations with respect to each OTC swap agreement is accrued on a daily basis and an amount of cash and/or securities having an aggregate value at least equal to such accrued excess is maintained for the benefit of the Fund in a segregated account by a third party custodian. Until a swap agreement is settled in cash, the gain or loss on the notional amount less any transaction costs or trading spreads payable by each Fund on the notional amount are recorded as “unrealized appreciation or depreciation on swap agreements” and, when cash is exchanged, the gain or loss realized is recorded as “realized gains or losses on swap agreements.” Swap agreements are generally valued at the last settled price of the benchmark referenced asset.

 

Swap agreements contain various conditions, events of default, termination events, covenants and representations. The triggering of certain events or the default on certain terms of the agreement could allow a party to terminate a transaction under the agreement and request immediate payment in an amount equal to the net positions owed to the party under the agreement. This could cause a Fund to have to enter into a new transaction with the same counterparty, enter into a transaction with a different counterparty or seek to achieve its investment objective through any number of different investments or investment techniques.

 

Swap agreements involve, to varying degrees, elements of market risk and exposure to loss in excess of the unrealized gain/loss reflected. The notional amounts reflect the extent of the total investment exposure each Fund has under the swap agreement, which may exceed the NAV of each Fund. Additional risks associated with the use of swap agreements are imperfect correlations between movements in the notional amount and the price of the underlying reference Index and the inability of counterparties to perform. Each Fund bears the risk of loss of the amount expected to be received under a swap agreement in the event of the default or bankruptcy of a swap agreement counterparty. A Fund will typically enter into swap agreements only with major global financial institutions. The creditworthiness of each of the firms that is a party to a swap agreement is monitored by the Sponsor. The Sponsor may use various techniques to minimize credit risk including early termination and payment, using different counterparties, limiting the net amount due from any individual counterparty and generally requiring collateral to be posted by the counterparty in an amount approximately equal to that owed to the Funds. Outstanding swap agreements contractually terminate within one month but may be terminated without penalty by either party at any time. Upon termination, the Fund is obligated to pay or receive the “unrealized appreciation or depreciation” amount.

 

F-22

 

 

The Funds, as applicable, collateralize swap agreements by segregating or designating cash and/or certain securities as indicated on the Statements of Financial Condition or Schedules of Investments. As noted above, collateral posted in connection with OTC derivative transactions is held for the benefit of the counterparty in a segregated tri-party account at the Custodian to protect the counterparty against non-payment by the Funds. The collateral held in this account is restricted as to its use. In the event of a default by the counterparty, the Funds will seek withdrawal of this collateral from the segregated account and may incur certain costs in exercising its right with respect to the collateral. If a counterparty becomes bankrupt or otherwise fails to perform its obligations due to financial difficulties, the Funds may experience significant delays in obtaining any recovery in a bankruptcy or other reorganizational proceeding. The Funds may obtain only limited recovery or may obtain no recovery in such circumstances.

 

The Funds remain subject to credit risk with respect to the amount they expect to receive from counterparties. However, the Funds have sought to mitigate these risks in connection with OTC swaps by generally requiring that the counterparties for each Fund agree to post collateral for the benefit of the Fund, marked to market daily, in an amount approximately equal to what the counterparty owes the Fund, subject to certain minimum thresholds. In the event of a bankruptcy of a counterparty, such Fund will have direct access to the collateral received from the counterparty, generally as of the day prior to the bankruptcy, because there is a one day time lag between the Fund’s request for collateral and the delivery of such collateral. To the extent any such collateral is insufficient, the Funds will be exposed to counterparty risk as described above, including the possible delays in recovering amounts as a result of bankruptcy proceedings.

 

The counterparty/credit risk for cleared derivative transactions is generally lower than for OTC derivatives since generally a clearing organization becomes substituted for each counterparty to a cleared derivative contract and, in effect, guarantees the parties’ performance under the contract as each party to a trade looks only to the clearing organization for performance of financial obligations. In addition, cleared derivative transactions benefit from daily marking-to-market and settlement, and segregation and minimum capital requirements applicable to intermediaries.

 

Fair Value of Derivative Instruments as of December 31, 2022

 

      Asset Derivatives   Liability Derivatives 
Derivatives Not Accounted for as Hedging Instruments  Fund  Statement of
Financial
Condition
Location
   Unrealized
Appreciation
   Statement of
Financial
Condition
Location
   Unrealized
Depreciation
 
VIX Futures Contracts  -1x Short VIX Futures ETF               $1,156,106                                    
   2x Long VIX Futures ETF                  (9,203,522)
   Total Trust                 $(8,047,416)

 

* Includes cumulative appreciation (depreciation) of futures contracts as reported in the Schedule of Investments. Only current day’s variation margin is reported within the Statements of Financial Condition in variation margin receivable/payable.

 

The Effect of Derivative Instruments on the Statement of Operations

For the Period Ended December 31, 2022

 

Derivatives Not Accounted for as hedging Instruments  Location of Gain
(Loss) on Derivatives
Recognized in income
  Fund  Realized Gain (Loss) on Derivatives Recognized in Income   Change in Unrealized Appreciation (Depreciation) on Derivatives Recognized in Income 
VIX Futures Contracts  Net realized gain (loss) on futures contracts/ changes in unrealized appreciation (depreciation) on futures contrats           
    -1x Short VIX Futures ETF  $16,573,816   $1,156,106 
      2x Long VIX Futures ETF   (67,298,870)   (9,203,522)
      Total Trust  $(50,725,054)  $(8,047,416)

 

F-23

 

 

The Effect of Derivative Instruments on the Statement of Operations

For the three months ended December 31, 2022

 

Offsetting Assets and Liabilities

 

Each Fund is subject to master netting agreements or similar arrangements that allow for amounts owed between each Fund and the counterparty to be netted upon an early termination. The party that has the larger payable pays the excess of the larger amount over the smaller amount to the other party. The master netting agreements or similar arrangements do not apply to amounts owed to/from different counterparties. As described above, the Funds utilize derivative instruments to achieve their investment objective during the year. The amounts shown in the Statements of Financial Condition do not take into consideration the effects of legally enforceable master netting agreements or similar arrangements.

 

For financial reporting purposes, the Funds do not offset derivative assets and derivative liabilities that are subject to netting arrangements in the Statements of Financial Condition. The following table presents each Fund’s derivatives by investment type and by counterparty net of amounts available for offset under a master netting agreement and the related collateral received or pledged by the Funds as of December 31, 2022.

 

Fair Values of Derivative Instruments as of December 31, 2022
   Assets   Liabilities 
Fund  Gross
Amounts of
Recognized
Assets
presented
in the
Statements of
Financial
Condition
   Gross
Amounts
Offset
in the
Statements of
Financial
Condition
   Net
Amounts of
Assets
presented
in the
Statements of
Financial
Condition
   Gross
Amounts of
Recognized
Liabilities
presented
in the
Statements of
Financial
Condition
   Gross
Amounts
Offset
in the
Statements of
Financial
Condition
   Net
Amounts of
Liabilities
presented
in the
Statements of
Financial
Condition
 
-1x Short VIX Futures ETF  $          -   $          -   $          -   $187,030   $          -   $187,030 
2x Long VIX Futures ETF   830,840    -    830,840    -    -    - 

 

Asset (Liability) amounts shown in the table below represent amounts owed to (by) the Funds for the derivative-related investments at December 31, 2022. These amounts may be collateralized by cash or financial instruments, segregated for the benefit of the Funds or the counterparties, depending on whether the related contracts are in an appreciated or depreciated position at period end. Amounts shown in the column labeled “Net Amount” represent the uncollateralized portions of these amounts at period end. These amounts may be un-collateralized due to timing differences related to market movements or due to minimum thresholds for collateral movement, as further described above under the caption “Accounting for Derivative Instruments”.

 

F-24

 

 

Gross Amounts Not Offset in the Statements of Financial Condition as of December 31, 2022
Fund  Amounts of
Recognized
Assets /
(Liabilities)
presented
in the
Statements of
Financial
Condition
   Financial
Instruments for
the Benefit of
(the Funds) /
the
Counterparties
   Cash
Collateral for
the Benefit of
(the Funds) /
the
Counterparties
   Net
Amount
 
-1x Short VIX Futures ETF  $(187,030)  $              -   $            -   $(187,030)
2x Long VIX Futures ETF   830,840    -    -    830,840 

 

NOTE 4 – AGREEMENTS

 

Management Fee

 

SVIX pays the Sponsor a management fee (the “Management Fee”), monthly in arrears, in an amount equal to 1.35% per annum of its average daily net assets. UVIX pays the Sponsor a Management Fee, monthly in arrears, in an amount equal to 1.65% per annum of its average daily net assets. “Average daily net assets” is calculated by dividing the month-end net assets of each Fund by the number of calendar days in such month.

 

No other Management Fee is paid by the Funds. The Management Fee is paid in consideration of the Sponsor’s trading advisory services and the other services provided to the Fund that the Sponsor pays directly.

 

Pursuant to the Sponsor Agreement between Sponsor and the Trust, on behalf of the Funds, the Sponsor oversees and pays Milliman FRM (“Commodity Sub-Adviser”) for its services as Commodity Sub-Adviser. The Commodity Sub-Adviser is paid by the Sponsor an annual sub-advisory fee of 0.25% based on each Fund’s average daily net assets (total assets of the Fund, minus the sum of its accrued liabilities). The commodity sub-advisory fee is waived for the first 6 months of each Fund’s operations or until a Fund reaches $35 million in average daily net assets. The Funds do not directly pay the Commodity Sub-Adviser.

 

Non-Recurring Fees and Expenses

 

Each Fund pays all its non-recurring and unusual fees and expenses, if any, as determined by the Sponsor. Non-recurring and unusual fees and expenses are fees and expenses that are unexpected or unusual in nature, such as legal claims and liabilities, litigation costs or indemnification or other material expenses which are not currently anticipated obligations of the Funds.

 

The Administrator, Transfer Agent and Custodian

 

U.S. Bancorp Fund Services, LLC, doing business as U.S. Bank Global Fund Services (“Fund Services”), an indirect subsidiary of U.S. Bancorp, serves as the Fund’s fund accountant, administrator and transfer agent pursuant to certain fund accounting servicing, fund administration servicing and transfer agent servicing agreements. U.S. Bank National Association, a subsidiary of U.S. Bancorp and parent company of Fund Services, intends to serve as the Fund’s custodian pursuant to a custody agreement.

 

F-25

 

 

The Marketing Agent

 

Foreside Fund Services, LLC (the “Marketing Agent”) serves as the Marketing Agent of the Funds. Its principal duties are: (i) to work with the Transfer Agent to review and approve orders placed by Authorized Participants and transmitted to the Transfer Agent; (ii) maintain copies of confirmations of Creation Unit creation and redemption order acceptances; (iii) maintain telephonic, facsimile and/or access to direct computer communications links with the Transfer Agent; and (iv) review and approve, prior to use, all Trust marketing materials for compliance with applicable SEC and FINRA advertising rules.

 

The Marketing Agent retains all marketing materials separately for the Funds, at their offices located at Three Canal Plaza, Suite 100 Portland, Maine 04101.

 

As compensation for the services it provides, the Marketing Agent receives a fee from the Funds.

 

NOTE 5 – OFFERING COSTS

 

Offering costs will be amortized by the Funds over a twelve month period on a straight-line basis beginning once the fund commences operations. The Sponsor will not charge its Management Fee in the first year of operations of a Fund in an amount equal to the offering costs. Normal and expected expenses incurred in connection with the continuous offering of Shares of a Fund after the commencement of its trading operations will be paid by the Sponsor.

 

NOTE 6 – CREATION AND REDEMPTION OF CREATION UNITS

 

Each Fund issues and redeems shares from time to time, but only in one or more Creation Units. A Creation Unit is a block of at least 10,000 Shares of a Fund. Creation Units may be created or redeemed only by Authorized Participants.

 

Except when aggregated in Creation Units, the Shares are not redeemable securities. Retail investors, therefore, generally will not be able to purchase or redeem Shares directly from or with a Fund. Rather, most retail investors will purchase or sell Shares in the secondary market with the assistance of a broker. Thus, some of the information contained in these Notes to Financial Statements—such as references to the Transaction Fees imposed on purchases and redemptions is not relevant to retail investors.

 

Transaction Fees on Creation and Redemption Transactions

 

The manner by which Creation Units are purchased or redeemed is governed by the terms of the Authorized Participant Agreement and Authorized Participant Procedures Handbook. By placing a purchase order, an Authorized Participant agrees to: (1) deposit cash with the Custodian; and (2) if permitted by the Sponsor in its sole discretion, enter into or arrange for an exchange of futures contract for related position or block trade with the relevant fund whereby the Authorized Participant would also transfer to such Fund a number and type of exchange-traded futures contracts at or near the closing settlement price for such contracts on the purchase order date.

 

Authorized Participants may pay a fee up to 0.03% of the value of each order they place with each order to create or redeem a Creation Unit in order to compensate the Administrator, the Custodian and the Transfer Agent of each Fund and its Shares, for services in processing the creation and redemption of Creation Units and to offset the costs of increasing or decreasing derivative positions, unless the transaction fee is waived or otherwise adjusted by the Sponsor. The Sponsor provides such Authorized Participant with prompt notice in advance of any such waiver or adjustment of the transaction fee. Authorized Participants may sell the Shares included in the Creation Units they purchase from the Funds to other investors in the secondary market.

 

Transaction Fees for the period ended December 31, 2022:

 

Fund  Period
Ended
December 31,
2022
 
-1x Short VIX Futures ETF  $105,025 
2x Long VIX Futures ETF   178,809 
Total Trust  $283,834 

 

F-26

 

 

NOTE 7 – FINANCIAL HIGHLIGHTS

 

Selected data is for a Share outstanding throughout the period ended December 31, 2022:

 

VS Trust

Financial Highlights

 

   -1x Short VIX Futures ETF   2x Long VIX Futures ETF 
   Period Ended
December 31,
2022(1)
   Period Ended
December 31,
2022(1)
 
Net Asset Value, Beginning of Period  $15.00   $15.00 
Net investment loss per share (2)   (0.18)   (0.15)
Net Realized and Unrealized Gain (Loss) on Investments and Futures Contracts (3)   (0.19)   (9.00)
Net Increase (Decrease) in Net Asset Value Resulting from Operations   (0.37)   (9.15)
Net Asset Value, End of Period  $14.63   $5.85 
Market Value Per Share, at December 31, 2022 (4)  $14.66   $5.82 
Total Return at Net Asset Value (5)   (2.47)%   (61.00)%
Total Return at Market Value (5)   (2.27)%   (61.20)%
           
Ratios to Average Net Assets: (6)          
Expense ratio (7)   2.41%   2.46%
Net Investment Loss   (2.03)%   (1.96)%

 

(1)Both Funds commenced operations on March 28, 2022.
(2)Net investment loss per share represents net investment loss divided by the daily average shares of beneficial interest outstanding during the period.
(3)Due to timing of capital share transactions, per share amounts may not compare with amounts appearing elsewhere within these Financial Statements.
(4)Market values are determined at the close of the applicable primary listing exchange, which may be later than when the Funds’ net asset value is calculated.
(5)Percentages are not annualized for the period ended December 31, 2022.
(6)Percentages are annualized.
(7)The expense ratio would be 2.29% and 2.39% respectively, if brokerage commissions and futures and futures account fees were excluded.

 

F-27

 

 

NOTE 8 – RISK

 

Correlation and Compounding Risk

 

The Funds do not seek to achieve their stated investment objective over a period of time greater than a single day (as measured from NAV calculation time to NAV calculation time). The return of a Fund for a period longer than a single day is the result of its return for each day compounded over the period and usually will differ in amount and possibly even direction from the inverse (-1x) or two times (2x) the return of the Fund’s benchmark for the period. A Fund will lose money if its benchmark performance is flat over time, and it is possible for a Fund to lose money over time even if the performance of its benchmark increases in the case of UVIX (or decreases in the case of SVIX), as a result of daily rebalancing, the benchmark’s volatility, compounding, and other factors. Compounding is the cumulative effect of applying investment gains and losses and income to the principal amount invested over time. Gains or losses experienced over a given period will increase or reduce the principal amount invested from which the subsequent period’s returns are calculated. The effects of compounding will likely cause the performance of a Fund to differ from the Fund’s stated multiple times the return of its benchmark for the same period. The effect of compounding becomes more pronounced as benchmark volatility and holding period increase. The impact of compounding will impact each shareholder differently depending on the period of time an investment in a Fund is held and the volatility of the benchmark during the holding period of an investment in the Fund. Longer holding periods, higher benchmark volatility, inverse exposure and greater leverage each affect the impact of compounding on a Fund’s returns. Daily compounding of a Fund’s investment returns can dramatically and adversely affect its longer-term performance during periods of high volatility. Volatility may be at least as important to a Fund’s return for a period as the return of the Fund’s underlying benchmark.

 

Each Fund uses leverage and should produce daily returns that are more volatile than that of its benchmark. For example, the daily return of UVIX should be approximately two times as volatile on a daily basis as is the return of a fund with an objective of matching the same benchmark. The daily return of SVIX is designed to return the inverse (-1x) of the return that would be expected of a fund with an objective of matching the same benchmark. The Funds are not appropriate for all investors and present significant risks not applicable to other types of funds. The Funds use leverage and are riskier than similarly benchmarked exchange-traded funds that do not use leverage. An investor should only consider an investment in a Fund if he or she understands the consequences of seeking daily leveraged or daily inverse investment results. Shareholders who invest in the Funds should actively manage and monitor their investments, as frequently as daily.

 

While the Funds seek to meet their investment objectives, there is no guarantee they will do so. Factors that may affect a Fund’s ability to meet its investment objective include: (1) the Sponsor’s ability to purchase and sell Financial Instruments in a manner that correlates to a Fund’s objective; (2) an imperfect correlation between the performance of Financial Instruments held by a Fund and the performance of the applicable benchmark; (3) bid-ask spreads on such Financial Instruments; (4) fees, expenses, transaction costs, financing costs associated with the use of Financial Instruments and commission costs; (5) holding or trading instruments in a market that has become illiquid or disrupted; (6) a Fund’s Share prices being rounded to the nearest cent and/or valuation methodology; (7) changes to a benchmark Index that are not disseminated in advance; (8) the need to conform a Fund’s portfolio holdings to comply with investment restrictions or policies or regulatory or tax law requirements; (9) early and unanticipated closings of the markets on which the holdings of a Fund trade, resulting in the inability of the Fund to execute intended portfolio transactions; (10) accounting standards; and (11) differences caused by a Fund obtaining exposure to only a representative sample of the components of a benchmark, over weighting or under weighting certain components of a benchmark or obtaining exposure to assets that are not included in a benchmark.

 

F-28

 

 

A number of factors may affect a Fund’s ability to achieve a high degree of correlation with its benchmark, and there can be no guarantee that a Fund will achieve a high degree of correlation. Failure to achieve a high degree of correlation may prevent a Fund from achieving its investment objective. In order to achieve a high degree of correlation with their underlying benchmarks, the Funds seek to rebalance their portfolios daily to keep exposure consistent with their investment objectives. Being materially under- or over-exposed to the benchmark may prevent such Funds from achieving a high degree of correlation with such benchmark. Market disruptions or closure, large amounts of assets into or out of the Funds, regulatory restrictions, extreme market volatility, and other factors will adversely affect such Funds’ ability to adjust exposure to requisite levels. The target amount of portfolio exposure is impacted dynamically by the benchmarks’ movements during each day. Other things being equal, more significant movement in the value of its benchmark up or down will require more significant adjustments to a Fund’s portfolio. Because of this, it is unlikely that the Funds will be perfectly exposed (i.e., --1x, -2x, as applicable) to its benchmark at the end of each day, and the likelihood of being materially under- or over-exposed is higher on days when the benchmark levels are volatile near the close of the trading day.

 

Each Fund seeks to rebalance its portfolio on a daily basis. The time and manner in which a Fund rebalances its portfolio may vary from day to day depending upon market conditions and other circumstances at the discretion of the Sponsor. Unlike other funds that do not rebalance their portfolios as frequently, each Fund may be subject to increased trading costs associated with daily portfolio rebalancing in order to maintain appropriate exposure to the underlying benchmarks.

 

Counterparty Risk

 

Each Fund may use derivatives such as swap agreements and forward contracts (collectively referred to herein as “derivatives”) in the manner described herein as a means to achieve their respective investment objectives. The use of derivatives by a Fund exposes the Fund to counterparty risks.

 

Regulatory Treatment

 

Derivatives are generally traded in OTC markets and have only recently become subject to comprehensive regulation in the United States. Cash-settled forwards are generally regulated as “swaps”, whereas physically settled forwards are generally not subject to regulation (in the case of commodities other than currencies) or subject to the federal securities laws (in the case of securities). Title VII of the Dodd-Frank Act (“Title VII”) created a regulatory regime for derivatives, with the CFTC responsible for the regulation of swaps and the SEC responsible for the regulation of “security-based swaps.” The SEC requirements have largely yet to be made effective, but the CFTC requirements are largely in place. The CFTC requirements have included rules for some of the types of transactions in which the Funds will engage, including mandatory clearing and exchange trading, reporting, and margin for OTC swaps. Title VII also created new categories of regulated market participants, such as “swap dealers,” “security-based swap dealers,” “major swap participants,” and “major security-based swap participants” who are, or will be, subject to significant new capital, registration, recordkeeping, reporting, disclosure, business conduct and other regulatory requirements. The regulatory requirements under Title VII continue to be developed and there may be further modifications that could materially and adversely impact the Funds, the markets in which a Fund trades and the counterparties with which the Fund engages in transactions.

 

As noted, the CFTC rules may not apply to all of the swap agreements and forward contracts entered into by the Funds. Investors, therefore, may not receive the protection of CFTC regulation or the statutory scheme of the Commodity Exchange Act (the “CEA”) in connection with each Fund’s swap agreements or forward contracts. The lack of regulation in these markets could expose investors to significant losses under certain circumstances, including in the event of trading abuses or financial failure by participants.

 

Counterparty Credit Risk

 

The Funds will be subject to the credit risk of the counterparties to the derivatives. In the case of cleared derivatives, the Funds will have credit risk to the clearing corporation in a similar manner as the Funds would for futures contracts. In the case of OTC derivatives, the Funds will be subject to the credit risk of the counterparty to the transaction – typically a single bank or financial institution. As a result, a Fund is subject to increased credit risk with respect to the amount it expects to receive from counterparties to OTC derivatives entered into as part of that Fund’s principal investment strategy. If a counterparty becomes bankrupt or otherwise fails to perform its obligations due to financial difficulties, a Fund could suffer significant losses on these contracts and the value of an investor’s investment in a Fund may decline.

 

The Funds have sought to mitigate these risks by generally requiring that the counterparties for each Fund agree to post collateral for the benefit of the Fund, marked to market daily, subject to certain minimum thresholds. However, there are no limitations on the percentage of assets each Fund may invest in swap agreements or forward contracts with a particular counterparty. To the extent any such collateral is insufficient or there are delays in accessing the collateral, the Funds will be exposed to counterparty risk as described above, including possible delays in recovering amounts as a result of bankruptcy proceedings. The Funds typically enter into transactions only with major global financial institutions.

 

F-29

 

 

OTC derivatives of the type that may be utilized by the Funds are generally less liquid than futures contracts because they are not traded on an exchange, do not have uniform terms and conditions, and are generally entered into based upon the creditworthiness of the parties and the availability of credit support, such as collateral, and in general, are not transferable without the consent of the counterparty. These agreements contain various conditions, events of default, termination events, covenants and representations. The triggering of certain events or the default on certain terms of the agreement could allow a party to terminate a transaction under the agreement and request immediate payment in an amount equal to the net positions owed to the party under the agreement. For example, if the level of the Fund’s benchmark has a dramatic intraday move that would cause a material decline in the Fund’s NAV, the terms of the swap may permit the counterparty to immediately close out the transaction with the Fund. In that event, it may not be possible for the Fund to enter into another swap or to invest in other Financial Instruments necessary to achieve the desired exposure consistent with the Fund’s objective. This, in turn, may prevent the Fund from achieving its investment objective, particularly if the level of the Fund’s benchmark reverses all or part of its intraday move by the end of the day.

 

In addition, cleared derivatives benefit from daily marking-to-market and settlement, and segregation and minimum capital requirements applicable to intermediaries. To the extent the Fund enters into cleared swap transactions, the Fund will deposit collateral with a FCM in cleared swaps customer accounts, which are required by CFTC regulations to be separate from its proprietary collateral posted for cleared swaps transactions. Cleared swap customer collateral is subject to regulations that closely parallel the regulations governing customer segregated funds for futures transactions but provide certain additional protections to cleared swaps collateral in the event of a clearing broker or clearing broker customer default. For example, in the event of a default of both the clearing broker and a customer of the clearing broker, a clearing house is only permitted to access the cleared swaps collateral in the legally separate (but operationally comingled) account of the defaulting cleared swap customer of the clearing broker, as opposed to the treatment of customer segregated funds, under which the clearing house may access all of the commingled customer segregated funds of a defaulting clearing broker. Derivatives entered into directly between two counterparties do not necessarily benefit from such protections, particularly if entered into with an entity that is not registered as a “swap dealer” with the CFTC. This exposes the Funds to the risk that a counterparty will not settle a transaction in accordance with its terms and conditions because of a dispute over the terms of the contract (whether or not bona fide) or because of a credit or liquidity problem, thus causing the Funds to suffer a loss.

 

The Sponsor regularly reviews the performance of its counterparties for, among other things, creditworthiness and execution quality. In addition, the Sponsor periodically considers the addition of new counterparties and the counterparties used by a Fund may change at any time. Each day, the Funds disclose their portfolio holdings as of the prior Business Day. Each Fund’s portfolio holdings identifies its counterparties, as applicable. This portfolio holdings information may be accessed through the web on the Sponsor’s website at www.volatilityshares.com.

 

Each counterparty and/or any of its affiliates may be an Authorized Participant or shareholder of a Fund, subject to applicable law.

 

The counterparty risk for cleared derivatives transactions is generally lower than for OTC derivatives. Once a transaction is cleared, the clearing organization is substituted and is a Fund’s counterparty on the derivative. The clearing organization guarantees the performance of the other side of the derivative. Nevertheless, some risk remains, as there is no assurance that the clearing organization, or its members, will satisfy its obligations to a Fund.

 

Leverage Risk

 

The Funds may utilize leverage in seeking to achieve their respective investment objectives and will lose more money in market environments adverse to their respective daily investment objectives than funds that do not employ leverage. The use of leveraged and/or inverse leveraged positions increases the risk of total loss of an investor’s investment, even over periods as short as a single day.

 

For example, because UVIX includes a two times (2x) multiplier, a single-day movement in the relevant benchmark approaching 50% at any point in the day could result in the total loss or almost total loss of an investor’s investment if that movement is contrary to the investment objective of the Fund in which an investor has invested, even if such Fund’s benchmark subsequently moves in an opposite direction, eliminating all or a portion of the movement. This would be the case with downward single-day or intraday movements in the underlying benchmark of a Fund or upward single-day or intraday movements in the benchmark of a Fund, even if the underlying benchmark maintains a level greater than zero at all times.

 

Liquidity Risk

 

Financial Instruments cannot always be liquidated at the desired price. It is difficult to execute a trade at a specific price when there is a relatively small volume of buy and sell orders in a market. A market disruption can also make it difficult to liquidate a position or find a swap or forward contract counterparty at a reasonable cost. Market illiquidity may cause losses for the Funds. The large size of the positions which the Funds may acquire increases the risk of illiquidity by both making their positions more difficult to liquidate and increasing the losses incurred while trying to do so. Any type of disruption or illiquidity will potentially be exacerbated due to the fact that the Funds will typically invest in Financial Instruments related to one benchmark, which in many cases is highly concentrated.

 

F-30

 

 

“Contango” and “Backwardation” Risk

 

The Funds typically hold futures contracts. As the futures contracts near expiration, they are generally replaced by contracts that have a later expiration. Thus, for example, a contract purchased and held in November 2019 may specify a January 2020 expiration. As that contract nears expiration, it may be replaced by selling the January 2020 contract and purchasing the contract expiring in March 2020. This process is referred to as “rolling.” Rolling may have a positive or negative impact on performance. For example, historically, the prices of certain types of futures contracts have frequently been higher for contracts with shorter-term expirations than for contracts with longer-term expirations, which is referred to as “backwardation.” In these circumstances, absent other factors, the sale of the January 2020 contract would take place at a price that is higher than the price at which the March 2020 contract is purchased, thereby creating a gain in connection with rolling. While certain types of futures contracts have historically exhibited consistent periods of backwardation, backwardation will likely not exist in these markets at all times.

 

Since the introduction of VIX futures contracts, there have frequently been periods where VIX futures prices reflect higher expected volatility levels further out in time. This can result in a loss from “rolling” the VIX futures to maintain the constant weighted average maturity of the applicable Fund benchmark. Losses from exchanging a lower priced VIX future for a higher priced longer-term future in the rolling process could adversely affect the value of a Fund and, accordingly, decrease the return of a Fund.

 

Natural Disaster/Epidemic Risk

 

Natural or environmental disasters, such as earthquakes, fires, floods, hurricanes, tsunamis and other severe weather-related phenomena generally, and widespread disease, including pandemics and epidemics (for example, the novel coronavirus COVID-19), have been and can be highly disruptive to economies and markets and have recently led, and may continue to lead, to increased market volatility and significant market losses. Such natural disaster and health crises could exacerbate political, social, and economic risks previously mentioned, and result in significant breakdowns, delays, shutdowns, social isolation, and other disruptions to important global, local and regional supply chains affected, with potential corresponding results on the operating performance of the Funds and their investments. A climate of uncertainty and panic, including the contagion of infectious viruses or diseases, may adversely affect global, regional, and local economies and reduce the availability of potential investment opportunities, and increases the difficulty of performing due diligence and modeling market conditions, potentially reducing the accuracy of financial projections. Under these circumstances, the Funds may have difficulty achieving their investment objectives which may adversely impact performance. Further, such events can be highly disruptive to economies and markets, significantly disrupt the operations of individual companies (including, but not limited to, the Funds’ Sponsor and third party service providers), sectors, industries, markets, securities and commodity exchanges, currencies, interest and inflation rates, credit ratings, investor sentiment, and other factors affecting the value of the Funds’ investments. These factors can cause substantial market volatility, exchange trading suspensions and closures and can impact the ability of the Funds to complete redemptions and otherwise affect Fund performance and Fund trading in the secondary market. A widespread crisis may also affect the global economy in ways that cannot necessarily be foreseen at the current time. How long such events will last and whether they will continue or recur cannot be predicted. Impacts from these events could have significant impact on a Fund’s performance, resulting in losses to your investment.

 

Risk that Current Assumptions and Expectations Could Become Outdated As a Result of Global Economic Shocks

 

The onset of the novel coronavirus (COVID-19) has caused significant shocks to global financial markets and economies, with many governments taking extreme actions to slow and contain the spread of COVID-19. These actions have had, and likely will continue to have, a severe economic impact on global economies as economic activity in some instances has essentially ceased. Financial markets across the globe are experiencing severe distress at least equal to what was experienced during the global financial crisis in 2008. In March 2020, U.S. equity markets entered a bear market in the fastest such move in the history of U.S. financial markets. Contemporaneous with the onset of the COVID-19 pandemic in the US, oil experienced shocks to supply and demand, impacting the price and volatility of oil. The global economic shocks being experienced as of the date hereof may cause the underlying assumptions and expectations of the Funds to become outdated quickly or inaccurate, resulting in significant losses.

 

NOTE 9 – SUBSEQUENT EVENTS

 

Management has evaluated the possibility of subsequent events existing in the Trust’s and the Funds’ financial statements through the date the financial statements were issued. On January 11, 2023, the Trust announced a 1-for-5 reverse share split (a “Reverse Split”) of the shares of beneficial interest of 2x Long VIX Futures ETF (ticker symbol: UVIX). The Reverse Split was effective prior to market open on January 25, 2023, when the fund began trading at its post-split price. The Reverse Split increased the price per share of the fund with a proportionate decrease in the number of shares outstanding. Therefore, the Reverse Split did not change the aggregate net asset value of a shareholder’s investment at the time of the Reverse Split.

 

For UVIX shareholders who held a quantity of shares that was not an exact multiple of the Reverse Split ratio (i.e., not a multiple of 5), the Reverse Split resulted in the creation of a fractional share. Post-Reverse Split fractional shares were made available to be redeemed for cash and sent to the shareholder’s broker of record. This redemption may have caused some shareholders to realize gains or losses, which could have been a taxable event for those shareholders.

 

 

F-31

 

 

No Par Value false FY 0001793497 0001793497 2022-01-01 2022-12-31 0001793497 cik0001793497:OneShortVIXFuturesETFMember 2022-01-01 2022-12-31 0001793497 cik0001793497:TwoxLongVIXFuturesETFMember 2022-01-01 2022-12-31 0001793497 2023-02-28 0001793497 cik0001793497:OneShortVIXFuturesETFMember 2022-06-30 0001793497 cik0001793497:TwoxLongVIXFuturesETFMember 2022-06-30 0001793497 2022-06-30 0001793497 cik0001793497:OneShortVIXFuturesETFMember 2022-12-31 0001793497 cik0001793497:TwoxLongVIXFuturesETFMember 2022-12-31 0001793497 2022-12-31 0001793497 cik0001793497:OnexShortVIXFuturesETFMember 2022-12-31 0001793497 cik0001793497:OnexShortVIXFuturesETFMember 2022-01-01 2022-12-31 0001793497 cik0001793497:OnexShortVIXFuturesETFMember cik0001793497:CBOEVIXFUTUREJan23Member 2022-01-01 2022-12-31 0001793497 cik0001793497:OnexShortVIXFuturesETFMember cik0001793497:CBOEVIXFUTUREJan23Member 2022-12-31 0001793497 cik0001793497:OnexShortVIXFuturesETFMember cik0001793497:CBOEVIXFUTUREFeb23Member 2022-01-01 2022-12-31 0001793497 cik0001793497:OnexShortVIXFuturesETFMember cik0001793497:CBOEVIXFUTUREFeb23Member 2022-12-31 0001793497 cik0001793497:TwoxLongVIXFuturesETFMember 2022-01-01 2022-12-31 0001793497 cik0001793497:TwoxLongVIXFuturesETFMember cik0001793497:CBOEVIXFUTURESJan23Member 2022-01-01 2022-12-31 0001793497 cik0001793497:TwoxLongVIXFuturesETFMember cik0001793497:CBOEVIXFUTURESJan23Member 2022-12-31 0001793497 cik0001793497:TwoxLongVIXFuturesETFMember cik0001793497:CBOEVIXFUTURESFeb23Member 2022-01-01 2022-12-31 0001793497 cik0001793497:TwoxLongVIXFuturesETFMember cik0001793497:CBOEVIXFUTURESFeb23Member 2022-12-31 0001793497 cik0001793497:OneShortVIXFuturesETFMember 2022-01-01 2022-12-31 0001793497 cik0001793497:TwoXLongVIXFuturesETFMember 2022-01-01 2022-12-31 0001793497 cik0001793497:OneShortVIXFuturesETFMember 2021-12-31 0001793497 cik0001793497:TwoxLongVIXFuturesETFMember 2021-12-31 0001793497 2021-12-31 0001793497 cik0001793497:SVIXMember 2022-01-01 2022-12-31 0001793497 cik0001793497:UVIXMember 2022-01-01 2022-12-31 0001793497 cik0001793497:OneShortVIXFuturesETFMember us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member 2022-12-31 0001793497 cik0001793497:OneShortVIXFuturesETFMember cik0001793497:FuturesContractsMember us-gaap:FairValueInputsLevel1Member 2022-12-31 0001793497 cik0001793497:TwoxLongVIXFuturesETFMember us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member 2022-12-31 0001793497 cik0001793497:TwoxLongVIXFuturesETFMember cik0001793497:FuturesContractsMember us-gaap:FairValueInputsLevel1Member 2022-12-31 0001793497 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member 2022-12-31 0001793497 cik0001793497:FuturesContractsMember us-gaap:FairValueInputsLevel1Member 2022-12-31 0001793497 cik0001793497:AssetDerivativesMember cik0001793497:UnrealizedAppreciationMember 2022-12-31 0001793497 cik0001793497:OnexShortVIXFuturesETFMember 2022-10-01 2022-12-31 0001793497 cik0001793497:TwoXLongVIXFuturesETFMember 2022-10-01 2022-12-31 0001793497 2022-10-01 2022-12-31 0001793497 cik0001793497:OneShortVIXFuturesETFMember us-gaap:OtherLiabilitiesMember 2022-01-01 2022-12-31 0001793497 cik0001793497:TwoxLongVIXFuturesETFMember us-gaap:OtherAssetsMember 2022-01-01 2022-12-31 0001793497 cik0001793497:SVIXMember 2022-12-31 0001793497 cik0001793497:UVIXMember 2022-12-31 0001793497 cik0001793497:OneShortVIXFuturesETFMember 2022-10-01 2022-12-31 0001793497 cik0001793497:TwoxLongVIXFuturesETFMember 2022-10-01 2022-12-31 0001793497 cik0001793497:OneShortVIXFuturesETFMember srt:ScenarioPreviouslyReportedMember 2022-12-31 0001793497 cik0001793497:TwoxLongVIXFuturesETFMember srt:ScenarioPreviouslyReportedMember 2022-12-31 xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure
EX-4.3 2 f10k2022ex4-3_vstrust.htm DESCRIPTION OF SHARES OF BENEFICIAL INTEREST

 

DESCRIPTION OF SHARES OF BENEFICIAL INTEREST

 

The following summary describes in brief the shares of beneficial interest (“Shares”) in each of the two series (“Funds”) of VS Trust (the “Trust”) and certain aspects of the operation of the Trust, the Funds. Prospective investors should carefully review the Trust Agreement filed as an exhibit to the annual report on Form 10-K and consult with their own advisors concerning the implications to such prospective investors of investing in a series of a Delaware statutory trust. Capitalized terms used in this section and not otherwise defined shall have such meanings assigned to them under the annual report on Form 10-K.

 

Description of the Shares

 

The Funds issue common units of beneficial interest, or Shares, which represent units of fractional undivided beneficial interest in and ownership of the Funds.

 

The Shares may be purchased from the Funds or redeemed on a continuous basis, but only by Authorized Participants and only in blocks of Shares (“Creation Units”). Individual Shares may not be purchased or redeemed from the Funds. Shareholders that are not Authorized Participants may not purchase or redeem any Shares or Creation Units from the Funds.

 

The Funds

 

The Funds are separate series of the Trust. The Trust is formed and operated in a manner such that each Fund is liable only for obligations attributable to that Fund and shareholders of each Fund are not subject to the losses or liabilities of the other Fund, or any other series of the Trust. If any creditor or shareholder in a Fund asserted against the Fund a valid claim with respect to its indebtedness or Shares, the creditor or shareholder would only be able to recover money from that particular Fund and its assets. Accordingly, the debts, liabilities, obligations and expenses, or collectively, claims, incurred, contracted for or otherwise existing solely with respect to the Fund are enforceable only against the assets of the Fund, and not against any other series of the Trust or the Trust generally, or any of their respective assets. The assets of a Fund include only those funds and other assets that are paid to, held by or distributed to the Fund on account of and for the benefit of the Fund, including, without limitation, funds delivered to the Trust for the purchase of Shares or Creation Units in the Fund. This limitation on liability is referred to as the “Inter-Series Limitation on Liability.” The Inter-Series Limitation on Liability is expressly provided for under the DSTA, which provides that if certain conditions (as set forth in Section 3804(a)) are met, then the debts of any particular series will be enforceable only against the assets of such series and not against the assets of any other series of the Trust or the Trust generally.

 

The Trustee

 

Wilmington Trust Company, a Delaware trust company, is the sole Trustee of the Trust. The rights and duties of the Trustee and the Sponsor with respect to the offering of the Shares and Fund management and the shareholders are governed by the provisions of the DSTA and by the Trust Agreement. The Trustee will accept service of legal process on the Trust in the State of Delaware and will make certain filings under the DSTA. The Trustee does not owe any other duties to the Trust, the Sponsor or the shareholders of the Funds. The Trustee’s principal offices are located at 1100 North Market Street, Wilmington, Delaware 19890. The Trustee is unaffiliated with the Sponsor.

 

The Trustee is permitted to resign upon at least sixty (60) days’ notice to the Trust, provided, that any such resignation will not be effective until a successor Trustee is appointed by the Sponsor. The Trustee is compensated by a Fund, as appropriate, and is indemnified by the Fund, as appropriate, against any expenses it incurs relating to or arising out of the formation, operation or termination of the Fund, as appropriate, or the performance of its duties pursuant to the Trust Agreement, except to the extent that such expenses result from the gross negligence or willful misconduct of the Trustee. The Sponsor has the discretion to replace the Trustee.

 

Only the assets of the Trust and the Sponsor are subject to issuer liability under the federal securities laws for the information contained in this Prospectus and under federal securities laws with respect to the issuance and sale of the Shares. Under such laws, neither the Trustee, either in its capacity as Trustee or in its individual capacity, nor any director, officer or controlling person of the Trustee is, or has any liability as, the issuer or a director, officer or controlling person of the issuer of the Shares. The Trustee’s liability in connection with the issuance and sale of the Shares is limited solely to the express obligations of the Trustee set forth in the Trust Agreement.

 

Under the Trust Agreement, the Sponsor has exclusive management and control of all aspects of the Trust’s business. The Trustee has no duty or liability to supervise the performance of the Sponsor, nor will the Trustee have any liability for the acts or omissions of the Sponsor. The shareholders have no voice in the day-to-day management of the business and operations of a Fund and the Trust, other than certain limited voting rights as set forth in the Trust Agreement. In the course of its management of the business and affairs of a Fund and the Trust, the Sponsor may, in its sole and absolute discretion, appoint an affiliate or affiliates of the Sponsor as additional sponsors and retain such persons, including affiliates of the Sponsor, as it deems necessary to effectuate and carry out the purposes, business and objectives of the Trust.

 

Because the Trustee has no authority over the Trust’s operations, the Trustee itself is not registered in any capacity with the CFTC.

 

 

 

 

Shares Freely Transferable

 

The Shares of the Funds are listed for trading on the Exchange and provide institutional and retail investors with direct access to the Funds. Each Fund’s Shares may be bought and sold on Cboe BZX Exchange (the “Exchange”) like any other exchange-listed security.

 

Book-Entry Form

 

Individual certificates will not be issued for the Shares. Instead, global certificates are deposited by the Trust with DTC and registered in the name of Cede & Co., as nominee for DTC. The global certificates evidence all of the Shares outstanding at any time. Under the Trust Agreement, shareholders are limited to (1) participants in DTC such as banks, brokers, dealers and trust companies (“DTC Participants”), (2) those who maintain, either directly or indirectly, a custodial relationship with a DTC Participant (“Indirect Participants”), and (3) those banks, brokers, dealers, trust companies and others who hold interests in the Shares through DTC.

 

The Shares are only transferable through the book-entry system of DTC. Shareholders who are not DTC Participants may transfer their Shares through DTC by instructing the DTC Participant holding their Shares (or by instructing the Indirect Participant or other entity through which their Shares are held) to transfer the Shares. Transfers are made in accordance with standard securities industry practice.

 

Distributions

 

The Sponsor does not expect to make distributions. Depending on a Fund’s performance and an investor’s own tax situation, an investor’s income tax liability for his, her or its allocable share of the Fund’s net ordinary income or loss and capital gain or loss may exceed the capital gains an investor may realize from selling his, her or its Shares of the Fund in a taxable year.

 

Buying and Selling Shares

 

Most investors buy and sell Shares in secondary market transactions through brokers. Shares of each Fund trade on the Exchange under the ticker symbol listed in this Prospectus. Shares are bought and sold throughout the trading day like other publicly traded securities. When buying or selling Shares through a broker, most investors incur customary brokerage commissions and charges.

 

Authorized Participants

 

Each Fund continuously offers Shares in Creation Units to Authorized Participants. Shares of a Fund are to be offered to Authorized Participants in Creation Units at the Fund’s NAV.

 

Authorized Participants may offer to the public, from time to time, Shares of a Fund from any Creation Units they create. Shares of a Fund offered to the public by Authorized Participants are offered at a per Share market price that varies depending on, among other factors, the trading price of the Shares of a Fund on the Exchange, the NAV per Share and the supply of and demand for the Shares at the time of the offer. Shares initially comprising the same Creation Unit but offered by Authorized Participants to the public at different times may have different offering prices. Additionally, the price at which an Authorized Participant sells a Share may be higher or lower than the price paid by such Authorized Participant in connection with the creation of such Share in a Creation Unit.

 

Authorized Participants do not receive from a Fund, the Sponsor or any of their affiliates, any fee or other compensation in connection with their sale of Shares to the public, although investors are expected to be charged a customary commission by their brokers in connection with the purchase and sale of Shares that varies from investor to investor. Investors are encouraged to review the terms of their brokerage accounts for applicable charges.

 

 

 

 

 

EX-31.1 3 f10k2022ex31-1_vstrust.htm CERTIFICATION

Exhibit 31.1

 

Certification of Principal Executive Officer

Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

 

I, Justin Young, certify that:

 

1. I have reviewed this Annual Report on Form 10-K of VS Trust;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

  (a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

  (b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

  (c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

  (d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  (a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

  (b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: March 28, 2023 By:

/s/ Justin Young

  Name:  Justin Young
  Title: Principal Executive Officer
    VS Trust

 

 

EX-31.2 4 f10k2022ex31-2_vstrust.htm CERTIFICATION

Exhibit 31.2

 

Certification of Principal Financial and Accounting Officer

Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

 

I, Justin Young, certify that:

 

1. I have reviewed this Annual Report on Form 10-K of VS Trust;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

  (a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

  (b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

  (c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

  (d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  (a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

  (b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: March 28, 2023 By: /s/ Justin Young
  Name:  Justin Young
  Title: Principal Financial and Accounting Officer
    VS Trust

 

EX-32.1 5 f10k2022ex32-1_vstrust.htm CERTIFICATION

Exhibit 32.1

 

Certification of Principal Executive Officer

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

 

In connection with this Annual Report on Form 10-K for the year ended December 31, 2022 (the “Report”) of VS Trust (the “Registrant”) and each of its series, as filed with the U.S. Securities and Exchange Commission on the date hereof, I, Justin Young, the Principal Executive Officer of the Registrant, hereby certify, to the best of my knowledge, that:

 

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

 

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.

 

Date: March 28, 2023 By:

/s/ Justin Young

  Name:  Justin Young
  Title: Principal Executive Officer
    VS Trust

 

 

EX-32.2 6 f10k2022ex32-2_vstrust.htm CERTIFICATION

Exhibit 32.2

 

Certification of Principal Financial and Accounting Officer

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

 

In connection with this Annual Report on Form 10-K for the year ended December 31, 2022 (the “Report”) of VS Trust (the “Registrant”) and each of its series, as filed with the U.S. Securities and Exchange Commission on the date hereof, I, Justin Young, the Principal Financial and Accounting Officer of the Registrant, hereby certify, to the best of my knowledge, that:

 

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

 

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.

 

Date: March 28, 2023 By:

/s/ Justin Young

  Name:  Justin Young
  Title: Principal Financial and Accounting Officer
    VS Trust

 

 

GRAPHIC 7 image_001.jpg GRAPHIC begin 644 image_001.jpg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end GRAPHIC 8 image_002.jpg GRAPHIC begin 644 image_002.jpg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end GRAPHIC 9 image_003.jpg GRAPHIC begin 644 image_003.jpg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end EX-101.SCH 10 cik0001793497-20221231.xsd XBRL SCHEMA FILE 001 - Statement - Statement of Financial Condition link:presentationLink link:definitionLink link:calculationLink 001 - Statement - Statement of Financial Condition Alternate 0 link:presentationLink link:definitionLink link:calculationLink 001 - Statement - Statement of Financial Condition Alternate 1 link:presentationLink link:definitionLink link:calculationLink 002 - Statement - Schedule of Investments link:presentationLink link:definitionLink link:calculationLink 003 - Statement - Schedule of Investments (Parentheticals) link:presentationLink link:definitionLink link:calculationLink 004 - Statement - Statement of Operations link:presentationLink link:definitionLink link:calculationLink 005 - Statement - Statement of Changes in Net Assets link:presentationLink link:definitionLink link:calculationLink 006 - Statement - Statement of Cash Flows link:presentationLink link:definitionLink link:calculationLink 007 - Disclosure - Organization link:presentationLink link:definitionLink link:calculationLink 008 - Disclosure - Significant Accounting Policies link:presentationLink link:definitionLink link:calculationLink 009 - Disclosure - Investments link:presentationLink link:definitionLink link:calculationLink 010 - Disclosure - Agreements link:presentationLink link:definitionLink link:calculationLink 011 - Disclosure - Offering Costs link:presentationLink link:definitionLink link:calculationLink 012 - Disclosure - Creation and Redemption of Creation Units link:presentationLink link:definitionLink link:calculationLink 013 - Disclosure - Financial Highlights link:presentationLink link:definitionLink link:calculationLink 014 - Disclosure - Risk link:presentationLink link:definitionLink link:calculationLink 015 - Disclosure - Subsequent Events link:presentationLink link:definitionLink link:calculationLink 016 - Disclosure - Accounting Policies, by Policy (Policies) link:presentationLink link:definitionLink link:calculationLink 017 - Disclosure - Significant Accounting Policies (Tables) link:presentationLink link:definitionLink link:calculationLink 018 - Disclosure - Investments (Tables) link:presentationLink link:definitionLink link:calculationLink 019 - Disclosure - Creation and Redemption of Creation Units (Tables) link:presentationLink link:definitionLink link:calculationLink 020 - Disclosure - Financial Highlights (Tables) link:presentationLink link:definitionLink link:calculationLink 021 - Disclosure - Significant Accounting Policies (Details) link:presentationLink link:definitionLink link:calculationLink 022 - Disclosure - Significant Accounting Policies (Details) - Schedule of cut-off times and the times of the calculation of the funds link:presentationLink link:definitionLink link:calculationLink 023 - Disclosure - Significant Accounting Policies (Details) - Schedule of valuation of investments at using the fair value hierarchy link:presentationLink link:definitionLink link:calculationLink 024 - Disclosure - Investments (Details) - Schedule of fair value of derivative instruments link:presentationLink link:definitionLink link:calculationLink 025 - Disclosure - Investments (Details) - Schedule of effect of derivative instruments on the statement of operations link:presentationLink link:definitionLink link:calculationLink 026 - Disclosure - Investments (Details) - Schedule of pledged by funds fair values of derivative instruments link:presentationLink link:definitionLink link:calculationLink 027 - Disclosure - Investments (Details) - Schedule of gross amounts not offset in the statements of financial condition link:presentationLink link:definitionLink link:calculationLink 028 - Disclosure - Agreements (Details) link:presentationLink link:definitionLink link:calculationLink 029 - Disclosure - Creation and Redemption of Creation Units (Details) link:presentationLink link:definitionLink link:calculationLink 030 - Disclosure - Creation and Redemption of Creation Units (Details) - Schedule of transaction fees link:presentationLink link:definitionLink link:calculationLink 031 - Disclosure - Financial Highlights (Details) - Schedule of share outstanding link:presentationLink link:definitionLink link:calculationLink 032 - Disclosure - Risk (Details) link:presentationLink link:definitionLink link:calculationLink 000 - Document - Document And Entity Information link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 11 cik0001793497-20221231_cal.xml XBRL CALCULATION FILE EX-101.DEF 12 cik0001793497-20221231_def.xml XBRL DEFINITION FILE EX-101.LAB 13 cik0001793497-20221231_lab.xml XBRL LABEL FILE EX-101.PRE 14 cik0001793497-20221231_pre.xml XBRL PRESENTATION FILE XML 15 R1.htm IDEA: XBRL DOCUMENT v3.23.1
Document And Entity Information - USD ($)
12 Months Ended
Dec. 31, 2022
Feb. 28, 2023
Jun. 30, 2022
Document Information Line Items      
Entity Registrant Name VS Trust    
Document Type 10-K    
Current Fiscal Year End Date --12-31    
Entity Common Stock, Shares Outstanding   7,570,000  
Entity Public Float     $ 107,325,826
Amendment Flag false    
Entity Central Index Key 0001793497    
Entity Current Reporting Status Yes    
Entity Voluntary Filers No    
Entity Filer Category Non-accelerated Filer    
Entity Well-known Seasoned Issuer No    
Document Period End Date Dec. 31, 2022    
Document Fiscal Year Focus 2022    
Document Fiscal Period Focus FY    
Entity Small Business true    
Entity Emerging Growth Company true    
Entity Shell Company false    
Entity Ex Transition Period true    
ICFR Auditor Attestation Flag true    
Document Annual Report true    
Document Transition Report false    
Entity File Number 001-41280    
Entity Incorporation, State or Country Code DE    
Entity Tax Identification Number 84-6704517    
Entity Address, Address Line One 2000 PGA Boulevard    
Entity Address, Address Line Two Suite 4440    
Entity Address, City or Town Palm Beach Gardens    
Entity Address, State or Province FL    
Entity Address, Postal Zip Code 33408    
City Area Code (866)    
Local Phone Number 261-0273    
Entity Interactive Data Current Yes    
Auditor Firm ID 238    
Auditor Name TAIT, WELLER & BAKER LLP    
Auditor Location Philadelphia, Pennsylvania    
-1x Short VIX Futures ETF      
Document Information Line Items      
Trading Symbol SVIX    
Entity Public Float     46,889,371
Title of 12(b) Security -1x Short VIX Futures ETF    
Security Exchange Name CboeBZX    
2x Long VIX Futures ETF      
Document Information Line Items      
Trading Symbol UVIX    
Entity Public Float     $ 60,436,455
Title of 12(b) Security 2x Long VIX Futures ETF    
Security Exchange Name CboeBZX    
XML 16 R2.htm IDEA: XBRL DOCUMENT v3.23.1
Statement of Financial Condition
Dec. 31, 2022
USD ($)
$ / shares
shares
ASSETS  
Cash $ 504,600
Interest receivable 63,392
Prepaid expenses and other assets 25,961
Deposit at Broker for Futures 162,965,826
Other receivable 1,150
Total Assets 174,573,082
LIABILITIES  
Variation margin payable 187,030
Fund shares redeemed 1,903,018
Management fees payable 231,212
Administrative, accounting and custodian fees payable 35,826
Professional fees payable 328,685
Licensing and registration fees payable 19,942
Total Liabilities 2,705,713
Net Assets 171,867,369 [1]
NET ASSETS CONSIST OF:  
Paid-in capital 232,568,597
Total distributable earnings (accumulated deficit) (60,701,228)
Net Assets 171,867,369 [1]
NET ASSET VALUE:  
Net Assets $ 171,867,369 [1]
Shares Outstanding (in Shares) | shares 24,620,000 [2]
Investments in securities, at cost $ 8,250,285
ASSETS  
Investments in securities, at value 8,250,285
Receivable for shares sold 1,931,028
Variation margin receivable 830,840
-1x Short VIX Futures ETF  
ASSETS  
Cash 504,600
Interest receivable 12,909
Prepaid expenses and other assets 10,295
Deposit at Broker for Futures 48,144,554
Other receivable 571
Total Assets 48,672,929
LIABILITIES  
Variation margin payable 187,030
Fund shares redeemed 1,903,018
Management fees payable 54,374
Administrative, accounting and custodian fees payable 15,869
Professional fees payable 125,274
Licensing and registration fees payable 8,761
Total Liabilities 2,294,326
Net Assets 46,378,603
NET ASSETS CONSIST OF:  
Paid-in capital 29,386,125
Total distributable earnings (accumulated deficit) 16,992,478
Net Assets 46,378,603
NET ASSET VALUE:  
Net Assets $ 46,378,603
Shares Outstanding (in Shares) | shares 3,170,000 [2]
Net Asset Value, Offering and Redemption Price per Share (in Dollars per share) | $ / shares $ 14.63
Market Value per Share (Note 2) (in Dollars per share) | $ / shares $ 14.66
2x Long VIX Futures ETF  
ASSETS  
Cash
Interest receivable 50,483
Prepaid expenses and other assets 15,666
Deposit at Broker for Futures 114,821,272
Other receivable 579
Total Assets 125,900,153
LIABILITIES  
Management fees payable 176,838
Administrative, accounting and custodian fees payable 19,957
Professional fees payable 203,411
Licensing and registration fees payable 11,181
Total Liabilities 411,387
Net Assets 125,488,766
NET ASSETS CONSIST OF:  
Paid-in capital 203,182,472
Total distributable earnings (accumulated deficit) (77,693,706)
Net Assets 125,488,766
NET ASSET VALUE:  
Net Assets $ 125,488,766
Shares Outstanding (in Shares) | shares 21,450,000 [2]
Net Asset Value, Offering and Redemption Price per Share (in Dollars per share) | $ / shares $ 5.85
Market Value per Share (Note 2) (in Dollars per share) | $ / shares $ 5.82
Investments in securities, at cost $ 8,250,285
ASSETS  
Investments in securities, at value 8,250,285
Receivable for shares sold 1,931,028
Variation margin receivable $ 830,840
[1] The Fund commenced operations on March 28, 2022.
[2] No Par Value
XML 17 R3.htm IDEA: XBRL DOCUMENT v3.23.1
Schedule of Investments
12 Months Ended
Dec. 31, 2022
USD ($)
-1x Short VIX Futures ETF [Member]  
Cash - 10.4% $ 504,600 [1]
Other assets in excess of liabilities - 89.6% 45,874,003 [1]
TOTAL NET ASSETS - 100.0% 46,378,603
Number of Contracts (1,954)
Unrealized Appreciation (Depreciation) 1,156,106
Notional Amount at Value (46,388,280)
-1x Short VIX Futures ETF [Member] | CBOE VIX FUTURE Jan23 [Member]  
Number of Contracts $ (1,150)
Expiration Date Jan. 18, 2023
Unrealized Appreciation (Depreciation) $ 1,058,571
Notional Amount at Value (26,634,000)
-1x Short VIX Futures ETF [Member] | CBOE VIX FUTURE Feb23 [Member]  
Number of Contracts $ (804)
Expiration Date Feb. 15, 2023
Unrealized Appreciation (Depreciation) $ 97,536
Notional Amount at Value (19,754,280)
2x Long VIX Futures ETF [Member]  
Other assets in excess of liabilities - 89.6% 117,238,481 [2]
TOTAL NET ASSETS - 100.0% 125,488,766
Number of Contracts 10,576
Unrealized Appreciation (Depreciation) (9,203,522)
Notional Amount at Value 251,080,710
TOTAL SHORT TERM INVESTMENT (Cost $8,250,285) 8,250,285
TOTAL INVESTMENTS (Cost $8,250,285) - 6.6% 8,250,285
2x Long VIX Futures ETF [Member] | CBOE VIX FUTURES Jan23 [Member]  
Number of Contracts $ 6,221
Expiration Date Jan. 18, 2023
Unrealized Appreciation (Depreciation) $ (8,416,975)
Notional Amount at Value 144,078,360
2x Long VIX Futures ETF [Member] | CBOE VIX FUTURES Feb23 [Member]  
Number of Contracts $ 4,355
Expiration Date Feb. 15, 2023
Unrealized Appreciation (Depreciation) $ (786,547)
Notional Amount at Value $ 107,002,350
[1] $48,144,554 of cash is pledged as collateral for futures contracts.
[2] $114,821,272 of cash is pledged as collateral for futures contracts.
XML 18 R4.htm IDEA: XBRL DOCUMENT v3.23.1
Schedule of Investments (Parentheticals)
12 Months Ended
Dec. 31, 2022
USD ($)
-1x Short VIX Futures ETF [Member]  
Cash, percentage 1.10%
Other assets in excess of liabilities, percentage 98.90%
Total net assets, percentage 100.00%
2x Long VIX Futures ETF [Member]  
Other assets in excess of liabilities, percentage 93.40%
Total net assets, percentage 100.00%
Cash pledged as collateral (in Dollars) $ 8,250,285
Money market fund, percentage 6.60%
XML 19 R5.htm IDEA: XBRL DOCUMENT v3.23.1
Statement of Operations
12 Months Ended
Dec. 31, 2022
USD ($)
[1]
Income:  
Dividends $ 9
Interest income 440,735
Other income 220
Total Income 440,964
Expenses:  
Management fees 1,494,152
Administrative, accounting and custodian fees 96,541
Professional fees 558,820
Licensing and registration fees 135,452
Broker interest expense 84,807
Total Expenses 2,369,772
Net Investment loss (1,928,808)
Net realized gain on:  
Short Term Investments 50
Futures (50,725,054)
Net change in unrealized appreciation of:  
Short Term Investments
Futures (8,047,416)
Net realized and unrealized gain (loss) on investments and futures contracts (58,772,420)
NET INCREASE IN NET ASSETS RESULTING FROM OPERATIONS (60,701,228)
1x Short VIX Futures ETF  
Income:  
Dividends 2
Interest income 134,714
Other income 61
Total Income 134,777
Expenses:  
Management fees 489,398
Administrative, accounting and custodian fees 40,782
Professional fees 240,079
Licensing and registration fees 60,805
Broker interest expense 41,169
Total Expenses 872,233
Net Investment loss (737,456)
Net realized gain on:  
Short Term Investments 12
Futures 16,573,816
Net change in unrealized appreciation of:  
Short Term Investments
Futures 1,156,106
Net realized and unrealized gain (loss) on investments and futures contracts 17,729,934
NET INCREASE IN NET ASSETS RESULTING FROM OPERATIONS 16,992,478
2x Long VIX Futures ETF  
Income:  
Dividends 7
Interest income 306,021
Other income 159
Total Income 306,187
Expenses:  
Management fees 1,004,754
Administrative, accounting and custodian fees 55,759
Professional fees 318,741
Licensing and registration fees 74,647
Broker interest expense 43,638
Total Expenses 1,497,539
Net Investment loss (1,191,352)
Net realized gain on:  
Short Term Investments 38
Futures (67,298,870)
Net change in unrealized appreciation of:  
Short Term Investments
Futures (9,203,522)
Net realized and unrealized gain (loss) on investments and futures contracts (76,502,354)
NET INCREASE IN NET ASSETS RESULTING FROM OPERATIONS $ (77,693,706)
[1] The Fund commenced operations on March 28, 2022.
XML 20 R6.htm IDEA: XBRL DOCUMENT v3.23.1
Statement of Changes in Net Assets
12 Months Ended
Dec. 31, 2022
USD ($)
OPERATIONS  
Net investment loss $ (1,928,808) [1]
Net realized gain (loss) on investments and futures contracts (50,725,004) [1]
Net change in unrealized appreciation (depreciation) of investments and futures contracts (8,047,416) [1]
Net increase (decrease) in net assets resulting from operations (60,701,228) [2]
CAPITAL SHARE TRANSACTIONS  
Shares sold 589,482,401 [1]
Shares redeemed (356,913,804) [1]
Net increase in net assets from capital share transactions 232,568,597 [1]
Total increase in net assets 171,867,369 [1]
NET ASSETS  
Beginning of Period [1]
End of Period # 171,867,369 [1]
-1x Short VIX Futures ETF  
OPERATIONS  
Net investment loss (737,456) [1]
Net realized gain (loss) on investments and futures contracts 16,573,828 [1]
Net change in unrealized appreciation (depreciation) of investments and futures contracts 1,156,106 [1]
Net increase (decrease) in net assets resulting from operations 16,992,478 [2]
CAPITAL SHARE TRANSACTIONS  
Shares sold 189,786,132 [1]
Shares redeemed (160,400,007) [1]
Net increase in net assets from capital share transactions 29,386,125 [1]
Total increase in net assets 46,378,603 [1]
NET ASSETS  
Beginning of Period [1]
End of Period # 46,378,603
2x Long VIX Futures ETF  
OPERATIONS  
Net investment loss (1,191,352) [1]
Net realized gain (loss) on investments and futures contracts (67,298,832) [1]
Net change in unrealized appreciation (depreciation) of investments and futures contracts (9,203,522) [1]
Net increase (decrease) in net assets resulting from operations (77,693,706) [1]
CAPITAL SHARE TRANSACTIONS  
Shares sold 399,696,269 [1]
Shares redeemed (196,513,797) [1]
Net increase in net assets from capital share transactions 203,182,472 [1]
Total increase in net assets 125,488,766 [1]
NET ASSETS  
Beginning of Period [1]
End of Period # $ 125,488,766
[1] The Fund commenced operations on March 28, 2022.
[2] The Fund commenced operations on March 28, 2022.
XML 21 R7.htm IDEA: XBRL DOCUMENT v3.23.1
Statement of Cash Flows
12 Months Ended
Dec. 31, 2022
USD ($)
CASH FLOW FROM OPERATING ACTIVITIES  
Net increase (decrease) in net assets resulting from operations $ (60,701,228) [1]
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities  
Purchase of investments (583,140,644) [1]
Proceeds from sales or maturities of investments held 574,890,359 [1]
Decrease (Increase) in Deposits at broker for futures contracts (162,965,826) [1]
Decrease (Increase) in Variation margin receivable (830,840) [1]
Decrease (Increase) in Prepaid expenses and other assets (25,961) [1]
Decrease (Increase) in interest receivable (63,392) [1]
Decrease (Increase) in other receivables (1,150) [1]
Increase (Decrease) in Variation margin payable 187,030 [1]
Increase (Decrease) in Payable to Sponsor 231,212 [1]
Increase (Decrease) in Administrative, accounting and custodian fees payable 35,826 [1]
Increase (Decrease) in Professional fees payable 328,685 [1]
Increase (Decrease) in Licensing and registration fees payable 19,942 [1]
Net cash provided by (used in) operating activities (232,035,987)
CASH FLOW FROM FINANCING ACTIVITIES  
Proceeds from shares sold, net of cost from shares purchased 587,551,373 [1]
Cost of shares redeemed (355,010,786) [1]
Net cash provided by (used in) financing activities 232,540,587
NET INCREASE IN CASH 504,600 [1]
Beginning of Period [1]
End of Period 504,600 [1]
1x Short VIX Futures ETF  
CASH FLOW FROM OPERATING ACTIVITIES  
Net increase (decrease) in net assets resulting from operations 16,992,478 [1]
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities  
Purchase of investments (224,609,285) [1]
Proceeds from sales or maturities of investments held 224,609,285 [1]
Decrease (Increase) in Deposits at broker for futures contracts (48,144,554) [1]
Decrease (Increase) in Prepaid expenses and other assets (10,295) [1]
Decrease (Increase) in interest receivable (12,909) [1]
Decrease (Increase) in other receivables (571) [1]
Increase (Decrease) in Variation margin payable 187,030 [1]
Increase (Decrease) in Payable to Sponsor 54,374 [1]
Increase (Decrease) in Administrative, accounting and custodian fees payable 15,869 [1]
Increase (Decrease) in Professional fees payable 125,274 [1]
Increase (Decrease) in Licensing and registration fees payable 8,761 [1]
Net cash provided by (used in) operating activities (30,784,543) [1]
CASH FLOW FROM FINANCING ACTIVITIES  
Proceeds from shares sold, net of cost from shares purchased 189,786,132 [1]
Cost of shares redeemed (158,496,989) [1]
Net cash provided by (used in) financing activities 31,289,143 [1]
NET INCREASE IN CASH 504,600 [1]
Beginning of Period [1]
End of Period 504,600
2x Long VIX Futures ETF  
CASH FLOW FROM OPERATING ACTIVITIES  
Net increase (decrease) in net assets resulting from operations (77,693,706) [1]
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities  
Purchase of investments (358,531,359) [1]
Proceeds from sales or maturities of investments held 350,281,074 [1]
Decrease (Increase) in Deposits at broker for futures contracts (114,821,272) [1]
Decrease (Increase) in Variation margin receivable (830,840) [1]
Decrease (Increase) in Prepaid expenses and other assets (15,666) [1]
Decrease (Increase) in interest receivable (50,483) [1]
Decrease (Increase) in other receivables (579) [1]
Increase (Decrease) in Payable to Sponsor 176,838 [1]
Increase (Decrease) in Administrative, accounting and custodian fees payable 19,957 [1]
Increase (Decrease) in Professional fees payable 203,411 [1]
Increase (Decrease) in Licensing and registration fees payable 11,181 [1]
Net cash provided by (used in) operating activities (201,251,444) [1]
CASH FLOW FROM FINANCING ACTIVITIES  
Proceeds from shares sold, net of cost from shares purchased 397,765,241 [1]
Cost of shares redeemed (196,513,797) [1]
Net cash provided by (used in) financing activities 201,251,444 [1]
NET INCREASE IN CASH [1]
Beginning of Period [1]
End of Period [1]
[1] The Fund commenced operations on March 28, 2022.
XML 22 R8.htm IDEA: XBRL DOCUMENT v3.23.1
Organization
12 Months Ended
Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
ORGANIZATION

NOTE 1 – ORGANIZATION

 

VS Trust (the “Trust”) is a Delaware statutory trust formed on October 24, 2019 and is currently organized into separate series (each, a “Fund” and collectively, the “Funds”). As of December 31, 2022, the following two series of the Trust have commenced investment operations: -1x Short VIX Futures ETF (“SVIX”) and 2x Long VIX Futures ETF (“UVIX”). Each of the Funds listed above issues common units of beneficial interest (“Shares”), which represent units of fractional undivided beneficial interest in and ownership of only that Fund. The Shares of each Fund are listed on the Cboe BZX Exchange (“Cboe BZX”).

 

The Funds’ inception of operation was March 28, 2022. Neither the Trust nor the Funds had any operations prior to March 28, 2022, other than matters relating to its organization and the registration of each series under the Securities Act of 1933.

 

Each Fund’s investment exposure to VIX futures contracts will cause each to be deemed a commodity pool, thereby subjecting each Fund to regulation under the Commodity Exchange Act of 1934 (“CEA”) and Commodity Futures Trading Commission (“CFTC”) rules. The Sponsor is registered as a Commodity Pool Operator (“CPO”) and the Fund will be operated in accordance with applicable CFTC rules. Registration as a CPO imposes additional compliance obligations on the Sponsor and the Funds related to additional laws, regulations and enforcement policies, which could increase compliance costs and may affect the operations and financial performance of the Funds.

 

Volatility Shares LLC (the “Sponsor”) is the sponsor of the Trust and the Funds. The Sponsor also will serve as the Trust’s commodity pool operator. The Funds are commodity pools, as defined under the Commodity Exchange Act (the “CEA”), and the applicable regulations of the CFTC and are operated by the Sponsor, which is registered as a commodity pool operator with the CFTC. The Trust is not an investment company registered under the Investment Company Act of 1940.

XML 23 R9.htm IDEA: XBRL DOCUMENT v3.23.1
Significant Accounting Policies
12 Months Ended
Dec. 31, 2022
Accounting Policies [Abstract]  
SIGNIFICANT ACCOUNTING POLICIES

NOTE 2 – SIGNIFICANT ACCOUNTING POLICIES

 

Each Fund is an investment company, as defined by Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 946 “Financial Services — Investment Companies.” As such, the Funds follow the investment company accounting and reporting guidance. The following is a summary of significant accounting policies followed by each Fund, as applicable, in preparation of its financial statements. These policies are in conformity with accounting principles generally accepted in the United States of America (“GAAP”).

 

The accompanying unaudited financial statements were prepared in accordance with GAAP for interim financial information and with the instructions for Form 10-K and the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”). In the opinion of management, all material adjustments, consisting only of normal recurring adjustments, considered necessary for a fair statement of the interim period financial statements have been made. Interim period results are not necessarily indicative of results for a full-year period.

 

Emerging growth company

 

The Trust is an “emerging growth company,” as defined in the Jumpstart Our Business Startups Act of 2012. It will remain an emerging growth company until the earlier of (1) the beginning of the first fiscal year following the fifth anniversary of its initial public offering, (2) the beginning of the first fiscal year after annual gross revenue is $1.07 billion (subject to adjustment for inflation) or more, (3) the date on which the Fund has, during the previous three-year period, issued more than $1.0 billion in non-convertible debt securities and (4) as of the end of any fiscal year in which the market value of common equity held by non-affiliates exceeded $700 million as of the end of the second quarter of that fiscal year.

 

For as long as the Trust remains an “emerging growth company,” it may take advantage of certain exemptions from the various reporting requirements that are applicable to public companies that are not “emerging growth companies” including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation and financial statements in our periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote to approve executive compensation and shareholder approval of any golden parachute payments not previously approved. The Trust will take advantage of these reporting exemptions until it is no longer an “emerging growth company.”

 

Use of Estimates & Indemnifications

 

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

 

In the normal course of business, the Trust enters into contracts that contain a variety of representations which provide general indemnifications. The Trust’s maximum exposure under these arrangements cannot be known; however, the Trust expects any risk of loss to be remote.

 

Basis of Presentation

 

Pursuant to rules and regulations of the SEC, these financial statements are presented for the Trust as a whole, as the SEC registrant, and for each Fund individually. The debts, liabilities, obligations and expenses incurred, contracted for or otherwise existing with respect to a particular Fund shall be enforceable only against the assets of such Fund and not against the assets of the Trust generally or any other Fund. Accordingly, the assets of each Fund of the Trust include only those funds and other assets that are paid to, held by or distributed to the Trust for the purchase of Shares in that Fund.

 

Statements of Cash Flows

 

The cash amount shown in the Statements of Cash Flows is the amount reported as cash in the Statements of Financial Condition dated December 31, 2022, and represents cash but does not include short-term investments.

 

Final Net Asset Value for Fiscal Period

 

The cut-off times and the times of the calculation of the Funds’ final net asset value for creation and redemption of fund Shares for the three months ended December 31, 2022 were typically as follows. All times are Eastern Standard Time:

 

    Create/Redeem   NAV Calculation   NAV
Fund   Cut-off*(EST)   Time (EST)   Calculation Date
-1x Short VIX Futures ETF and   2:00 p.m.   4:00 p.m.   December 31, 2022
2x Long VIX Futures ETF   2:00 p.m.   4:00 p.m.   December 31, 2022

  

* Although the Funds’ shares may continue to trade on secondary markets subsequent to the calculation of the final NAV, these times represent the final opportunity to transact in creation or redemption units for the three months ended December 31, 2022.

 

Market value per Share is determined at the close of Cboe BZX and may be later than when the Funds’ NAV per Share is calculated.

 

For financial reporting purposes, the Funds value transactions based upon the final closing price in their primary markets. Accordingly, the investment valuations in these financial statements may differ from those used in the calculation of certain of the Funds’ final creation/redemption NAV for the three months ended December 31, 2022.

 

Investment Valuation

 

Short-term investments are valued at amortized cost which approximates fair value for daily NAV purposes. For financial reporting purposes, short-term investments are valued at their market price using information provided by a third-party pricing service or market quotations. In each of these situations, valuations are typically categorized as Level I in the fair value hierarchy.

 

VIX futures contracts are valued using the Time Weighted Average Price (TWAP) of the futures during the last 15 minutes of NYSE’s regular trading session, rather than solely from the VIX futures’ settlement price. The value of a Fund’s non-exchange-traded Financial Instruments typically is determined by applying the then-current disseminated levels for the Index to the terms of the Fund’s non-exchange-traded Financial Instruments.

 

In certain circumstances (e.g., if the Sponsor believes market quotations do not accurately reflect the fair value of a Fund’s investment, or a trading halt closes an exchange or market early), the Sponsor may, in its sole discretion, choose to determine a fair value price as the basis for determining the market value of such investment for such day. Such fair value prices would generally be determined based on available inputs about the current value of the underlying VIX futures contract and would be based on principles that the Sponsor deems fair and equitable.

 

The Funds may use a variety of money market instruments. Money market instruments generally will be valued using market prices or at amortized cost.

 

Fair value pricing may require subjective determinations about the value of an investment. While the Funds’ policies are intended to result in a calculation of its respective Fund’s NAV that fairly reflects investment values as of the time of pricing, such Fund cannot ensure that fair values determined by the Sponsor or persons acting at their direction would accurately reflect the price that a Fund could obtain for an investment if it were to dispose of that investment as of the time of pricing (for instance, in a forced or distressed sale). The prices used by such Fund may differ from the value that would be realized if the investments were sold and the differences could be material to the financial statements.

 

Fair Value of Financial Instruments

 

The Funds disclose the fair value of their investments in a hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The disclosure requirements establish a fair value hierarchy that distinguishes between: (1) market participant assumptions developed based on market data obtained from sources independent of the Funds (observable inputs); and (2) the Funds’ own assumptions about market participant assumptions developed based on the best information available under the circumstances (unobservable inputs). The three levels defined by the disclosure requirements hierarchy are as follows:

 

Level I – Quoted prices (unadjusted) in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date.

 

Level II – Inputs other than quoted prices included within Level I that are observable for the asset or liability, either directly or indirectly. Level II assets include the following: quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the asset or liability, and inputs that are derived principally from or corroborated by observable market data by correlation or other means (market-corroborated inputs).

 

Level III – Unobservable pricing input at the measurement date for the asset or liability. Unobservable inputs shall be used to measure fair value to the extent that observable inputs are not available.

 

In some instances, the inputs used to measure fair value might fall in different levels of the fair value hierarchy. The level in the fair value hierarchy within which the fair value measurement in its entirety falls is determined based on the lowest input level that is significant to the fair value measurement in its entirety.

 

Fair value measurements also require additional disclosure when the volume and level of activity for the asset or liability have significantly decreased, as well as when circumstances indicate that a transaction is not orderly.

 

The following table summarizes the valuation of investments at December 31, 2022 using the fair value hierarchy:

 

   Level 1 - 
Quoted
Prices
   Level 2 -
Other
Significant
Observable
Inputs
     
Fund  Money
Market Fund
   Futures
Contracts*
   Total 
-1x Short VIX Futures ETF  $
-
   $1,156,106   $1,156,106 
2x Long VIX Futures ETF   8,250,285    (9,203,522)   (953,237)
Total Trust  $8,250,285   $(8,047,416)  $202,869 

 

*Includes cumulative appreciation (depreciation) of futures contracts as reported in the Schedule of Investments. Only current day’s variation margin is reported within the Statements of Financial Condition in receivable/payable on open futures.

 

The inputs or methodology used for valuing investments are not necessarily an indication of the risk associated with investing in those securities.

 

Investment Transactions and Related Income

 

Investment transactions are recorded on the trade date. All such transactions are recorded on the identified cost basis and marked to market daily. Unrealized appreciation (depreciation) on open contracts are reflected in the Statements of Financial Condition and changes in the unrealized appreciation (depreciation) between periods are reflected in the Statements of Operations.

 

Interest income is recognized on an accrual basis and includes, where applicable, the amortization of premium or discount, and is reflected as Interest Income in the Statement of Operations.

 

Brokerage Commissions and Futures Account Fees

 

Each Fund pays its respective brokerage commissions, including applicable exchange fees, National Futures Association (“NFA”) fees, give-up fees, pit brokerage fees and other transaction related fees and expenses charged in connection with trading activities for each Fund’s investment in U.S. Commodity Futures Trading Commission (“CFTC”) regulated investments. The effects of trading spreads, financing costs/fees associated with Financial Instruments, and costs relating to the purchase of U.S. Treasury securities or similar high credit quality short-term fixed-income would also be borne by the Funds. Brokerage commissions on futures contracts are recognized on a half-turn basis (e.g., the first half is recognized when the contract is purchased (opened) and the second half is recognized when the transaction is closed). The Sponsor is currently paying brokerage commissions on VIX futures contracts for the Funds that exceed variable create/redeem fees collected by more than 0.04% and 0.09%, for SVIX and UVIX, respectively, of each Fund’s average net assets annually.

 

Federal Income Tax

 

Each Fund is registered as a series of a Delaware statutory trust and is treated as a partnership for U.S. federal income tax purposes. Accordingly, no Fund expects to incur U.S. federal income tax liability; rather, each beneficial owner of a Fund’s Shares is required to take into account its allocable share of its Fund’s income, gain, loss, deductions and other items for its Fund’s taxable year ending with or within the beneficial owner’s taxable year.

 

Management of the Funds has reviewed all open tax years and major jurisdictions (i.e., the last four tax year ends and the interim tax period since then, as applicable) and concluded that there is no tax liability resulting from unrecognized tax benefits relating to uncertain income tax positions taken or expected to be taken in future tax returns. The Funds are also not aware of any tax positions for which it is reasonably possible that the total amounts of unrecognized tax benefits will significantly change in the next twelve months. On an ongoing basis, management monitors its tax positions taken under the interpretation to determine if adjustments to conclusions are necessary based on factors including, but not limited to, on-going analysis of tax law, regulation, and interpretations thereof.

XML 24 R10.htm IDEA: XBRL DOCUMENT v3.23.1
Investments
12 Months Ended
Dec. 31, 2022
Investments [Abstract]  
INVESTMENTS

NOTE 3 – INVESTMENTS

 

Short-Term Investments

 

The Funds may purchase U.S. Treasury Bills, agency securities, and other high-credit quality short-term fixed income or similar securities with original maturities of one year or less. A portion of these investments may be posted as collateral in connection with swap agreements, futures, and/or forward contracts.

 

Accounting for Derivative Instruments

 

In seeking to achieve each Fund’s investment objective, the Sponsor uses a mathematical approach to investing. Using this approach, the Sponsor determines the type, quantity and mix of investment positions, including derivative positions, which the Sponsor believes in combination, should produce returns consistent with a Fund’s objective.

 

All open derivative positions at period end are reflected on each respective Fund’s Schedule of Investments. Certain Funds utilized a varying level of derivative instruments in conjunction with investment securities in seeking to meet their investment objectives during the period. While the volume of open positions may vary on a daily basis as each Fund transacts derivatives contracts in order to achieve the appropriate exposure to meet its investment objective, the volume of these open positions relative to the net assets of each respective Fund at the date of this report is generally representative of open positions throughout the reporting period.

 

Following is a description of the derivative instruments used by the Funds during the reporting period, including the primary underlying risk exposures related to each instrument type.

 

Futures Contracts

 

The Funds may enter into futures contracts to gain exposure to changes in the value of, or as a substitute for investing directly in (or shorting), an underlying benchmark. A futures contract obligates the seller to deliver (and the purchaser to accept) the future delivery of a specified quantity and type of asset at a specified time and place. The contractual obligations of a buyer or seller may generally be satisfied by taking or making physical delivery of the underlying commodity, if applicable, or by making an offsetting sale or purchase of an identical futures contract on the same or linked exchange before the designated date of delivery, or by cash settlement at expiration of contract.

 

Upon entering into a futures contract, each Fund is required to deposit and maintain as collateral at least such initial margin as required by the exchange on which the transaction is affected. The initial margin is segregated as cash and/or securities balances with brokers for futures contracts, as disclosed in the Statements of Financial Condition, and is restricted as to its use. The Funds that enter into futures contracts maintain collateral at the broker in the form of cash and/or securities. Pursuant to the futures contract, each Fund generally agrees to receive from or pay to the broker(s) an amount of cash equal to the daily fluctuation in value of the futures contract. Such receipts or payments are known as variation margin and are recorded by each Fund as unrealized gains or losses. Each Fund will realize a gain or loss upon closing of a futures transaction.

 

Futures contracts involve, to varying degrees, elements of market risk (specifically exchange rate sensitivity, commodity price risk or equity market volatility risk) and exposure to loss in excess of the amount of variation margin. The face or contract amounts reflect the extent of the total exposure each Fund has in the particular classes of instruments. Additional risks associated with the use of futures contracts are imperfect correlation between movements in the price of the futures contracts and the market value of the underlying Index or commodity and the possibility of an illiquid market for a futures contract. With futures contracts, there is minimal but some counterparty risk to the Funds since futures contracts are exchange-traded and the credit risk resides with the Funds’ clearing broker or clearinghouse itself. Many futures exchanges and boards of trade limit the amount of fluctuation permitted in futures contract prices during a single trading day. Once the daily limit has been reached in a particular contract, no trades may be made that day at a price beyond that limit or trading may be suspended for specified times during the trading day. Futures contracts prices could move to the limit for several consecutive trading days with little or no trading, thereby preventing prompt liquidation of futures positions and potentially subjecting a Fund to substantial losses. If trading is not possible, or if a Fund determines not to close a futures position in anticipation of adverse price movements, the Fund will be required to make daily cash payments of variation margin. The risk the Fund will be unable to close out a futures position will be minimized by entering into such transactions on a national exchange with an active and liquid secondary market.

 

Option Contracts

 

An option is a contract that gives the buyer the right, but not the obligation, to buy or sell a specified quantity of a commodity or other instrument at a specific (or strike) price within a specified period of time, regardless of the market price of that instrument. There are two types of options: calls and puts. A call option conveys to the option buyer the right to purchase a particular futures contract at a stated price at any time during the life of the option. A put option conveys to the option buyer the right to sell a particular futures contract at a stated price at any time during the life of the option. Options written by a Fund may be wholly or partially covered (meaning that the Fund holds an offsetting position) or uncovered. In the case of the purchase of an option, the risk of loss of an investor’s entire investment (i.e., the premium paid plus transaction charges) reflects the nature of an option as a wasting asset that may become worthless when the option expires. Where an option is written or granted (i.e., sold) uncovered, the seller may be liable to pay substantial additional margin, and the risk of loss is unlimited, as the seller will be obligated to deliver, or take delivery of, an asset at a predetermined price which may, upon exercise of the option, be significantly different from the market value.

 

When a Fund writes a call or put, an amount equal to the premium received is recorded and subsequently marked to market to reflect the current value of the option written. Premiums received from writing options which expire are treated as realized gains. Premiums received from writing options which are exercised or closed are added to the proceeds or offset against amounts paid on the underlying futures, swap or security transaction to determine the realized gain (loss).

 

When a Fund purchases an option, the Fund pays a premium which is included as an asset on the Statement of Financial Condition and subsequently marked to market to reflect the current value of the option. Premiums paid for purchasing options which expire are treated as realized losses. The risk associated with purchasing put and call options is limited to the premium paid. Premiums paid for purchasing options which are exercised or closed are added to the amounts paid or offset against the proceeds on the underlying investment transaction to determine the realized gain (loss) when the underlying transaction is executed.

 

Certain options transactions may subject the writer (seller) to unlimited risk of loss in the event of an increase in the price of the contract to be purchased or delivered. The value of a Fund’s options transactions, if any, will be affected by, among other things, changes in the value of a Fund’s underlying benchmark relative to the strike price, changes in interest rates, changes in the actual and implied volatility of the Fund’s underlying benchmark, and the remaining time until the options expire, or any combination thereof. The value of the options should not be expected to increase or decrease at the same rate as the level of the Fund’s underlying benchmark, which may contribute to tracking error. Options may be less liquid than certain other securities. A Fund’s ability to trade options will be dependent on the willingness of counterparties to trade such options with the Fund. In a less liquid market for options, a Fund may have difficulty closing out certain option positions at desired times and prices. A Fund may experience substantial downside from specific option positions and certain option positions may expire worthless. Over-the-counter options generally are not assignable except by agreement between the parties concerned, and no party or purchaser has any obligation to permit such assignments. The over-the-counter market for options is relatively illiquid, particularly for relatively small transactions. The use of options transactions exposes a Fund to liquidity risk and counterparty credit risk, and in certain circumstances may expose the Fund to unlimited risk of loss. The Funds may buy and sell options on futures contracts, which may present even greater volatility and risk of loss.

 

Swap Agreements

 

The Funds may enter into swap agreements for purposes of pursuing their investment objectives or as a substitute for investing directly in (or shorting) an underlying Index or to create an economic hedge against a position. Swap agreements are two-party contracts that have traditionally been entered into primarily with institutional investors in over-the-counter (“OTC”) markets for a specified period, ranging from a day to more than one year. However, the Dodd-Frank Wall Street Reform and Consumer Protection Act (the “Dodd-Frank Act”) provides for significant reforms of the OTC derivative markets, including a requirement to execute certain swap transactions on a CFTC-regulated market and/or to clear such transactions through a CFTC-regulated central clearing organization. In a standard swap transaction, two parties agree to exchange the returns earned or realized on a particular predetermined investment, instrument or Index in exchange for a fixed or floating rate of return in respect of a predetermined notional amount. Transaction or commission costs are reflected in the benchmark level at which the transaction is entered into. The gross returns to be exchanged are calculated with respect to a notional amount and the benchmark returns to which the swap is linked. Swap agreements do not involve the delivery of underlying instruments.

 

Generally, swap agreements entered into by the Funds calculate and settle the obligations of the parties to the agreement on a “net basis” with a single payment. Consequently, each Fund’s current obligations (or rights) under a swap agreement will generally be equal only to the net amount to be paid or received under the agreement based on the relative values of such obligations (or rights) (the “net amount”). In a typical swap agreement entered into by UVIX, the would be entitled to settlement payments in the event the level of the benchmark increases and would be required to make payments to the swap counterparties in the event the level of the benchmark decreases, adjusted for any transaction costs or trading spreads on the notional amount the Funds may pay. In a typical swap agreement entered into by SVIX, the Fund would be required to make payments to the swap counterparties in the event the level of the benchmark increases and would be entitled to settlement payments in the event the level of the benchmark decreases, adjusted for any transaction costs or trading spreads on the notional amount the Funds may pay.

 

The net amount of the excess, if any, of each Fund’s obligations over its entitlements with respect to each OTC swap agreement is accrued on a daily basis and an amount of cash and/or securities having an aggregate value at least equal to such accrued excess is maintained for the benefit of the counterparty in a segregated account by the Funds’ Custodian. The net amount of the excess, if any, of each Fund’s entitlements over its obligations with respect to each OTC swap agreement is accrued on a daily basis and an amount of cash and/or securities having an aggregate value at least equal to such accrued excess is maintained for the benefit of the Fund in a segregated account by a third party custodian. Until a swap agreement is settled in cash, the gain or loss on the notional amount less any transaction costs or trading spreads payable by each Fund on the notional amount are recorded as “unrealized appreciation or depreciation on swap agreements” and, when cash is exchanged, the gain or loss realized is recorded as “realized gains or losses on swap agreements.” Swap agreements are generally valued at the last settled price of the benchmark referenced asset.

 

Swap agreements contain various conditions, events of default, termination events, covenants and representations. The triggering of certain events or the default on certain terms of the agreement could allow a party to terminate a transaction under the agreement and request immediate payment in an amount equal to the net positions owed to the party under the agreement. This could cause a Fund to have to enter into a new transaction with the same counterparty, enter into a transaction with a different counterparty or seek to achieve its investment objective through any number of different investments or investment techniques.

 

Swap agreements involve, to varying degrees, elements of market risk and exposure to loss in excess of the unrealized gain/loss reflected. The notional amounts reflect the extent of the total investment exposure each Fund has under the swap agreement, which may exceed the NAV of each Fund. Additional risks associated with the use of swap agreements are imperfect correlations between movements in the notional amount and the price of the underlying reference Index and the inability of counterparties to perform. Each Fund bears the risk of loss of the amount expected to be received under a swap agreement in the event of the default or bankruptcy of a swap agreement counterparty. A Fund will typically enter into swap agreements only with major global financial institutions. The creditworthiness of each of the firms that is a party to a swap agreement is monitored by the Sponsor. The Sponsor may use various techniques to minimize credit risk including early termination and payment, using different counterparties, limiting the net amount due from any individual counterparty and generally requiring collateral to be posted by the counterparty in an amount approximately equal to that owed to the Funds. Outstanding swap agreements contractually terminate within one month but may be terminated without penalty by either party at any time. Upon termination, the Fund is obligated to pay or receive the “unrealized appreciation or depreciation” amount.

 

The Funds, as applicable, collateralize swap agreements by segregating or designating cash and/or certain securities as indicated on the Statements of Financial Condition or Schedules of Investments. As noted above, collateral posted in connection with OTC derivative transactions is held for the benefit of the counterparty in a segregated tri-party account at the Custodian to protect the counterparty against non-payment by the Funds. The collateral held in this account is restricted as to its use. In the event of a default by the counterparty, the Funds will seek withdrawal of this collateral from the segregated account and may incur certain costs in exercising its right with respect to the collateral. If a counterparty becomes bankrupt or otherwise fails to perform its obligations due to financial difficulties, the Funds may experience significant delays in obtaining any recovery in a bankruptcy or other reorganizational proceeding. The Funds may obtain only limited recovery or may obtain no recovery in such circumstances.

 

The Funds remain subject to credit risk with respect to the amount they expect to receive from counterparties. However, the Funds have sought to mitigate these risks in connection with OTC swaps by generally requiring that the counterparties for each Fund agree to post collateral for the benefit of the Fund, marked to market daily, in an amount approximately equal to what the counterparty owes the Fund, subject to certain minimum thresholds. In the event of a bankruptcy of a counterparty, such Fund will have direct access to the collateral received from the counterparty, generally as of the day prior to the bankruptcy, because there is a one day time lag between the Fund’s request for collateral and the delivery of such collateral. To the extent any such collateral is insufficient, the Funds will be exposed to counterparty risk as described above, including the possible delays in recovering amounts as a result of bankruptcy proceedings.

 

The counterparty/credit risk for cleared derivative transactions is generally lower than for OTC derivatives since generally a clearing organization becomes substituted for each counterparty to a cleared derivative contract and, in effect, guarantees the parties’ performance under the contract as each party to a trade looks only to the clearing organization for performance of financial obligations. In addition, cleared derivative transactions benefit from daily marking-to-market and settlement, and segregation and minimum capital requirements applicable to intermediaries.

 

Fair Value of Derivative Instruments as of December 31, 2022

 

      Asset Derivatives   Liability Derivatives 
Derivatives Not Accounted for as Hedging Instruments  Fund  Statement of
Financial
Condition
Location
   Unrealized
Appreciation
   Statement of
Financial
Condition
Location
   Unrealized
Depreciation
 
VIX Futures Contracts  -1x Short VIX Futures ETF               $1,156,106                                    
   2x Long VIX Futures ETF                  (9,203,522)
   Total Trust                 $(8,047,416)

 

* Includes cumulative appreciation (depreciation) of futures contracts as reported in the Schedule of Investments. Only current day’s variation margin is reported within the Statements of Financial Condition in variation margin receivable/payable.

 

The Effect of Derivative Instruments on the Statement of Operations

For the Period Ended December 31, 2022

 

Derivatives Not Accounted for as hedging Instruments  Location of Gain
(Loss) on Derivatives
Recognized in income
  Fund  Realized Gain (Loss) on Derivatives Recognized in Income   Change in Unrealized Appreciation (Depreciation) on Derivatives Recognized in Income 
VIX Futures Contracts  Net realized gain (loss) on futures contracts/ changes in unrealized appreciation (depreciation) on futures contrats           
    -1x Short VIX Futures ETF  $16,573,816   $1,156,106 
      2x Long VIX Futures ETF   (67,298,870)   (9,203,522)
      Total Trust  $(50,725,054)  $(8,047,416)

 

Offsetting Assets and Liabilities

 

Each Fund is subject to master netting agreements or similar arrangements that allow for amounts owed between each Fund and the counterparty to be netted upon an early termination. The party that has the larger payable pays the excess of the larger amount over the smaller amount to the other party. The master netting agreements or similar arrangements do not apply to amounts owed to/from different counterparties. As described above, the Funds utilize derivative instruments to achieve their investment objective during the year. The amounts shown in the Statements of Financial Condition do not take into consideration the effects of legally enforceable master netting agreements or similar arrangements.

 

For financial reporting purposes, the Funds do not offset derivative assets and derivative liabilities that are subject to netting arrangements in the Statements of Financial Condition. The following table presents each Fund’s derivatives by investment type and by counterparty net of amounts available for offset under a master netting agreement and the related collateral received or pledged by the Funds as of December 31, 2022.

 

Fair Values of Derivative Instruments as of December 31, 2022
   Assets   Liabilities 
Fund  Gross
Amounts of
Recognized
Assets
presented
in the
Statements of
Financial
Condition
   Gross
Amounts
Offset
in the
Statements of
Financial
Condition
   Net
Amounts of
Assets
presented
in the
Statements of
Financial
Condition
   Gross
Amounts of
Recognized
Liabilities
presented
in the
Statements of
Financial
Condition
   Gross
Amounts
Offset
in the
Statements of
Financial
Condition
   Net
Amounts of
Liabilities
presented
in the
Statements of
Financial
Condition
 
-1x Short VIX Futures ETF  $          -   $          -   $          -   $187,030   $          -   $187,030 
2x Long VIX Futures ETF   830,840    -    830,840    -    -    - 

 

Asset (Liability) amounts shown in the table below represent amounts owed to (by) the Funds for the derivative-related investments at December 31, 2022. These amounts may be collateralized by cash or financial instruments, segregated for the benefit of the Funds or the counterparties, depending on whether the related contracts are in an appreciated or depreciated position at period end. Amounts shown in the column labeled “Net Amount” represent the uncollateralized portions of these amounts at period end. These amounts may be un-collateralized due to timing differences related to market movements or due to minimum thresholds for collateral movement, as further described above under the caption “Accounting for Derivative Instruments”.

 

Gross Amounts Not Offset in the Statements of Financial Condition as of December 31, 2022
Fund  Amounts of
Recognized
Assets /
(Liabilities)
presented
in the
Statements of
Financial
Condition
   Financial
Instruments for
the Benefit of
(the Funds) /
the
Counterparties
   Cash
Collateral for
the Benefit of
(the Funds) /
the
Counterparties
   Net
Amount
 
-1x Short VIX Futures ETF  $(187,030)  $              -   $            -   $(187,030)
2x Long VIX Futures ETF   830,840    -    -    830,840 
XML 25 R11.htm IDEA: XBRL DOCUMENT v3.23.1
Agreements
12 Months Ended
Dec. 31, 2022
Agreements [Abstract]  
AGREEMENTS

NOTE 4 – AGREEMENTS

 

Management Fee

 

SVIX pays the Sponsor a management fee (the “Management Fee”), monthly in arrears, in an amount equal to 1.35% per annum of its average daily net assets. UVIX pays the Sponsor a Management Fee, monthly in arrears, in an amount equal to 1.65% per annum of its average daily net assets. “Average daily net assets” is calculated by dividing the month-end net assets of each Fund by the number of calendar days in such month.

 

No other Management Fee is paid by the Funds. The Management Fee is paid in consideration of the Sponsor’s trading advisory services and the other services provided to the Fund that the Sponsor pays directly.

 

Pursuant to the Sponsor Agreement between Sponsor and the Trust, on behalf of the Funds, the Sponsor oversees and pays Milliman FRM (“Commodity Sub-Adviser”) for its services as Commodity Sub-Adviser. The Commodity Sub-Adviser is paid by the Sponsor an annual sub-advisory fee of 0.25% based on each Fund’s average daily net assets (total assets of the Fund, minus the sum of its accrued liabilities). The commodity sub-advisory fee is waived for the first 6 months of each Fund’s operations or until a Fund reaches $35 million in average daily net assets. The Funds do not directly pay the Commodity Sub-Adviser.

 

Non-Recurring Fees and Expenses

 

Each Fund pays all its non-recurring and unusual fees and expenses, if any, as determined by the Sponsor. Non-recurring and unusual fees and expenses are fees and expenses that are unexpected or unusual in nature, such as legal claims and liabilities, litigation costs or indemnification or other material expenses which are not currently anticipated obligations of the Funds.

 

The Administrator, Transfer Agent and Custodian

 

U.S. Bancorp Fund Services, LLC, doing business as U.S. Bank Global Fund Services (“Fund Services”), an indirect subsidiary of U.S. Bancorp, serves as the Fund’s fund accountant, administrator and transfer agent pursuant to certain fund accounting servicing, fund administration servicing and transfer agent servicing agreements. U.S. Bank National Association, a subsidiary of U.S. Bancorp and parent company of Fund Services, intends to serve as the Fund’s custodian pursuant to a custody agreement.

 

The Marketing Agent

 

Foreside Fund Services, LLC (the “Marketing Agent”) serves as the Marketing Agent of the Funds. Its principal duties are: (i) to work with the Transfer Agent to review and approve orders placed by Authorized Participants and transmitted to the Transfer Agent; (ii) maintain copies of confirmations of Creation Unit creation and redemption order acceptances; (iii) maintain telephonic, facsimile and/or access to direct computer communications links with the Transfer Agent; and (iv) review and approve, prior to use, all Trust marketing materials for compliance with applicable SEC and FINRA advertising rules.

 

The Marketing Agent retains all marketing materials separately for the Funds, at their offices located at Three Canal Plaza, Suite 100 Portland, Maine 04101.

 

As compensation for the services it provides, the Marketing Agent receives a fee from the Funds.

XML 26 R12.htm IDEA: XBRL DOCUMENT v3.23.1
Offering Costs
12 Months Ended
Dec. 31, 2022
Offering Costs [Abstract]  
OFFERING COSTS

NOTE 5 – OFFERING COSTS

 

Offering costs will be amortized by the Funds over a twelve month period on a straight-line basis beginning once the fund commences operations. The Sponsor will not charge its Management Fee in the first year of operations of a Fund in an amount equal to the offering costs. Normal and expected expenses incurred in connection with the continuous offering of Shares of a Fund after the commencement of its trading operations will be paid by the Sponsor.

XML 27 R13.htm IDEA: XBRL DOCUMENT v3.23.1
Creation and Redemption of Creation Units
12 Months Ended
Dec. 31, 2022
Creation and Redemption of Creation Units [Abstract]  
CREATION AND REDEMPTION OF CREATION UNITS

NOTE 6 – CREATION AND REDEMPTION OF CREATION UNITS

 

Each Fund issues and redeems shares from time to time, but only in one or more Creation Units. A Creation Unit is a block of at least 10,000 Shares of a Fund. Creation Units may be created or redeemed only by Authorized Participants.

 

Except when aggregated in Creation Units, the Shares are not redeemable securities. Retail investors, therefore, generally will not be able to purchase or redeem Shares directly from or with a Fund. Rather, most retail investors will purchase or sell Shares in the secondary market with the assistance of a broker. Thus, some of the information contained in these Notes to Financial Statements—such as references to the Transaction Fees imposed on purchases and redemptions is not relevant to retail investors.

 

Transaction Fees on Creation and Redemption Transactions

 

The manner by which Creation Units are purchased or redeemed is governed by the terms of the Authorized Participant Agreement and Authorized Participant Procedures Handbook. By placing a purchase order, an Authorized Participant agrees to: (1) deposit cash with the Custodian; and (2) if permitted by the Sponsor in its sole discretion, enter into or arrange for an exchange of futures contract for related position or block trade with the relevant fund whereby the Authorized Participant would also transfer to such Fund a number and type of exchange-traded futures contracts at or near the closing settlement price for such contracts on the purchase order date.

 

Authorized Participants may pay a fee up to 0.03% of the value of each order they place with each order to create or redeem a Creation Unit in order to compensate the Administrator, the Custodian and the Transfer Agent of each Fund and its Shares, for services in processing the creation and redemption of Creation Units and to offset the costs of increasing or decreasing derivative positions, unless the transaction fee is waived or otherwise adjusted by the Sponsor. The Sponsor provides such Authorized Participant with prompt notice in advance of any such waiver or adjustment of the transaction fee. Authorized Participants may sell the Shares included in the Creation Units they purchase from the Funds to other investors in the secondary market.

 

Transaction Fees for the period ended December 31, 2022:

 

Fund  Period
Ended
December 31,
2022
 
-1x Short VIX Futures ETF  $105,025 
2x Long VIX Futures ETF   178,809 
Total Trust  $283,834 
XML 28 R14.htm IDEA: XBRL DOCUMENT v3.23.1
Financial Highlights
12 Months Ended
Dec. 31, 2022
Financial Highlights Disclosure [Abstract]  
FINANCIAL HIGHLIGHTS

NOTE 7 – FINANCIAL HIGHLIGHTS

 

Selected data is for a Share outstanding throughout the period ended December 31, 2022:

 

   -1x Short VIX Futures ETF   2x Long VIX Futures ETF 
   Period Ended
December 31,
2022(1)
   Period Ended
December 31,
2022(1)
 
Net Asset Value, Beginning of Period  $15.00   $15.00 
Net investment loss per share (2)   (0.18)   (0.15)
Net Realized and Unrealized Gain (Loss) on Investments and Futures Contracts (3)   (0.19)   (9.00)
Net Increase (Decrease) in Net Asset Value Resulting from Operations   (0.37)   (9.15)
Net Asset Value, End of Period  $14.63   $5.85 
Market Value Per Share, at December 31, 2022 (4)  $14.66   $5.82 
Total Return at Net Asset Value (5)   (2.47)%   (61.00)%
Total Return at Market Value (5)   (2.27)%   (61.20)%
           
Ratios to Average Net Assets: (6)          
Expense ratio (7)   2.41%   2.46%
Net Investment Loss   (2.03)%   (1.96)%

 

(1)Both Funds commenced operations on March 28, 2022.
(2)Net investment loss per share represents net investment loss divided by the daily average shares of beneficial interest outstanding during the period.
(3)Due to timing of capital share transactions, per share amounts may not compare with amounts appearing elsewhere within these Financial Statements.
(4)Market values are determined at the close of the applicable primary listing exchange, which may be later than when the Funds’ net asset value is calculated.
(5)Percentages are not annualized for the period ended December 31, 2022.
(6)Percentages are annualized.
(7)The expense ratio would be 2.29% and 2.39% respectively, if brokerage commissions and futures and futures account fees were excluded.
XML 29 R15.htm IDEA: XBRL DOCUMENT v3.23.1
Risk
12 Months Ended
Dec. 31, 2022
Risk [Abstract]  
RISK

NOTE 8 – RISK

 

Correlation and Compounding Risk

 

The Funds do not seek to achieve their stated investment objective over a period of time greater than a single day (as measured from NAV calculation time to NAV calculation time). The return of a Fund for a period longer than a single day is the result of its return for each day compounded over the period and usually will differ in amount and possibly even direction from the inverse (-1x) or two times (2x) the return of the Fund’s benchmark for the period. A Fund will lose money if its benchmark performance is flat over time, and it is possible for a Fund to lose money over time even if the performance of its benchmark increases in the case of UVIX (or decreases in the case of SVIX), as a result of daily rebalancing, the benchmark’s volatility, compounding, and other factors. Compounding is the cumulative effect of applying investment gains and losses and income to the principal amount invested over time. Gains or losses experienced over a given period will increase or reduce the principal amount invested from which the subsequent period’s returns are calculated. The effects of compounding will likely cause the performance of a Fund to differ from the Fund’s stated multiple times the return of its benchmark for the same period. The effect of compounding becomes more pronounced as benchmark volatility and holding period increase. The impact of compounding will impact each shareholder differently depending on the period of time an investment in a Fund is held and the volatility of the benchmark during the holding period of an investment in the Fund. Longer holding periods, higher benchmark volatility, inverse exposure and greater leverage each affect the impact of compounding on a Fund’s returns. Daily compounding of a Fund’s investment returns can dramatically and adversely affect its longer-term performance during periods of high volatility. Volatility may be at least as important to a Fund’s return for a period as the return of the Fund’s underlying benchmark.

 

Each Fund uses leverage and should produce daily returns that are more volatile than that of its benchmark. For example, the daily return of UVIX should be approximately two times as volatile on a daily basis as is the return of a fund with an objective of matching the same benchmark. The daily return of SVIX is designed to return the inverse (-1x) of the return that would be expected of a fund with an objective of matching the same benchmark. The Funds are not appropriate for all investors and present significant risks not applicable to other types of funds. The Funds use leverage and are riskier than similarly benchmarked exchange-traded funds that do not use leverage. An investor should only consider an investment in a Fund if he or she understands the consequences of seeking daily leveraged or daily inverse investment results. Shareholders who invest in the Funds should actively manage and monitor their investments, as frequently as daily.

 

While the Funds seek to meet their investment objectives, there is no guarantee they will do so. Factors that may affect a Fund’s ability to meet its investment objective include: (1) the Sponsor’s ability to purchase and sell Financial Instruments in a manner that correlates to a Fund’s objective; (2) an imperfect correlation between the performance of Financial Instruments held by a Fund and the performance of the applicable benchmark; (3) bid-ask spreads on such Financial Instruments; (4) fees, expenses, transaction costs, financing costs associated with the use of Financial Instruments and commission costs; (5) holding or trading instruments in a market that has become illiquid or disrupted; (6) a Fund’s Share prices being rounded to the nearest cent and/or valuation methodology; (7) changes to a benchmark Index that are not disseminated in advance; (8) the need to conform a Fund’s portfolio holdings to comply with investment restrictions or policies or regulatory or tax law requirements; (9) early and unanticipated closings of the markets on which the holdings of a Fund trade, resulting in the inability of the Fund to execute intended portfolio transactions; (10) accounting standards; and (11) differences caused by a Fund obtaining exposure to only a representative sample of the components of a benchmark, over weighting or under weighting certain components of a benchmark or obtaining exposure to assets that are not included in a benchmark.

 

A number of factors may affect a Fund’s ability to achieve a high degree of correlation with its benchmark, and there can be no guarantee that a Fund will achieve a high degree of correlation. Failure to achieve a high degree of correlation may prevent a Fund from achieving its investment objective. In order to achieve a high degree of correlation with their underlying benchmarks, the Funds seek to rebalance their portfolios daily to keep exposure consistent with their investment objectives. Being materially under- or over-exposed to the benchmark may prevent such Funds from achieving a high degree of correlation with such benchmark. Market disruptions or closure, large amounts of assets into or out of the Funds, regulatory restrictions, extreme market volatility, and other factors will adversely affect such Funds’ ability to adjust exposure to requisite levels. The target amount of portfolio exposure is impacted dynamically by the benchmarks’ movements during each day. Other things being equal, more significant movement in the value of its benchmark up or down will require more significant adjustments to a Fund’s portfolio. Because of this, it is unlikely that the Funds will be perfectly exposed (i.e., --1x, -2x, as applicable) to its benchmark at the end of each day, and the likelihood of being materially under- or over-exposed is higher on days when the benchmark levels are volatile near the close of the trading day.

 

Each Fund seeks to rebalance its portfolio on a daily basis. The time and manner in which a Fund rebalances its portfolio may vary from day to day depending upon market conditions and other circumstances at the discretion of the Sponsor. Unlike other funds that do not rebalance their portfolios as frequently, each Fund may be subject to increased trading costs associated with daily portfolio rebalancing in order to maintain appropriate exposure to the underlying benchmarks.

 

Counterparty Risk

 

Each Fund may use derivatives such as swap agreements and forward contracts (collectively referred to herein as “derivatives”) in the manner described herein as a means to achieve their respective investment objectives. The use of derivatives by a Fund exposes the Fund to counterparty risks.

 

Regulatory Treatment

 

Derivatives are generally traded in OTC markets and have only recently become subject to comprehensive regulation in the United States. Cash-settled forwards are generally regulated as “swaps”, whereas physically settled forwards are generally not subject to regulation (in the case of commodities other than currencies) or subject to the federal securities laws (in the case of securities). Title VII of the Dodd-Frank Act (“Title VII”) created a regulatory regime for derivatives, with the CFTC responsible for the regulation of swaps and the SEC responsible for the regulation of “security-based swaps.” The SEC requirements have largely yet to be made effective, but the CFTC requirements are largely in place. The CFTC requirements have included rules for some of the types of transactions in which the Funds will engage, including mandatory clearing and exchange trading, reporting, and margin for OTC swaps. Title VII also created new categories of regulated market participants, such as “swap dealers,” “security-based swap dealers,” “major swap participants,” and “major security-based swap participants” who are, or will be, subject to significant new capital, registration, recordkeeping, reporting, disclosure, business conduct and other regulatory requirements. The regulatory requirements under Title VII continue to be developed and there may be further modifications that could materially and adversely impact the Funds, the markets in which a Fund trades and the counterparties with which the Fund engages in transactions.

 

As noted, the CFTC rules may not apply to all of the swap agreements and forward contracts entered into by the Funds. Investors, therefore, may not receive the protection of CFTC regulation or the statutory scheme of the Commodity Exchange Act (the “CEA”) in connection with each Fund’s swap agreements or forward contracts. The lack of regulation in these markets could expose investors to significant losses under certain circumstances, including in the event of trading abuses or financial failure by participants.

 

Counterparty Credit Risk

 

The Funds will be subject to the credit risk of the counterparties to the derivatives. In the case of cleared derivatives, the Funds will have credit risk to the clearing corporation in a similar manner as the Funds would for futures contracts. In the case of OTC derivatives, the Funds will be subject to the credit risk of the counterparty to the transaction – typically a single bank or financial institution. As a result, a Fund is subject to increased credit risk with respect to the amount it expects to receive from counterparties to OTC derivatives entered into as part of that Fund’s principal investment strategy. If a counterparty becomes bankrupt or otherwise fails to perform its obligations due to financial difficulties, a Fund could suffer significant losses on these contracts and the value of an investor’s investment in a Fund may decline.

 

The Funds have sought to mitigate these risks by generally requiring that the counterparties for each Fund agree to post collateral for the benefit of the Fund, marked to market daily, subject to certain minimum thresholds. However, there are no limitations on the percentage of assets each Fund may invest in swap agreements or forward contracts with a particular counterparty. To the extent any such collateral is insufficient or there are delays in accessing the collateral, the Funds will be exposed to counterparty risk as described above, including possible delays in recovering amounts as a result of bankruptcy proceedings. The Funds typically enter into transactions only with major global financial institutions.

 

OTC derivatives of the type that may be utilized by the Funds are generally less liquid than futures contracts because they are not traded on an exchange, do not have uniform terms and conditions, and are generally entered into based upon the creditworthiness of the parties and the availability of credit support, such as collateral, and in general, are not transferable without the consent of the counterparty. These agreements contain various conditions, events of default, termination events, covenants and representations. The triggering of certain events or the default on certain terms of the agreement could allow a party to terminate a transaction under the agreement and request immediate payment in an amount equal to the net positions owed to the party under the agreement. For example, if the level of the Fund’s benchmark has a dramatic intraday move that would cause a material decline in the Fund’s NAV, the terms of the swap may permit the counterparty to immediately close out the transaction with the Fund. In that event, it may not be possible for the Fund to enter into another swap or to invest in other Financial Instruments necessary to achieve the desired exposure consistent with the Fund’s objective. This, in turn, may prevent the Fund from achieving its investment objective, particularly if the level of the Fund’s benchmark reverses all or part of its intraday move by the end of the day.

 

In addition, cleared derivatives benefit from daily marking-to-market and settlement, and segregation and minimum capital requirements applicable to intermediaries. To the extent the Fund enters into cleared swap transactions, the Fund will deposit collateral with a FCM in cleared swaps customer accounts, which are required by CFTC regulations to be separate from its proprietary collateral posted for cleared swaps transactions. Cleared swap customer collateral is subject to regulations that closely parallel the regulations governing customer segregated funds for futures transactions but provide certain additional protections to cleared swaps collateral in the event of a clearing broker or clearing broker customer default. For example, in the event of a default of both the clearing broker and a customer of the clearing broker, a clearing house is only permitted to access the cleared swaps collateral in the legally separate (but operationally comingled) account of the defaulting cleared swap customer of the clearing broker, as opposed to the treatment of customer segregated funds, under which the clearing house may access all of the commingled customer segregated funds of a defaulting clearing broker. Derivatives entered into directly between two counterparties do not necessarily benefit from such protections, particularly if entered into with an entity that is not registered as a “swap dealer” with the CFTC. This exposes the Funds to the risk that a counterparty will not settle a transaction in accordance with its terms and conditions because of a dispute over the terms of the contract (whether or not bona fide) or because of a credit or liquidity problem, thus causing the Funds to suffer a loss.

 

The Sponsor regularly reviews the performance of its counterparties for, among other things, creditworthiness and execution quality. In addition, the Sponsor periodically considers the addition of new counterparties and the counterparties used by a Fund may change at any time. Each day, the Funds disclose their portfolio holdings as of the prior Business Day. Each Fund’s portfolio holdings identifies its counterparties, as applicable. This portfolio holdings information may be accessed through the web on the Sponsor’s website at www.volatilityshares.com.

 

Each counterparty and/or any of its affiliates may be an Authorized Participant or shareholder of a Fund, subject to applicable law.

 

The counterparty risk for cleared derivatives transactions is generally lower than for OTC derivatives. Once a transaction is cleared, the clearing organization is substituted and is a Fund’s counterparty on the derivative. The clearing organization guarantees the performance of the other side of the derivative. Nevertheless, some risk remains, as there is no assurance that the clearing organization, or its members, will satisfy its obligations to a Fund.

 

Leverage Risk

 

The Funds may utilize leverage in seeking to achieve their respective investment objectives and will lose more money in market environments adverse to their respective daily investment objectives than funds that do not employ leverage. The use of leveraged and/or inverse leveraged positions increases the risk of total loss of an investor’s investment, even over periods as short as a single day.

 

For example, because UVIX includes a two times (2x) multiplier, a single-day movement in the relevant benchmark approaching 50% at any point in the day could result in the total loss or almost total loss of an investor’s investment if that movement is contrary to the investment objective of the Fund in which an investor has invested, even if such Fund’s benchmark subsequently moves in an opposite direction, eliminating all or a portion of the movement. This would be the case with downward single-day or intraday movements in the underlying benchmark of a Fund or upward single-day or intraday movements in the benchmark of a Fund, even if the underlying benchmark maintains a level greater than zero at all times.

 

Liquidity Risk

 

Financial Instruments cannot always be liquidated at the desired price. It is difficult to execute a trade at a specific price when there is a relatively small volume of buy and sell orders in a market. A market disruption can also make it difficult to liquidate a position or find a swap or forward contract counterparty at a reasonable cost. Market illiquidity may cause losses for the Funds. The large size of the positions which the Funds may acquire increases the risk of illiquidity by both making their positions more difficult to liquidate and increasing the losses incurred while trying to do so. Any type of disruption or illiquidity will potentially be exacerbated due to the fact that the Funds will typically invest in Financial Instruments related to one benchmark, which in many cases is highly concentrated.

 

“Contango” and “Backwardation” Risk

 

The Funds typically hold futures contracts. As the futures contracts near expiration, they are generally replaced by contracts that have a later expiration. Thus, for example, a contract purchased and held in November 2019 may specify a January 2020 expiration. As that contract nears expiration, it may be replaced by selling the January 2020 contract and purchasing the contract expiring in March 2020. This process is referred to as “rolling.” Rolling may have a positive or negative impact on performance. For example, historically, the prices of certain types of futures contracts have frequently been higher for contracts with shorter-term expirations than for contracts with longer-term expirations, which is referred to as “backwardation.” In these circumstances, absent other factors, the sale of the January 2020 contract would take place at a price that is higher than the price at which the March 2020 contract is purchased, thereby creating a gain in connection with rolling. While certain types of futures contracts have historically exhibited consistent periods of backwardation, backwardation will likely not exist in these markets at all times.

 

Since the introduction of VIX futures contracts, there have frequently been periods where VIX futures prices reflect higher expected volatility levels further out in time. This can result in a loss from “rolling” the VIX futures to maintain the constant weighted average maturity of the applicable Fund benchmark. Losses from exchanging a lower priced VIX future for a higher priced longer-term future in the rolling process could adversely affect the value of a Fund and, accordingly, decrease the return of a Fund.

 

Natural Disaster/Epidemic Risk

 

Natural or environmental disasters, such as earthquakes, fires, floods, hurricanes, tsunamis and other severe weather-related phenomena generally, and widespread disease, including pandemics and epidemics (for example, the novel coronavirus COVID-19), have been and can be highly disruptive to economies and markets and have recently led, and may continue to lead, to increased market volatility and significant market losses. Such natural disaster and health crises could exacerbate political, social, and economic risks previously mentioned, and result in significant breakdowns, delays, shutdowns, social isolation, and other disruptions to important global, local and regional supply chains affected, with potential corresponding results on the operating performance of the Funds and their investments. A climate of uncertainty and panic, including the contagion of infectious viruses or diseases, may adversely affect global, regional, and local economies and reduce the availability of potential investment opportunities, and increases the difficulty of performing due diligence and modeling market conditions, potentially reducing the accuracy of financial projections. Under these circumstances, the Funds may have difficulty achieving their investment objectives which may adversely impact performance. Further, such events can be highly disruptive to economies and markets, significantly disrupt the operations of individual companies (including, but not limited to, the Funds’ Sponsor and third party service providers), sectors, industries, markets, securities and commodity exchanges, currencies, interest and inflation rates, credit ratings, investor sentiment, and other factors affecting the value of the Funds’ investments. These factors can cause substantial market volatility, exchange trading suspensions and closures and can impact the ability of the Funds to complete redemptions and otherwise affect Fund performance and Fund trading in the secondary market. A widespread crisis may also affect the global economy in ways that cannot necessarily be foreseen at the current time. How long such events will last and whether they will continue or recur cannot be predicted. Impacts from these events could have significant impact on a Fund’s performance, resulting in losses to your investment.

 

Risk that Current Assumptions and Expectations Could Become Outdated As a Result of Global Economic Shocks

 

The onset of the novel coronavirus (COVID-19) has caused significant shocks to global financial markets and economies, with many governments taking extreme actions to slow and contain the spread of COVID-19. These actions have had, and likely will continue to have, a severe economic impact on global economies as economic activity in some instances has essentially ceased. Financial markets across the globe are experiencing severe distress at least equal to what was experienced during the global financial crisis in 2008. In March 2020, U.S. equity markets entered a bear market in the fastest such move in the history of U.S. financial markets. Contemporaneous with the onset of the COVID-19 pandemic in the US, oil experienced shocks to supply and demand, impacting the price and volatility of oil. The global economic shocks being experienced as of the date hereof may cause the underlying assumptions and expectations of the Funds to become outdated quickly or inaccurate, resulting in significant losses.

XML 30 R16.htm IDEA: XBRL DOCUMENT v3.23.1
Subsequent Events
12 Months Ended
Dec. 31, 2022
Subsequent Events [Abstract]  
SUBSEQUENT EVENTS

NOTE 9 – SUBSEQUENT EVENTS

 

Management has evaluated the possibility of subsequent events existing in the Trust’s and the Funds’ financial statements through the date the financial statements were issued. On January 11, 2023, the Trust announced a 1-for-5 reverse share split (a “Reverse Split”) of the shares of beneficial interest of 2x Long VIX Futures ETF (ticker symbol: UVIX). The Reverse Split was effective prior to market open on January 25, 2023, when the fund began trading at its post-split price. The Reverse Split increased the price per share of the fund with a proportionate decrease in the number of shares outstanding. Therefore, the Reverse Split did not change the aggregate net asset value of a shareholder’s investment at the time of the Reverse Split.

 

For UVIX shareholders who held a quantity of shares that was not an exact multiple of the Reverse Split ratio (i.e., not a multiple of 5), the Reverse Split resulted in the creation of a fractional share. Post-Reverse Split fractional shares were made available to be redeemed for cash and sent to the shareholder’s broker of record. This redemption may have caused some shareholders to realize gains or losses, which could have been a taxable event for those shareholders.

XML 31 R17.htm IDEA: XBRL DOCUMENT v3.23.1
Accounting Policies, by Policy (Policies)
12 Months Ended
Dec. 31, 2022
Accounting Policies [Abstract]  
Emerging growth company

Emerging growth company

 

The Trust is an “emerging growth company,” as defined in the Jumpstart Our Business Startups Act of 2012. It will remain an emerging growth company until the earlier of (1) the beginning of the first fiscal year following the fifth anniversary of its initial public offering, (2) the beginning of the first fiscal year after annual gross revenue is $1.07 billion (subject to adjustment for inflation) or more, (3) the date on which the Fund has, during the previous three-year period, issued more than $1.0 billion in non-convertible debt securities and (4) as of the end of any fiscal year in which the market value of common equity held by non-affiliates exceeded $700 million as of the end of the second quarter of that fiscal year.

 

For as long as the Trust remains an “emerging growth company,” it may take advantage of certain exemptions from the various reporting requirements that are applicable to public companies that are not “emerging growth companies” including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation and financial statements in our periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote to approve executive compensation and shareholder approval of any golden parachute payments not previously approved. The Trust will take advantage of these reporting exemptions until it is no longer an “emerging growth company.”

 

Use of Estimates & Indemnifications

Use of Estimates & Indemnifications

 

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

 

In the normal course of business, the Trust enters into contracts that contain a variety of representations which provide general indemnifications. The Trust’s maximum exposure under these arrangements cannot be known; however, the Trust expects any risk of loss to be remote.

 

Basis of Presentation

Basis of Presentation

 

Pursuant to rules and regulations of the SEC, these financial statements are presented for the Trust as a whole, as the SEC registrant, and for each Fund individually. The debts, liabilities, obligations and expenses incurred, contracted for or otherwise existing with respect to a particular Fund shall be enforceable only against the assets of such Fund and not against the assets of the Trust generally or any other Fund. Accordingly, the assets of each Fund of the Trust include only those funds and other assets that are paid to, held by or distributed to the Trust for the purchase of Shares in that Fund.

 

Statements of Cash Flows

Statements of Cash Flows

 

The cash amount shown in the Statements of Cash Flows is the amount reported as cash in the Statements of Financial Condition dated December 31, 2022, and represents cash but does not include short-term investments.

 

Final Net Asset Value for Fiscal Period

Final Net Asset Value for Fiscal Period

 

The cut-off times and the times of the calculation of the Funds’ final net asset value for creation and redemption of fund Shares for the three months ended December 31, 2022 were typically as follows. All times are Eastern Standard Time:

 

    Create/Redeem   NAV Calculation   NAV
Fund   Cut-off*(EST)   Time (EST)   Calculation Date
-1x Short VIX Futures ETF and   2:00 p.m.   4:00 p.m.   December 31, 2022
2x Long VIX Futures ETF   2:00 p.m.   4:00 p.m.   December 31, 2022

  

* Although the Funds’ shares may continue to trade on secondary markets subsequent to the calculation of the final NAV, these times represent the final opportunity to transact in creation or redemption units for the three months ended December 31, 2022.

 

Market value per Share is determined at the close of Cboe BZX and may be later than when the Funds’ NAV per Share is calculated.

 

For financial reporting purposes, the Funds value transactions based upon the final closing price in their primary markets. Accordingly, the investment valuations in these financial statements may differ from those used in the calculation of certain of the Funds’ final creation/redemption NAV for the three months ended December 31, 2022.

 

Investment Valuation

Investment Valuation

 

Short-term investments are valued at amortized cost which approximates fair value for daily NAV purposes. For financial reporting purposes, short-term investments are valued at their market price using information provided by a third-party pricing service or market quotations. In each of these situations, valuations are typically categorized as Level I in the fair value hierarchy.

 

VIX futures contracts are valued using the Time Weighted Average Price (TWAP) of the futures during the last 15 minutes of NYSE’s regular trading session, rather than solely from the VIX futures’ settlement price. The value of a Fund’s non-exchange-traded Financial Instruments typically is determined by applying the then-current disseminated levels for the Index to the terms of the Fund’s non-exchange-traded Financial Instruments.

 

In certain circumstances (e.g., if the Sponsor believes market quotations do not accurately reflect the fair value of a Fund’s investment, or a trading halt closes an exchange or market early), the Sponsor may, in its sole discretion, choose to determine a fair value price as the basis for determining the market value of such investment for such day. Such fair value prices would generally be determined based on available inputs about the current value of the underlying VIX futures contract and would be based on principles that the Sponsor deems fair and equitable.

 

The Funds may use a variety of money market instruments. Money market instruments generally will be valued using market prices or at amortized cost.

 

Fair value pricing may require subjective determinations about the value of an investment. While the Funds’ policies are intended to result in a calculation of its respective Fund’s NAV that fairly reflects investment values as of the time of pricing, such Fund cannot ensure that fair values determined by the Sponsor or persons acting at their direction would accurately reflect the price that a Fund could obtain for an investment if it were to dispose of that investment as of the time of pricing (for instance, in a forced or distressed sale). The prices used by such Fund may differ from the value that would be realized if the investments were sold and the differences could be material to the financial statements.

 

Fair Value of Financial Instruments

Fair Value of Financial Instruments

 

The Funds disclose the fair value of their investments in a hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The disclosure requirements establish a fair value hierarchy that distinguishes between: (1) market participant assumptions developed based on market data obtained from sources independent of the Funds (observable inputs); and (2) the Funds’ own assumptions about market participant assumptions developed based on the best information available under the circumstances (unobservable inputs). The three levels defined by the disclosure requirements hierarchy are as follows:

 

Level I – Quoted prices (unadjusted) in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date.

 

Level II – Inputs other than quoted prices included within Level I that are observable for the asset or liability, either directly or indirectly. Level II assets include the following: quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the asset or liability, and inputs that are derived principally from or corroborated by observable market data by correlation or other means (market-corroborated inputs).

 

Level III – Unobservable pricing input at the measurement date for the asset or liability. Unobservable inputs shall be used to measure fair value to the extent that observable inputs are not available.

 

In some instances, the inputs used to measure fair value might fall in different levels of the fair value hierarchy. The level in the fair value hierarchy within which the fair value measurement in its entirety falls is determined based on the lowest input level that is significant to the fair value measurement in its entirety.

 

Fair value measurements also require additional disclosure when the volume and level of activity for the asset or liability have significantly decreased, as well as when circumstances indicate that a transaction is not orderly.

 

The following table summarizes the valuation of investments at December 31, 2022 using the fair value hierarchy:

 

   Level 1 - 
Quoted
Prices
   Level 2 -
Other
Significant
Observable
Inputs
     
Fund  Money
Market Fund
   Futures
Contracts*
   Total 
-1x Short VIX Futures ETF  $
-
   $1,156,106   $1,156,106 
2x Long VIX Futures ETF   8,250,285    (9,203,522)   (953,237)
Total Trust  $8,250,285   $(8,047,416)  $202,869 

 

*Includes cumulative appreciation (depreciation) of futures contracts as reported in the Schedule of Investments. Only current day’s variation margin is reported within the Statements of Financial Condition in receivable/payable on open futures.

 

The inputs or methodology used for valuing investments are not necessarily an indication of the risk associated with investing in those securities.

 

Investment Transactions and Related Income

Investment Transactions and Related Income

 

Investment transactions are recorded on the trade date. All such transactions are recorded on the identified cost basis and marked to market daily. Unrealized appreciation (depreciation) on open contracts are reflected in the Statements of Financial Condition and changes in the unrealized appreciation (depreciation) between periods are reflected in the Statements of Operations.

 

Interest income is recognized on an accrual basis and includes, where applicable, the amortization of premium or discount, and is reflected as Interest Income in the Statement of Operations.

 

Brokerage Commissions and Futures Account Fees

Brokerage Commissions and Futures Account Fees

 

Each Fund pays its respective brokerage commissions, including applicable exchange fees, National Futures Association (“NFA”) fees, give-up fees, pit brokerage fees and other transaction related fees and expenses charged in connection with trading activities for each Fund’s investment in U.S. Commodity Futures Trading Commission (“CFTC”) regulated investments. The effects of trading spreads, financing costs/fees associated with Financial Instruments, and costs relating to the purchase of U.S. Treasury securities or similar high credit quality short-term fixed-income would also be borne by the Funds. Brokerage commissions on futures contracts are recognized on a half-turn basis (e.g., the first half is recognized when the contract is purchased (opened) and the second half is recognized when the transaction is closed). The Sponsor is currently paying brokerage commissions on VIX futures contracts for the Funds that exceed variable create/redeem fees collected by more than 0.04% and 0.09%, for SVIX and UVIX, respectively, of each Fund’s average net assets annually.

 

Federal Income Tax

Federal Income Tax

 

Each Fund is registered as a series of a Delaware statutory trust and is treated as a partnership for U.S. federal income tax purposes. Accordingly, no Fund expects to incur U.S. federal income tax liability; rather, each beneficial owner of a Fund’s Shares is required to take into account its allocable share of its Fund’s income, gain, loss, deductions and other items for its Fund’s taxable year ending with or within the beneficial owner’s taxable year.

 

Management of the Funds has reviewed all open tax years and major jurisdictions (i.e., the last four tax year ends and the interim tax period since then, as applicable) and concluded that there is no tax liability resulting from unrecognized tax benefits relating to uncertain income tax positions taken or expected to be taken in future tax returns. The Funds are also not aware of any tax positions for which it is reasonably possible that the total amounts of unrecognized tax benefits will significantly change in the next twelve months. On an ongoing basis, management monitors its tax positions taken under the interpretation to determine if adjustments to conclusions are necessary based on factors including, but not limited to, on-going analysis of tax law, regulation, and interpretations thereof.

XML 32 R18.htm IDEA: XBRL DOCUMENT v3.23.1
Significant Accounting Policies (Tables)
12 Months Ended
Dec. 31, 2022
Accounting Policies [Abstract]  
Schedule of cut-off times and the times of the calculation of the funds
    Create/Redeem   NAV Calculation   NAV
Fund   Cut-off*(EST)   Time (EST)   Calculation Date
-1x Short VIX Futures ETF and   2:00 p.m.   4:00 p.m.   December 31, 2022
2x Long VIX Futures ETF   2:00 p.m.   4:00 p.m.   December 31, 2022

  

* Although the Funds’ shares may continue to trade on secondary markets subsequent to the calculation of the final NAV, these times represent the final opportunity to transact in creation or redemption units for the three months ended December 31, 2022.

 

Schedule of valuation of investments at using the fair value hierarchy
   Level 1 - 
Quoted
Prices
   Level 2 -
Other
Significant
Observable
Inputs
     
Fund  Money
Market Fund
   Futures
Contracts*
   Total 
-1x Short VIX Futures ETF  $
-
   $1,156,106   $1,156,106 
2x Long VIX Futures ETF   8,250,285    (9,203,522)   (953,237)
Total Trust  $8,250,285   $(8,047,416)  $202,869 

 

*Includes cumulative appreciation (depreciation) of futures contracts as reported in the Schedule of Investments. Only current day’s variation margin is reported within the Statements of Financial Condition in receivable/payable on open futures.

 

XML 33 R19.htm IDEA: XBRL DOCUMENT v3.23.1
Investments (Tables)
12 Months Ended
Dec. 31, 2022
Investments [Abstract]  
Schedule of fair value of derivative instruments
      Asset Derivatives   Liability Derivatives 
Derivatives Not Accounted for as Hedging Instruments  Fund  Statement of
Financial
Condition
Location
   Unrealized
Appreciation
   Statement of
Financial
Condition
Location
   Unrealized
Depreciation
 
VIX Futures Contracts  -1x Short VIX Futures ETF               $1,156,106                                    
   2x Long VIX Futures ETF                  (9,203,522)
   Total Trust                 $(8,047,416)

 

* Includes cumulative appreciation (depreciation) of futures contracts as reported in the Schedule of Investments. Only current day’s variation margin is reported within the Statements of Financial Condition in variation margin receivable/payable.

 

Schedule of effect of derivative instruments on the statement of operations
Derivatives Not Accounted for as hedging Instruments  Location of Gain
(Loss) on Derivatives
Recognized in income
  Fund  Realized Gain (Loss) on Derivatives Recognized in Income   Change in Unrealized Appreciation (Depreciation) on Derivatives Recognized in Income 
VIX Futures Contracts  Net realized gain (loss) on futures contracts/ changes in unrealized appreciation (depreciation) on futures contrats           
    -1x Short VIX Futures ETF  $16,573,816   $1,156,106 
      2x Long VIX Futures ETF   (67,298,870)   (9,203,522)
      Total Trust  $(50,725,054)  $(8,047,416)

 

Schedule of pledged by funds fair values of derivative instruments
Fair Values of Derivative Instruments as of December 31, 2022
   Assets   Liabilities 
Fund  Gross
Amounts of
Recognized
Assets
presented
in the
Statements of
Financial
Condition
   Gross
Amounts
Offset
in the
Statements of
Financial
Condition
   Net
Amounts of
Assets
presented
in the
Statements of
Financial
Condition
   Gross
Amounts of
Recognized
Liabilities
presented
in the
Statements of
Financial
Condition
   Gross
Amounts
Offset
in the
Statements of
Financial
Condition
   Net
Amounts of
Liabilities
presented
in the
Statements of
Financial
Condition
 
-1x Short VIX Futures ETF  $          -   $          -   $          -   $187,030   $          -   $187,030 
2x Long VIX Futures ETF   830,840    -    830,840    -    -    - 

 

Schedule of gross amounts not offset in the statements of financial condition
Gross Amounts Not Offset in the Statements of Financial Condition as of December 31, 2022
Fund  Amounts of
Recognized
Assets /
(Liabilities)
presented
in the
Statements of
Financial
Condition
   Financial
Instruments for
the Benefit of
(the Funds) /
the
Counterparties
   Cash
Collateral for
the Benefit of
(the Funds) /
the
Counterparties
   Net
Amount
 
-1x Short VIX Futures ETF  $(187,030)  $              -   $            -   $(187,030)
2x Long VIX Futures ETF   830,840    -    -    830,840 
XML 34 R20.htm IDEA: XBRL DOCUMENT v3.23.1
Creation and Redemption of Creation Units (Tables)
12 Months Ended
Dec. 31, 2022
Creation and Redemption of Creation Units [Abstract]  
Schedule of transaction fees
Fund  Period
Ended
December 31,
2022
 
-1x Short VIX Futures ETF  $105,025 
2x Long VIX Futures ETF   178,809 
Total Trust  $283,834 
XML 35 R21.htm IDEA: XBRL DOCUMENT v3.23.1
Financial Highlights (Tables)
12 Months Ended
Dec. 31, 2022
Financial Highlights Disclosure [Abstract]  
Schedule of share outstanding
   -1x Short VIX Futures ETF   2x Long VIX Futures ETF 
   Period Ended
December 31,
2022(1)
   Period Ended
December 31,
2022(1)
 
Net Asset Value, Beginning of Period  $15.00   $15.00 
Net investment loss per share (2)   (0.18)   (0.15)
Net Realized and Unrealized Gain (Loss) on Investments and Futures Contracts (3)   (0.19)   (9.00)
Net Increase (Decrease) in Net Asset Value Resulting from Operations   (0.37)   (9.15)
Net Asset Value, End of Period  $14.63   $5.85 
Market Value Per Share, at December 31, 2022 (4)  $14.66   $5.82 
Total Return at Net Asset Value (5)   (2.47)%   (61.00)%
Total Return at Market Value (5)   (2.27)%   (61.20)%
           
Ratios to Average Net Assets: (6)          
Expense ratio (7)   2.41%   2.46%
Net Investment Loss   (2.03)%   (1.96)%

 

(1)Both Funds commenced operations on March 28, 2022.
(2)Net investment loss per share represents net investment loss divided by the daily average shares of beneficial interest outstanding during the period.
(3)Due to timing of capital share transactions, per share amounts may not compare with amounts appearing elsewhere within these Financial Statements.
(4)Market values are determined at the close of the applicable primary listing exchange, which may be later than when the Funds’ net asset value is calculated.
(5)Percentages are not annualized for the period ended December 31, 2022.
(6)Percentages are annualized.
(7)The expense ratio would be 2.29% and 2.39% respectively, if brokerage commissions and futures and futures account fees were excluded.
XML 36 R22.htm IDEA: XBRL DOCUMENT v3.23.1
Significant Accounting Policies (Details)
$ in Millions
12 Months Ended
Dec. 31, 2022
USD ($)
Significant Accounting Policies (Details) [Line Items]  
Annual gross revenue $ 1,070
Non-convertible debt securities 1,000
Non-affiliates exceeded $ 700
SVIX [Member]  
Significant Accounting Policies (Details) [Line Items]  
Fund’s average net assets annually 0.04%
UVIX [Member]  
Significant Accounting Policies (Details) [Line Items]  
Fund’s average net assets annually 0.09%
XML 37 R23.htm IDEA: XBRL DOCUMENT v3.23.1
Significant Accounting Policies (Details) - Schedule of cut-off times and the times of the calculation of the funds
12 Months Ended
Dec. 31, 2022
-1x Short VIX Futures ETF [Member]  
Significant Accounting Policies (Details) - Schedule of cut-off times and the times of the calculation of the funds [Line Items]  
Create/Redeem Cut-off (EST) 2:00 p.m. [1]
NAV Calculation Time (EST) 4:00 p.m.
NAV Calculation Date Dec. 31, 2022
2x Long VIX Futures ETF [Member]  
Significant Accounting Policies (Details) - Schedule of cut-off times and the times of the calculation of the funds [Line Items]  
Create/Redeem Cut-off (EST) 2:00 p.m. [1]
NAV Calculation Time (EST) 4:00 p.m.
NAV Calculation Date Dec. 31, 2022
[1] Although the Funds’ shares may continue to trade on secondary markets subsequent to the calculation of the final NAV, these times represent the final opportunity to transact in creation or redemption units for the three months ended December 31, 2022.
XML 38 R24.htm IDEA: XBRL DOCUMENT v3.23.1
Significant Accounting Policies (Details) - Schedule of valuation of investments at using the fair value hierarchy
Dec. 31, 2022
USD ($)
Significant Accounting Policies (Details) - Schedule of valuation of investments at using the fair value hierarchy [Line Items]  
Total Trust $ 202,869
-1x Short VIX Futures ETF [Member]  
Significant Accounting Policies (Details) - Schedule of valuation of investments at using the fair value hierarchy [Line Items]  
Total Trust 1,156,106
2x Long VIX Futures ETF [Member]  
Significant Accounting Policies (Details) - Schedule of valuation of investments at using the fair value hierarchy [Line Items]  
Total Trust (953,237)
Level I - Quoted Prices [Member] | Money Market Fund [Member]  
Significant Accounting Policies (Details) - Schedule of valuation of investments at using the fair value hierarchy [Line Items]  
Total Trust 8,250,285
Level I - Quoted Prices [Member] | Money Market Fund [Member] | -1x Short VIX Futures ETF [Member]  
Significant Accounting Policies (Details) - Schedule of valuation of investments at using the fair value hierarchy [Line Items]  
Total Trust
Level I - Quoted Prices [Member] | Money Market Fund [Member] | 2x Long VIX Futures ETF [Member]  
Significant Accounting Policies (Details) - Schedule of valuation of investments at using the fair value hierarchy [Line Items]  
Total Trust 8,250,285
Level I - Quoted Prices [Member] | Futures Contracts [Member]  
Significant Accounting Policies (Details) - Schedule of valuation of investments at using the fair value hierarchy [Line Items]  
Total Trust (8,047,416) [1]
Level I - Quoted Prices [Member] | Futures Contracts [Member] | -1x Short VIX Futures ETF [Member]  
Significant Accounting Policies (Details) - Schedule of valuation of investments at using the fair value hierarchy [Line Items]  
Total Trust 1,156,106 [1]
Level I - Quoted Prices [Member] | Futures Contracts [Member] | 2x Long VIX Futures ETF [Member]  
Significant Accounting Policies (Details) - Schedule of valuation of investments at using the fair value hierarchy [Line Items]  
Total Trust $ (9,203,522) [1]
[1] Includes cumulative appreciation (depreciation) of futures contracts as reported in the Schedule of Investments. Only current day’s variation margin is reported within the Statements of Financial Condition in receivable/payable on open futures.
XML 39 R25.htm IDEA: XBRL DOCUMENT v3.23.1
Investments (Details) - Schedule of fair value of derivative instruments
Dec. 31, 2022
USD ($)
-1x Short VIX Futures ETF [Member]  
Derivatives, Fair Value [Line Items]  
Total Trust $ (9,203,522)
2x Long VIX Futures ETF [Member]  
Derivatives, Fair Value [Line Items]  
Total Trust (8,047,416)
Asset Derivatives [Member] | Unrealized Appreciation [Member]  
Derivatives, Fair Value [Line Items]  
Total Trust $ 1,156,106
XML 40 R26.htm IDEA: XBRL DOCUMENT v3.23.1
Investments (Details) - Schedule of effect of derivative instruments on the statement of operations
3 Months Ended
Dec. 31, 2022
USD ($)
Investments (Details) - Schedule of effect of derivative instruments on the statement of operations [Line Items]  
Realized Gain (Loss) on Derivatives Recognized in Income $ (50,725,054)
Change in Unrealized Appreciation (Depreciation) on Derivatives Recognized in Income (8,047,416)
-1x Short VIX Futures ETF [Member]  
Investments (Details) - Schedule of effect of derivative instruments on the statement of operations [Line Items]  
Realized Gain (Loss) on Derivatives Recognized in Income 16,573,816
Change in Unrealized Appreciation (Depreciation) on Derivatives Recognized in Income 1,156,106
2x Long VIX Futures ETF [Member]  
Investments (Details) - Schedule of effect of derivative instruments on the statement of operations [Line Items]  
Realized Gain (Loss) on Derivatives Recognized in Income (67,298,870)
Change in Unrealized Appreciation (Depreciation) on Derivatives Recognized in Income $ (9,203,522)
XML 41 R27.htm IDEA: XBRL DOCUMENT v3.23.1
Investments (Details) - Schedule of pledged by funds fair values of derivative instruments
12 Months Ended
Dec. 31, 2022
USD ($)
-1x Short VIX Futures ETF [Member] | Liabilities [Member]  
Investments (Details) - Schedule of pledged by funds fair values of derivative instruments [Line Items]  
Gross Amounts of Recognized Assets presented in the Statements of Financial Condition $ 187,030
2x Long VIX Futures ETF [Member] | Assets [Member]  
Investments (Details) - Schedule of pledged by funds fair values of derivative instruments [Line Items]  
Gross Amounts of Recognized Assets presented in the Statements of Financial Condition 830,840
Net Amounts of Assets presented in the Statements of Financial Condition $ 830,840
XML 42 R28.htm IDEA: XBRL DOCUMENT v3.23.1
Investments (Details) - Schedule of gross amounts not offset in the statements of financial condition
12 Months Ended
Dec. 31, 2022
USD ($)
-1x Short VIX Futures ETF [Member]  
Investments (Details) - Schedule of gross amounts not offset in the statements of financial condition [Line Items]  
Amounts of Recognized Assets / (Liabilities) presented in the Statements of Financial Condition $ (187,030)
2x Long VIX Futures ETF [Member]  
Investments (Details) - Schedule of gross amounts not offset in the statements of financial condition [Line Items]  
Amounts of Recognized Assets / (Liabilities) presented in the Statements of Financial Condition $ 830,840
XML 43 R29.htm IDEA: XBRL DOCUMENT v3.23.1
Agreements (Details)
$ in Millions
Dec. 31, 2022
USD ($)
Agreements (Details) [Line Items]  
Sub-advisory fee rate 0.25%
Average daily net assets (in Dollars) $ 35
SVIX [Member]  
Agreements (Details) [Line Items]  
Average daily net assets rate 1.35%
UVIX [Member]  
Agreements (Details) [Line Items]  
Average daily net assets rate 1.65%
XML 44 R30.htm IDEA: XBRL DOCUMENT v3.23.1
Creation and Redemption of Creation Units (Details)
12 Months Ended
Dec. 31, 2022
shares
Creation and Redemption of Creation Units [Abstract]  
Shares of fund 10,000
Authorized participants percentage 0.03%
XML 45 R31.htm IDEA: XBRL DOCUMENT v3.23.1
Creation and Redemption of Creation Units (Details) - Schedule of transaction fees
3 Months Ended
Dec. 31, 2022
USD ($)
Creation and Redemption of Creation Units (Details) - Schedule of transaction fees [Line Items]  
Total Trust $ 283,834
-1x Short VIX Futures ETF [Member]  
Creation and Redemption of Creation Units (Details) - Schedule of transaction fees [Line Items]  
Total Trust 105,025
2x Long VIX Futures ETF [Member]  
Creation and Redemption of Creation Units (Details) - Schedule of transaction fees [Line Items]  
Total Trust $ 178,809
XML 46 R32.htm IDEA: XBRL DOCUMENT v3.23.1
Financial Highlights (Details) - Schedule of share outstanding
12 Months Ended
Dec. 31, 2022
$ / shares
-1x Short VIX Futures ETF [Member]  
Financial Highlights (Details) - Schedule of share outstanding [Line Items]  
Net Asset Value, Beginning of Period $ 15 [1]
Net investment loss per share (0.18) [1],[2]
Net Realized and Unrealized Gain (Loss) on Investments and Futures Contracts (0.19) [1],[3]
Net Increase (Decrease) in Net Asset Value Resulting from Operations (0.37) [1]
Net Asset Value, End of Period 14.63
Market Value Per Share, at December 31, 2022 $ 14.66 [1],[4]
Total Return at Net Asset Value (2.47%) [1],[5]
Total Return at Market Value (2.27%) [1],[5]
Ratios to Average Net Assets: (6)  
Expense ratio 2.41% [1],[6]
Net Investment Loss (2.03%)
-1x Short VIX Futures ETF [Member] | Previously Reported [Member]  
Financial Highlights (Details) - Schedule of share outstanding [Line Items]  
Net Asset Value, End of Period $ 14.63 [1]
2x Long VIX Futures ETF [Member]  
Financial Highlights (Details) - Schedule of share outstanding [Line Items]  
Net Asset Value, Beginning of Period 15 [1]
Net investment loss per share (0.15) [1],[2]
Net Realized and Unrealized Gain (Loss) on Investments and Futures Contracts (9) [1],[3]
Net Increase (Decrease) in Net Asset Value Resulting from Operations (9.15) [1]
Net Asset Value, End of Period 5.85
Market Value Per Share, at December 31, 2022 $ 5.82 [1],[4]
Total Return at Net Asset Value (61.00%) [1],[5]
Total Return at Market Value (61.20%) [1],[5]
Ratios to Average Net Assets: (6)  
Expense ratio 2.46% [1],[6]
Net Investment Loss (1.96%)
2x Long VIX Futures ETF [Member] | Previously Reported [Member]  
Financial Highlights (Details) - Schedule of share outstanding [Line Items]  
Net Asset Value, End of Period $ 5.85 [1]
[1] Both Funds commenced operations on March 28, 2022.
[2] Net investment loss per share represents net investment loss divided by the daily average shares of beneficial interest outstanding during the period.
[3] Due to timing of capital share transactions, per share amounts may not compare with amounts appearing elsewhere within these Financial Statements.
[4] Market values are determined at the close of the applicable primary listing exchange, which may be later than when the Funds’ net asset value is calculated.
[5] Percentages are not annualized for the period ended December 31, 2022.
[6] The expense ratio would be 2.29% and 2.39% respectively, if brokerage commissions and futures and futures account fees were excluded.
XML 47 R33.htm IDEA: XBRL DOCUMENT v3.23.1
Risk (Details)
12 Months Ended
Dec. 31, 2022
Risk [Abstract]  
Relevant benchmark percentage 50.00%
XML 48 f10k2022_vstrust_htm.xml IDEA: XBRL DOCUMENT 0001793497 2022-01-01 2022-12-31 0001793497 cik0001793497:OneShortVIXFuturesETFMember 2022-01-01 2022-12-31 0001793497 cik0001793497:TwoxLongVIXFuturesETFMember 2022-01-01 2022-12-31 0001793497 2023-02-28 0001793497 cik0001793497:OneShortVIXFuturesETFMember 2022-06-30 0001793497 cik0001793497:TwoxLongVIXFuturesETFMember 2022-06-30 0001793497 2022-06-30 0001793497 cik0001793497:OneShortVIXFuturesETFMember 2022-12-31 0001793497 cik0001793497:TwoxLongVIXFuturesETFMember 2022-12-31 0001793497 2022-12-31 0001793497 cik0001793497:OnexShortVIXFuturesETFMember 2022-12-31 0001793497 cik0001793497:OnexShortVIXFuturesETFMember 2022-01-01 2022-12-31 0001793497 cik0001793497:OnexShortVIXFuturesETFMember cik0001793497:CBOEVIXFUTUREJan23Member 2022-01-01 2022-12-31 0001793497 cik0001793497:OnexShortVIXFuturesETFMember cik0001793497:CBOEVIXFUTUREJan23Member 2022-12-31 0001793497 cik0001793497:OnexShortVIXFuturesETFMember cik0001793497:CBOEVIXFUTUREFeb23Member 2022-01-01 2022-12-31 0001793497 cik0001793497:OnexShortVIXFuturesETFMember cik0001793497:CBOEVIXFUTUREFeb23Member 2022-12-31 0001793497 cik0001793497:TwoxLongVIXFuturesETFMember 2022-01-01 2022-12-31 0001793497 cik0001793497:TwoxLongVIXFuturesETFMember cik0001793497:CBOEVIXFUTURESJan23Member 2022-01-01 2022-12-31 0001793497 cik0001793497:TwoxLongVIXFuturesETFMember cik0001793497:CBOEVIXFUTURESJan23Member 2022-12-31 0001793497 cik0001793497:TwoxLongVIXFuturesETFMember cik0001793497:CBOEVIXFUTURESFeb23Member 2022-01-01 2022-12-31 0001793497 cik0001793497:TwoxLongVIXFuturesETFMember cik0001793497:CBOEVIXFUTURESFeb23Member 2022-12-31 0001793497 cik0001793497:OneShortVIXFuturesETFMember 2022-01-01 2022-12-31 0001793497 cik0001793497:TwoXLongVIXFuturesETFMember 2022-01-01 2022-12-31 0001793497 cik0001793497:OneShortVIXFuturesETFMember 2021-12-31 0001793497 cik0001793497:TwoxLongVIXFuturesETFMember 2021-12-31 0001793497 2021-12-31 0001793497 cik0001793497:SVIXMember 2022-01-01 2022-12-31 0001793497 cik0001793497:UVIXMember 2022-01-01 2022-12-31 0001793497 cik0001793497:OneShortVIXFuturesETFMember us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member 2022-12-31 0001793497 cik0001793497:OneShortVIXFuturesETFMember cik0001793497:FuturesContractsMember us-gaap:FairValueInputsLevel1Member 2022-12-31 0001793497 cik0001793497:TwoxLongVIXFuturesETFMember us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member 2022-12-31 0001793497 cik0001793497:TwoxLongVIXFuturesETFMember cik0001793497:FuturesContractsMember us-gaap:FairValueInputsLevel1Member 2022-12-31 0001793497 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member 2022-12-31 0001793497 cik0001793497:FuturesContractsMember us-gaap:FairValueInputsLevel1Member 2022-12-31 0001793497 cik0001793497:AssetDerivativesMember cik0001793497:UnrealizedAppreciationMember 2022-12-31 0001793497 cik0001793497:OnexShortVIXFuturesETFMember 2022-10-01 2022-12-31 0001793497 cik0001793497:TwoXLongVIXFuturesETFMember 2022-10-01 2022-12-31 0001793497 2022-10-01 2022-12-31 0001793497 cik0001793497:OneShortVIXFuturesETFMember us-gaap:OtherLiabilitiesMember 2022-01-01 2022-12-31 0001793497 cik0001793497:TwoxLongVIXFuturesETFMember us-gaap:OtherAssetsMember 2022-01-01 2022-12-31 0001793497 cik0001793497:SVIXMember 2022-12-31 0001793497 cik0001793497:UVIXMember 2022-12-31 0001793497 cik0001793497:OneShortVIXFuturesETFMember 2022-10-01 2022-12-31 0001793497 cik0001793497:TwoxLongVIXFuturesETFMember 2022-10-01 2022-12-31 0001793497 cik0001793497:OneShortVIXFuturesETFMember srt:ScenarioPreviouslyReportedMember 2022-12-31 0001793497 cik0001793497:TwoxLongVIXFuturesETFMember srt:ScenarioPreviouslyReportedMember 2022-12-31 shares iso4217:USD iso4217:USD shares pure 10-K true 2022-12-31 --12-31 2022 false 001-41280 VS Trust DE 84-6704517 2000 PGA Boulevard Suite 4440 Palm Beach Gardens FL 33408 (866) 261-0273 -1x Short VIX Futures ETF SVIX CboeBZX 2x Long VIX Futures ETF UVIX CboeBZX No No Yes Yes true Non-accelerated Filer true true true false 7570000 46889371 60436455 107325826 238 TAIT, WELLER & BAKER LLP Philadelphia, Pennsylvania 504600 12909 10295 48144554 571 48672929 187030 1903018 54374 15869 125274 8761 2294326 46378603 -29386125 -16992478 46378603 46378603 3170000 14.63 14.66 0.011 504600 0.989 45874003 1 46378603 2023-01-18 -1150 26634000 -1058571 2023-02-15 -804 19754280 -97536 -1954 46388280 -1156106 2 134714 61 134777 489398 40782 240079 60805 41169 872233 737456 -12 -16573816 -1156106 17729934 16992478 -737456 16573828 1156106 16992478 -189786132 160400007 29386125 46378603 46378603 16992478 224609285 224609285 48144554 10295 12909 571 187030 -54374 15869 125274 8761 -30784543 189786132 158496989 31289143 504600 504600 8250285 50483 15666 1931028 114821272 830840 579 125900153 176838 19957 203411 11181 411387 125488766 -203182472 77693706 125488766 125488766 21450000 5.85 5.82 8250285 8250285 8250285 0.066 8250285 0.934 117238481 1 125488766 2023-01-18 6221 -144078360 8416975 2023-02-15 4355 -107002350 786547 10576 -251080710 9203522 7 306021 159 306187 1004754 55759 318741 74647 43638 1497539 1191352 -38 67298870 9203522 -76502354 -77693706 -1191352 -67298832 -9203522 -77693706 -399696269 196513797 203182472 125488766 125488766 -77693706 358531359 350281074 114821272 830840 15666 50483 579 -176838 19957 203411 11181 -201251444 397765241 196513797 201251444 504600 8250285 63392 25961 1931028 162965826 830840 1150 174573082 187030 1903018 231212 35826 328685 19942 2705713 171867369 -232568597 60701228 171867369 171867369 24620000 8250285 9 440735 220 440964 1494152 96541 558820 135452 84807 2369772 1928808 -50 50725054 8047416 -58772420 -60701228 -1928808 -50725004 -8047416 -60701228 -589482401 356913804 232568597 171867369 171867369 -60701228 583140644 574890359 162965826 830840 25961 63392 1150 187030 -231212 35826 328685 19942 -232035987 587551373 355010786 232540587 504600 504600 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>NOTE 1 – ORGANIZATION</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">VS Trust (the “Trust”) is a Delaware statutory trust formed on October 24, 2019 and is currently organized into separate series (each, a “Fund” and collectively, the “Funds”). As of December 31, 2022, the following two series of the Trust have commenced investment operations: -1x Short VIX Futures ETF (“SVIX”) and 2x Long VIX Futures ETF (“UVIX”). Each of the Funds listed above issues common units of beneficial interest (“Shares”), which represent units of fractional undivided beneficial interest in and ownership of only that Fund. The Shares of each Fund are listed on the Cboe BZX Exchange (“Cboe BZX”).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Funds’ inception of operation was March 28, 2022. Neither the Trust nor the Funds had any operations prior to March 28, 2022, other than matters relating to its organization and the registration of each series under the Securities Act of 1933.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Each Fund’s investment exposure to VIX futures contracts will cause each to be deemed a commodity pool, thereby subjecting each Fund to regulation under the Commodity Exchange Act of 1934 (“CEA”) and Commodity Futures Trading Commission (“CFTC”) rules. The Sponsor is registered as a Commodity Pool Operator (“CPO”) and the Fund will be operated in accordance with applicable CFTC rules. Registration as a CPO imposes additional compliance obligations on the Sponsor and the Funds related to additional laws, regulations and enforcement policies, which could increase compliance costs and may affect the operations and financial performance of the Funds.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Volatility Shares LLC (the “Sponsor”) is the sponsor of the Trust and the Funds. The Sponsor also will serve as the Trust’s commodity pool operator. The Funds are commodity pools, as defined under the Commodity Exchange Act (the “CEA”), and the applicable regulations of the CFTC and are operated by the Sponsor, which is registered as a commodity pool operator with the CFTC. The Trust is not an investment company registered under the Investment Company Act of 1940.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>NOTE 2 – SIGNIFICANT ACCOUNTING POLICIES</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Each Fund is an investment company, as defined by Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 946 “Financial Services — Investment Companies.” As such, the Funds follow the investment company accounting and reporting guidance. The following is a summary of significant accounting policies followed by each Fund, as applicable, in preparation of its financial statements. These policies are in conformity with accounting principles generally accepted in the United States of America (“GAAP”).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The accompanying unaudited financial statements were prepared in accordance with GAAP for interim financial information and with the instructions for Form 10-K and the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”). In the opinion of management, all material adjustments, consisting only of normal recurring adjustments, considered necessary for a fair statement of the interim period financial statements have been made. Interim period results are not necessarily indicative of results for a full-year period.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Emerging growth company</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Trust is an “emerging growth company,” as defined in the Jumpstart Our Business Startups Act of 2012. It will remain an emerging growth company until the earlier of (1) the beginning of the first fiscal year following the fifth anniversary of its initial public offering, (2) the beginning of the first fiscal year after annual gross revenue is $1.07 billion (subject to adjustment for inflation) or more, (3) the date on which the Fund has, during the previous three-year period, issued more than $1.0 billion in non-convertible debt securities and (4) as of the end of any fiscal year in which the market value of common equity held by non-affiliates exceeded $700 million as of the end of the second quarter of that fiscal year.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">For as long as the Trust remains an “emerging growth company,” it may take advantage of certain exemptions from the various reporting requirements that are applicable to public companies that are not “emerging growth companies” including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation and financial statements in our periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote to approve executive compensation and shareholder approval of any golden parachute payments not previously approved. The Trust will take advantage of these reporting exemptions until it is no longer an “emerging growth company.”</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Use of Estimates &amp; Indemnifications</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In the normal course of business, the Trust enters into contracts that contain a variety of representations which provide general indemnifications. The Trust’s maximum exposure under these arrangements cannot be known; however, the Trust expects any risk of loss to be remote.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Basis of Presentation</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Pursuant to rules and regulations of the SEC, these financial statements are presented for the Trust as a whole, as the SEC registrant, and for each Fund individually. The debts, liabilities, obligations and expenses incurred, contracted for or otherwise existing with respect to a particular Fund shall be enforceable only against the assets of such Fund and not against the assets of the Trust generally or any other Fund. Accordingly, the assets of each Fund of the Trust include only those funds and other assets that are paid to, held by or distributed to the Trust for the purchase of Shares in that Fund.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Statements of Cash Flows</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The cash amount shown in the Statements of Cash Flows is the amount reported as cash in the Statements of Financial Condition dated December 31, 2022, and represents cash but does not include short-term investments.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Final Net Asset Value for Fiscal Period</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The cut-off times and the times of the calculation of the Funds’ final net asset value for creation and redemption of fund Shares for the three months ended December 31, 2022 were typically as follows. All times are Eastern Standard Time:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td> </td> <td style="text-align: center"> </td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Create/Redeem</b></span></td> <td style="text-align: center"> </td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NAV Calculation</b></span></td> <td style="text-align: center"> </td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NAV</b></span></td></tr> <tr style="vertical-align: bottom"> <td style="width: 55%; border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fund</b></span></td> <td style="width: 1%; text-align: center"> </td> <td style="width: 14%; border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Cut-off*(EST)</b></span></td> <td style="width: 1%; text-align: center"> </td> <td style="width: 14%; border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Time (EST)</b></span></td> <td style="width: 1%; text-align: center"> </td> <td style="width: 14%; border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Calculation Date</b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-1x Short VIX Futures ETF and</span></td> <td style="white-space: nowrap; text-align: center"> </td> <td style="white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2:00 p.m.</span></td> <td style="white-space: nowrap; text-align: center"> </td> <td style="white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4:00 p.m.</span></td> <td style="white-space: nowrap; text-align: center"> </td> <td style="white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2022</span></td></tr> <tr style="vertical-align: bottom; "> <td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2x Long VIX Futures ETF</span></td> <td style="white-space: nowrap; text-align: center"> </td> <td style="white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2:00 p.m.</span></td> <td style="white-space: nowrap; text-align: center"> </td> <td style="white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4:00 p.m.</span></td> <td style="white-space: nowrap; text-align: center"> </td> <td style="white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2022</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">  </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0px"/> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although the Funds’ shares may continue to trade on secondary markets subsequent to the calculation of the final NAV, these times represent the final opportunity to transact in creation or redemption units for the three months ended December 31, 2022.</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Market value per Share is determined at the close of Cboe BZX and may be later than when the Funds’ NAV per Share is calculated.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">For financial reporting purposes, the Funds value transactions based upon the final closing price in their primary markets. Accordingly, the investment valuations in these financial statements may differ from those used in the calculation of certain of the Funds’ final creation/redemption NAV for the three months ended December 31, 2022.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Investment Valuation</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Short-term investments are valued at amortized cost which approximates fair value for daily NAV purposes. For financial reporting purposes, short-term investments are valued at their market price using information provided by a third-party pricing service or market quotations. In each of these situations, valuations are typically categorized as Level I in the fair value hierarchy.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">VIX futures contracts are valued using the Time Weighted Average Price (TWAP) of the futures during the last 15 minutes of NYSE’s regular trading session, rather than solely from the VIX futures’ settlement price. The value of a Fund’s non-exchange-traded Financial Instruments typically is determined by applying the then-current disseminated levels for the Index to the terms of the Fund’s non-exchange-traded Financial Instruments.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In certain circumstances (e.g., if the Sponsor believes market quotations do not accurately reflect the fair value of a Fund’s investment, or a trading halt closes an exchange or market early), the Sponsor may, in its sole discretion, choose to determine a fair value price as the basis for determining the market value of such investment for such day. Such fair value prices would generally be determined based on available inputs about the current value of the underlying VIX futures contract and would be based on principles that the Sponsor deems fair and equitable.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Funds may use a variety of money market instruments. Money market instruments generally will be valued using market prices or at amortized cost.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Fair value pricing may require subjective determinations about the value of an investment. While the Funds’ policies are intended to result in a calculation of its respective Fund’s NAV that fairly reflects investment values as of the time of pricing, such Fund cannot ensure that fair values determined by the Sponsor or persons acting at their direction would accurately reflect the price that a Fund could obtain for an investment if it were to dispose of that investment as of the time of pricing (for instance, in a forced or distressed sale). The prices used by such Fund may differ from the value that would be realized if the investments were sold and the differences could be material to the financial statements.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 7pt"><b> </b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Fair Value of Financial Instruments</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 7pt"><b> </b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Funds disclose the fair value of their investments in a hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The disclosure requirements establish a fair value hierarchy that distinguishes between: (1) market participant assumptions developed based on market data obtained from sources independent of the Funds (observable inputs); and (2) the Funds’ own assumptions about market participant assumptions developed based on the best information available under the circumstances (unobservable inputs). The three levels defined by the disclosure requirements hierarchy are as follows:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 7pt"><b> </b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Level I – Quoted prices (unadjusted) in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 7pt"><b> </b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Level II – Inputs other than quoted prices included within Level I that are observable for the asset or liability, either directly or indirectly. Level II assets include the following: quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the asset or liability, and inputs that are derived principally from or corroborated by observable market data by correlation or other means (market-corroborated inputs).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 7pt"><b> </b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Level III – Unobservable pricing input at the measurement date for the asset or liability. Unobservable inputs shall be used to measure fair value to the extent that observable inputs are not available.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 7pt"><b> </b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In some instances, the inputs used to measure fair value might fall in different levels of the fair value hierarchy. The level in the fair value hierarchy within which the fair value measurement in its entirety falls is determined based on the lowest input level that is significant to the fair value measurement in its entirety.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 7pt"><b> </b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Fair value measurements also require additional disclosure when the volume and level of activity for the asset or liability have significantly decreased, as well as when circumstances indicate that a transaction is not orderly.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 7pt"><b> </b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The following table summarizes the valuation of investments at December 31, 2022 using the fair value hierarchy:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Level 1 - <br/> Quoted<br/> Prices</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Level 2 -<br/> Other<br/> Significant<br/> Observable <br/> Inputs</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: left; border-bottom: Black 1.5pt solid">Fund</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Money<br/> Market Fund</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Futures <br/> Contracts*</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; font-weight: bold; text-align: left">-1x Short VIX Futures ETF</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-12">-</div></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,156,106</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,156,106</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">2x Long VIX Futures ETF</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">8,250,285</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(9,203,522</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(953,237</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; padding-bottom: 4pt; font-weight: bold; text-align: left">Total Trust</td><td style="padding-bottom: 4pt; font-weight: bold"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">8,250,285</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 4pt; font-weight: bold"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(8,047,416</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 4pt; font-weight: bold"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">202,869</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 7pt"><b> </b></span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in; text-align: left">*</td><td style="text-align: justify">Includes cumulative appreciation (depreciation) of futures contracts as reported in the Schedule of Investments. Only current day’s variation margin is reported within the Statements of Financial Condition in receivable/payable on open futures.</td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 7pt"><b> </b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The inputs or methodology used for valuing investments are not necessarily an indication of the risk associated with investing in those securities.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 7pt"><b> </b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Investment Transactions and Related Income</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-size: 7pt"><b> </b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Investment transactions are recorded on the trade date. All such transactions are recorded on the identified cost basis and marked to market daily. Unrealized appreciation (depreciation) on open contracts are reflected in the Statements of Financial Condition and changes in the unrealized appreciation (depreciation) between periods are reflected in the Statements of Operations.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-size: 7pt"><b> </b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Interest income is recognized on an accrual basis and includes, where applicable, the amortization of premium or discount, and is reflected as Interest Income in the Statement of Operations.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 7pt"><b> </b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Brokerage Commissions and Futures Account Fees</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-size: 7pt"><b> </b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Each Fund pays its respective brokerage commissions, including applicable exchange fees, National Futures Association (“NFA”) fees, give-up fees, pit brokerage fees and other transaction related fees and expenses charged in connection with trading activities for each Fund’s investment in U.S. Commodity Futures Trading Commission (“CFTC”) regulated investments. The effects of trading spreads, financing costs/fees associated with Financial Instruments, and costs relating to the purchase of U.S. Treasury securities or similar high credit quality short-term fixed-income would also be borne by the Funds. Brokerage commissions on futures contracts are recognized on a half-turn basis (e.g., the first half is recognized when the contract is purchased (opened) and the second half is recognized when the transaction is closed). The Sponsor is currently paying brokerage commissions on VIX futures contracts for the Funds that exceed variable create/redeem fees collected by more than 0.04% and 0.09%, for SVIX and UVIX, respectively, of each Fund’s average net assets annually.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Federal Income Tax</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Each Fund is registered as a series of a Delaware statutory trust and is treated as a partnership for U.S. federal income tax purposes. Accordingly, no Fund expects to incur U.S. federal income tax liability; rather, each beneficial owner of a Fund’s Shares is required to take into account its allocable share of its Fund’s income, gain, loss, deductions and other items for its Fund’s taxable year ending with or within the beneficial owner’s taxable year.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Management of the Funds has reviewed all open tax years and major jurisdictions (i.e., the last four tax year ends and the interim tax period since then, as applicable) and concluded that there is no tax liability resulting from unrecognized tax benefits relating to uncertain income tax positions taken or expected to be taken in future tax returns. The Funds are also not aware of any tax positions for which it is reasonably possible that the total amounts of unrecognized tax benefits will significantly change in the next twelve months. On an ongoing basis, management monitors its tax positions taken under the interpretation to determine if adjustments to conclusions are necessary based on factors including, but not limited to, on-going analysis of tax law, regulation, and interpretations thereof.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Emerging growth company</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Trust is an “emerging growth company,” as defined in the Jumpstart Our Business Startups Act of 2012. It will remain an emerging growth company until the earlier of (1) the beginning of the first fiscal year following the fifth anniversary of its initial public offering, (2) the beginning of the first fiscal year after annual gross revenue is $1.07 billion (subject to adjustment for inflation) or more, (3) the date on which the Fund has, during the previous three-year period, issued more than $1.0 billion in non-convertible debt securities and (4) as of the end of any fiscal year in which the market value of common equity held by non-affiliates exceeded $700 million as of the end of the second quarter of that fiscal year.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">For as long as the Trust remains an “emerging growth company,” it may take advantage of certain exemptions from the various reporting requirements that are applicable to public companies that are not “emerging growth companies” including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation and financial statements in our periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote to approve executive compensation and shareholder approval of any golden parachute payments not previously approved. The Trust will take advantage of these reporting exemptions until it is no longer an “emerging growth company.”</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> </p> 1070000000.00 1000000000 700000000 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Use of Estimates &amp; Indemnifications</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In the normal course of business, the Trust enters into contracts that contain a variety of representations which provide general indemnifications. The Trust’s maximum exposure under these arrangements cannot be known; however, the Trust expects any risk of loss to be remote.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Basis of Presentation</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Pursuant to rules and regulations of the SEC, these financial statements are presented for the Trust as a whole, as the SEC registrant, and for each Fund individually. The debts, liabilities, obligations and expenses incurred, contracted for or otherwise existing with respect to a particular Fund shall be enforceable only against the assets of such Fund and not against the assets of the Trust generally or any other Fund. Accordingly, the assets of each Fund of the Trust include only those funds and other assets that are paid to, held by or distributed to the Trust for the purchase of Shares in that Fund.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Statements of Cash Flows</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The cash amount shown in the Statements of Cash Flows is the amount reported as cash in the Statements of Financial Condition dated December 31, 2022, and represents cash but does not include short-term investments.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Final Net Asset Value for Fiscal Period</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The cut-off times and the times of the calculation of the Funds’ final net asset value for creation and redemption of fund Shares for the three months ended December 31, 2022 were typically as follows. All times are Eastern Standard Time:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td> </td> <td style="text-align: center"> </td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Create/Redeem</b></span></td> <td style="text-align: center"> </td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NAV Calculation</b></span></td> <td style="text-align: center"> </td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NAV</b></span></td></tr> <tr style="vertical-align: bottom"> <td style="width: 55%; border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fund</b></span></td> <td style="width: 1%; text-align: center"> </td> <td style="width: 14%; border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Cut-off*(EST)</b></span></td> <td style="width: 1%; text-align: center"> </td> <td style="width: 14%; border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Time (EST)</b></span></td> <td style="width: 1%; text-align: center"> </td> <td style="width: 14%; border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Calculation Date</b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-1x Short VIX Futures ETF and</span></td> <td style="white-space: nowrap; text-align: center"> </td> <td style="white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2:00 p.m.</span></td> <td style="white-space: nowrap; text-align: center"> </td> <td style="white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4:00 p.m.</span></td> <td style="white-space: nowrap; text-align: center"> </td> <td style="white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2022</span></td></tr> <tr style="vertical-align: bottom; "> <td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2x Long VIX Futures ETF</span></td> <td style="white-space: nowrap; text-align: center"> </td> <td style="white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2:00 p.m.</span></td> <td style="white-space: nowrap; text-align: center"> </td> <td style="white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4:00 p.m.</span></td> <td style="white-space: nowrap; text-align: center"> </td> <td style="white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2022</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">  </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0px"/> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although the Funds’ shares may continue to trade on secondary markets subsequent to the calculation of the final NAV, these times represent the final opportunity to transact in creation or redemption units for the three months ended December 31, 2022.</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Market value per Share is determined at the close of Cboe BZX and may be later than when the Funds’ NAV per Share is calculated.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">For financial reporting purposes, the Funds value transactions based upon the final closing price in their primary markets. Accordingly, the investment valuations in these financial statements may differ from those used in the calculation of certain of the Funds’ final creation/redemption NAV for the three months ended December 31, 2022.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td> </td> <td style="text-align: center"> </td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Create/Redeem</b></span></td> <td style="text-align: center"> </td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NAV Calculation</b></span></td> <td style="text-align: center"> </td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NAV</b></span></td></tr> <tr style="vertical-align: bottom"> <td style="width: 55%; border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fund</b></span></td> <td style="width: 1%; text-align: center"> </td> <td style="width: 14%; border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Cut-off*(EST)</b></span></td> <td style="width: 1%; text-align: center"> </td> <td style="width: 14%; border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Time (EST)</b></span></td> <td style="width: 1%; text-align: center"> </td> <td style="width: 14%; border-bottom: black 1.5pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Calculation Date</b></span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-1x Short VIX Futures ETF and</span></td> <td style="white-space: nowrap; text-align: center"> </td> <td style="white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2:00 p.m.</span></td> <td style="white-space: nowrap; text-align: center"> </td> <td style="white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4:00 p.m.</span></td> <td style="white-space: nowrap; text-align: center"> </td> <td style="white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2022</span></td></tr> <tr style="vertical-align: bottom; "> <td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2x Long VIX Futures ETF</span></td> <td style="white-space: nowrap; text-align: center"> </td> <td style="white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2:00 p.m.</span></td> <td style="white-space: nowrap; text-align: center"> </td> <td style="white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4:00 p.m.</span></td> <td style="white-space: nowrap; text-align: center"> </td> <td style="white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2022</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">  </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0px"/> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although the Funds’ shares may continue to trade on secondary markets subsequent to the calculation of the final NAV, these times represent the final opportunity to transact in creation or redemption units for the three months ended December 31, 2022.</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0pt"> </p> 2:00 p.m. 4:00 p.m. 2022-12-31 2:00 p.m. 4:00 p.m. 2022-12-31 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Investment Valuation</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Short-term investments are valued at amortized cost which approximates fair value for daily NAV purposes. For financial reporting purposes, short-term investments are valued at their market price using information provided by a third-party pricing service or market quotations. In each of these situations, valuations are typically categorized as Level I in the fair value hierarchy.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">VIX futures contracts are valued using the Time Weighted Average Price (TWAP) of the futures during the last 15 minutes of NYSE’s regular trading session, rather than solely from the VIX futures’ settlement price. The value of a Fund’s non-exchange-traded Financial Instruments typically is determined by applying the then-current disseminated levels for the Index to the terms of the Fund’s non-exchange-traded Financial Instruments.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In certain circumstances (e.g., if the Sponsor believes market quotations do not accurately reflect the fair value of a Fund’s investment, or a trading halt closes an exchange or market early), the Sponsor may, in its sole discretion, choose to determine a fair value price as the basis for determining the market value of such investment for such day. Such fair value prices would generally be determined based on available inputs about the current value of the underlying VIX futures contract and would be based on principles that the Sponsor deems fair and equitable.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Funds may use a variety of money market instruments. Money market instruments generally will be valued using market prices or at amortized cost.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Fair value pricing may require subjective determinations about the value of an investment. While the Funds’ policies are intended to result in a calculation of its respective Fund’s NAV that fairly reflects investment values as of the time of pricing, such Fund cannot ensure that fair values determined by the Sponsor or persons acting at their direction would accurately reflect the price that a Fund could obtain for an investment if it were to dispose of that investment as of the time of pricing (for instance, in a forced or distressed sale). The prices used by such Fund may differ from the value that would be realized if the investments were sold and the differences could be material to the financial statements.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 7pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Fair Value of Financial Instruments</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 7pt"><b> </b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Funds disclose the fair value of their investments in a hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The disclosure requirements establish a fair value hierarchy that distinguishes between: (1) market participant assumptions developed based on market data obtained from sources independent of the Funds (observable inputs); and (2) the Funds’ own assumptions about market participant assumptions developed based on the best information available under the circumstances (unobservable inputs). The three levels defined by the disclosure requirements hierarchy are as follows:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 7pt"><b> </b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Level I – Quoted prices (unadjusted) in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 7pt"><b> </b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Level II – Inputs other than quoted prices included within Level I that are observable for the asset or liability, either directly or indirectly. Level II assets include the following: quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the asset or liability, and inputs that are derived principally from or corroborated by observable market data by correlation or other means (market-corroborated inputs).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 7pt"><b> </b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Level III – Unobservable pricing input at the measurement date for the asset or liability. Unobservable inputs shall be used to measure fair value to the extent that observable inputs are not available.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 7pt"><b> </b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In some instances, the inputs used to measure fair value might fall in different levels of the fair value hierarchy. The level in the fair value hierarchy within which the fair value measurement in its entirety falls is determined based on the lowest input level that is significant to the fair value measurement in its entirety.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 7pt"><b> </b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Fair value measurements also require additional disclosure when the volume and level of activity for the asset or liability have significantly decreased, as well as when circumstances indicate that a transaction is not orderly.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 7pt"><b> </b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The following table summarizes the valuation of investments at December 31, 2022 using the fair value hierarchy:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Level 1 - <br/> Quoted<br/> Prices</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Level 2 -<br/> Other<br/> Significant<br/> Observable <br/> Inputs</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: left; border-bottom: Black 1.5pt solid">Fund</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Money<br/> Market Fund</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Futures <br/> Contracts*</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; font-weight: bold; text-align: left">-1x Short VIX Futures ETF</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-12">-</div></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,156,106</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,156,106</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">2x Long VIX Futures ETF</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">8,250,285</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(9,203,522</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(953,237</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; padding-bottom: 4pt; font-weight: bold; text-align: left">Total Trust</td><td style="padding-bottom: 4pt; font-weight: bold"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">8,250,285</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 4pt; font-weight: bold"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(8,047,416</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 4pt; font-weight: bold"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">202,869</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 7pt"><b> </b></span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in; text-align: left">*</td><td style="text-align: justify">Includes cumulative appreciation (depreciation) of futures contracts as reported in the Schedule of Investments. Only current day’s variation margin is reported within the Statements of Financial Condition in receivable/payable on open futures.</td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 7pt"><b> </b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The inputs or methodology used for valuing investments are not necessarily an indication of the risk associated with investing in those securities.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 7pt"><b> </b></span></p> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Level 1 - <br/> Quoted<br/> Prices</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Level 2 -<br/> Other<br/> Significant<br/> Observable <br/> Inputs</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: left; border-bottom: Black 1.5pt solid">Fund</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Money<br/> Market Fund</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Futures <br/> Contracts*</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; font-weight: bold; text-align: left">-1x Short VIX Futures ETF</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-12">-</div></td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,156,106</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,156,106</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">2x Long VIX Futures ETF</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">8,250,285</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(9,203,522</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(953,237</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; padding-bottom: 4pt; font-weight: bold; text-align: left">Total Trust</td><td style="padding-bottom: 4pt; font-weight: bold"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">8,250,285</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td><td style="padding-bottom: 4pt; font-weight: bold"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(8,047,416</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left">)</td><td style="padding-bottom: 4pt; font-weight: bold"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">202,869</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 7pt"><b> </b></span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in; text-align: left">*</td><td style="text-align: justify">Includes cumulative appreciation (depreciation) of futures contracts as reported in the Schedule of Investments. Only current day’s variation margin is reported within the Statements of Financial Condition in receivable/payable on open futures.</td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 7pt"><b> </b></span></p> 1156106 1156106 8250285 -9203522 -953237 8250285 -8047416 202869 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Investment Transactions and Related Income</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-size: 7pt"><b> </b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Investment transactions are recorded on the trade date. All such transactions are recorded on the identified cost basis and marked to market daily. Unrealized appreciation (depreciation) on open contracts are reflected in the Statements of Financial Condition and changes in the unrealized appreciation (depreciation) between periods are reflected in the Statements of Operations.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-size: 7pt"><b> </b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Interest income is recognized on an accrual basis and includes, where applicable, the amortization of premium or discount, and is reflected as Interest Income in the Statement of Operations.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 7pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Brokerage Commissions and Futures Account Fees</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-size: 7pt"><b> </b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Each Fund pays its respective brokerage commissions, including applicable exchange fees, National Futures Association (“NFA”) fees, give-up fees, pit brokerage fees and other transaction related fees and expenses charged in connection with trading activities for each Fund’s investment in U.S. Commodity Futures Trading Commission (“CFTC”) regulated investments. The effects of trading spreads, financing costs/fees associated with Financial Instruments, and costs relating to the purchase of U.S. Treasury securities or similar high credit quality short-term fixed-income would also be borne by the Funds. Brokerage commissions on futures contracts are recognized on a half-turn basis (e.g., the first half is recognized when the contract is purchased (opened) and the second half is recognized when the transaction is closed). The Sponsor is currently paying brokerage commissions on VIX futures contracts for the Funds that exceed variable create/redeem fees collected by more than 0.04% and 0.09%, for SVIX and UVIX, respectively, of each Fund’s average net assets annually.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> </p> 0.0004 0.0009 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Federal Income Tax</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Each Fund is registered as a series of a Delaware statutory trust and is treated as a partnership for U.S. federal income tax purposes. Accordingly, no Fund expects to incur U.S. federal income tax liability; rather, each beneficial owner of a Fund’s Shares is required to take into account its allocable share of its Fund’s income, gain, loss, deductions and other items for its Fund’s taxable year ending with or within the beneficial owner’s taxable year.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Management of the Funds has reviewed all open tax years and major jurisdictions (i.e., the last four tax year ends and the interim tax period since then, as applicable) and concluded that there is no tax liability resulting from unrecognized tax benefits relating to uncertain income tax positions taken or expected to be taken in future tax returns. The Funds are also not aware of any tax positions for which it is reasonably possible that the total amounts of unrecognized tax benefits will significantly change in the next twelve months. On an ongoing basis, management monitors its tax positions taken under the interpretation to determine if adjustments to conclusions are necessary based on factors including, but not limited to, on-going analysis of tax law, regulation, and interpretations thereof.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>NOTE 3 – INVESTMENTS</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Short-Term Investments</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Funds may purchase U.S. Treasury Bills, agency securities, and other high-credit quality short-term fixed income or similar securities with original maturities of one year or less. A portion of these investments may be posted as collateral in connection with swap agreements, futures, and/or forward contracts.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Accounting for Derivative Instruments</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In seeking to achieve each Fund’s investment objective, the Sponsor uses a mathematical approach to investing. Using this approach, the Sponsor determines the type, quantity and mix of investment positions, including derivative positions, which the Sponsor believes in combination, should produce returns consistent with a Fund’s objective.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">All open derivative positions at period end are reflected on each respective Fund’s Schedule of Investments. Certain Funds utilized a varying level of derivative instruments in conjunction with investment securities in seeking to meet their investment objectives during the period. While the volume of open positions may vary on a daily basis as each Fund transacts derivatives contracts in order to achieve the appropriate exposure to meet its investment objective, the volume of these open positions relative to the net assets of each respective Fund at the date of this report is generally representative of open positions throughout the reporting period.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Following is a description of the derivative instruments used by the Funds during the reporting period, including the primary underlying risk exposures related to each instrument type.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Futures Contracts</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Funds may enter into futures contracts to gain exposure to changes in the value of, or as a substitute for investing directly in (or shorting), an underlying benchmark. A futures contract obligates the seller to deliver (and the purchaser to accept) the future delivery of a specified quantity and type of asset at a specified time and place. The contractual obligations of a buyer or seller may generally be satisfied by taking or making physical delivery of the underlying commodity, if applicable, or by making an offsetting sale or purchase of an identical futures contract on the same or linked exchange before the designated date of delivery, or by cash settlement at expiration of contract.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Upon entering into a futures contract, each Fund is required to deposit and maintain as collateral at least such initial margin as required by the exchange on which the transaction is affected. The initial margin is segregated as cash and/or securities balances with brokers for futures contracts, as disclosed in the Statements of Financial Condition, and is restricted as to its use. The Funds that enter into futures contracts maintain collateral at the broker in the form of cash and/or securities. Pursuant to the futures contract, each Fund generally agrees to receive from or pay to the broker(s) an amount of cash equal to the daily fluctuation in value of the futures contract. Such receipts or payments are known as variation margin and are recorded by each Fund as unrealized gains or losses. Each Fund will realize a gain or loss upon closing of a futures transaction.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Futures contracts involve, to varying degrees, elements of market risk (specifically exchange rate sensitivity, commodity price risk or equity market volatility risk) and exposure to loss in excess of the amount of variation margin. The face or contract amounts reflect the extent of the total exposure each Fund has in the particular classes of instruments. Additional risks associated with the use of futures contracts are imperfect correlation between movements in the price of the futures contracts and the market value of the underlying Index or commodity and the possibility of an illiquid market for a futures contract. With futures contracts, there is minimal but some counterparty risk to the Funds since futures contracts are exchange-traded and the credit risk resides with the Funds’ clearing broker or clearinghouse itself. Many futures exchanges and boards of trade limit the amount of fluctuation permitted in futures contract prices during a single trading day. Once the daily limit has been reached in a particular contract, no trades may be made that day at a price beyond that limit or trading may be suspended for specified times during the trading day. Futures contracts prices could move to the limit for several consecutive trading days with little or no trading, thereby preventing prompt liquidation of futures positions and potentially subjecting a Fund to substantial losses. If trading is not possible, or if a Fund determines not to close a futures position in anticipation of adverse price movements, the Fund will be required to make daily cash payments of variation margin. The risk the Fund will be unable to close out a futures position will be minimized by entering into such transactions on a national exchange with an active and liquid secondary market.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Option Contracts</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">An option is a contract that gives the buyer the right, but not the obligation, to buy or sell a specified quantity of a commodity or other instrument at a specific (or strike) price within a specified period of time, regardless of the market price of that instrument. There are two types of options: calls and puts. A call option conveys to the option buyer the right to purchase a particular futures contract at a stated price at any time during the life of the option. A put option conveys to the option buyer the right to sell a particular futures contract at a stated price at any time during the life of the option. Options written by a Fund may be wholly or partially covered (meaning that the Fund holds an offsetting position) or uncovered. In the case of the purchase of an option, the risk of loss of an investor’s entire investment (i.e., the premium paid plus transaction charges) reflects the nature of an option as a wasting asset that may become worthless when the option expires. Where an option is written or granted (i.e., sold) uncovered, the seller may be liable to pay substantial additional margin, and the risk of loss is unlimited, as the seller will be obligated to deliver, or take delivery of, an asset at a predetermined price which may, upon exercise of the option, be significantly different from the market value.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">When a Fund writes a call or put, an amount equal to the premium received is recorded and subsequently marked to market to reflect the current value of the option written. Premiums received from writing options which expire are treated as realized gains. Premiums received from writing options which are exercised or closed are added to the proceeds or offset against amounts paid on the underlying futures, swap or security transaction to determine the realized gain (loss).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">When a Fund purchases an option, the Fund pays a premium which is included as an asset on the Statement of Financial Condition and subsequently marked to market to reflect the current value of the option. Premiums paid for purchasing options which expire are treated as realized losses. The risk associated with purchasing put and call options is limited to the premium paid. Premiums paid for purchasing options which are exercised or closed are added to the amounts paid or offset against the proceeds on the underlying investment transaction to determine the realized gain (loss) when the underlying transaction is executed.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Certain options transactions may subject the writer (seller) to unlimited risk of loss in the event of an increase in the price of the contract to be purchased or delivered. The value of a Fund’s options transactions, if any, will be affected by, among other things, changes in the value of a Fund’s underlying benchmark relative to the strike price, changes in interest rates, changes in the actual and implied volatility of the Fund’s underlying benchmark, and the remaining time until the options expire, or any combination thereof. The value of the options should not be expected to increase or decrease at the same rate as the level of the Fund’s underlying benchmark, which may contribute to tracking error. Options may be less liquid than certain other securities. A Fund’s ability to trade options will be dependent on the willingness of counterparties to trade such options with the Fund. In a less liquid market for options, a Fund may have difficulty closing out certain option positions at desired times and prices. A Fund may experience substantial downside from specific option positions and certain option positions may expire worthless. Over-the-counter options generally are not assignable except by agreement between the parties concerned, and no party or purchaser has any obligation to permit such assignments. The over-the-counter market for options is relatively illiquid, particularly for relatively small transactions. The use of options transactions exposes a Fund to liquidity risk and counterparty credit risk, and in certain circumstances may expose the Fund to unlimited risk of loss. The Funds may buy and sell options on futures contracts, which may present even greater volatility and risk of loss.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Swap Agreements</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Funds may enter into swap agreements for purposes of pursuing their investment objectives or as a substitute for investing directly in (or shorting) an underlying Index or to create an economic hedge against a position. Swap agreements are two-party contracts that have traditionally been entered into primarily with institutional investors in over-the-counter (“OTC”) markets for a specified period, ranging from a day to more than one year. However, the Dodd-Frank Wall Street Reform and Consumer Protection Act (the “Dodd-Frank Act”) provides for significant reforms of the OTC derivative markets, including a requirement to execute certain swap transactions on a CFTC-regulated market and/or to clear such transactions through a CFTC-regulated central clearing organization. In a standard swap transaction, two parties agree to exchange the returns earned or realized on a particular predetermined investment, instrument or Index in exchange for a fixed or floating rate of return in respect of a predetermined notional amount. Transaction or commission costs are reflected in the benchmark level at which the transaction is entered into. The gross returns to be exchanged are calculated with respect to a notional amount and the benchmark returns to which the swap is linked. Swap agreements do not involve the delivery of underlying instruments.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Generally, swap agreements entered into by the Funds calculate and settle the obligations of the parties to the agreement on a “net basis” with a single payment. Consequently, each Fund’s current obligations (or rights) under a swap agreement will generally be equal only to the net amount to be paid or received under the agreement based on the relative values of such obligations (or rights) (the “net amount”). In a typical swap agreement entered into by UVIX, the would be entitled to settlement payments in the event the level of the benchmark increases and would be required to make payments to the swap counterparties in the event the level of the benchmark decreases, adjusted for any transaction costs or trading spreads on the notional amount the Funds may pay. In a typical swap agreement entered into by SVIX, the Fund would be required to make payments to the swap counterparties in the event the level of the benchmark increases and would be entitled to settlement payments in the event the level of the benchmark decreases, adjusted for any transaction costs or trading spreads on the notional amount the Funds may pay.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The net amount of the excess, if any, of each Fund’s obligations over its entitlements with respect to each OTC swap agreement is accrued on a daily basis and an amount of cash and/or securities having an aggregate value at least equal to such accrued excess is maintained for the benefit of the counterparty in a segregated account by the Funds’ Custodian. The net amount of the excess, if any, of each Fund’s entitlements over its obligations with respect to each OTC swap agreement is accrued on a daily basis and an amount of cash and/or securities having an aggregate value at least equal to such accrued excess is maintained for the benefit of the Fund in a segregated account by a third party custodian. Until a swap agreement is settled in cash, the gain or loss on the notional amount less any transaction costs or trading spreads payable by each Fund on the notional amount are recorded as “unrealized appreciation or depreciation on swap agreements” and, when cash is exchanged, the gain or loss realized is recorded as “realized gains or losses on swap agreements.” Swap agreements are generally valued at the last settled price of the benchmark referenced asset.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Swap agreements contain various conditions, events of default, termination events, covenants and representations. The triggering of certain events or the default on certain terms of the agreement could allow a party to terminate a transaction under the agreement and request immediate payment in an amount equal to the net positions owed to the party under the agreement. This could cause a Fund to have to enter into a new transaction with the same counterparty, enter into a transaction with a different counterparty or seek to achieve its investment objective through any number of different investments or investment techniques.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Swap agreements involve, to varying degrees, elements of market risk and exposure to loss in excess of the unrealized gain/loss reflected. The notional amounts reflect the extent of the total investment exposure each Fund has under the swap agreement, which may exceed the NAV of each Fund. Additional risks associated with the use of swap agreements are imperfect correlations between movements in the notional amount and the price of the underlying reference Index and the inability of counterparties to perform. Each Fund bears the risk of loss of the amount expected to be received under a swap agreement in the event of the default or bankruptcy of a swap agreement counterparty. A Fund will typically enter into swap agreements only with major global financial institutions. The creditworthiness of each of the firms that is a party to a swap agreement is monitored by the Sponsor. The Sponsor may use various techniques to minimize credit risk including early termination and payment, using different counterparties, limiting the net amount due from any individual counterparty and generally requiring collateral to be posted by the counterparty in an amount approximately equal to that owed to the Funds. Outstanding swap agreements contractually terminate within one month but may be terminated without penalty by either party at any time. Upon termination, the Fund is obligated to pay or receive the “unrealized appreciation or depreciation” amount.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Funds, as applicable, collateralize swap agreements by segregating or designating cash and/or certain securities as indicated on the Statements of Financial Condition or Schedules of Investments. As noted above, collateral posted in connection with OTC derivative transactions is held for the benefit of the counterparty in a segregated tri-party account at the Custodian to protect the counterparty against non-payment by the Funds. The collateral held in this account is restricted as to its use. In the event of a default by the counterparty, the Funds will seek withdrawal of this collateral from the segregated account and may incur certain costs in exercising its right with respect to the collateral. If a counterparty becomes bankrupt or otherwise fails to perform its obligations due to financial difficulties, the Funds may experience significant delays in obtaining any recovery in a bankruptcy or other reorganizational proceeding. The Funds may obtain only limited recovery or may obtain no recovery in such circumstances.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Funds remain subject to credit risk with respect to the amount they expect to receive from counterparties. However, the Funds have sought to mitigate these risks in connection with OTC swaps by generally requiring that the counterparties for each Fund agree to post collateral for the benefit of the Fund, marked to market daily, in an amount approximately equal to what the counterparty owes the Fund, subject to certain minimum thresholds. In the event of a bankruptcy of a counterparty, such Fund will have direct access to the collateral received from the counterparty, generally as of the day prior to the bankruptcy, because there is a one day time lag between the Fund’s request for collateral and the delivery of such collateral. To the extent any such collateral is insufficient, the Funds will be exposed to counterparty risk as described above, including the possible delays in recovering amounts as a result of bankruptcy proceedings.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The counterparty/credit risk for cleared derivative transactions is generally lower than for OTC derivatives since generally a clearing organization becomes substituted for each counterparty to a cleared derivative contract and, in effect, guarantees the parties’ performance under the contract as each party to a trade looks only to the clearing organization for performance of financial obligations. In addition, cleared derivative transactions benefit from daily marking-to-market and settlement, and segregation and minimum capital requirements applicable to intermediaries.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Fair Value of Derivative Instruments as of December 31, 2022</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: center; padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="text-align: center; border-bottom: Black 1.5pt solid; font-weight: bold">Asset Derivatives</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Liability Derivatives</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; text-align: left; font-weight: bold">Derivatives Not Accounted for as Hedging Instruments</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">Fund</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">Statement of<br/> Financial<br/> Condition<br/> Location</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">Unrealized<br/> Appreciation</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">Statement of<br/> Financial<br/> Condition<br/> Location</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">Unrealized<br/> Depreciation</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 35%; text-align: left">VIX Futures Contracts</td><td style="width: 1%"> </td> <td style="width: 16%; text-align: left">-1x Short VIX Futures ETF</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"/><td style="width: 9%; text-align: right">          </td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,156,106</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"/><td style="width: 9%; text-align: right">         </td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"/><td style="width: 9%; text-align: right">                    </td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left">2x Long VIX Futures ETF</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(9,203,522</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left">Total Trust</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">(8,047,416</td><td style="font-weight: bold; text-align: left">)</td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0px"/> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes cumulative appreciation (depreciation) of futures contracts as reported in the Schedule of Investments. Only current day’s variation margin is reported within the Statements of Financial Condition in variation margin receivable/payable.</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>The Effect of Derivative Instruments on the Statement of Operations</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>For the Period Ended December 31, 2022</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">Derivatives Not Accounted for as hedging Instruments</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Location of Gain<br/> (Loss) on Derivatives<br/> Recognized in income</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="white-space: nowrap; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Fund</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Realized Gain (Loss) on Derivatives Recognized in Income</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Change in Unrealized Appreciation (Depreciation) on Derivatives Recognized in Income</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="vertical-align: top; text-align: left">VIX Futures Contracts</td><td> </td> <td style="vertical-align: top; text-align: left">Net realized gain (loss) on futures contracts/ changes in unrealized appreciation (depreciation) on futures contrats</td><td> </td> <td style="white-space: nowrap"> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 16%"/><td style="width: 1%"> </td> <td style="width: 38%"/><td style="width: 1%"> </td> <td style="white-space: nowrap; vertical-align: top; width: 20%; text-align: left">-1x Short VIX Futures ETF</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">16,573,816</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,156,106</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="white-space: nowrap; vertical-align: top; text-align: left; padding-bottom: 1.5pt">2x Long VIX Futures ETF</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(67,298,870</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(9,203,522</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td> </td><td style="font-weight: bold"> </td> <td style="white-space: nowrap; vertical-align: top; font-weight: bold; text-align: left">Total Trust</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(50,725,054</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(8,047,416</td><td style="text-align: left">)</td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Offsetting Assets and Liabilities</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Each Fund is subject to master netting agreements or similar arrangements that allow for amounts owed between each Fund and the counterparty to be netted upon an early termination. The party that has the larger payable pays the excess of the larger amount over the smaller amount to the other party. The master netting agreements or similar arrangements do not apply to amounts owed to/from different counterparties. As described above, the Funds utilize derivative instruments to achieve their investment objective during the year. The amounts shown in the Statements of Financial Condition do not take into consideration the effects of legally enforceable master netting agreements or similar arrangements.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">For financial reporting purposes, the Funds do not offset derivative assets and derivative liabilities that are subject to netting arrangements in the Statements of Financial Condition. The following table presents each Fund’s derivatives by investment type and by counterparty net of amounts available for offset under a master netting agreement and the related collateral received or pledged by the Funds as of December 31, 2022.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td colspan="25" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Fair Values of Derivative Instruments as of December 31, 2022</td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Assets</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Liabilities</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: justify; border-bottom: Black 1.5pt solid">Fund</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Gross<br/> Amounts of<br/> Recognized<br/> Assets<br/> presented<br/> in the<br/> Statements of<br/> Financial<br/> Condition</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Gross<br/> Amounts<br/> Offset <br/> in the<br/> Statements of <br/> Financial<br/> Condition</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Net<br/> Amounts of <br/> Assets<br/> presented<br/> in the<br/> Statements of<br/> Financial<br/> Condition</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Gross<br/> Amounts of<br/> Recognized<br/> Liabilities<br/> presented<br/> in the<br/> Statements of<br/> Financial<br/> Condition</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Gross<br/> Amounts<br/> Offset <br/> in the<br/> Statements of <br/> Financial<br/> Condition</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Net<br/> Amounts of<br/> Liabilities<br/> presented<br/> in the<br/> Statements of<br/> Financial<br/> Condition</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 28%; text-align: justify">-1x Short VIX Futures ETF</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">          -</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">          -</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">          -</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">187,030</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">          -</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">187,030</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: justify">2x Long VIX Futures ETF</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">830,840</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">830,840</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Asset (Liability) amounts shown in the table below represent amounts owed to (by) the Funds for the derivative-related investments at December 31, 2022. These amounts may be collateralized by cash or financial instruments, segregated for the benefit of the Funds or the counterparties, depending on whether the related contracts are in an appreciated or depreciated position at period end. Amounts shown in the column labeled “Net Amount” represent the uncollateralized portions of these amounts at period end. These amounts may be un-collateralized due to timing differences related to market movements or due to minimum thresholds for collateral movement, as further described above under the caption “Accounting for Derivative Instruments”.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td colspan="17" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Gross Amounts Not Offset in the Statements of Financial Condition as of December 31, 2022</td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: left">Fund</td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Amounts of<br/> Recognized<br/> Assets /<br/> (Liabilities)<br/> presented<br/> in the<br/> Statements of <br/> Financial<br/> Condition</td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Financial<br/> Instruments for <br/> the Benefit of<br/> (the Funds) /<br/> the<br/> Counterparties</td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Cash<br/> Collateral for<br/> the Benefit of<br/> (the Funds) /<br/> the<br/> Counterparties</td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Net<br/> Amount</td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%; text-align: left">-1x Short VIX Futures ETF</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(187,030</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">              -</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">            -</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(187,030</td><td style="width: 1%; text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">2x Long VIX Futures ETF</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">830,840</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">830,840</td><td style="text-align: left"> </td></tr> </table> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: center; padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="text-align: center; border-bottom: Black 1.5pt solid; font-weight: bold">Asset Derivatives</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Liability Derivatives</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; text-align: left; font-weight: bold">Derivatives Not Accounted for as Hedging Instruments</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">Fund</td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">Statement of<br/> Financial<br/> Condition<br/> Location</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">Unrealized<br/> Appreciation</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">Statement of<br/> Financial<br/> Condition<br/> Location</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">Unrealized<br/> Depreciation</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 35%; text-align: left">VIX Futures Contracts</td><td style="width: 1%"> </td> <td style="width: 16%; text-align: left">-1x Short VIX Futures ETF</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"/><td style="width: 9%; text-align: right">          </td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,156,106</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"/><td style="width: 9%; text-align: right">         </td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"/><td style="width: 9%; text-align: right">                    </td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left">2x Long VIX Futures ETF</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(9,203,522</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left">Total Trust</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right">(8,047,416</td><td style="font-weight: bold; text-align: left">)</td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0px"/> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes cumulative appreciation (depreciation) of futures contracts as reported in the Schedule of Investments. Only current day’s variation margin is reported within the Statements of Financial Condition in variation margin receivable/payable.</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> 1156106 -9203522 -8047416 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">Derivatives Not Accounted for as hedging Instruments</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Location of Gain<br/> (Loss) on Derivatives<br/> Recognized in income</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="white-space: nowrap; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Fund</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Realized Gain (Loss) on Derivatives Recognized in Income</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Change in Unrealized Appreciation (Depreciation) on Derivatives Recognized in Income</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="vertical-align: top; text-align: left">VIX Futures Contracts</td><td> </td> <td style="vertical-align: top; text-align: left">Net realized gain (loss) on futures contracts/ changes in unrealized appreciation (depreciation) on futures contrats</td><td> </td> <td style="white-space: nowrap"> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 16%"/><td style="width: 1%"> </td> <td style="width: 38%"/><td style="width: 1%"> </td> <td style="white-space: nowrap; vertical-align: top; width: 20%; text-align: left">-1x Short VIX Futures ETF</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">16,573,816</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,156,106</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="white-space: nowrap; vertical-align: top; text-align: left; padding-bottom: 1.5pt">2x Long VIX Futures ETF</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(67,298,870</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(9,203,522</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td> </td><td style="font-weight: bold"> </td> <td style="white-space: nowrap; vertical-align: top; font-weight: bold; text-align: left">Total Trust</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(50,725,054</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(8,047,416</td><td style="text-align: left">)</td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> </p> 16573816 1156106 -67298870 -9203522 -50725054 -8047416 <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td colspan="25" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Fair Values of Derivative Instruments as of December 31, 2022</td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Assets</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="10" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Liabilities</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: justify; border-bottom: Black 1.5pt solid">Fund</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Gross<br/> Amounts of<br/> Recognized<br/> Assets<br/> presented<br/> in the<br/> Statements of<br/> Financial<br/> Condition</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Gross<br/> Amounts<br/> Offset <br/> in the<br/> Statements of <br/> Financial<br/> Condition</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Net<br/> Amounts of <br/> Assets<br/> presented<br/> in the<br/> Statements of<br/> Financial<br/> Condition</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Gross<br/> Amounts of<br/> Recognized<br/> Liabilities<br/> presented<br/> in the<br/> Statements of<br/> Financial<br/> Condition</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Gross<br/> Amounts<br/> Offset <br/> in the<br/> Statements of <br/> Financial<br/> Condition</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Net<br/> Amounts of<br/> Liabilities<br/> presented<br/> in the<br/> Statements of<br/> Financial<br/> Condition</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 28%; text-align: justify">-1x Short VIX Futures ETF</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">          -</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">          -</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">          -</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">187,030</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">          -</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">187,030</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: justify">2x Long VIX Futures ETF</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">830,840</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">830,840</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> 187030 187030 830840 830840 <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td colspan="17" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Gross Amounts Not Offset in the Statements of Financial Condition as of December 31, 2022</td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: left">Fund</td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Amounts of<br/> Recognized<br/> Assets /<br/> (Liabilities)<br/> presented<br/> in the<br/> Statements of <br/> Financial<br/> Condition</td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Financial<br/> Instruments for <br/> the Benefit of<br/> (the Funds) /<br/> the<br/> Counterparties</td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Cash<br/> Collateral for<br/> the Benefit of<br/> (the Funds) /<br/> the<br/> Counterparties</td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Net<br/> Amount</td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%; text-align: left">-1x Short VIX Futures ETF</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(187,030</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">              -</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">            -</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(187,030</td><td style="width: 1%; text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">2x Long VIX Futures ETF</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">830,840</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">830,840</td><td style="text-align: left"> </td></tr> </table> -187030 -187030 830840 830840 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>NOTE 4 – AGREEMENTS</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Management Fee</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">SVIX pays the Sponsor a management fee (the “Management Fee”), monthly in arrears, in an amount equal to <b>1.35</b>% per annum of its average daily net assets. UVIX pays the Sponsor a Management Fee, monthly in arrears, in an amount equal to <b>1.65</b>% per annum of its average daily net assets. “Average daily net assets” is calculated by dividing the month-end net assets of each Fund by the number of calendar days in such month.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">No other Management Fee is paid by the Funds. The Management Fee is paid in consideration of the Sponsor’s trading advisory services and the other services provided to the Fund that the Sponsor pays directly.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Pursuant to the Sponsor Agreement between Sponsor and the Trust, on behalf of the Funds, the Sponsor oversees and pays Milliman FRM (“Commodity Sub-Adviser”) for its services as Commodity Sub-Adviser. The Commodity Sub-Adviser is paid by the Sponsor an annual sub-advisory fee of 0.25% based on each Fund’s average daily net assets (total assets of the Fund, minus the sum of its accrued liabilities). The commodity sub-advisory fee is waived for the first 6 months of each Fund’s operations or until a Fund reaches $35 million in average daily net assets. The Funds do not directly pay the Commodity Sub-Adviser.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Non-Recurring Fees and Expenses</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Each Fund pays all its non-recurring and unusual fees and expenses, if any, as determined by the Sponsor. Non-recurring and unusual fees and expenses are fees and expenses that are unexpected or unusual in nature, such as legal claims and liabilities, litigation costs or indemnification or other material expenses which are not currently anticipated obligations of the Funds.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>The Administrator, Transfer Agent and Custodian</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">U.S. Bancorp Fund Services, LLC, doing business as U.S. Bank Global Fund Services (“Fund Services”), an indirect subsidiary of U.S. Bancorp, serves as the Fund’s fund accountant, administrator and transfer agent pursuant to certain fund accounting servicing, fund administration servicing and transfer agent servicing agreements. U.S. Bank National Association, a subsidiary of U.S. Bancorp and parent company of Fund Services, intends to serve as the Fund’s custodian pursuant to a custody agreement.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>The Marketing Agent</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Foreside Fund Services, LLC (the “Marketing Agent”) serves as the Marketing Agent of the Funds. Its principal duties are: (i) to work with the Transfer Agent to review and approve orders placed by Authorized Participants and transmitted to the Transfer Agent; (ii) maintain copies of confirmations of Creation Unit creation and redemption order acceptances; (iii) maintain telephonic, facsimile and/or access to direct computer communications links with the Transfer Agent; and (iv) review and approve, prior to use, all Trust marketing materials for compliance with applicable SEC and FINRA advertising rules.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Marketing Agent retains all marketing materials separately for the Funds, at their offices located at Three Canal Plaza, Suite 100 Portland, Maine 04101.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As compensation for the services it provides, the Marketing Agent receives a fee from the Funds.</p> 0.0135 0.0165 0.0025 35000000 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>NOTE 5 – OFFERING COSTS</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Offering costs will be amortized by the Funds over a twelve month period on a straight-line basis beginning once the fund commences operations. The Sponsor will not charge its Management Fee in the first year of operations of a Fund in an amount equal to the offering costs. Normal and expected expenses incurred in connection with the continuous offering of Shares of a Fund after the commencement of its trading operations will be paid by the Sponsor.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>NOTE 6 – CREATION AND REDEMPTION OF CREATION UNITS</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Each Fund issues and redeems shares from time to time, but only in one or more Creation Units. A Creation Unit is a block of at least 10,000 Shares of a Fund. Creation Units may be created or redeemed only by Authorized Participants.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Except when aggregated in Creation Units, the Shares are not redeemable securities. Retail investors, therefore, generally will not be able to purchase or redeem Shares directly from or with a Fund. Rather, most retail investors will purchase or sell Shares in the secondary market with the assistance of a broker. Thus, some of the information contained in these Notes to Financial Statements—such as references to the Transaction Fees imposed on purchases and redemptions is not relevant to retail investors.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Transaction Fees on Creation and Redemption Transactions</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The manner by which Creation Units are purchased or redeemed is governed by the terms of the Authorized Participant Agreement and Authorized Participant Procedures Handbook. By placing a purchase order, an Authorized Participant agrees to: (1) deposit cash with the Custodian; and (2) if permitted by the Sponsor in its sole discretion, enter into or arrange for an exchange of futures contract for related position or block trade with the relevant fund whereby the Authorized Participant would also transfer to such Fund a number and type of exchange-traded futures contracts at or near the closing settlement price for such contracts on the purchase order date.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Authorized Participants may pay a fee up to 0.03% of the value of each order they place with each order to create or redeem a Creation Unit in order to compensate the Administrator, the Custodian and the Transfer Agent of each Fund and its Shares, for services in processing the creation and redemption of Creation Units and to offset the costs of increasing or decreasing derivative positions, unless the transaction fee is waived or otherwise adjusted by the Sponsor. The Sponsor provides such Authorized Participant with prompt notice in advance of any such waiver or adjustment of the transaction fee. Authorized Participants may sell the Shares included in the Creation Units they purchase from the Funds to other investors in the secondary market.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Transaction Fees for the period ended December 31, 2022:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Fund</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Period<br/> Ended<br/> December 31, <br/> 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 88%; text-align: left">-1x Short VIX Futures ETF</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">105,025</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt">2x Long VIX Futures ETF</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">178,809</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-bottom: 4pt">Total Trust</td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">283,834</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td></tr> </table> 10000 0.0003 <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Fund</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Period<br/> Ended<br/> December 31, <br/> 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 88%; text-align: left">-1x Short VIX Futures ETF</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">105,025</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt">2x Long VIX Futures ETF</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">178,809</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-bottom: 4pt">Total Trust</td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">283,834</td><td style="padding-bottom: 4pt; font-weight: bold; text-align: left"> </td></tr> </table> 105025 178809 283834 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>NOTE 7 – FINANCIAL HIGHLIGHTS</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Selected data is for a Share outstanding throughout the period ended December 31, 2022:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-indent: -0.3in"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">-1x Short VIX Futures ETF</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2x Long VIX Futures ETF</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-size: 10pt"><b>Period Ended<br/> December 31, <br/> 2022<sup>(1)</sup></b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-size: 10pt"><b>Period Ended<br/> December 31, <br/> 2022<sup>(1)</sup></b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%">Net Asset Value, Beginning of Period</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">15.00</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">15.00</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td><span style="font-size: 10pt">Net investment loss per share <sup>(2)</sup></span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(0.18</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(0.15</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-size: 10pt">Net Realized and Unrealized Gain (Loss) on Investments and Futures Contracts <sup>(3)</sup></span></td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(0.19</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(9.00</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt">Net Increase (Decrease) in Net Asset Value Resulting from Operations</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(0.37</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(9.15</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt">Net Asset Value, End of Period</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">14.63</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">5.85</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td><span style="font-size: 10pt">Market Value Per Share, at December 31, 2022 <sup>(4)</sup></span></td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">14.66</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">5.82</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left"><span style="font-size: 10pt"><b>Total Return at Net Asset Value <sup>(5)</sup></b></span></td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">(2.47)</td><td style="font-weight: bold; text-align: left">%</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">(61.00)</td><td style="font-weight: bold; text-align: left">%</td></tr> <tr style="vertical-align: bottom; "> <td style="font-weight: bold; text-align: left"><span style="font-size: 10pt"><b>Total Return at Market Value <sup>(5)</sup></b></span></td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">(2.27)</td><td style="font-weight: bold; text-align: left">%</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">(61.20)</td><td style="font-weight: bold; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-weight: bold; text-align: left"><span style="font-size: 10pt"><b>Ratios to Average Net Assets: <sup>(6)</sup></b></span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-size: 10pt">Expense ratio <sup>(7)</sup></span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2.41</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2.46</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Net Investment Loss</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(2.03)</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1.96)</td><td style="text-align: left">%</td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"/><td style="width: 0.25in; text-align: left">(1)</td><td style="text-align: justify">Both Funds commenced operations on March 28, 2022.</td> </tr></table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"/><td style="width: 0.25in; text-align: left">(2)</td><td style="text-align: left">Net investment loss per share represents net investment loss divided by the daily average shares of beneficial interest outstanding during the period.</td> </tr></table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="text-align: left; width: 0in"/><td style="width: 0.25in; text-align: left">(3)</td><td style="text-align: left">Due to timing of capital share transactions, per share amounts may not compare with amounts appearing elsewhere within these Financial Statements.</td> </tr></table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="text-align: left; width: 0in"/><td style="width: 0.25in; text-align: left">(4)</td><td style="text-align: left">Market values are determined at the close of the applicable primary listing exchange, which may be later than when the Funds’ net asset value is calculated.</td> </tr></table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="text-align: left; width: 0in"/><td style="width: 0.25in; text-align: left">(5)</td><td style="text-align: left">Percentages are not annualized for the period ended December 31, 2022.</td> </tr></table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="text-align: left; width: 0in"/><td style="width: 0.25in; text-align: left">(6)</td><td style="text-align: left">Percentages are annualized.</td> </tr></table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="text-align: left; width: 0in"/><td style="width: 0.25in; text-align: left">(7)</td><td style="text-align: left">The expense ratio would be 2.29% and 2.39% respectively, if brokerage commissions and futures and futures account fees were excluded.</td> </tr></table> <table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">-1x Short VIX Futures ETF</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2x Long VIX Futures ETF</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-size: 10pt"><b>Period Ended<br/> December 31, <br/> 2022<sup>(1)</sup></b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><span style="font-size: 10pt"><b>Period Ended<br/> December 31, <br/> 2022<sup>(1)</sup></b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%">Net Asset Value, Beginning of Period</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">15.00</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">15.00</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td><span style="font-size: 10pt">Net investment loss per share <sup>(2)</sup></span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(0.18</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(0.15</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-size: 10pt">Net Realized and Unrealized Gain (Loss) on Investments and Futures Contracts <sup>(3)</sup></span></td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(0.19</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(9.00</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt">Net Increase (Decrease) in Net Asset Value Resulting from Operations</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(0.37</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(9.15</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt">Net Asset Value, End of Period</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">14.63</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">5.85</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td><span style="font-size: 10pt">Market Value Per Share, at December 31, 2022 <sup>(4)</sup></span></td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">14.66</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">5.82</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left"><span style="font-size: 10pt"><b>Total Return at Net Asset Value <sup>(5)</sup></b></span></td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">(2.47)</td><td style="font-weight: bold; text-align: left">%</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">(61.00)</td><td style="font-weight: bold; text-align: left">%</td></tr> <tr style="vertical-align: bottom; "> <td style="font-weight: bold; text-align: left"><span style="font-size: 10pt"><b>Total Return at Market Value <sup>(5)</sup></b></span></td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">(2.27)</td><td style="font-weight: bold; text-align: left">%</td><td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right">(61.20)</td><td style="font-weight: bold; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-weight: bold; text-align: left"><span style="font-size: 10pt"><b>Ratios to Average Net Assets: <sup>(6)</sup></b></span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-size: 10pt">Expense ratio <sup>(7)</sup></span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2.41</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2.46</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Net Investment Loss</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(2.03)</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1.96)</td><td style="text-align: left">%</td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"/><td style="width: 0.25in; text-align: left">(1)</td><td style="text-align: justify">Both Funds commenced operations on March 28, 2022.</td> </tr></table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"/><td style="width: 0.25in; text-align: left">(2)</td><td style="text-align: left">Net investment loss per share represents net investment loss divided by the daily average shares of beneficial interest outstanding during the period.</td> </tr></table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="text-align: left; width: 0in"/><td style="width: 0.25in; text-align: left">(3)</td><td style="text-align: left">Due to timing of capital share transactions, per share amounts may not compare with amounts appearing elsewhere within these Financial Statements.</td> </tr></table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="text-align: left; width: 0in"/><td style="width: 0.25in; text-align: left">(4)</td><td style="text-align: left">Market values are determined at the close of the applicable primary listing exchange, which may be later than when the Funds’ net asset value is calculated.</td> </tr></table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="text-align: left; width: 0in"/><td style="width: 0.25in; text-align: left">(5)</td><td style="text-align: left">Percentages are not annualized for the period ended December 31, 2022.</td> </tr></table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="text-align: left; width: 0in"/><td style="width: 0.25in; text-align: left">(6)</td><td style="text-align: left">Percentages are annualized.</td> </tr></table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="text-align: left; width: 0in"/><td style="width: 0.25in; text-align: left">(7)</td><td style="text-align: left">The expense ratio would be 2.29% and 2.39% respectively, if brokerage commissions and futures and futures account fees were excluded.</td> </tr></table> 15 15 -0.18 -0.15 -0.19 -9 -0.37 -9.15 14.63 5.85 14.66 5.82 -0.0247 -0.61 -0.0227 -0.612 0.0241 0.0246 -0.0203 -0.0196 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>NOTE 8 – RISK</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Correlation and Compounding Risk</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Funds do not seek to achieve their stated investment objective over a period of time greater than a single day (as measured from NAV calculation time to NAV calculation time). The return of a Fund for a period longer than a single day is the result of its return for each day compounded over the period and usually will differ in amount and possibly even direction from the inverse (-1x) or two times (2x) the return of the Fund’s benchmark for the period. A Fund will lose money if its benchmark performance is flat over time, and it is possible for a Fund to lose money over time even if the performance of its benchmark increases in the case of UVIX (or decreases in the case of SVIX), as a result of daily rebalancing, the benchmark’s volatility, compounding, and other factors. Compounding is the cumulative effect of applying investment gains and losses and income to the principal amount invested over time. Gains or losses experienced over a given period will increase or reduce the principal amount invested from which the subsequent period’s returns are calculated. The effects of compounding will likely cause the performance of a Fund to differ from the Fund’s stated multiple times the return of its benchmark for the same period. The effect of compounding becomes more pronounced as benchmark volatility and holding period increase. The impact of compounding will impact each shareholder differently depending on the period of time an investment in a Fund is held and the volatility of the benchmark during the holding period of an investment in the Fund. Longer holding periods, higher benchmark volatility, inverse exposure and greater leverage each affect the impact of compounding on a Fund’s returns. Daily compounding of a Fund’s investment returns can dramatically and adversely affect its longer-term performance during periods of high volatility. Volatility may be at least as important to a Fund’s return for a period as the return of the Fund’s underlying benchmark.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Each Fund uses leverage and should produce daily returns that are more volatile than that of its benchmark. For example, the daily return of UVIX should be approximately two times as volatile on a daily basis as is the return of a fund with an objective of matching the same benchmark. The daily return of SVIX is designed to return the inverse (-1x) of the return that would be expected of a fund with an objective of matching the same benchmark. <b><i>The Funds are not appropriate for all investors and present significant risks not applicable to other types of funds. </i></b>The Funds use leverage and are riskier than similarly benchmarked exchange-traded funds that do not use leverage. An investor should only consider an investment in a Fund if he or she understands the consequences of seeking daily leveraged or daily inverse investment results. Shareholders who invest in the Funds should actively manage and monitor their investments, as frequently as daily.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">While the Funds seek to meet their investment objectives, there is no guarantee they will do so. Factors that may affect a Fund’s ability to meet its investment objective include: (1) the Sponsor’s ability to purchase and sell Financial Instruments in a manner that correlates to a Fund’s objective; (2) an imperfect correlation between the performance of Financial Instruments held by a Fund and the performance of the applicable benchmark; (3) bid-ask spreads on such Financial Instruments; (4) fees, expenses, transaction costs, financing costs associated with the use of Financial Instruments and commission costs; (5) holding or trading instruments in a market that has become illiquid or disrupted; (6) a Fund’s Share prices being rounded to the nearest cent and/or valuation methodology; (7) changes to a benchmark Index that are not disseminated in advance; (8) the need to conform a Fund’s portfolio holdings to comply with investment restrictions or policies or regulatory or tax law requirements; (9) early and unanticipated closings of the markets on which the holdings of a Fund trade, resulting in the inability of the Fund to execute intended portfolio transactions; (10) accounting standards; and (11) differences caused by a Fund obtaining exposure to only a representative sample of the components of a benchmark, over weighting or under weighting certain components of a benchmark or obtaining exposure to assets that are not included in a benchmark.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">A number of factors may affect a Fund’s ability to achieve a high degree of correlation with its benchmark, and there can be no guarantee that a Fund will achieve a high degree of correlation. Failure to achieve a high degree of correlation may prevent a Fund from achieving its investment objective. In order to achieve a high degree of correlation with their underlying benchmarks, the Funds seek to rebalance their portfolios daily to keep exposure consistent with their investment objectives. Being materially under- or over-exposed to the benchmark may prevent such Funds from achieving a high degree of correlation with such benchmark. Market disruptions or closure, large amounts of assets into or out of the Funds, regulatory restrictions, extreme market volatility, and other factors will adversely affect such Funds’ ability to adjust exposure to requisite levels. The target amount of portfolio exposure is impacted dynamically by the benchmarks’ movements during each day. Other things being equal, more significant movement in the value of its benchmark up or down will require more significant adjustments to a Fund’s portfolio. Because of this, it is unlikely that the Funds will be perfectly exposed (i.e., --1x, -2x, as applicable) to its benchmark at the end of each day, and the likelihood of being materially under- or over-exposed is higher on days when the benchmark levels are volatile near the close of the trading day.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Each Fund seeks to rebalance its portfolio on a daily basis. The time and manner in which a Fund rebalances its portfolio may vary from day to day depending upon market conditions and other circumstances at the discretion of the Sponsor. Unlike other funds that do not rebalance their portfolios as frequently, each Fund may be subject to increased trading costs associated with daily portfolio rebalancing in order to maintain appropriate exposure to the underlying benchmarks.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Counterparty Risk</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Each Fund may use derivatives such as swap agreements and forward contracts (collectively referred to herein as “derivatives”) in the manner described herein as a means to achieve their respective investment objectives. The use of derivatives by a Fund exposes the Fund to counterparty risks.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span style="text-decoration:underline">Regulatory Treatment</span></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Derivatives are generally traded in OTC markets and have only recently become subject to comprehensive regulation in the United States. Cash-settled forwards are generally regulated as “swaps”, whereas physically settled forwards are generally not subject to regulation (in the case of commodities other than currencies) or subject to the federal securities laws (in the case of securities). Title VII of the Dodd-Frank Act (“Title VII”) created a regulatory regime for derivatives, with the CFTC responsible for the regulation of swaps and the SEC responsible for the regulation of “security-based swaps.” The SEC requirements have largely yet to be made effective, but the CFTC requirements are largely in place. The CFTC requirements have included rules for some of the types of transactions in which the Funds will engage, including mandatory clearing and exchange trading, reporting, and margin for OTC swaps. Title VII also created new categories of regulated market participants, such as “swap dealers,” “security-based swap dealers,” “major swap participants,” and “major security-based swap participants” who are, or will be, subject to significant new capital, registration, recordkeeping, reporting, disclosure, business conduct and other regulatory requirements. The regulatory requirements under Title VII continue to be developed and there may be further modifications that could materially and adversely impact the Funds, the markets in which a Fund trades and the counterparties with which the Fund engages in transactions.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">As noted, the CFTC rules may not apply to all of the swap agreements and forward contracts entered into by the Funds. Investors, therefore, may not receive the protection of CFTC regulation or the statutory scheme of the Commodity Exchange Act (the “CEA”) in connection with each Fund’s swap agreements or forward contracts. The lack of regulation in these markets could expose investors to significant losses under certain circumstances, including in the event of trading abuses or financial failure by participants.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span style="text-decoration:underline">Counterparty Credit Risk</span></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Funds will be subject to the credit risk of the counterparties to the derivatives. In the case of cleared derivatives, the Funds will have credit risk to the clearing corporation in a similar manner as the Funds would for futures contracts. In the case of OTC derivatives, the Funds will be subject to the credit risk of the counterparty to the transaction – typically a single bank or financial institution. As a result, a Fund is subject to increased credit risk with respect to the amount it expects to receive from counterparties to OTC derivatives entered into as part of that Fund’s principal investment strategy. If a counterparty becomes bankrupt or otherwise fails to perform its obligations due to financial difficulties, a Fund could suffer significant losses on these contracts and the value of an investor’s investment in a Fund may decline.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Funds have sought to mitigate these risks by generally requiring that the counterparties for each Fund agree to post collateral for the benefit of the Fund, marked to market daily, subject to certain minimum thresholds. However, there are no limitations on the percentage of assets each Fund may invest in swap agreements or forward contracts with a particular counterparty. To the extent any such collateral is insufficient or there are delays in accessing the collateral, the Funds will be exposed to counterparty risk as described above, including possible delays in recovering amounts as a result of bankruptcy proceedings. The Funds typically enter into transactions only with major global financial institutions.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">OTC derivatives of the type that may be utilized by the Funds are generally less liquid than futures contracts because they are not traded on an exchange, do not have uniform terms and conditions, and are generally entered into based upon the creditworthiness of the parties and the availability of credit support, such as collateral, and in general, are not transferable without the consent of the counterparty. These agreements contain various conditions, events of default, termination events, covenants and representations. The triggering of certain events or the default on certain terms of the agreement could allow a party to terminate a transaction under the agreement and request immediate payment in an amount equal to the net positions owed to the party under the agreement. For example, if the level of the Fund’s benchmark has a dramatic intraday move that would cause a material decline in the Fund’s NAV, the terms of the swap may permit the counterparty to immediately close out the transaction with the Fund. In that event, it may not be possible for the Fund to enter into another swap or to invest in other Financial Instruments necessary to achieve the desired exposure consistent with the Fund’s objective. This, in turn, may prevent the Fund from achieving its investment objective, particularly if the level of the Fund’s benchmark reverses all or part of its intraday move by the end of the day.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In addition, cleared derivatives benefit from daily marking-to-market and settlement, and segregation and minimum capital requirements applicable to intermediaries. To the extent the Fund enters into cleared swap transactions, the Fund will deposit collateral with a FCM in cleared swaps customer accounts, which are required by CFTC regulations to be separate from its proprietary collateral posted for cleared swaps transactions. Cleared swap customer collateral is subject to regulations that closely parallel the regulations governing customer segregated funds for futures transactions but provide certain additional protections to cleared swaps collateral in the event of a clearing broker or clearing broker customer default. For example, in the event of a default of both the clearing broker and a customer of the clearing broker, a clearing house is only permitted to access the cleared swaps collateral in the legally separate (but operationally comingled) account of the defaulting cleared swap customer of the clearing broker, as opposed to the treatment of customer segregated funds, under which the clearing house may access all of the commingled customer segregated funds of a defaulting clearing broker. Derivatives entered into directly between two counterparties do not necessarily benefit from such protections, particularly if entered into with an entity that is not registered as a “swap dealer” with the CFTC. This exposes the Funds to the risk that a counterparty will not settle a transaction in accordance with its terms and conditions because of a dispute over the terms of the contract (whether or not bona fide) or because of a credit or liquidity problem, thus causing the Funds to suffer a loss.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Sponsor regularly reviews the performance of its counterparties for, among other things, creditworthiness and execution quality. In addition, the Sponsor periodically considers the addition of new counterparties and the counterparties used by a Fund may change at any time. Each day, the Funds disclose their portfolio holdings as of the prior Business Day. Each Fund’s portfolio holdings identifies its counterparties, as applicable. This portfolio holdings information may be accessed through the web on the Sponsor’s website at www.volatilityshares.com.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Each counterparty and/or any of its affiliates may be an Authorized Participant or shareholder of a Fund, subject to applicable law.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The counterparty risk for cleared derivatives transactions is generally lower than for OTC derivatives. Once a transaction is cleared, the clearing organization is substituted and is a Fund’s counterparty on the derivative. The clearing organization guarantees the performance of the other side of the derivative. Nevertheless, some risk remains, as there is no assurance that the clearing organization, or its members, will satisfy its obligations to a Fund.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Leverage Risk</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Funds may utilize leverage in seeking to achieve their respective investment objectives and will lose more money in market environments adverse to their respective daily investment objectives than funds that do not employ leverage. The use of leveraged and/or inverse leveraged positions increases the risk of total loss of an investor’s investment, even over periods as short as a single day.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">For example, because UVIX includes a two times (2x) multiplier, a single-day movement in the relevant benchmark approaching 50% at any point in the day could result in the total loss or almost total loss of an investor’s investment if that movement is contrary to the investment objective of the Fund in which an investor has invested, even if such Fund’s benchmark subsequently moves in an opposite direction, eliminating all or a portion of the movement. This would be the case with downward single-day or intraday movements in the underlying benchmark of a Fund or upward single-day or intraday movements in the benchmark of a Fund, even if the underlying benchmark maintains a level greater than zero at all times.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Liquidity Risk</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Financial Instruments cannot always be liquidated at the desired price. It is difficult to execute a trade at a specific price when there is a relatively small volume of buy and sell orders in a market. A market disruption can also make it difficult to liquidate a position or find a swap or forward contract counterparty at a reasonable cost. Market illiquidity may cause losses for the Funds. The large size of the positions which the Funds may acquire increases the risk of illiquidity by both making their positions more difficult to liquidate and increasing the losses incurred while trying to do so. Any type of disruption or illiquidity will potentially be exacerbated due to the fact that the Funds will typically invest in Financial Instruments related to one benchmark, which in many cases is highly concentrated.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>“Contango” and “Backwardation” Risk</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Funds typically hold futures contracts. As the futures contracts near expiration, they are generally replaced by contracts that have a later expiration. Thus, for example, a contract purchased and held in November 2019 may specify a January 2020 expiration. As that contract nears expiration, it may be replaced by selling the January 2020 contract and purchasing the contract expiring in March 2020. This process is referred to as “rolling.” Rolling may have a positive or negative impact on performance. For example, historically, the prices of certain types of futures contracts have frequently been higher for contracts with shorter-term expirations than for contracts with longer-term expirations, which is referred to as “backwardation.” In these circumstances, absent other factors, the sale of the January 2020 contract would take place at a price that is higher than the price at which the March 2020 contract is purchased, thereby creating a gain in connection with rolling. While certain types of futures contracts have historically exhibited consistent periods of backwardation, backwardation will likely not exist in these markets at all times.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Since the introduction of VIX futures contracts, there have frequently been periods where VIX futures prices reflect higher expected volatility levels further out in time. This can result in a loss from “rolling” the VIX futures to maintain the constant weighted average maturity of the applicable Fund benchmark. Losses from exchanging a lower priced VIX future for a higher priced longer-term future in the rolling process could adversely affect the value of a Fund and, accordingly, decrease the return of a Fund.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Natural Disaster/Epidemic Risk</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Natural or environmental disasters, such as earthquakes, fires, floods, hurricanes, tsunamis and other severe weather-related phenomena generally, and widespread disease, including pandemics and epidemics (for example, the novel coronavirus COVID-19), have been and can be highly disruptive to economies and markets and have recently led, and may continue to lead, to increased market volatility and significant market losses. Such natural disaster and health crises could exacerbate political, social, and economic risks previously mentioned, and result in significant breakdowns, delays, shutdowns, social isolation, and other disruptions to important global, local and regional supply chains affected, with potential corresponding results on the operating performance of the Funds and their investments. A climate of uncertainty and panic, including the contagion of infectious viruses or diseases, may adversely affect global, regional, and local economies and reduce the availability of potential investment opportunities, and increases the difficulty of performing due diligence and modeling market conditions, potentially reducing the accuracy of financial projections. Under these circumstances, the Funds may have difficulty achieving their investment objectives which may adversely impact performance. Further, such events can be highly disruptive to economies and markets, significantly disrupt the operations of individual companies (including, but not limited to, the Funds’ Sponsor and third party service providers), sectors, industries, markets, securities and commodity exchanges, currencies, interest and inflation rates, credit ratings, investor sentiment, and other factors affecting the value of the Funds’ investments. These factors can cause substantial market volatility, exchange trading suspensions and closures and can impact the ability of the Funds to complete redemptions and otherwise affect Fund performance and Fund trading in the secondary market. A widespread crisis may also affect the global economy in ways that cannot necessarily be foreseen at the current time. How long such events will last and whether they will continue or recur cannot be predicted. Impacts from these events could have significant impact on a Fund’s performance, resulting in losses to your investment.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Risk that Current Assumptions and Expectations Could Become Outdated As a Result of Global Economic Shocks</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The onset of the novel coronavirus (COVID-19) has caused significant shocks to global financial markets and economies, with many governments taking extreme actions to slow and contain the spread of COVID-19. These actions have had, and likely will continue to have, a severe economic impact on global economies as economic activity in some instances has essentially ceased. Financial markets across the globe are experiencing severe distress at least equal to what was experienced during the global financial crisis in 2008. In March 2020, U.S. equity markets entered a bear market in the fastest such move in the history of U.S. financial markets. Contemporaneous with the onset of the COVID-19 pandemic in the US, oil experienced shocks to supply and demand, impacting the price and volatility of oil. The global economic shocks being experienced as of the date hereof may cause the underlying assumptions and expectations of the Funds to become outdated quickly or inaccurate, resulting in significant losses.</p> 0.50 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>NOTE 9 – SUBSEQUENT EVENTS</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Management has evaluated the possibility of subsequent events existing in the Trust’s and the Funds’ financial statements through the date the financial statements were issued. On January 11, 2023, the Trust announced a 1-for-5 reverse share split (a “Reverse Split”) of the shares of beneficial interest of 2x Long VIX Futures ETF (ticker symbol: UVIX). The Reverse Split was effective prior to market open on January 25, 2023, when the fund began trading at its post-split price. The Reverse Split increased the price per share of the fund with a proportionate decrease in the number of shares outstanding. Therefore, the Reverse Split did not change the aggregate net asset value of a shareholder’s investment at the time of the Reverse Split.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">For UVIX shareholders who held a quantity of shares that was not an exact multiple of the Reverse Split ratio (i.e., not a multiple of 5), the Reverse Split resulted in the creation of a fractional share. Post-Reverse Split fractional shares were made available to be redeemed for cash and sent to the shareholder’s broker of record. This redemption may have caused some shareholders to realize gains or losses, which could have been a taxable event for those shareholders.</p> false FY 0001793497 No Par Value $48,144,554 of cash is pledged as collateral for futures contracts. $114,821,272 of cash is pledged as collateral for futures contracts. The Fund commenced operations on March 28, 2022. The Fund commenced operations on March 28, 2022. The Fund commenced operations on March 28, 2022. Although the Funds’ shares may continue to trade on secondary markets subsequent to the calculation of the final NAV, these times represent the final opportunity to transact in creation or redemption units for the three months ended December 31, 2022. Includes cumulative appreciation (depreciation) of futures contracts as reported in the Schedule of Investments. Only current day’s variation margin is reported within the Statements of Financial Condition in receivable/payable on open futures. Both Funds commenced operations on March 28, 2022. Net investment loss per share represents net investment loss divided by the daily average shares of beneficial interest outstanding during the period. Due to timing of capital share transactions, per share amounts may not compare with amounts appearing elsewhere within these Financial Statements. Market values are determined at the close of the applicable primary listing exchange, which may be later than when the Funds’ net asset value is calculated. Percentages are not annualized for the period ended December 31, 2022. The expense ratio would be 2.29% and 2.39% respectively, if brokerage commissions and futures and futures account fees were excluded. EXCEL 49 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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

*QV?:+)0*=(.QB\T!4P_IC6D[F M <2K)Y+>41.LO_4DUM*6]^T#:LUHX*EB'<_F\N8IN-/VV:\_73\3@Y&@KLO! M2%+7U6"DJ.MZ,-+4=3,8&>IZ-!A%U/5X,(JIZ\E@E)#QA]B!D/RDZ1K9-P'X M"4T#NRW(?@OLN"![+K#K@NR[P,X+LO<"NR_(_@L$($@" A$(D@$@ R 9 #( MD@$@ R 9 #( D@$@ R 9 #( D@$@ R 9 #( D@$@ R 9 #( DH%$!I)D()&! MI.O6F+A[:!Y8_%W5=+-N7 M&PO=V]R:W-H965T&ULO9IK;]LV%(:_[U<0[C T MP!*+A[IFC@''3= ;1K$;C>@V =%IFVANG@2G63[]2-E1;0EF;1CI_F0Z,;# M]^7M.534>TJS'_F<4H:>XRC)+SISQA;GW6X>S&GLYV?I@B;\SC3-8I_QTVS6 MS1<9]2=%H3CJ@F'8W=@/DTZ_5UR[R_J]=,FB,*%W&QG_U[2*'VZZ.#. MRX7[<#9GXD*WWUOX,SJB[.OB+N-GW2K*)(QIDH=I@C(ZO>@,\/G0M$2!XHEO M(7W*UXZ1L/*0IC_$RBJ?-3HH M6.8LC.6,;OAKP4Y;WNHS7(Y[N!F7,RU5,V!(3 _J<)FR>HZMD0B>; ;I<8*427E1>@C+B M!QJ<(8)_1V H*^C#^C]KR>*N*1R3XJX9$O<+W=7]X/QS9?;49O+55FSO:R8 M7^?YP@_H18=/H)QFC[33_^T=MHT_%,K,2IFIBMX7[1\FCS1G1>=$:=[:$:L@ M=A%$S-C'_BGVP'4-M]=]7'MPJ*[M._Y;H=FJ-%M:S7PIB<+_Z 3-^!*"W@O= M)XA/5^DE1WXR0=,E6_)60P$?*!F?RZWN5M59Z^XLPP'+,,R:/;4PM3V[LF=K M[07%#!$39)E45OT%'P!!Z!?KTOL)E650;'@[F8\^(1&'P?W5VA\/[@=#89;UP7W#=8%KU+J M*?V.YKX8.WD:3=JD>8UFM5S/=,$T<*U9U=6HQPTV)%V,7>1F=$(Y95HEEQ$V MA@*Q; \3MS'--;5I5*\Q$>\^WC<'>3&T W\1,C]"N7"'^"1.[MD-LK^Y 7;/&@>0V5H/[ M]FJ,!J/1U;AU@N*W(#>6Z,9JFE[269@D8B'DJ_\=S<*T?> KH[2K1"V!AAHY MFC:7=,=JBO)D3AI"[UHM-8F]=: <@FPLF8W5 #S%SV@T3S.&OMW\A:Y+]%Z- MKUOE*V.]=MQ(RF+G@&P4*T'X6G&2D%B)M5T3TC+*QFKN$,>TZGF+ICI-_TM< M8C7(CIZ3XB9BL6TYQ&TD+AIE:H<@$0MJZ/W4M!2:L,;8LK%1[UZ-:(UY26K8 M@]3'R4RAB6ML>QZ83KV#-=K4J2E(6@,<,3D%)8!?N4R !#,HV:K+3\O2&XWK M>HYK8P+UUE57I!E!$M:@IN,.&6H986--XPUF&ORGGL%I:M.HEBP&_5;[>!DJ M-+$-'N&= E;=WB'4!DEM4%-[WP05FMMETR9\6!FD;N"0_3)(E(,:Y>K\%-X" MY2!1#FJV[IB?JJ/LD9]JY&C:7*(>U$#=(3^%)KP;XV3S1:+$,%$3#9[1IY0W MZ0YIICK2*[N?2&82?,A+3R747BM.PHZH-X@[IIFDN2,]Q=C#Q*IC1%.?>O"1 MM1?):AP=/<\D35*>V@YXKML@I4::QJ(D)=&_DOYIB29I8:X'!N_?AOM#B$LD M<Q#U.IDE:WF\[CNT1IY%.:\1I3$KN$ON(J29YB^TRD8PEZE>_FE23-%\Q M$\^S/1L:[R(T%6E:5W*7J$&W0ZI)6K;/V+,M3)S&RT)-;1K5$JM$OX,^7JI) MF@3FLQJ[?'O5F-B'[)]-"6Y3#>Y]_7"^YLB"-.6\#SF9)()&)?/:S8([ 7?TC_6SO FU-UUW[^""FV:SX M)D/0?9FPU?^.JZO5=Q^#XFN'VO5+?#[$;=?A?-CV_, TSX>\R=KN6"^?EG2E MI-6'*=P1'Y YBNB4RS/.'-ZLV>I;C]4)2Q?%YQ(/*6-I7!S.J3^AF7B WY^F M*7LY$1547]ST_P=02P,$% @ MGQ\5O*3+UB$"0 23P !@ !X;"]W M;W)K.U:*9G*JGDP[NO!RX21\F M976@VSN>)P_R5I:_SZ]S_:V[CC)*9S(K4I6A7(Y/.J?XJ!_2ZH+Z%S]2^51L M?$85E'NE?E9?!J.33E!E)*=R6%8A$OWO4?;E=%I%TGG\;Q6TL[YG=>'FYY?H MES5X#>8^*61?3?](1^7DI!-UT$B.D\6TO%%/O\D5(%[%&ZII4?]%3ZO?!ATT M7!2EFJTNUAG,TFSY/WE>/8B-"PC9<@%974 :%V"ZY0*ZNJ!^L>Y>D)Y]6L=K?I0/YOZ:HTFS:HRWI:Y/IOJZ\K>;9F44I>E1&J,^DDQ09>Z MLL5QM]3!JY]TAZM 9\M 9$L@3- WE963 EUD(SEZ':"KLUJG1EY2.R-@Q',Y M_((H_H1(0 CZ_?84QPU8<$(PK&@-*P*CG,N7[C7(-KK7N9RK(M4HDA+=Y^JG MS)'F3C1>:+0:JFZF9:Y;F;-PD5TX+$@L>$1$ R&<&XPP7B.,]T'X(\G3>IC0 M)YG"?I",EG+7<* M7:, 0 X;L V99$H/$71?BZ$>8-QN<)P,/$B,>,$CTO<&:AL\EU(OF MR:^MM:$6(!R% ;40P9EX$!EM@6$&WX+H>@F@XMO;N181*G=B81860C'!5CMK MHR*PD1$8).UM6$Y'6CJG15G)@D?Y2>N"H5ID2XF@1X9:9X_2)$-CJ0<+J'3< M@DL=P[DG2P]:HR$P3.C;*I>KL2RJB58R]2.RY04ED8AX$U(;;8&-N, PF6^! M]#4=5E/'5;UR^; JIMJA9+;.P'',K ;:1F1@HS(P3.57AY&NV*$M""65=HK" M-;+7.1J=@..W3) N!U>G5WW_! F#E+^GGB9&"A"8=QNZ=))4^JQ0T]&G>KZ@ M1>E0:=KLKG;?G$5@.ZX7,6\&T- MGQAN)S"C7EW6(;+"HA^#?Z'+U03QXN[2F3H8:M^QTK L"=_# B,@1^Z;M>%.XN?. M [M@Q.91+.*8L+#I@GER\S0BP[T$YMX_Q0@C[\'[S M,;$4J^>N<,6H864*\^/!_#!J<_96:&THFQK*IGO-VMMX8M0QF6<19HSSIIGI M2I+P M@#%R@,(TW<9"HK92^,S#IK'G2< #Q.@$NM>L_2T.$K4G[4X'R9.)!Y&1$W2O M2?MN#A)UO =@-+1&@S;S>$9M,)C:#^0?,9<_$(01 MTUVO":R-UF!&:S#R'J83 T7"OJ_EC7A@,%,?VG1BKE<#<1@)3)N&I2>[JR=Z(!@9S]H%,)^:P_3&)8FSWEC8:@AD- MP6#FWM6I8K90<%HDGMMYTC9"@<$LO:-3!4=Y@U/E2<<#RX@&!M.QUZEB-NLW MRO#ZSH; &O(?EQ$%:W3=K0[?<3[<'MIRX M@WK#4,0T#)K.O"Q W-\3-/<2]N^?$'9-ZRB-.L;U2 MR7-73\4,*7.8'@_F.7&;LBD/2(0#2[][4O) VU@(N-%O#A/J8=9B<TTKAM"V@Q*80U1K:A M>&XHGN^U/'!'*XT[7M=K 1 UU:,G"0\8HQKX7BL!=[+2N&,!( ^M<;#-9%\8 M42'VFNSO9CP)>UZ/0Q'1YIL?3PX>+$9J")C-W]MY$K;NP'',PR;:-II#&,TA M8/?^$,Z3<"P%""C#36O&DXH'DI$48J^5@2V<)^%P S".+'QM1(SM]$\^V--[$N^R@6!C!X%G"\&!O2?A6 D8ZYD) M)\QJ<6WTA#!Z0L#D_0;O2;CD0BRJU5JQ-<2UD0S"2 ;1:JG?KMZ3L+7#UN[2 M1CX((Q\$S-Z[FD]PF#?8.)Y\//M:C)H(82;?T9V"H[P!EB<=#RPC+$*8LKWN M%'S]6P"UT0YAI1U>'S'4&WHI#MU-Y%\N%Y4D4C,]Z1WJ;F:,&*39]ENB!S]$ MHN6&PB^N5+H;®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

,"2. MFW-P[SP*U^=4N/E]9_0;4$L#!!0 ( +9\?%:7BKL

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end XML 50 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 51 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 52 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.1 html 46 172 1 true 22 0 false 4 false false R1.htm 000 - Document - Document And Entity Information Sheet http://www.vts.com/role/DocumentAndEntityInformation Document And Entity Information Cover 1 false false R2.htm 001 - Statement - Statement of Financial Condition Sheet http://www.vts.com/role/ConsolidatedBalanceSheet Statement of Financial Condition Statements 2 false false R3.htm 002 - Statement - Schedule of Investments Sheet http://www.vts.com/role/ScheduleofInvestmentsTable Schedule of Investments Statements 3 false false R4.htm 003 - Statement - Schedule of Investments (Parentheticals) Sheet http://www.vts.com/role/ScheduleofInvestmentsTable_Parentheticals Schedule of Investments (Parentheticals) Statements 4 false false R5.htm 004 - Statement - Statement of Operations Sheet http://www.vts.com/role/ConsolidatedIncomeStatement Statement of Operations Statements 5 false false R6.htm 005 - Statement - Statement of Changes in Net Assets Sheet http://www.vts.com/role/ConsolidatedIncomeStatement0 Statement of Changes in Net Assets Statements 6 false false R7.htm 006 - Statement - Statement of Cash Flows Sheet http://www.vts.com/role/ConsolidatedCashFlow Statement of Cash Flows Statements 7 false false R8.htm 007 - Disclosure - Organization Sheet http://www.vts.com/role/Organization Organization Notes 8 false false R9.htm 008 - Disclosure - Significant Accounting Policies Sheet http://www.vts.com/role/SignificantAccountingPolicies Significant Accounting Policies Notes 9 false false R10.htm 009 - Disclosure - Investments Sheet http://www.vts.com/role/Investments Investments Notes 10 false false R11.htm 010 - Disclosure - Agreements Sheet http://www.vts.com/role/Agreements Agreements Notes 11 false false R12.htm 011 - Disclosure - Offering Costs Sheet http://www.vts.com/role/OfferingCosts Offering Costs Notes 12 false false R13.htm 012 - Disclosure - Creation and Redemption of Creation Units Sheet http://www.vts.com/role/CreationandRedemptionofCreationUnits Creation and Redemption of Creation Units Notes 13 false false R14.htm 013 - Disclosure - Financial Highlights Sheet http://www.vts.com/role/FinancialHighlights Financial Highlights Notes 14 false false R15.htm 014 - Disclosure - Risk Sheet http://www.vts.com/role/Risk Risk Notes 15 false false R16.htm 015 - Disclosure - Subsequent Events Sheet http://www.vts.com/role/SubsequentEvents Subsequent Events Notes 16 false false R17.htm 016 - Disclosure - Accounting Policies, by Policy (Policies) Sheet http://www.vts.com/role/AccountingPoliciesByPolicy Accounting Policies, by Policy (Policies) Policies http://www.vts.com/role/SignificantAccountingPolicies 17 false false R18.htm 017 - Disclosure - Significant Accounting Policies (Tables) Sheet http://www.vts.com/role/SignificantAccountingPoliciesTables Significant Accounting Policies (Tables) Tables http://www.vts.com/role/SignificantAccountingPolicies 18 false false R19.htm 018 - Disclosure - Investments (Tables) Sheet http://www.vts.com/role/InvestmentsTables Investments (Tables) Tables http://www.vts.com/role/Investments 19 false false R20.htm 019 - Disclosure - Creation and Redemption of Creation Units (Tables) Sheet http://www.vts.com/role/CreationandRedemptionofCreationUnitsTables Creation and Redemption of Creation Units (Tables) Tables http://www.vts.com/role/CreationandRedemptionofCreationUnits 20 false false R21.htm 020 - Disclosure - Financial Highlights (Tables) Sheet http://www.vts.com/role/FinancialHighlightsTables Financial Highlights (Tables) Tables http://www.vts.com/role/FinancialHighlights 21 false false R22.htm 021 - Disclosure - Significant Accounting Policies (Details) Sheet http://www.vts.com/role/SignificantAccountingPoliciesDetails Significant Accounting Policies (Details) Details http://www.vts.com/role/SignificantAccountingPoliciesTables 22 false false R23.htm 022 - Disclosure - Significant Accounting Policies (Details) - Schedule of cut-off times and the times of the calculation of the funds Sheet http://www.vts.com/role/ScheduleofcutofftimesandthetimesofthecalculationofthefundsTable Significant Accounting Policies (Details) - Schedule of cut-off times and the times of the calculation of the funds Details http://www.vts.com/role/SignificantAccountingPoliciesTables 23 false false R24.htm 023 - Disclosure - Significant Accounting Policies (Details) - Schedule of valuation of investments at using the fair value hierarchy Sheet http://www.vts.com/role/ScheduleofvaluationofinvestmentsatusingthefairvaluehierarchyTable Significant Accounting Policies (Details) - Schedule of valuation of investments at using the fair value hierarchy Details http://www.vts.com/role/SignificantAccountingPoliciesTables 24 false false R25.htm 024 - Disclosure - Investments (Details) - Schedule of fair value of derivative instruments Sheet http://www.vts.com/role/ScheduleoffairvalueofderivativeinstrumentsTable Investments (Details) - Schedule of fair value of derivative instruments Details http://www.vts.com/role/InvestmentsTables 25 false false R26.htm 025 - Disclosure - Investments (Details) - Schedule of effect of derivative instruments on the statement of operations Sheet http://www.vts.com/role/ScheduleofeffectofderivativeinstrumentsonthestatementofoperationsTable Investments (Details) - Schedule of effect of derivative instruments on the statement of operations Details http://www.vts.com/role/InvestmentsTables 26 false false R27.htm 026 - Disclosure - Investments (Details) - Schedule of pledged by funds fair values of derivative instruments Sheet http://www.vts.com/role/ScheduleofpledgedbyfundsfairvaluesofderivativeinstrumentsTable Investments (Details) - Schedule of pledged by funds fair values of derivative instruments Details http://www.vts.com/role/InvestmentsTables 27 false false R28.htm 027 - Disclosure - Investments (Details) - Schedule of gross amounts not offset in the statements of financial condition Sheet http://www.vts.com/role/ScheduleofgrossamountsnotoffsetinthestatementsoffinancialconditionTable Investments (Details) - Schedule of gross amounts not offset in the statements of financial condition Details http://www.vts.com/role/InvestmentsTables 28 false false R29.htm 028 - Disclosure - Agreements (Details) Sheet http://www.vts.com/role/AgreementsDetails Agreements (Details) Details http://www.vts.com/role/Agreements 29 false false R30.htm 029 - Disclosure - Creation and Redemption of Creation Units (Details) Sheet http://www.vts.com/role/CreationandRedemptionofCreationUnitsDetails Creation and Redemption of Creation Units (Details) Details http://www.vts.com/role/CreationandRedemptionofCreationUnitsTables 30 false false R31.htm 030 - Disclosure - Creation and Redemption of Creation Units (Details) - Schedule of transaction fees Sheet http://www.vts.com/role/ScheduleoftransactionfeesTable Creation and Redemption of Creation Units (Details) - Schedule of transaction fees Details http://www.vts.com/role/CreationandRedemptionofCreationUnitsTables 31 false false R32.htm 031 - Disclosure - Financial Highlights (Details) - Schedule of share outstanding Sheet http://www.vts.com/role/ScheduleofshareoutstandingTable Financial Highlights (Details) - Schedule of share outstanding Details http://www.vts.com/role/FinancialHighlightsTables 32 false false R33.htm 032 - Disclosure - Risk (Details) Sheet http://www.vts.com/role/RiskDetails Risk (Details) Details http://www.vts.com/role/Risk 33 false false All Reports Book All Reports [dq-0542-Deprecated-Concept] Concept InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease in us-gaap/2022 used in 6 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. f10k2022_vstrust.htm 4329, 4387, 4897, 4948, 5349, 5410 [dq-0542-Deprecated-Concept] Concept InvestmentCompanyNetAssetsPeriodIncreaseDecrease in us-gaap/2022 used in 3 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. f10k2022_vstrust.htm 4406, 4967, 5430 f10k2022_vstrust.htm cik0001793497-20221231.xsd cik0001793497-20221231_cal.xml cik0001793497-20221231_def.xml cik0001793497-20221231_lab.xml cik0001793497-20221231_pre.xml f10k2022ex31-1_vstrust.htm f10k2022ex31-2_vstrust.htm f10k2022ex32-1_vstrust.htm f10k2022ex32-2_vstrust.htm f10k2022ex4-3_vstrust.htm image_001.jpg image_002.jpg image_003.jpg http://fasb.org/us-gaap/2022 http://xbrl.sec.gov/dei/2022 true true JSON 55 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "f10k2022_vstrust.htm": { "axisCustom": 0, "axisStandard": 10, "baseTaxonomies": { "http://fasb.org/us-gaap/2022": 195, "http://xbrl.sec.gov/dei/2022": 43 }, "contextCount": 46, "dts": { "calculationLink": { "local": [ "cik0001793497-20221231_cal.xml" ] }, "definitionLink": { "local": [ "cik0001793497-20221231_def.xml" ] }, "inline": { "local": [ "f10k2022_vstrust.htm" ] }, "labelLink": { "local": [ "cik0001793497-20221231_lab.xml" ] }, "presentationLink": { "local": [ "cik0001793497-20221231_pre.xml" ] }, "schema": { "local": [ "cik0001793497-20221231.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd", "https://xbrl.sec.gov/sic/2022/sic-2022.xsd" ] } }, "elementCount": 280, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2022": 9, "http://www.vts.com/20221231": 4, "http://xbrl.sec.gov/dei/2022": 3, "total": 16 }, "keyCustom": 60, "keyStandard": 112, "memberCustom": 13, "memberStandard": 5, "nsprefix": "cik0001793497", "nsuri": "http://www.vts.com/20221231", "report": { "R1": { "firstAnchor": { "ancestors": [ "p", "div", "body", "html" ], "baseRef": "f10k2022_vstrust.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "dei:EntityRegistrantName", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "000 - Document - Document And Entity Information", "menuCat": "Cover", "order": "1", "role": "http://www.vts.com/role/DocumentAndEntityInformation", "shortName": "Document And Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "div", "body", "html" ], "baseRef": "f10k2022_vstrust.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "dei:EntityRegistrantName", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10k2022_vstrust.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "009 - Disclosure - Investments", "menuCat": "Notes", "order": "10", "role": "http://www.vts.com/role/Investments", "shortName": "Investments", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10k2022_vstrust.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10k2022_vstrust.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "cik0001793497:AgreementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "010 - Disclosure - Agreements", "menuCat": "Notes", "order": "11", "role": "http://www.vts.com/role/Agreements", "shortName": "Agreements", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10k2022_vstrust.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "cik0001793497:AgreementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10k2022_vstrust.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "cik0001793497:OfferingCostsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "011 - Disclosure - Offering Costs", "menuCat": "Notes", "order": "12", "role": "http://www.vts.com/role/OfferingCosts", "shortName": "Offering Costs", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10k2022_vstrust.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "cik0001793497:OfferingCostsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10k2022_vstrust.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "012 - Disclosure - Creation and Redemption of Creation Units", "menuCat": "Notes", "order": "13", "role": "http://www.vts.com/role/CreationandRedemptionofCreationUnits", "shortName": "Creation and Redemption of Creation Units", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10k2022_vstrust.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10k2022_vstrust.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:QuarterlyFinancialInformationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "013 - Disclosure - Financial Highlights", "menuCat": "Notes", "order": "14", "role": "http://www.vts.com/role/FinancialHighlights", "shortName": "Financial Highlights", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10k2022_vstrust.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:QuarterlyFinancialInformationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10k2022_vstrust.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConcentrationRiskDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "014 - Disclosure - Risk", "menuCat": "Notes", "order": "15", "role": "http://www.vts.com/role/Risk", "shortName": "Risk", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10k2022_vstrust.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConcentrationRiskDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10k2022_vstrust.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "015 - Disclosure - Subsequent Events", "menuCat": "Notes", "order": "16", "role": "http://www.vts.com/role/SubsequentEvents", "shortName": "Subsequent Events", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10k2022_vstrust.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10k2022_vstrust.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "cik0001793497:EmergingGrowthCompanyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "016 - Disclosure - Accounting Policies, by Policy (Policies)", "menuCat": "Policies", "order": "17", "role": "http://www.vts.com/role/AccountingPoliciesByPolicy", "shortName": "Accounting Policies, by Policy (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10k2022_vstrust.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "cik0001793497:EmergingGrowthCompanyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10k2022_vstrust.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "cik0001793497:ScheduleOfCutoffTimesAndTimesOfCalculationTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "017 - Disclosure - Significant Accounting Policies (Tables)", "menuCat": "Tables", "order": "18", "role": "http://www.vts.com/role/SignificantAccountingPoliciesTables", "shortName": "Significant Accounting Policies (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10k2022_vstrust.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "cik0001793497:ScheduleOfCutoffTimesAndTimesOfCalculationTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10k2022_vstrust.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "018 - Disclosure - Investments (Tables)", "menuCat": "Tables", "order": "19", "role": "http://www.vts.com/role/InvestmentsTables", "shortName": "Investments (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10k2022_vstrust.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10k2022_vstrust.htm", "contextRef": "c9", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "001 - Statement - Statement of Financial Condition", "menuCat": "Statements", "order": "2", "role": "http://www.vts.com/role/ConsolidatedBalanceSheet", "shortName": "Statement of Financial Condition", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10k2022_vstrust.htm", "contextRef": "c9", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10k2022_vstrust.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "cik0001793497:ScheduleOfTransactionFeesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "019 - Disclosure - Creation and Redemption of Creation Units (Tables)", "menuCat": "Tables", "order": "20", "role": "http://www.vts.com/role/CreationandRedemptionofCreationUnitsTables", "shortName": "Creation and Redemption of Creation Units (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10k2022_vstrust.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "cik0001793497:ScheduleOfTransactionFeesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10k2022_vstrust.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "cik0001793497:ScheduleOfShareOutstandingTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "020 - Disclosure - Financial Highlights (Tables)", "menuCat": "Tables", "order": "21", "role": "http://www.vts.com/role/FinancialHighlightsTables", "shortName": "Financial Highlights (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10k2022_vstrust.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "cik0001793497:ScheduleOfShareOutstandingTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "f10k2022_vstrust.htm", "contextRef": "c0", "decimals": "-7", "first": true, "lang": null, "name": "cik0001793497:GrossRevenue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "021 - Disclosure - Significant Accounting Policies (Details)", "menuCat": "Details", "order": "22", "role": "http://www.vts.com/role/SignificantAccountingPoliciesDetails", "shortName": "Significant Accounting Policies (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "f10k2022_vstrust.htm", "contextRef": "c0", "decimals": "-7", "first": true, "lang": null, "name": "cik0001793497:GrossRevenue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "cik0001793497:ScheduleOfCutoffTimesAndTimesOfCalculationTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10k2022_vstrust.htm", "contextRef": "c21", "decimals": null, "first": true, "lang": "en-US", "name": "cik0001793497:CreateRedeemCutoffDescription", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "022 - Disclosure - Significant Accounting Policies (Details) - Schedule of cut-off times and the times of the calculation of the funds", "menuCat": "Details", "order": "23", "role": "http://www.vts.com/role/ScheduleofcutofftimesandthetimesofthecalculationofthefundsTable", "shortName": "Significant Accounting Policies (Details) - Schedule of cut-off times and the times of the calculation of the funds", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "cik0001793497:ScheduleOfCutoffTimesAndTimesOfCalculationTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10k2022_vstrust.htm", "contextRef": "c21", "decimals": null, "first": true, "lang": "en-US", "name": "cik0001793497:CreateRedeemCutoffDescription", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10k2022_vstrust.htm", "contextRef": "c9", "decimals": "0", "first": true, "lang": null, "name": "cik0001793497:AmountOfTotalTrust", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "023 - Disclosure - Significant Accounting Policies (Details) - Schedule of valuation of investments at using the fair value hierarchy", "menuCat": "Details", "order": "24", "role": "http://www.vts.com/role/ScheduleofvaluationofinvestmentsatusingthefairvaluehierarchyTable", "shortName": "Significant Accounting Policies (Details) - Schedule of valuation of investments at using the fair value hierarchy", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10k2022_vstrust.htm", "contextRef": "c9", "decimals": "0", "first": true, "lang": null, "name": "cik0001793497:AmountOfTotalTrust", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10k2022_vstrust.htm", "contextRef": "c7", "decimals": "0", "first": true, "lang": null, "name": "cik0001793497:TotalTrust", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "024 - Disclosure - Investments (Details) - Schedule of fair value of derivative instruments", "menuCat": "Details", "order": "25", "role": "http://www.vts.com/role/ScheduleoffairvalueofderivativeinstrumentsTable", "shortName": "Investments (Details) - Schedule of fair value of derivative instruments", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10k2022_vstrust.htm", "contextRef": "c7", "decimals": "0", "first": true, "lang": null, "name": "cik0001793497:TotalTrust", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10k2022_vstrust.htm", "contextRef": "c37", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DebtSecuritiesRealizedGainLoss", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "025 - Disclosure - Investments (Details) - Schedule of effect of derivative instruments on the statement of operations", "menuCat": "Details", "order": "26", "role": "http://www.vts.com/role/ScheduleofeffectofderivativeinstrumentsonthestatementofoperationsTable", "shortName": "Investments (Details) - Schedule of effect of derivative instruments on the statement of operations", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10k2022_vstrust.htm", "contextRef": "c37", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DebtSecuritiesRealizedGainLoss", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "cik0001793497:ScheduleOfPledgedByFundsFairValuesOfDerivativeInstrumentsTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10k2022_vstrust.htm", "contextRef": "c38", "decimals": "0", "first": true, "lang": null, "name": "cik0001793497:GrossAmountsOfRecognizedAssetsPresentedInTheStatementsOfFinancialCondition", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "026 - Disclosure - Investments (Details) - Schedule of pledged by funds fair values of derivative instruments", "menuCat": "Details", "order": "27", "role": "http://www.vts.com/role/ScheduleofpledgedbyfundsfairvaluesofderivativeinstrumentsTable", "shortName": "Investments (Details) - Schedule of pledged by funds fair values of derivative instruments", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "cik0001793497:ScheduleOfPledgedByFundsFairValuesOfDerivativeInstrumentsTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10k2022_vstrust.htm", "contextRef": "c38", "decimals": "0", "first": true, "lang": null, "name": "cik0001793497:GrossAmountsOfRecognizedAssetsPresentedInTheStatementsOfFinancialCondition", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10k2022_vstrust.htm", "contextRef": "c21", "decimals": "0", "first": true, "lang": null, "name": "cik0001793497:AmountsOfRecognizedAssetsLiabilitiesPresentedInTheStatementsOfFinancialConditionOne", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "027 - Disclosure - Investments (Details) - Schedule of gross amounts not offset in the statements of financial condition", "menuCat": "Details", "order": "28", "role": "http://www.vts.com/role/ScheduleofgrossamountsnotoffsetinthestatementsoffinancialconditionTable", "shortName": "Investments (Details) - Schedule of gross amounts not offset in the statements of financial condition", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10k2022_vstrust.htm", "contextRef": "c21", "decimals": "0", "first": true, "lang": null, "name": "cik0001793497:AmountsOfRecognizedAssetsLiabilitiesPresentedInTheStatementsOfFinancialConditionOne", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10k2022_vstrust.htm", "contextRef": "c9", "decimals": "4", "first": true, "lang": null, "name": "cik0001793497:SubadvisoryFeeRate", "reportCount": 1, "unique": true, "unitRef": "pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "028 - Disclosure - Agreements (Details)", "menuCat": "Details", "order": "29", "role": "http://www.vts.com/role/AgreementsDetails", "shortName": "Agreements (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10k2022_vstrust.htm", "contextRef": "c9", "decimals": "4", "first": true, "lang": null, "name": "cik0001793497:SubadvisoryFeeRate", "reportCount": 1, "unique": true, "unitRef": "pure", "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10k2022_vstrust.htm", "contextRef": "c10", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Cash", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "002 - Statement - Schedule of Investments", "menuCat": "Statements", "order": "3", "role": "http://www.vts.com/role/ScheduleofInvestmentsTable", "shortName": "Schedule of Investments", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10k2022_vstrust.htm", "contextRef": "c10", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Cash", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10k2022_vstrust.htm", "contextRef": "c9", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:SharesIssued", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "029 - Disclosure - Creation and Redemption of Creation Units (Details)", "menuCat": "Details", "order": "30", "role": "http://www.vts.com/role/CreationandRedemptionofCreationUnitsDetails", "shortName": "Creation and Redemption of Creation Units (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10k2022_vstrust.htm", "contextRef": "c9", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:SharesIssued", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "cik0001793497:ScheduleOfTransactionFeesTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10k2022_vstrust.htm", "contextRef": "c37", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:SaleOfTrustAssetsToPayExpenses", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "030 - Disclosure - Creation and Redemption of Creation Units (Details) - Schedule of transaction fees", "menuCat": "Details", "order": "31", "role": "http://www.vts.com/role/ScheduleoftransactionfeesTable", "shortName": "Creation and Redemption of Creation Units (Details) - Schedule of transaction fees", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "cik0001793497:ScheduleOfTransactionFeesTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10k2022_vstrust.htm", "contextRef": "c37", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:SaleOfTrustAssetsToPayExpenses", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "cik0001793497:ScheduleOfShareOutstandingTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10k2022_vstrust.htm", "contextRef": "c23", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:NetAssetValuePerShare", "reportCount": 1, "unique": true, "unitRef": "usdPershares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "031 - Disclosure - Financial Highlights (Details) - Schedule of share outstanding", "menuCat": "Details", "order": "32", "role": "http://www.vts.com/role/ScheduleofshareoutstandingTable", "shortName": "Financial Highlights (Details) - Schedule of share outstanding", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "cik0001793497:ScheduleOfShareOutstandingTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10k2022_vstrust.htm", "contextRef": "c23", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:NetAssetValuePerShare", "reportCount": 1, "unique": true, "unitRef": "usdPershares", "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10k2022_vstrust.htm", "contextRef": "c0", "decimals": "2", "first": true, "lang": null, "name": "cik0001793497:RelevantBenchmark", "reportCount": 1, "unique": true, "unitRef": "pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "032 - Disclosure - Risk (Details)", "menuCat": "Details", "order": "33", "role": "http://www.vts.com/role/RiskDetails", "shortName": "Risk (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10k2022_vstrust.htm", "contextRef": "c0", "decimals": "2", "first": true, "lang": null, "name": "cik0001793497:RelevantBenchmark", "reportCount": 1, "unique": true, "unitRef": "pure", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10k2022_vstrust.htm", "contextRef": "c11", "decimals": "3", "first": true, "lang": null, "name": "cik0001793497:CashPercentage", "reportCount": 1, "unique": true, "unitRef": "pure", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "003 - Statement - Schedule of Investments (Parentheticals)", "menuCat": "Statements", "order": "4", "role": "http://www.vts.com/role/ScheduleofInvestmentsTable_Parentheticals", "shortName": "Schedule of Investments (Parentheticals)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10k2022_vstrust.htm", "contextRef": "c11", "decimals": "3", "first": true, "lang": null, "name": "cik0001793497:CashPercentage", "reportCount": 1, "unique": true, "unitRef": "pure", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10k2022_vstrust.htm", "contextRef": "c0", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OtherInterestAndDividendIncome", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "004 - Statement - Statement of Operations", "menuCat": "Statements", "order": "5", "role": "http://www.vts.com/role/ConsolidatedIncomeStatement", "shortName": "Statement of Operations", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10k2022_vstrust.htm", "contextRef": "c0", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OtherInterestAndDividendIncome", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10k2022_vstrust.htm", "contextRef": "c0", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:GainLossOnInvestments", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "005 - Statement - Statement of Changes in Net Assets", "menuCat": "Statements", "order": "6", "role": "http://www.vts.com/role/ConsolidatedIncomeStatement0", "shortName": "Statement of Changes in Net Assets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10k2022_vstrust.htm", "contextRef": "c0", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:GainLossOnInvestments", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10k2022_vstrust.htm", "contextRef": "c0", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "006 - Statement - Statement of Cash Flows", "menuCat": "Statements", "order": "7", "role": "http://www.vts.com/role/ConsolidatedCashFlow", "shortName": "Statement of Cash Flows", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10k2022_vstrust.htm", "contextRef": "c0", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10k2022_vstrust.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "007 - Disclosure - Organization", "menuCat": "Notes", "order": "8", "role": "http://www.vts.com/role/Organization", "shortName": "Organization", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10k2022_vstrust.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10k2022_vstrust.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "008 - Disclosure - Significant Accounting Policies", "menuCat": "Notes", "order": "9", "role": "http://www.vts.com/role/SignificantAccountingPolicies", "shortName": "Significant Accounting Policies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10k2022_vstrust.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 22, "tag": { "cik0001793497_AdministrativeAccountingAndCustodianFeesPayable": { "auth_ref": [], "calculation": { "http://www.vts.com/role/ConsolidatedBalanceSheet": { "order": 4.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligations incurred classified as other, payable within one year or the normal operating cycle, if longer.", "label": "Administrative Accounting And Custodian Fees Payable", "terseLabel": "Administrative, accounting and custodian fees payable" } } }, "localname": "AdministrativeAccountingAndCustodianFeesPayable", "nsuri": "http://www.vts.com/20221231", "presentation": [ "http://www.vts.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "cik0001793497_AgreementsDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Agreements (Details) [Line Items]" } } }, "localname": "AgreementsDetailsLineItems", "nsuri": "http://www.vts.com/20221231", "presentation": [ "http://www.vts.com/role/AgreementsDetails" ], "xbrltype": "stringItemType" }, "cik0001793497_AgreementsDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Agreements (Details) [Table]" } } }, "localname": "AgreementsDetailsTable", "nsuri": "http://www.vts.com/20221231", "presentation": [ "http://www.vts.com/role/AgreementsDetails" ], "xbrltype": "stringItemType" }, "cik0001793497_AgreementsDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Agreements Disclosure Abstract" } } }, "localname": "AgreementsDisclosureAbstract", "nsuri": "http://www.vts.com/20221231", "xbrltype": "stringItemType" }, "cik0001793497_AgreementsDisclosureTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure of agreements disclosure.", "label": "Agreements Disclosure Text Block", "terseLabel": "AGREEMENTS" } } }, "localname": "AgreementsDisclosureTextBlock", "nsuri": "http://www.vts.com/20221231", "presentation": [ "http://www.vts.com/role/Agreements" ], "xbrltype": "textBlockItemType" }, "cik0001793497_AgreementsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Agreements [Abstract]" } } }, "localname": "AgreementsLineItems", "nsuri": "http://www.vts.com/20221231", "presentation": [ "http://www.vts.com/role/Agreements" ], "xbrltype": "stringItemType" }, "cik0001793497_AgreementsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Agreements [Table]" } } }, "localname": "AgreementsTable", "nsuri": "http://www.vts.com/20221231", "presentation": [ "http://www.vts.com/role/Agreements" ], "xbrltype": "stringItemType" }, "cik0001793497_AmountOfTotalTrust": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Total amount of trust.", "label": "Amount Of Total Trust", "terseLabel": "Total Trust" } } }, "localname": "AmountOfTotalTrust", "nsuri": "http://www.vts.com/20221231", "presentation": [ "http://www.vts.com/role/ScheduleofvaluationofinvestmentsatusingthefairvaluehierarchyTable" ], "xbrltype": "monetaryItemType" }, "cik0001793497_AmountsOfRecognizedAssetsLiabilitiesPresentedInTheStatementsOfFinancialConditionOne": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The sales price you receive with any selling costs you paid deducted.", "label": "Amounts Of Recognized Assets Liabilities Presented In The Statements Of Financial Condition One", "terseLabel": "Amounts of Recognized Assets / (Liabilities) presented in the Statements of Financial Condition" } } }, "localname": "AmountsOfRecognizedAssetsLiabilitiesPresentedInTheStatementsOfFinancialConditionOne", "nsuri": "http://www.vts.com/20221231", "presentation": [ "http://www.vts.com/role/ScheduleofgrossamountsnotoffsetinthestatementsoffinancialconditionTable" ], "xbrltype": "monetaryItemType" }, "cik0001793497_AssetDerivativesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Asset Derivatives Member", "terseLabel": "Asset Derivatives [Member]" } } }, "localname": "AssetDerivativesMember", "nsuri": "http://www.vts.com/20221231", "presentation": [ "http://www.vts.com/role/ScheduleoffairvalueofderivativeinstrumentsTable" ], "xbrltype": "domainItemType" }, "cik0001793497_AssetsAbstract0": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets Abstract0", "terseLabel": "ASSETS" } } }, "localname": "AssetsAbstract0", "nsuri": "http://www.vts.com/20221231", "presentation": [ "http://www.vts.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "stringItemType" }, "cik0001793497_AssetsAbstract1": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets Abstract1", "terseLabel": "ASSETS" } } }, "localname": "AssetsAbstract1", "nsuri": "http://www.vts.com/20221231", "presentation": [ "http://www.vts.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "stringItemType" }, "cik0001793497_AuthorizedParticipantsPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of authorized participants percentage.", "label": "Authorized Participants Percentage", "terseLabel": "Authorized participants percentage" } } }, "localname": "AuthorizedParticipantsPercentage", "nsuri": "http://www.vts.com/20221231", "presentation": [ "http://www.vts.com/role/CreationandRedemptionofCreationUnitsDetails" ], "xbrltype": "percentItemType" }, "cik0001793497_AverageDailyNetAssets": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Average daily net assets.", "label": "Average Daily Net Assets", "terseLabel": "Average daily net assets (in Dollars)" } } }, "localname": "AverageDailyNetAssets", "nsuri": "http://www.vts.com/20221231", "presentation": [ "http://www.vts.com/role/AgreementsDetails" ], "xbrltype": "monetaryItemType" }, "cik0001793497_AverageDailyNetAssetsRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Average daily net assets rate.", "label": "Average Daily Net Assets Rate", "terseLabel": "Average daily net assets rate" } } }, "localname": "AverageDailyNetAssetsRate", "nsuri": "http://www.vts.com/20221231", "presentation": [ "http://www.vts.com/role/AgreementsDetails" ], "xbrltype": "percentItemType" }, "cik0001793497_CBOEVIXFUTUREFeb23Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CBOEVIXFUTUREFeb23 Member", "terseLabel": "CBOE VIX FUTURE Feb23 [Member]" } } }, "localname": "CBOEVIXFUTUREFeb23Member", "nsuri": "http://www.vts.com/20221231", "presentation": [ "http://www.vts.com/role/ScheduleofInvestmentsTable" ], "xbrltype": "domainItemType" }, "cik0001793497_CBOEVIXFUTUREJan23Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CBOEVIXFUTUREJan23 Member", "terseLabel": "CBOE VIX FUTURE Jan23 [Member]" } } }, "localname": "CBOEVIXFUTUREJan23Member", "nsuri": "http://www.vts.com/20221231", "presentation": [ "http://www.vts.com/role/ScheduleofInvestmentsTable" ], "xbrltype": "domainItemType" }, "cik0001793497_CBOEVIXFUTURESFeb23Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CBOEVIXFUTURESFeb23 Member", "terseLabel": "CBOE VIX FUTURES Feb23 [Member]" } } }, "localname": "CBOEVIXFUTURESFeb23Member", "nsuri": "http://www.vts.com/20221231", "presentation": [ "http://www.vts.com/role/ScheduleofInvestmentsTable" ], "xbrltype": "domainItemType" }, "cik0001793497_CBOEVIXFUTURESJan23Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CBOEVIXFUTURESJan23 Member", "terseLabel": "CBOE VIX FUTURES Jan23 [Member]" } } }, "localname": "CBOEVIXFUTURESJan23Member", "nsuri": "http://www.vts.com/20221231", "presentation": [ "http://www.vts.com/role/ScheduleofInvestmentsTable" ], "xbrltype": "domainItemType" }, "cik0001793497_CapitalShareTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Capital Share Transactions Abstract", "terseLabel": "CAPITAL SHARE TRANSACTIONS" } } }, "localname": "CapitalShareTransactionsAbstract", "nsuri": "http://www.vts.com/20221231", "presentation": [ "http://www.vts.com/role/ConsolidatedIncomeStatement0" ], "xbrltype": "stringItemType" }, "cik0001793497_CashPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cash, percentage.", "label": "Cash Percentage", "terseLabel": "Cash, percentage" } } }, "localname": "CashPercentage", "nsuri": "http://www.vts.com/20221231", "presentation": [ "http://www.vts.com/role/ScheduleofInvestmentsTable_Parentheticals" ], "xbrltype": "percentItemType" }, "cik0001793497_CashPledgedAsCollateral": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cash pledged as collateral.", "label": "Cash Pledged As Collateral", "terseLabel": "Cash pledged as collateral (in Dollars)" } } }, "localname": "CashPledgedAsCollateral", "nsuri": "http://www.vts.com/20221231", "presentation": [ "http://www.vts.com/role/ScheduleofInvestmentsTable_Parentheticals" ], "xbrltype": "monetaryItemType" }, "cik0001793497_ChangeInUnrealizedAppreciationDepreciationOnDerivativesRecognizedInIncome": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Change in Unrealized Appreciation (Depreciation) on Derivatives Recognized in Income", "label": "Change In Unrealized Appreciation Depreciation On Derivatives Recognized In Income", "terseLabel": "Change in Unrealized Appreciation (Depreciation) on Derivatives Recognized in Income" } } }, "localname": "ChangeInUnrealizedAppreciationDepreciationOnDerivativesRecognizedInIncome", "nsuri": "http://www.vts.com/20221231", "presentation": [ "http://www.vts.com/role/ScheduleofeffectofderivativeinstrumentsonthestatementofoperationsTable" ], "xbrltype": "monetaryItemType" }, "cik0001793497_CreateRedeemCutoffDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Create/Redeem Cut-off (EST) 2x Long VIX Futures ETF, description", "label": "Create Redeem Cutoff Description", "terseLabel": "Create/Redeem Cut-off (EST)" } } }, "localname": "CreateRedeemCutoffDescription", "nsuri": "http://www.vts.com/20221231", "presentation": [ "http://www.vts.com/role/ScheduleofcutofftimesandthetimesofthecalculationofthefundsTable" ], "xbrltype": "stringItemType" }, "cik0001793497_CreationandRedemptionofCreationUnitsDetailsScheduleoftransactionfeesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Creation and Redemption of Creation Units (Details) - Schedule of transaction fees [Line Items]" } } }, "localname": "CreationandRedemptionofCreationUnitsDetailsScheduleoftransactionfeesLineItems", "nsuri": "http://www.vts.com/20221231", "presentation": [ "http://www.vts.com/role/ScheduleoftransactionfeesTable" ], "xbrltype": "stringItemType" }, "cik0001793497_CreationandRedemptionofCreationUnitsDetailsScheduleoftransactionfeesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Creation and Redemption of Creation Units (Details) - Schedule of transaction fees [Table]" } } }, "localname": "CreationandRedemptionofCreationUnitsDetailsScheduleoftransactionfeesTable", "nsuri": "http://www.vts.com/20221231", "presentation": [ "http://www.vts.com/role/ScheduleoftransactionfeesTable" ], "xbrltype": "stringItemType" }, "cik0001793497_DecreaseIncreaseInVariationMarginReceivable": { "auth_ref": [], "calculation": { "http://www.vts.com/role/ConsolidatedCashFlow": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Decrease Increase In Variation Margin Receivable", "negatedLabel": "Decrease (Increase) in Variation margin receivable" } } }, "localname": "DecreaseIncreaseInVariationMarginReceivable", "nsuri": "http://www.vts.com/20221231", "presentation": [ "http://www.vts.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "cik0001793497_DerivativeNotionalAmounts": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Nominal or face amount used to calculate payment on derivative.", "label": "Derivative Notional Amounts", "negatedLabel": "Notional Amount at Value" } } }, "localname": "DerivativeNotionalAmounts", "nsuri": "http://www.vts.com/20221231", "presentation": [ "http://www.vts.com/role/ScheduleofInvestmentsTable" ], "xbrltype": "monetaryItemType" }, "cik0001793497_DocumentAndEntityInformationAbstract": { "auth_ref": [], "localname": "DocumentAndEntityInformationAbstract", "nsuri": "http://www.vts.com/20221231", "xbrltype": "stringItemType" }, "cik0001793497_EmergingGrowthCompanyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for emerging growth company.", "label": "Emerging Growth Company Policy Text Block", "terseLabel": "Emerging growth company" } } }, "localname": "EmergingGrowthCompanyPolicyTextBlock", "nsuri": "http://www.vts.com/20221231", "presentation": [ "http://www.vts.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "cik0001793497_ExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Expenses Abstract", "terseLabel": "Expenses:" } } }, "localname": "ExpensesAbstract", "nsuri": "http://www.vts.com/20221231", "presentation": [ "http://www.vts.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "stringItemType" }, "cik0001793497_FinalNetAssetValueForFiscalPeriodPolcyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure of final net asset value for fiscal period.", "label": "Final Net Asset Value For Fiscal Period Polcy Text Block", "terseLabel": "Final Net Asset Value for Fiscal Period" } } }, "localname": "FinalNetAssetValueForFiscalPeriodPolcyTextBlock", "nsuri": "http://www.vts.com/20221231", "presentation": [ "http://www.vts.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "cik0001793497_FinancialHighlightsDetailsScheduleofshareoutstandingLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Financial Highlights (Details) - Schedule of share outstanding [Line Items]" } } }, "localname": "FinancialHighlightsDetailsScheduleofshareoutstandingLineItems", "nsuri": "http://www.vts.com/20221231", "presentation": [ "http://www.vts.com/role/ScheduleofshareoutstandingTable" ], "xbrltype": "stringItemType" }, "cik0001793497_FinancialHighlightsDetailsScheduleofshareoutstandingTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Financial Highlights (Details) - Schedule of share outstanding [Table]" } } }, "localname": "FinancialHighlightsDetailsScheduleofshareoutstandingTable", "nsuri": "http://www.vts.com/20221231", "presentation": [ "http://www.vts.com/role/ScheduleofshareoutstandingTable" ], "xbrltype": "stringItemType" }, "cik0001793497_FinancialHighlightsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Financial Highlights Line Items", "terseLabel": "Financial Highlights Disclosure [Abstract]" } } }, "localname": "FinancialHighlightsLineItems", "nsuri": "http://www.vts.com/20221231", "presentation": [ "http://www.vts.com/role/FinancialHighlights" ], "xbrltype": "stringItemType" }, "cik0001793497_FinancialHighlightsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Financial Highlights Table", "terseLabel": "Financial Highlights Disclosure [Abstract]" } } }, "localname": "FinancialHighlightsTable", "nsuri": "http://www.vts.com/20221231", "presentation": [ "http://www.vts.com/role/FinancialHighlights" ], "xbrltype": "stringItemType" }, "cik0001793497_FundSharesRedeemed": { "auth_ref": [], "calculation": { "http://www.vts.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Tha amount of Fund shares redeemed.", "label": "Fund Shares Redeemed", "terseLabel": "Fund shares redeemed" } } }, "localname": "FundSharesRedeemed", "nsuri": "http://www.vts.com/20221231", "presentation": [ "http://www.vts.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "cik0001793497_FundsAverageNetAssetsAnnually": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Funds Average Net Assets Annually", "terseLabel": "Fund\u2019s average net assets annually" } } }, "localname": "FundsAverageNetAssetsAnnually", "nsuri": "http://www.vts.com/20221231", "presentation": [ "http://www.vts.com/role/SignificantAccountingPoliciesDetails" ], "xbrltype": "percentItemType" }, "cik0001793497_FuturesContracts": { "auth_ref": [], "calculation": { "http://www.vts.com/role/ConsolidatedIncomeStatement": { "order": 2.0, "parentTag": "us-gaap_UnrealizedGainLossOnDerivatives", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of futures contracts.", "label": "Futures Contracts", "negatedLabel": "Futures" } } }, "localname": "FuturesContracts", "nsuri": "http://www.vts.com/20221231", "presentation": [ "http://www.vts.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "cik0001793497_FuturesContractsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Futures Contracts Member", "terseLabel": "Futures Contracts [Member]" } } }, "localname": "FuturesContractsMember", "nsuri": "http://www.vts.com/20221231", "presentation": [ "http://www.vts.com/role/ScheduleofvaluationofinvestmentsatusingthefairvaluehierarchyTable" ], "xbrltype": "domainItemType" }, "cik0001793497_FuturesContractsUnrealizedAppreciation": { "auth_ref": [], "calculation": { "http://www.vts.com/role/ConsolidatedIncomeStatement": { "order": 4.0, "parentTag": "us-gaap_UnrealizedGainLossOnDerivatives", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of futures contracts unrealized appreciation.", "label": "Futures Contracts Unrealized Appreciation", "negatedLabel": "Futures" } } }, "localname": "FuturesContractsUnrealizedAppreciation", "nsuri": "http://www.vts.com/20221231", "presentation": [ "http://www.vts.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "cik0001793497_GrossAmountsOfRecognizedAssetsPresentedInTheStatementsOfFinancialCondition": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of gross amounts of recognized assets presented.", "label": "Gross Amounts Of Recognized Assets Presented In The Statements Of Financial Condition", "terseLabel": "Gross Amounts of Recognized Assets presented in the Statements of Financial Condition" } } }, "localname": "GrossAmountsOfRecognizedAssetsPresentedInTheStatementsOfFinancialCondition", "nsuri": "http://www.vts.com/20221231", "presentation": [ "http://www.vts.com/role/ScheduleofpledgedbyfundsfairvaluesofderivativeinstrumentsTable" ], "xbrltype": "monetaryItemType" }, "cik0001793497_GrossRevenue": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of gross revenue.", "label": "Gross Revenue", "terseLabel": "Annual gross revenue" } } }, "localname": "GrossRevenue", "nsuri": "http://www.vts.com/20221231", "presentation": [ "http://www.vts.com/role/SignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "cik0001793497_IncomeAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Abstract", "terseLabel": "Income:" } } }, "localname": "IncomeAbstract", "nsuri": "http://www.vts.com/20221231", "presentation": [ "http://www.vts.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "stringItemType" }, "cik0001793497_IncreaseDecreaseInPayableToSponsor": { "auth_ref": [], "calculation": { "http://www.vts.com/role/ConsolidatedCashFlow": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Increase Decrease In Payable To Sponsor", "negatedLabel": "Increase (Decrease) in Payable to Sponsor" } } }, "localname": "IncreaseDecreaseInPayableToSponsor", "nsuri": "http://www.vts.com/20221231", "presentation": [ "http://www.vts.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "cik0001793497_IncreaseDecreaseInVariationMarginPayable": { "auth_ref": [], "calculation": { "http://www.vts.com/role/ConsolidatedCashFlow": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Increase decrease in variation margin payable.", "label": "Increase Decrease In Variation Margin Payable", "terseLabel": "Increase (Decrease) in Variation margin payable" } } }, "localname": "IncreaseDecreaseInVariationMarginPayable", "nsuri": "http://www.vts.com/20221231", "presentation": [ "http://www.vts.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "cik0001793497_IncreaseInLicensingAndRegistrationFeesPayable": { "auth_ref": [], "calculation": { "http://www.vts.com/role/ConsolidatedCashFlow": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Increase in licensing and registration fees payable.", "label": "Increase In Licensing And Registration Fees Payable", "terseLabel": "Increase (Decrease) in Licensing and registration fees payable" } } }, "localname": "IncreaseInLicensingAndRegistrationFeesPayable", "nsuri": "http://www.vts.com/20221231", "presentation": [ "http://www.vts.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "cik0001793497_IncreaseInProfessionalFeesPayable": { "auth_ref": [], "calculation": { "http://www.vts.com/role/ConsolidatedCashFlow": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Increase in professional fees payable.", "label": "Increase In Professional Fees Payable", "terseLabel": "Increase (Decrease) in Professional fees payable" } } }, "localname": "IncreaseInProfessionalFeesPayable", "nsuri": "http://www.vts.com/20221231", "presentation": [ "http://www.vts.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "cik0001793497_InvestmentCompanyTotalReturnMarketValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage increase (decrease) in fund market value, assuming reinvestment of dividends and capital gain distributions.", "label": "Investment Company Total Return Market Value", "terseLabel": "Total Return at Market Value" } } }, "localname": "InvestmentCompanyTotalReturnMarketValue", "nsuri": "http://www.vts.com/20221231", "presentation": [ "http://www.vts.com/role/ScheduleofshareoutstandingTable" ], "xbrltype": "percentItemType" }, "cik0001793497_InvestmentIncomeAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investment Income Abstract", "terseLabel": "INVESTMENT INCOME" } } }, "localname": "InvestmentIncomeAbstract", "nsuri": "http://www.vts.com/20221231", "presentation": [ "http://www.vts.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "stringItemType" }, "cik0001793497_InvestmentOwnedUnrecognizedUnrealizedDepreciations": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "This element represents the excess of the cost (face amount, notional amount) of an investment (security, contract) over its fair value which deficiency has not been recognized in earnings of the entity.", "label": "Investment Owned Unrecognized Unrealized Depreciations", "negatedLabel": "Unrealized Appreciation (Depreciation)" } } }, "localname": "InvestmentOwnedUnrecognizedUnrealizedDepreciations", "nsuri": "http://www.vts.com/20221231", "presentation": [ "http://www.vts.com/role/ScheduleofInvestmentsTable" ], "xbrltype": "monetaryItemType" }, "cik0001793497_InvestmentsDetailsScheduleofeffectofderivativeinstrumentsonthestatementofoperationsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investments (Details) - Schedule of effect of derivative instruments on the statement of operations [Line Items]" } } }, "localname": "InvestmentsDetailsScheduleofeffectofderivativeinstrumentsonthestatementofoperationsLineItems", "nsuri": "http://www.vts.com/20221231", "presentation": [ "http://www.vts.com/role/ScheduleofeffectofderivativeinstrumentsonthestatementofoperationsTable" ], "xbrltype": "stringItemType" }, "cik0001793497_InvestmentsDetailsScheduleofeffectofderivativeinstrumentsonthestatementofoperationsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investments (Details) - Schedule of effect of derivative instruments on the statement of operations [Table]" } } }, "localname": "InvestmentsDetailsScheduleofeffectofderivativeinstrumentsonthestatementofoperationsTable", "nsuri": "http://www.vts.com/20221231", "presentation": [ "http://www.vts.com/role/ScheduleofeffectofderivativeinstrumentsonthestatementofoperationsTable" ], "xbrltype": "stringItemType" }, "cik0001793497_InvestmentsDetailsScheduleofgrossamountsnotoffsetinthestatementsoffinancialconditionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investments (Details) - Schedule of gross amounts not offset in the statements of financial condition [Line Items]" } } }, "localname": "InvestmentsDetailsScheduleofgrossamountsnotoffsetinthestatementsoffinancialconditionLineItems", "nsuri": "http://www.vts.com/20221231", "presentation": [ "http://www.vts.com/role/ScheduleofgrossamountsnotoffsetinthestatementsoffinancialconditionTable" ], "xbrltype": "stringItemType" }, "cik0001793497_InvestmentsDetailsScheduleofgrossamountsnotoffsetinthestatementsoffinancialconditionTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investments (Details) - Schedule of gross amounts not offset in the statements of financial condition [Table]" } } }, "localname": "InvestmentsDetailsScheduleofgrossamountsnotoffsetinthestatementsoffinancialconditionTable", "nsuri": "http://www.vts.com/20221231", "presentation": [ "http://www.vts.com/role/ScheduleofgrossamountsnotoffsetinthestatementsoffinancialconditionTable" ], "xbrltype": "stringItemType" }, "cik0001793497_InvestmentsDetailsScheduleofpledgedbyfundsfairvaluesofderivativeinstrumentsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investments (Details) - Schedule of pledged by funds fair values of derivative instruments [Line Items]" } } }, "localname": "InvestmentsDetailsScheduleofpledgedbyfundsfairvaluesofderivativeinstrumentsLineItems", "nsuri": "http://www.vts.com/20221231", "presentation": [ "http://www.vts.com/role/ScheduleofpledgedbyfundsfairvaluesofderivativeinstrumentsTable" ], "xbrltype": "stringItemType" }, "cik0001793497_InvestmentsDetailsScheduleofpledgedbyfundsfairvaluesofderivativeinstrumentsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investments (Details) - Schedule of pledged by funds fair values of derivative instruments [Table]" } } }, "localname": "InvestmentsDetailsScheduleofpledgedbyfundsfairvaluesofderivativeinstrumentsTable", "nsuri": "http://www.vts.com/20221231", "presentation": [ "http://www.vts.com/role/ScheduleofpledgedbyfundsfairvaluesofderivativeinstrumentsTable" ], "xbrltype": "stringItemType" }, "cik0001793497_LicensingAndRegistrationFeesPayable": { "auth_ref": [], "calculation": { "http://www.vts.com/role/ConsolidatedBalanceSheet": { "order": 6.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of licensing and registration fees payable.", "label": "Licensing And Registration Fees Payable", "terseLabel": "Licensing and registration fees payable" } } }, "localname": "LicensingAndRegistrationFeesPayable", "nsuri": "http://www.vts.com/20221231", "presentation": [ "http://www.vts.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "cik0001793497_MarketValuePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share excess of market value per share.", "label": "Market Value Per Share", "terseLabel": "Market Value Per Share, at December 31, 2022" } } }, "localname": "MarketValuePerShare", "nsuri": "http://www.vts.com/20221231", "presentation": [ "http://www.vts.com/role/ScheduleofshareoutstandingTable" ], "xbrltype": "perShareItemType" }, "cik0001793497_MoneyMarketFundPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Money market fund, percentage", "label": "Money Market Fund Percentage", "terseLabel": "Money market fund, percentage" } } }, "localname": "MoneyMarketFundPercentage", "nsuri": "http://www.vts.com/20221231", "presentation": [ "http://www.vts.com/role/ScheduleofInvestmentsTable_Parentheticals" ], "xbrltype": "percentItemType" }, "cik0001793497_NAVCalculationDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Date the NAV calculation date.", "label": "NAVCalculation Date", "terseLabel": "NAV Calculation Date" } } }, "localname": "NAVCalculationDate", "nsuri": "http://www.vts.com/20221231", "presentation": [ "http://www.vts.com/role/ScheduleofcutofftimesandthetimesofthecalculationofthefundsTable" ], "xbrltype": "dateItemType" }, "cik0001793497_NAVCalculationTimeESTDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "NAV Calculation Time (EST), description.", "label": "NAVCalculation Time ESTDescription", "terseLabel": "NAV Calculation Time (EST)" } } }, "localname": "NAVCalculationTimeESTDescription", "nsuri": "http://www.vts.com/20221231", "presentation": [ "http://www.vts.com/role/ScheduleofcutofftimesandthetimesofthecalculationofthefundsTable" ], "xbrltype": "stringItemType" }, "cik0001793497_NetAmountsOfAssetsPresentedInTheStatementsOfFinancialCondition": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of net assets presented.", "label": "Net Amounts Of Assets Presented In The Statements Of Financial Condition", "terseLabel": "Net Amounts of Assets presented in the Statements of Financial Condition" } } }, "localname": "NetAmountsOfAssetsPresentedInTheStatementsOfFinancialCondition", "nsuri": "http://www.vts.com/20221231", "presentation": [ "http://www.vts.com/role/ScheduleofpledgedbyfundsfairvaluesofderivativeinstrumentsTable" ], "xbrltype": "monetaryItemType" }, "cik0001793497_NetAssetValueAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Asset Value Abstract", "terseLabel": "NET ASSET VALUE:" } } }, "localname": "NetAssetValueAbstract", "nsuri": "http://www.vts.com/20221231", "presentation": [ "http://www.vts.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "stringItemType" }, "cik0001793497_NetAssetValueAbstract1": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Asset Value Abstract1", "terseLabel": "NET ASSET VALUE:" } } }, "localname": "NetAssetValueAbstract1", "nsuri": "http://www.vts.com/20221231", "presentation": [ "http://www.vts.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "stringItemType" }, "cik0001793497_NetAssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Assets Abstract", "terseLabel": "NET ASSETS" } } }, "localname": "NetAssetsAbstract", "nsuri": "http://www.vts.com/20221231", "presentation": [ "http://www.vts.com/role/ConsolidatedIncomeStatement0" ], "xbrltype": "stringItemType" }, "cik0001793497_NetAssetsConsistOfAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Assets Consist Of Abstract", "terseLabel": "NET ASSETS CONSIST OF:" } } }, "localname": "NetAssetsConsistOfAbstract", "nsuri": "http://www.vts.com/20221231", "presentation": [ "http://www.vts.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "stringItemType" }, "cik0001793497_NetChangeInUnrealizedAppreciationOfAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Change In Unrealized Appreciation Of Abstract", "terseLabel": "Net change in unrealized appreciation of:" } } }, "localname": "NetChangeInUnrealizedAppreciationOfAbstract", "nsuri": "http://www.vts.com/20221231", "presentation": [ "http://www.vts.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "stringItemType" }, "cik0001793497_NetChangeInUnrealizedAppreciationdepreciationOfInvestmentsAndFuturesContracts": { "auth_ref": [], "calculation": { "http://www.vts.com/role/ConsolidatedIncomeStatement0": { "order": 3.0, "parentTag": "us-gaap_InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrealized gain (loss) on investment.", "label": "Net Change In Unrealized Appreciationdepreciation Of Investments And Futures Contracts", "terseLabel": "Net change in unrealized appreciation (depreciation) of investments and futures contracts" } } }, "localname": "NetChangeInUnrealizedAppreciationdepreciationOfInvestmentsAndFuturesContracts", "nsuri": "http://www.vts.com/20221231", "presentation": [ "http://www.vts.com/role/ConsolidatedIncomeStatement0" ], "xbrltype": "monetaryItemType" }, "cik0001793497_NetIncreaseInNetAssetsFromCapitalShareTransactions": { "auth_ref": [], "calculation": { "http://www.vts.com/role/ConsolidatedIncomeStatement0": { "order": 2.0, "parentTag": "us-gaap_InvestmentCompanyNetAssetsPeriodIncreaseDecrease", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of net increase in net assets from capital share transactions.", "label": "Net Increase In Net Assets From Capital Share Transactions", "totalLabel": "Net increase in net assets from capital share transactions" } } }, "localname": "NetIncreaseInNetAssetsFromCapitalShareTransactions", "nsuri": "http://www.vts.com/20221231", "presentation": [ "http://www.vts.com/role/ConsolidatedIncomeStatement0" ], "xbrltype": "monetaryItemType" }, "cik0001793497_NetRealizedAndUnrealizedGainLossOnInvestmentsAndFuturesContracts": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Amount of realized and unrealized gain (loss) on investment, and future contracts.", "label": "Net Realized And Unrealized Gain Loss On Investments And Futures Contracts", "terseLabel": "Net Realized and Unrealized Gain (Loss) on Investments and Futures Contracts" } } }, "localname": "NetRealizedAndUnrealizedGainLossOnInvestmentsAndFuturesContracts", "nsuri": "http://www.vts.com/20221231", "presentation": [ "http://www.vts.com/role/ScheduleofshareoutstandingTable" ], "xbrltype": "perShareItemType" }, "cik0001793497_NetRealizedGainOnAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Realized Gain On Abstract", "terseLabel": "Net realized gain on:" } } }, "localname": "NetRealizedGainOnAbstract", "nsuri": "http://www.vts.com/20221231", "presentation": [ "http://www.vts.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "stringItemType" }, "cik0001793497_NetRealizedGainlossOnInvestmentsAndFuturesContracts": { "auth_ref": [], "calculation": { "http://www.vts.com/role/ConsolidatedIncomeStatement0": { "order": 2.0, "parentTag": "us-gaap_InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of realized gain (loss) on investment.", "label": "Net Realized Gainloss On Investments And Futures Contracts", "terseLabel": "Net realized gain (loss) on investments and futures contracts" } } }, "localname": "NetRealizedGainlossOnInvestmentsAndFuturesContracts", "nsuri": "http://www.vts.com/20221231", "presentation": [ "http://www.vts.com/role/ConsolidatedIncomeStatement0" ], "xbrltype": "monetaryItemType" }, "cik0001793497_NonaffiliatesExceeded": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of non-affiliates exceeded.", "label": "Nonaffiliates Exceeded", "terseLabel": "Non-affiliates exceeded" } } }, "localname": "NonaffiliatesExceeded", "nsuri": "http://www.vts.com/20221231", "presentation": [ "http://www.vts.com/role/SignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "cik0001793497_NonconvertibleDebtSecurities": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of non-convertible debt securities.", "label": "Nonconvertible Debt Securities", "terseLabel": "Non-convertible debt securities" } } }, "localname": "NonconvertibleDebtSecurities", "nsuri": "http://www.vts.com/20221231", "presentation": [ "http://www.vts.com/role/SignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "cik0001793497_NumberOfContracts": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of contracts.", "label": "Number Of Contracts", "terseLabel": "Number of Contracts" } } }, "localname": "NumberOfContracts", "nsuri": "http://www.vts.com/20221231", "presentation": [ "http://www.vts.com/role/ScheduleofInvestmentsTable" ], "xbrltype": "monetaryItemType" }, "cik0001793497_OfferingCostsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Offering Costs [Abstract]" } } }, "localname": "OfferingCostsAbstract", "nsuri": "http://www.vts.com/20221231", "xbrltype": "stringItemType" }, "cik0001793497_OfferingCostsTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure of offering costs .", "label": "Offering Costs Text Block", "terseLabel": "OFFERING COSTS" } } }, "localname": "OfferingCostsTextBlock", "nsuri": "http://www.vts.com/20221231", "presentation": [ "http://www.vts.com/role/OfferingCosts" ], "xbrltype": "textBlockItemType" }, "cik0001793497_OneShortVIXFuturesETFMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "One Short VIXFutures ETFMember", "netLabel": "-1x Short VIX Futures ETF [Member]", "terseLabel": "-1x Short VIX Futures ETF", "verboseLabel": "1x Short VIX Futures ETF" } } }, "localname": "OneShortVIXFuturesETFMember", "nsuri": "http://www.vts.com/20221231", "presentation": [ "http://www.vts.com/role/ConsolidatedBalanceSheet", "http://www.vts.com/role/ConsolidatedCashFlow", "http://www.vts.com/role/ConsolidatedIncomeStatement", "http://www.vts.com/role/ConsolidatedIncomeStatement0", "http://www.vts.com/role/DocumentAndEntityInformation", "http://www.vts.com/role/ScheduleofcutofftimesandthetimesofthecalculationofthefundsTable", "http://www.vts.com/role/ScheduleoffairvalueofderivativeinstrumentsTable", "http://www.vts.com/role/ScheduleofgrossamountsnotoffsetinthestatementsoffinancialconditionTable", "http://www.vts.com/role/ScheduleofpledgedbyfundsfairvaluesofderivativeinstrumentsTable", "http://www.vts.com/role/ScheduleofshareoutstandingTable", "http://www.vts.com/role/ScheduleoftransactionfeesTable", "http://www.vts.com/role/ScheduleofvaluationofinvestmentsatusingthefairvaluehierarchyTable" ], "xbrltype": "domainItemType" }, "cik0001793497_OnexShortVIXFuturesETFMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Onex Short VIXFutures ETFMember", "terseLabel": "-1x Short VIX Futures ETF [Member]" } } }, "localname": "OnexShortVIXFuturesETFMember", "nsuri": "http://www.vts.com/20221231", "presentation": [ "http://www.vts.com/role/ScheduleofInvestmentsTable", "http://www.vts.com/role/ScheduleofInvestmentsTable_Parentheticals", "http://www.vts.com/role/ScheduleofeffectofderivativeinstrumentsonthestatementofoperationsTable" ], "xbrltype": "domainItemType" }, "cik0001793497_OperationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operations Abstract", "terseLabel": "OPERATIONS" } } }, "localname": "OperationsAbstract", "nsuri": "http://www.vts.com/20221231", "presentation": [ "http://www.vts.com/role/ConsolidatedIncomeStatement0" ], "xbrltype": "stringItemType" }, "cik0001793497_OtherAssetsInExcessOfLiabilitiesPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Other assets in excess of liabilities, percentage.", "label": "Other Assets In Excess Of Liabilities Percentage", "terseLabel": "Other assets in excess of liabilities, percentage" } } }, "localname": "OtherAssetsInExcessOfLiabilitiesPercentage", "nsuri": "http://www.vts.com/20221231", "presentation": [ "http://www.vts.com/role/ScheduleofInvestmentsTable_Parentheticals" ], "xbrltype": "percentItemType" }, "cik0001793497_ProceedsFromSaleOfUnits": { "auth_ref": [], "calculation": { "http://www.vts.com/role/ConsolidatedCashFlow": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Proceeds from sale of units.", "label": "Proceeds From Sale Of Units", "terseLabel": "Proceeds from shares sold, net of cost from shares purchased" } } }, "localname": "ProceedsFromSaleOfUnits", "nsuri": "http://www.vts.com/20221231", "presentation": [ "http://www.vts.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "cik0001793497_ProceedsFromSalesOrMaturitiesOfInvestments": { "auth_ref": [], "calculation": { "http://www.vts.com/role/ConsolidatedCashFlow": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Proceeds from sales or maturities of investments.", "label": "Proceeds From Sales Or Maturities Of Investments", "terseLabel": "Proceeds from sales or maturities of investments held" } } }, "localname": "ProceedsFromSalesOrMaturitiesOfInvestments", "nsuri": "http://www.vts.com/20221231", "presentation": [ "http://www.vts.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "cik0001793497_PurchasesOfInvestments": { "auth_ref": [], "calculation": { "http://www.vts.com/role/ConsolidatedCashFlow": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the purchase of all investments during the period.", "label": "Purchases Of Investments", "negatedLabel": "Purchase of investments" } } }, "localname": "PurchasesOfInvestments", "nsuri": "http://www.vts.com/20221231", "presentation": [ "http://www.vts.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "cik0001793497_RatiosToAverageNetAssets6Abstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Ratios To Average Net Assets6 Abstract", "terseLabel": "Ratios to Average Net Assets: (6)" } } }, "localname": "RatiosToAverageNetAssets6Abstract", "nsuri": "http://www.vts.com/20221231", "presentation": [ "http://www.vts.com/role/ScheduleofshareoutstandingTable" ], "xbrltype": "stringItemType" }, "cik0001793497_ReceivableForSharesSold": { "auth_ref": [], "calculation": { "http://www.vts.com/role/ConsolidatedBalanceSheet": { "order": 7.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "It represent receivable for shares sold.", "label": "Receivable For Shares Sold", "terseLabel": "Receivable for shares sold" } } }, "localname": "ReceivableForSharesSold", "nsuri": "http://www.vts.com/20221231", "presentation": [ "http://www.vts.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "cik0001793497_RelevantBenchmark": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of relevant benchmark.", "label": "Relevant Benchmark", "terseLabel": "Relevant benchmark percentage" } } }, "localname": "RelevantBenchmark", "nsuri": "http://www.vts.com/20221231", "presentation": [ "http://www.vts.com/role/RiskDetails" ], "xbrltype": "percentItemType" }, "cik0001793497_RiskLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Risk Line Items", "terseLabel": "Risk [Abstract]" } } }, "localname": "RiskLineItems", "nsuri": "http://www.vts.com/20221231", "presentation": [ "http://www.vts.com/role/Risk" ], "xbrltype": "stringItemType" }, "cik0001793497_RiskTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Risk [Table]" } } }, "localname": "RiskTable", "nsuri": "http://www.vts.com/20221231", "presentation": [ "http://www.vts.com/role/Risk" ], "xbrltype": "stringItemType" }, "cik0001793497_SVIXMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SVIXMember", "terseLabel": "SVIX [Member]" } } }, "localname": "SVIXMember", "nsuri": "http://www.vts.com/20221231", "presentation": [ "http://www.vts.com/role/AgreementsDetails", "http://www.vts.com/role/SignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "cik0001793497_ScheduleOfCutOffTimesAndTheTimesOfTheCalculationOfTheFundsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Cut Off Times And The Times Of The Calculation Of The Funds Abstract" } } }, "localname": "ScheduleOfCutOffTimesAndTheTimesOfTheCalculationOfTheFundsAbstract", "nsuri": "http://www.vts.com/20221231", "xbrltype": "stringItemType" }, "cik0001793497_ScheduleOfCutoffTimesAndTimesOfCalculationTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure of cut-off times and times of calculation.", "label": "Schedule Of Cutoff Times And Times Of Calculation Table Text Block", "terseLabel": "Schedule of cut-off times and the times of the calculation of the funds" } } }, "localname": "ScheduleOfCutoffTimesAndTimesOfCalculationTableTextBlock", "nsuri": "http://www.vts.com/20221231", "presentation": [ "http://www.vts.com/role/SignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "cik0001793497_ScheduleOfEffectOfDerivativeInstrumentsOnTheStatementOfOperationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Effect Of Derivative Instruments On The Statement Of Operations Abstract" } } }, "localname": "ScheduleOfEffectOfDerivativeInstrumentsOnTheStatementOfOperationsAbstract", "nsuri": "http://www.vts.com/20221231", "xbrltype": "stringItemType" }, "cik0001793497_ScheduleOfFairValueOfDerivativeInstrumentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Fair Value Of Derivative Instruments Abstract" } } }, "localname": "ScheduleOfFairValueOfDerivativeInstrumentsAbstract", "nsuri": "http://www.vts.com/20221231", "xbrltype": "stringItemType" }, "cik0001793497_ScheduleOfGrossAmountsNotOffsetInTheStatementsOfFinancialConditionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Gross Amounts Not Offset In The Statements Of Financial Condition Abstract" } } }, "localname": "ScheduleOfGrossAmountsNotOffsetInTheStatementsOfFinancialConditionAbstract", "nsuri": "http://www.vts.com/20221231", "xbrltype": "stringItemType" }, "cik0001793497_ScheduleOfPledgedByFundsFairValuesOfDerivativeInstrumentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Pledged By Funds Fair Values Of Derivative Instruments Abstract" } } }, "localname": "ScheduleOfPledgedByFundsFairValuesOfDerivativeInstrumentsAbstract", "nsuri": "http://www.vts.com/20221231", "xbrltype": "stringItemType" }, "cik0001793497_ScheduleOfPledgedByFundsFairValuesOfDerivativeInstrumentsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure of pledged by funds fair values of derivative instruments.", "label": "Schedule Of Pledged By Funds Fair Values Of Derivative Instruments Table Text Block", "terseLabel": "Schedule of pledged by funds fair values of derivative instruments" } } }, "localname": "ScheduleOfPledgedByFundsFairValuesOfDerivativeInstrumentsTableTextBlock", "nsuri": "http://www.vts.com/20221231", "presentation": [ "http://www.vts.com/role/InvestmentsTables" ], "xbrltype": "textBlockItemType" }, "cik0001793497_ScheduleOfShareOutstandingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Share Outstanding Abstract" } } }, "localname": "ScheduleOfShareOutstandingAbstract", "nsuri": "http://www.vts.com/20221231", "xbrltype": "stringItemType" }, "cik0001793497_ScheduleOfShareOutstandingTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure of share outstanding.", "label": "Schedule Of Share Outstanding Table Text Block", "terseLabel": "Schedule of share outstanding" } } }, "localname": "ScheduleOfShareOutstandingTableTextBlock", "nsuri": "http://www.vts.com/20221231", "presentation": [ "http://www.vts.com/role/FinancialHighlightsTables" ], "xbrltype": "textBlockItemType" }, "cik0001793497_ScheduleOfTransactionFeesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Transaction Fees Abstract" } } }, "localname": "ScheduleOfTransactionFeesAbstract", "nsuri": "http://www.vts.com/20221231", "xbrltype": "stringItemType" }, "cik0001793497_ScheduleOfTransactionFeesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure of transaction fees.", "label": "Schedule Of Transaction Fees Table Text Block", "terseLabel": "Schedule of transaction fees" } } }, "localname": "ScheduleOfTransactionFeesTableTextBlock", "nsuri": "http://www.vts.com/20221231", "presentation": [ "http://www.vts.com/role/CreationandRedemptionofCreationUnitsTables" ], "xbrltype": "textBlockItemType" }, "cik0001793497_ScheduleOfValuationOfInvestmentsAtUsingTheFairValueHierarchyAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Valuation Of Investments At Using The Fair Value Hierarchy Abstract" } } }, "localname": "ScheduleOfValuationOfInvestmentsAtUsingTheFairValueHierarchyAbstract", "nsuri": "http://www.vts.com/20221231", "xbrltype": "stringItemType" }, "cik0001793497_SharesSoldNetOfSharesRedeemedinDollarsPerShare": { "auth_ref": [], "calculation": { "http://www.vts.com/role/ConsolidatedIncomeStatement0": { "order": 2.0, "parentTag": "cik0001793497_NetIncreaseInNetAssetsFromCapitalShareTransactions", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of shares sold, net of shares redeemed.", "label": "Shares Sold Net Of Shares Redeemedin Dollars Per Share", "negatedLabel": "Shares redeemed" } } }, "localname": "SharesSoldNetOfSharesRedeemedinDollarsPerShare", "nsuri": "http://www.vts.com/20221231", "presentation": [ "http://www.vts.com/role/ConsolidatedIncomeStatement0" ], "xbrltype": "monetaryItemType" }, "cik0001793497_SharesSoldinShares": { "auth_ref": [], "calculation": { "http://www.vts.com/role/ConsolidatedIncomeStatement0": { "order": 1.0, "parentTag": "cik0001793497_NetIncreaseInNetAssetsFromCapitalShareTransactions", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Shares Soldin Shares", "negatedLabel": "Shares sold" } } }, "localname": "SharesSoldinShares", "nsuri": "http://www.vts.com/20221231", "presentation": [ "http://www.vts.com/role/ConsolidatedIncomeStatement0" ], "xbrltype": "monetaryItemType" }, "cik0001793497_ShortTermInvestmentsRealized": { "auth_ref": [], "calculation": { "http://www.vts.com/role/ConsolidatedIncomeStatement": { "order": 1.0, "parentTag": "us-gaap_UnrealizedGainLossOnDerivatives", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.", "label": "Short Term Investments Realized", "negatedLabel": "Short Term Investments" } } }, "localname": "ShortTermInvestmentsRealized", "nsuri": "http://www.vts.com/20221231", "presentation": [ "http://www.vts.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "cik0001793497_ShortTermInvestmentsUnrealized": { "auth_ref": [], "calculation": { "http://www.vts.com/role/ConsolidatedIncomeStatement": { "order": 3.0, "parentTag": "us-gaap_UnrealizedGainLossOnDerivatives", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.", "label": "Short Term Investments Unrealized", "negatedLabel": "Short Term Investments" } } }, "localname": "ShortTermInvestmentsUnrealized", "nsuri": "http://www.vts.com/20221231", "presentation": [ "http://www.vts.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "cik0001793497_SignificantAccountingPoliciesDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Significant Accounting Policies (Details) [Line Items]" } } }, "localname": "SignificantAccountingPoliciesDetailsLineItems", "nsuri": "http://www.vts.com/20221231", "presentation": [ "http://www.vts.com/role/SignificantAccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "cik0001793497_SignificantAccountingPoliciesDetailsScheduleofcutofftimesandthetimesofthecalculationofthefundsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Significant Accounting Policies (Details) - Schedule of cut-off times and the times of the calculation of the funds [Line Items]" } } }, "localname": "SignificantAccountingPoliciesDetailsScheduleofcutofftimesandthetimesofthecalculationofthefundsLineItems", "nsuri": "http://www.vts.com/20221231", "presentation": [ "http://www.vts.com/role/ScheduleofcutofftimesandthetimesofthecalculationofthefundsTable" ], "xbrltype": "stringItemType" }, "cik0001793497_SignificantAccountingPoliciesDetailsScheduleofcutofftimesandthetimesofthecalculationofthefundsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Significant Accounting Policies (Details) - Schedule of cut-off times and the times of the calculation of the funds [Table]" } } }, "localname": "SignificantAccountingPoliciesDetailsScheduleofcutofftimesandthetimesofthecalculationofthefundsTable", "nsuri": "http://www.vts.com/20221231", "presentation": [ "http://www.vts.com/role/ScheduleofcutofftimesandthetimesofthecalculationofthefundsTable" ], "xbrltype": "stringItemType" }, "cik0001793497_SignificantAccountingPoliciesDetailsScheduleofvaluationofinvestmentsatusingthefairvaluehierarchyLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Significant Accounting Policies (Details) - Schedule of valuation of investments at using the fair value hierarchy [Line Items]" } } }, "localname": "SignificantAccountingPoliciesDetailsScheduleofvaluationofinvestmentsatusingthefairvaluehierarchyLineItems", "nsuri": "http://www.vts.com/20221231", "presentation": [ "http://www.vts.com/role/ScheduleofvaluationofinvestmentsatusingthefairvaluehierarchyTable" ], "xbrltype": "stringItemType" }, "cik0001793497_SignificantAccountingPoliciesDetailsScheduleofvaluationofinvestmentsatusingthefairvaluehierarchyTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Significant Accounting Policies (Details) - Schedule of valuation of investments at using the fair value hierarchy [Table]" } } }, "localname": "SignificantAccountingPoliciesDetailsScheduleofvaluationofinvestmentsatusingthefairvaluehierarchyTable", "nsuri": "http://www.vts.com/20221231", "presentation": [ "http://www.vts.com/role/ScheduleofvaluationofinvestmentsatusingthefairvaluehierarchyTable" ], "xbrltype": "stringItemType" }, "cik0001793497_SignificantAccountingPoliciesDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Significant Accounting Policies (Details) [Table]" } } }, "localname": "SignificantAccountingPoliciesDetailsTable", "nsuri": "http://www.vts.com/20221231", "presentation": [ "http://www.vts.com/role/SignificantAccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "cik0001793497_StatementsOfCashFlowsPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure of statements of cash flows.", "label": "Statements Of Cash Flows Policy Text Block", "terseLabel": "Statements of Cash Flows" } } }, "localname": "StatementsOfCashFlowsPolicyTextBlock", "nsuri": "http://www.vts.com/20221231", "presentation": [ "http://www.vts.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "cik0001793497_SubadvisoryFeeRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of sub-advisory fee rate.", "label": "Subadvisory Fee Rate", "terseLabel": "Sub-advisory fee rate" } } }, "localname": "SubadvisoryFeeRate", "nsuri": "http://www.vts.com/20221231", "presentation": [ "http://www.vts.com/role/AgreementsDetails" ], "xbrltype": "percentItemType" }, "cik0001793497_TotalNetAssetsPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Total net assets, percentage.", "label": "Total Net Assets Percentage", "totalLabel": "Total net assets, percentage" } } }, "localname": "TotalNetAssetsPercentage", "nsuri": "http://www.vts.com/20221231", "presentation": [ "http://www.vts.com/role/ScheduleofInvestmentsTable_Parentheticals" ], "xbrltype": "percentItemType" }, "cik0001793497_TotalTrust": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Total Trust amount.", "label": "Total Trust", "terseLabel": "Total Trust" } } }, "localname": "TotalTrust", "nsuri": "http://www.vts.com/20221231", "presentation": [ "http://www.vts.com/role/ScheduleoffairvalueofderivativeinstrumentsTable" ], "xbrltype": "monetaryItemType" }, "cik0001793497_TwoXLongVIXFuturesETFMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Two XLong VIXFutures ETFMember", "terseLabel": "2x Long VIX Futures ETF", "verboseLabel": "2x Long VIX Futures ETF [Member]" } } }, "localname": "TwoXLongVIXFuturesETFMember", "nsuri": "http://www.vts.com/20221231", "presentation": [ "http://www.vts.com/role/ConsolidatedIncomeStatement", "http://www.vts.com/role/ScheduleofeffectofderivativeinstrumentsonthestatementofoperationsTable" ], "xbrltype": "domainItemType" }, "cik0001793497_TwoxLongVIXFuturesETFMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Twox Long VIXFutures ETFMember", "terseLabel": "2x Long VIX Futures ETF", "verboseLabel": "2x Long VIX Futures ETF [Member]" } } }, "localname": "TwoxLongVIXFuturesETFMember", "nsuri": "http://www.vts.com/20221231", "presentation": [ "http://www.vts.com/role/ConsolidatedBalanceSheet", "http://www.vts.com/role/ConsolidatedCashFlow", "http://www.vts.com/role/ConsolidatedIncomeStatement0", "http://www.vts.com/role/DocumentAndEntityInformation", "http://www.vts.com/role/ScheduleofInvestmentsTable", "http://www.vts.com/role/ScheduleofInvestmentsTable_Parentheticals", "http://www.vts.com/role/ScheduleofcutofftimesandthetimesofthecalculationofthefundsTable", "http://www.vts.com/role/ScheduleoffairvalueofderivativeinstrumentsTable", "http://www.vts.com/role/ScheduleofgrossamountsnotoffsetinthestatementsoffinancialconditionTable", "http://www.vts.com/role/ScheduleofpledgedbyfundsfairvaluesofderivativeinstrumentsTable", "http://www.vts.com/role/ScheduleofshareoutstandingTable", "http://www.vts.com/role/ScheduleoftransactionfeesTable", "http://www.vts.com/role/ScheduleofvaluationofinvestmentsatusingthefairvaluehierarchyTable" ], "xbrltype": "domainItemType" }, "cik0001793497_UVIXMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "UVIXMember", "terseLabel": "UVIX [Member]" } } }, "localname": "UVIXMember", "nsuri": "http://www.vts.com/20221231", "presentation": [ "http://www.vts.com/role/AgreementsDetails", "http://www.vts.com/role/SignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "cik0001793497_UnrealizedAppreciationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Unrealized Appreciation Member", "terseLabel": "Unrealized Appreciation [Member]" } } }, "localname": "UnrealizedAppreciationMember", "nsuri": "http://www.vts.com/20221231", "presentation": [ "http://www.vts.com/role/ScheduleoffairvalueofderivativeinstrumentsTable" ], "xbrltype": "domainItemType" }, "cik0001793497_VariationMarginReceivable": { "auth_ref": [], "calculation": { "http://www.vts.com/role/ConsolidatedBalanceSheet": { "order": 8.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of variation margin receivable.", "label": "Variation Margin Receivable", "terseLabel": "Variation margin receivable" } } }, "localname": "VariationMarginReceivable", "nsuri": "http://www.vts.com/20221231", "presentation": [ "http://www.vts.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.vts.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_AuditorFirmId": { "auth_ref": [ "r225", "r226", "r227" ], "lang": { "en-us": { "role": { "documentation": "PCAOB issued Audit Firm Identifier", "label": "Auditor Firm ID", "terseLabel": "Auditor Firm ID" } } }, "localname": "AuditorFirmId", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.vts.com/role/DocumentAndEntityInformation" ], "xbrltype": "nonemptySequenceNumberItemType" }, "dei_AuditorLocation": { "auth_ref": [ "r225", "r226", "r227" ], "lang": { "en-us": { "role": { "label": "Auditor Location", "terseLabel": "Auditor Location" } } }, "localname": "AuditorLocation", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.vts.com/role/DocumentAndEntityInformation" ], "xbrltype": "internationalNameItemType" }, "dei_AuditorName": { "auth_ref": [ "r225", "r226", "r227" ], "lang": { "en-us": { "role": { "label": "Auditor Name", "terseLabel": "Auditor Name" } } }, "localname": "AuditorName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.vts.com/role/DocumentAndEntityInformation" ], "xbrltype": "internationalNameItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.vts.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date", "terseLabel": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.vts.com/role/DocumentAndEntityInformation" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r225", "r226", "r227" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report", "terseLabel": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.vts.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus", "terseLabel": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.vts.com/role/DocumentAndEntityInformation" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus", "terseLabel": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.vts.com/role/DocumentAndEntityInformation" ], "xbrltype": "gYearItemType" }, "dei_DocumentInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "localname": "DocumentInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.vts.com/role/DocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_DocumentInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package." } } }, "localname": "DocumentInformationTable", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.vts.com/role/DocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.vts.com/role/DocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r228" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report", "terseLabel": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.vts.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.vts.com/role/DocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.vts.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two", "terseLabel": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.vts.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.vts.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.vts.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.vts.com/role/DocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r223" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.vts.com/role/DocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding", "terseLabel": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.vts.com/role/DocumentAndEntityInformation" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status", "terseLabel": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.vts.com/role/DocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.", "label": "Entity [Domain]" } } }, "localname": "EntityDomain", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.vts.com/role/DocumentAndEntityInformation", "http://www.vts.com/role/ScheduleofInvestmentsTable" ], "xbrltype": "domainItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r223" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.vts.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r231" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Entity Ex Transition Period", "terseLabel": "Entity Ex Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.vts.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.vts.com/role/DocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r223" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category", "terseLabel": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.vts.com/role/DocumentAndEntityInformation" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.vts.com/role/DocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r229" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current", "terseLabel": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.vts.com/role/DocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float", "terseLabel": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.vts.com/role/DocumentAndEntityInformation" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r223" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.vts.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r223" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company", "terseLabel": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.vts.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r223" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business", "terseLabel": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.vts.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r223" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.vts.com/role/DocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers", "terseLabel": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.vts.com/role/DocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r230" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer", "terseLabel": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.vts.com/role/DocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_IcfrAuditorAttestationFlag": { "auth_ref": [ "r225", "r226", "r227" ], "lang": { "en-us": { "role": { "label": "ICFR Auditor Attestation Flag", "terseLabel": "ICFR Auditor Attestation Flag" } } }, "localname": "IcfrAuditorAttestationFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.vts.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_LegalEntityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The set of legal entities associated with a report.", "label": "Legal Entity [Axis]" } } }, "localname": "LegalEntityAxis", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.vts.com/role/DocumentAndEntityInformation", "http://www.vts.com/role/ScheduleofInvestmentsTable" ], "xbrltype": "stringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.vts.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r222" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.vts.com/role/DocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r224" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.vts.com/role/DocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.vts.com/role/DocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "srt_ConsolidatedEntitiesAxis": { "auth_ref": [ "r93", "r160", "r161", "r162", "r163", "r176", "r209", "r247", "r250", "r251" ], "lang": { "en-us": { "role": { "label": "Consolidated Entities [Axis]" } } }, "localname": "ConsolidatedEntitiesAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.vts.com/role/ConsolidatedBalanceSheet", "http://www.vts.com/role/ConsolidatedCashFlow", "http://www.vts.com/role/ConsolidatedIncomeStatement", "http://www.vts.com/role/ConsolidatedIncomeStatement0", "http://www.vts.com/role/ScheduleofInvestmentsTable", "http://www.vts.com/role/ScheduleofInvestmentsTable_Parentheticals", "http://www.vts.com/role/ScheduleofcutofftimesandthetimesofthecalculationofthefundsTable", "http://www.vts.com/role/ScheduleofeffectofderivativeinstrumentsonthestatementofoperationsTable", "http://www.vts.com/role/ScheduleoffairvalueofderivativeinstrumentsTable", "http://www.vts.com/role/ScheduleofgrossamountsnotoffsetinthestatementsoffinancialconditionTable", "http://www.vts.com/role/ScheduleofpledgedbyfundsfairvaluesofderivativeinstrumentsTable", "http://www.vts.com/role/ScheduleofshareoutstandingTable", "http://www.vts.com/role/ScheduleoftransactionfeesTable", "http://www.vts.com/role/ScheduleofvaluationofinvestmentsatusingthefairvaluehierarchyTable" ], "xbrltype": "stringItemType" }, "srt_ConsolidatedEntitiesDomain": { "auth_ref": [ "r93", "r160", "r161", "r162", "r163", "r176", "r209", "r247", "r250", "r251" ], "lang": { "en-us": { "role": { "label": "Consolidated Entities [Domain]" } } }, "localname": "ConsolidatedEntitiesDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.vts.com/role/ConsolidatedBalanceSheet", "http://www.vts.com/role/ConsolidatedCashFlow", "http://www.vts.com/role/ConsolidatedIncomeStatement", "http://www.vts.com/role/ConsolidatedIncomeStatement0", "http://www.vts.com/role/ScheduleofeffectofderivativeinstrumentsonthestatementofoperationsTable", "http://www.vts.com/role/ScheduleoffairvalueofderivativeinstrumentsTable", "http://www.vts.com/role/ScheduleoftransactionfeesTable", "http://www.vts.com/role/ScheduleofvaluationofinvestmentsatusingthefairvaluehierarchyTable" ], "xbrltype": "domainItemType" }, "srt_RestatementAxis": { "auth_ref": [ "r82", "r94", "r95", "r96", "r97", "r98", "r99", "r100", "r101", "r102", "r104", "r105", "r106", "r107", "r108", "r109", "r111", "r127", "r128", "r159", "r164", "r165", "r166", "r167", "r171", "r172", "r173", "r195", "r196", "r197", "r198", "r199", "r200", "r201", "r202", "r203", "r204" ], "lang": { "en-us": { "role": { "label": "Revision of Prior Period [Axis]" } } }, "localname": "RestatementAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.vts.com/role/ScheduleofshareoutstandingTable" ], "xbrltype": "stringItemType" }, "srt_RestatementDomain": { "auth_ref": [ "r82", "r94", "r95", "r96", "r97", "r98", "r99", "r100", "r101", "r102", "r104", "r105", "r106", "r107", "r108", "r109", "r111", "r127", "r128", "r159", "r164", "r165", "r166", "r167", "r171", "r172", "r173", "r195", "r196", "r197", "r198", "r199", "r200", "r201", "r202", "r203", "r204" ], "lang": { "en-us": { "role": { "label": "Revision of Prior Period [Domain]" } } }, "localname": "RestatementDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.vts.com/role/ScheduleofshareoutstandingTable" ], "xbrltype": "domainItemType" }, "srt_ScenarioPreviouslyReportedMember": { "auth_ref": [ "r82", "r94", "r96", "r97", "r98", "r99", "r100", "r108", "r111", "r159", "r164", "r165", "r166", "r171", "r195", "r196", "r197", "r198", "r199", "r200", "r201", "r202", "r203", "r204", "r236", "r237", "r238", "r239", "r240", "r245", "r246", "r253", "r254", "r255" ], "lang": { "en-us": { "role": { "label": "Previously Reported [Member]", "terseLabel": "Previously Reported [Member]" } } }, "localname": "ScenarioPreviouslyReportedMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.vts.com/role/ScheduleofshareoutstandingTable" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r4", "r221" ], "calculation": { "http://www.vts.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts Payable, Current", "terseLabel": "Variation margin payable" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.vts.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent": { "auth_ref": [ "r52", "r61" ], "calculation": { "http://www.vts.com/role/ConsolidatedBalanceSheet": { "order": 5.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received.", "label": "Accrued Professional Fees", "terseLabel": "Professional fees payable" } } }, "localname": "AccruedProfessionalFeesCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.vts.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r2", "r221" ], "calculation": { "http://www.vts.com/role/ConsolidatedBalanceSheetAlt0": { "order": 1.0, "parentTag": "us-gaap_AssetsNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional Paid in Capital", "negatedLabel": "Paid-in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.vts.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.vts.com/role/ConsolidatedCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_Assets": { "auth_ref": [ "r49", "r58", "r86", "r92", "r118", "r120", "r122", "r126", "r131", "r132", "r133", "r134", "r135", "r136", "r137", "r138", "r139", "r160", "r162", "r170", "r221", "r248", "r249", "r257" ], "calculation": { "http://www.vts.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_AssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "Total Assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.vts.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets [Abstract]", "terseLabel": "ASSETS" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.vts.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsNet": { "auth_ref": [ "r0", "r65", "r75", "r79", "r80" ], "calculation": { "http://www.vts.com/role/ConsolidatedBalanceSheet": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.vts.com/role/ConsolidatedBalanceSheetAlt0": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of net assets (liabilities).", "label": "Net Assets", "periodEndLabel": "End of Period #", "periodStartLabel": "Beginning of Period", "terseLabel": "TOTAL NET ASSETS - 100.0%", "totalLabel": "Net Assets" } } }, "localname": "AssetsNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.vts.com/role/ConsolidatedBalanceSheet", "http://www.vts.com/role/ConsolidatedIncomeStatement0", "http://www.vts.com/role/ScheduleofInvestmentsTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_AuctionMarketPreferredSecuritiesStockSeriesParValuePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The par value of the auction market preferred security.", "label": "Auction Market Preferred Securities, Stock Series, Par Value Per Share", "terseLabel": "Market Value per Share (Note 2) (in Dollars per share)" } } }, "localname": "AuctionMarketPreferredSecuritiesStockSeriesParValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.vts.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "perShareItemType" }, "us-gaap_BalanceSheetLocationAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by location on balance sheet (statement of financial position).", "label": "Balance Sheet Location [Axis]" } } }, "localname": "BalanceSheetLocationAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.vts.com/role/ScheduleofpledgedbyfundsfairvaluesofderivativeinstrumentsTable" ], "xbrltype": "stringItemType" }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Basis of Accounting, Policy [Policy Text Block]", "terseLabel": "Basis of Presentation" } } }, "localname": "BasisOfAccountingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.vts.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r21" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity.", "label": "Basis of Presentation and Significant Accounting Policies [Text Block]", "terseLabel": "SIGNIFICANT ACCOUNTING POLICIES" } } }, "localname": "BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.vts.com/role/SignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_Cash": { "auth_ref": [ "r205", "r206", "r221", "r233" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash", "terseLabel": "Cash - 10.4%" } } }, "localname": "Cash", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.vts.com/role/ScheduleofInvestmentsTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r19", "r84", "r210" ], "calculation": { "http://www.vts.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and Cash Equivalents, at Carrying Value", "terseLabel": "Cash" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.vts.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAxis": { "auth_ref": [ "r84" ], "lang": { "en-us": { "role": { "documentation": "Information by type of cash and cash equivalent balance.", "label": "Cash and Cash Equivalents [Axis]" } } }, "localname": "CashAndCashEquivalentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.vts.com/role/ScheduleofvaluationofinvestmentsatusingthefairvaluehierarchyTable" ], "xbrltype": "stringItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r14", "r19", "r20" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents", "periodEndLabel": "End of Period", "periodStartLabel": "Beginning of Period" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.vts.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": { "auth_ref": [ "r14", "r45" ], "calculation": { "http://www.vts.com/role/ConsolidatedCashFlow": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect", "totalLabel": "NET INCREASE IN CASH" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.vts.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommodityContractAssetCurrent": { "auth_ref": [ "r235" ], "calculation": { "http://www.vts.com/role/ConsolidatedBalanceSheet": { "order": 4.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of the asset arising from commodity contracts such as futures contracts tied to the movement of a particular commodity, which are expected to be converted into cash or otherwise disposed of within a year or the normal operating cycle, if longer.", "label": "Commodity Contract Asset, Current", "terseLabel": "Deposit at Broker for Futures" } } }, "localname": "CommodityContractAssetCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.vts.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConcentrationRiskDisclosureTextBlock": { "auth_ref": [ "r26" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.", "label": "Concentration Risk Disclosure [Text Block]", "terseLabel": "RISK" } } }, "localname": "ConcentrationRiskDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.vts.com/role/Risk" ], "xbrltype": "textBlockItemType" }, "us-gaap_CostsAndExpenses": { "auth_ref": [ "r7" ], "calculation": { "http://www.vts.com/role/ConsolidatedIncomeStatement": { "order": 1.0, "parentTag": "us-gaap_NetInvestmentInLeaseAccruedInterestWriteoff", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Total costs of sales and operating expenses for the period.", "label": "Costs and Expenses", "totalLabel": "Total Expenses" } } }, "localname": "CostsAndExpenses", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.vts.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtSecuritiesRealizedGainLoss": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of realized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), investment in debt security measured at amortized cost (held-to-maturity) and investment in debt security measured at fair value with change in fair value recognized in net income (trading).", "label": "Debt Securities, Realized Gain (Loss)", "terseLabel": "Realized Gain (Loss) on Derivatives Recognized in Income" } } }, "localname": "DebtSecuritiesRealizedGainLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.vts.com/role/ScheduleofeffectofderivativeinstrumentsonthestatementofoperationsTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeContractTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.", "label": "Derivative Contract [Domain]" } } }, "localname": "DerivativeContractTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.vts.com/role/ScheduleoffairvalueofderivativeinstrumentsTable" ], "xbrltype": "domainItemType" }, "us-gaap_DerivativeInstrumentRiskAxis": { "auth_ref": [ "r33", "r34", "r37", "r38", "r211" ], "lang": { "en-us": { "role": { "documentation": "Information by type of derivative contract.", "label": "Derivative Instrument [Axis]" } } }, "localname": "DerivativeInstrumentRiskAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.vts.com/role/ScheduleoffairvalueofderivativeinstrumentsTable" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativesFairValueLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Derivatives, Fair Value [Line Items]" } } }, "localname": "DerivativesFairValueLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.vts.com/role/ScheduleoffairvalueofderivativeinstrumentsTable" ], "xbrltype": "stringItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "auth_ref": [ "r148", "r149", "r150", "r151", "r152", "r220" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for share-based payment arrangement.", "label": "Share-Based Payment Arrangement [Text Block]", "terseLabel": "CREATION AND REDEMPTION OF CREATION UNITS" } } }, "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.vts.com/role/CreationandRedemptionofCreationUnits" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Creation and Redemption of Creation Units [Abstract]" } } }, "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r140", "r141", "r142", "r143", "r144", "r145", "r146", "r169", "r179", "r180", "r181", "r215", "r216", "r217", "r218", "r219" ], "lang": { "en-us": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value Hierarchy and NAV [Axis]" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.vts.com/role/ScheduleofvaluationofinvestmentsatusingthefairvaluehierarchyTable" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueInputsLevel1Member": { "auth_ref": [ "r140", "r141", "r146", "r169", "r179", "r217", "r218", "r219" ], "lang": { "en-us": { "role": { "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.", "label": "Fair Value, Inputs, Level 1 [Member]", "terseLabel": "Level I - Quoted Prices [Member]" } } }, "localname": "FairValueInputsLevel1Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.vts.com/role/ScheduleofvaluationofinvestmentsatusingthefairvaluehierarchyTable" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [ "r140", "r141", "r142", "r143", "r144", "r145", "r146", "r179", "r180", "r181", "r215", "r216", "r217", "r218", "r219" ], "lang": { "en-us": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.", "label": "Fair Value Hierarchy and NAV [Domain]" } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.vts.com/role/ScheduleofvaluationofinvestmentsatusingthefairvaluehierarchyTable" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueOfFinancialInstrumentsPolicy": { "auth_ref": [ "r43", "r44" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.", "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]", "terseLabel": "Fair Value of Financial Instruments" } } }, "localname": "FairValueOfFinancialInstrumentsPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.vts.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable": { "auth_ref": [ "r32", "r35", "r39" ], "lang": { "en-us": { "role": { "documentation": "Schedule that discloses the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.", "label": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]" } } }, "localname": "FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.vts.com/role/ScheduleoffairvalueofderivativeinstrumentsTable" ], "xbrltype": "stringItemType" }, "us-gaap_FinancingReceivablesPeriodPastDueAxis": { "auth_ref": [ "r124", "r129", "r214" ], "lang": { "en-us": { "role": { "documentation": "Information by period in which financial asset is past due or not past due.", "label": "Financial Asset, Aging [Axis]" } } }, "localname": "FinancingReceivablesPeriodPastDueAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.vts.com/role/ScheduleoffairvalueofderivativeinstrumentsTable" ], "xbrltype": "stringItemType" }, "us-gaap_FinancingReceivablesPeriodPastDueDomain": { "auth_ref": [ "r124", "r129", "r214" ], "lang": { "en-us": { "role": { "documentation": "Period in which financial asset is past due or not past due. For past due, element name and standard label in Financial Asset, [numeric lower end] to [numeric higher end] [date measure] Past Due [Member] or Financial Asset, Greater than [low end numeric value] [date measure] Past Due [Member] or Financial Asset, Less than [high end numeric value] [date measure] Past Due [Member] formats.", "label": "Financial Asset, Aging [Domain]" } } }, "localname": "FinancingReceivablesPeriodPastDueDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.vts.com/role/ScheduleoffairvalueofderivativeinstrumentsTable" ], "xbrltype": "domainItemType" }, "us-gaap_FloorBrokerageExchangeAndClearanceFees": { "auth_ref": [], "calculation": { "http://www.vts.com/role/ConsolidatedIncomeStatement": { "order": 5.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of expense during the period for floor brokerage fees paid to other broker-dealers to execute trades on their behalf, stock exchange fees, order flow fees, and clearance fees.", "label": "Floor Brokerage, Exchange and Clearance Fees", "terseLabel": "Broker interest expense" } } }, "localname": "FloorBrokerageExchangeAndClearanceFees", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.vts.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_FloorBrokeragePolicy": { "auth_ref": [ "r47" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the recognition and recording of fees paid to other broker dealers for executing trades. Broker-dealers often use other brokers to execute trades on their behalf. The trading broker-dealer becomes a customer of the executing broker-dealer and pays a floor brokerage fee. Such fees are paid periodically either directly to the executing broker-dealer or through a clearinghouse. These include fees paid to clearing brokers and market specialists.", "label": "Floor Brokerage, Policy [Policy Text Block]", "terseLabel": "Brokerage Commissions and Futures Account Fees" } } }, "localname": "FloorBrokeragePolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.vts.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_GainLossOnInvestments": { "auth_ref": [ "r11", "r27", "r232" ], "calculation": { "http://www.vts.com/role/ConsolidatedIncomeStatement0": { "order": 1.0, "parentTag": "us-gaap_InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of realized and unrealized gain (loss) on investment.", "label": "Gain (Loss) on Investments", "terseLabel": "Net investment loss" } } }, "localname": "GainLossOnInvestments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.vts.com/role/ConsolidatedIncomeStatement0" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeneralAndAdministrativeExpense": { "auth_ref": [ "r9" ], "calculation": { "http://www.vts.com/role/ConsolidatedIncomeStatement": { "order": 2.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.", "label": "General and Administrative Expense", "terseLabel": "Administrative, accounting and custodian fees" } } }, "localname": "GeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.vts.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxPolicyTextBlock": { "auth_ref": [ "r89", "r153", "r154", "r155", "r156", "r157", "r158" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.", "label": "Income Tax, Policy [Policy Text Block]", "terseLabel": "Federal Income Tax" } } }, "localname": "IncomeTaxPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.vts.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet": { "auth_ref": [ "r16" ], "calculation": { "http://www.vts.com/role/ConsolidatedCashFlow": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amount due from borrowers for interest payments.", "label": "Increase (Decrease) in Accrued Interest Receivable, Net", "negatedLabel": "Decrease (Increase) in interest receivable" } } }, "localname": "IncreaseDecreaseInAccruedInterestReceivableNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.vts.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInEarnestMoneyDepositsOutstanding": { "auth_ref": [ "r16" ], "calculation": { "http://www.vts.com/role/ConsolidatedCashFlow": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amount of deposits given by the reporting entity to a seller which shows that the prospective buyer is serious about purchasing a property.", "label": "Increase (Decrease) in Earnest Money Deposits Outstanding", "negatedLabel": "Decrease (Increase) in Deposits at broker for futures contracts" } } }, "localname": "IncreaseDecreaseInEarnestMoneyDepositsOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.vts.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities": { "auth_ref": [ "r16" ], "calculation": { "http://www.vts.com/role/ConsolidatedCashFlow": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in other obligations or expenses incurred but not yet paid.", "label": "Increase (Decrease) in Other Accounts Payable and Accrued Liabilities", "terseLabel": "Increase (Decrease) in Administrative, accounting and custodian fees payable" } } }, "localname": "IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.vts.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOtherReceivables": { "auth_ref": [ "r16" ], "calculation": { "http://www.vts.com/role/ConsolidatedCashFlow": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in receivables classified as other.", "label": "Increase (Decrease) in Other Receivables", "negatedLabel": "Decrease (Increase) in other receivables" } } }, "localname": "IncreaseDecreaseInOtherReceivables", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.vts.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInPrepaidExpensesOther": { "auth_ref": [ "r16" ], "calculation": { "http://www.vts.com/role/ConsolidatedCashFlow": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) of consideration paid in advance for other costs that provide economic benefits in future periods.", "label": "Increase (Decrease) in Prepaid Expenses, Other", "negatedLabel": "Decrease (Increase) in Prepaid expenses and other assets" } } }, "localname": "IncreaseDecreaseInPrepaidExpensesOther", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.vts.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestAndOtherIncome": { "auth_ref": [], "calculation": { "http://www.vts.com/role/ConsolidatedIncomeStatement": { "order": 2.0, "parentTag": "us-gaap_InvestmentIncomeNet", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of interest income and other income recognized during the period. Included in this element is interest derived from investments in debt securities, cash and cash equivalents, and other investments which reflect the time value of money or transactions in which the payments are for the use or forbearance of money and other income from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business).", "label": "Interest and Other Income", "terseLabel": "Interest income" } } }, "localname": "InterestAndOtherIncome", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.vts.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestReceivable": { "auth_ref": [ "r234" ], "calculation": { "http://www.vts.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of interest earned but not received. Also called accrued interest or accrued interest receivable.", "label": "Interest Receivable", "terseLabel": "Interest receivable" } } }, "localname": "InterestReceivable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.vts.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentCompanyExpenseRatioAfterIncentiveAllocation": { "auth_ref": [ "r67" ], "lang": { "en-us": { "role": { "documentation": "Percentage of expense, after incentive allocation, to average net assets.", "label": "Investment Company, Expense Ratio after Incentive Allocation", "terseLabel": "Expense ratio" } } }, "localname": "InvestmentCompanyExpenseRatioAfterIncentiveAllocation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.vts.com/role/ScheduleofshareoutstandingTable" ], "xbrltype": "percentItemType" }, "us-gaap_InvestmentCompanyGainLossOnInvestmentPerShare": { "auth_ref": [ "r72" ], "lang": { "en-us": { "role": { "documentation": "Per share or unit amount of realized and unrealized gain (loss) on investment.", "label": "Investment Company, Gain (Loss) on Investment, Per Share", "terseLabel": "Net investment loss per share" } } }, "localname": "InvestmentCompanyGainLossOnInvestmentPerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.vts.com/role/ScheduleofshareoutstandingTable" ], "xbrltype": "perShareItemType" }, "us-gaap_InvestmentCompanyInvestmentIncomeLossRatio": { "auth_ref": [ "r66" ], "lang": { "en-us": { "role": { "documentation": "Percentage of investment income (loss) to average net assets.", "label": "Investment Company, Investment Income (Loss) Ratio", "terseLabel": "Net Investment Loss" } } }, "localname": "InvestmentCompanyInvestmentIncomeLossRatio", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.vts.com/role/ScheduleofshareoutstandingTable" ], "xbrltype": "percentItemType" }, "us-gaap_InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease": { "auth_ref": [ "r73" ], "lang": { "en-us": { "role": { "documentation": "Per share or unit amount of increase (decrease) in net asset value.", "label": "Investment Company, Net Asset Value Per Share, Period Increase (Decrease)", "terseLabel": "Net Increase (Decrease) in Net Asset Value Resulting from Operations" } } }, "localname": "InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.vts.com/role/ScheduleofshareoutstandingTable" ], "xbrltype": "perShareItemType" }, "us-gaap_InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease": { "auth_ref": [ "r64", "r77" ], "calculation": { "http://www.vts.com/role/ConsolidatedIncomeStatement": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.vts.com/role/ConsolidatedIncomeStatement0": { "order": 1.0, "parentTag": "us-gaap_InvestmentCompanyNetAssetsPeriodIncreaseDecrease", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in net assets from operations of investment company.", "label": "Investment Company, Net Assets from Operations, Increase (Decrease)", "terseLabel": "Net increase (decrease) in net assets resulting from operations", "totalLabel": "NET INCREASE IN NET ASSETS RESULTING FROM OPERATIONS" } } }, "localname": "InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.vts.com/role/ConsolidatedIncomeStatement", "http://www.vts.com/role/ConsolidatedIncomeStatement0" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentCompanyNetAssetsPeriodIncreaseDecrease": { "auth_ref": [ "r65" ], "calculation": { "http://www.vts.com/role/ConsolidatedIncomeStatement0": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in net assets of investment company.", "label": "Investment Company, Net Assets, Period Increase (Decrease)", "totalLabel": "Total increase in net assets" } } }, "localname": "InvestmentCompanyNetAssetsPeriodIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.vts.com/role/ConsolidatedIncomeStatement0" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentCompanyTotalReturn": { "auth_ref": [ "r68", "r69", "r70" ], "lang": { "en-us": { "role": { "documentation": "Percentage increase (decrease) in fund net asset value, assuming reinvestment of dividends and capital gain distributions.", "label": "Investment Company, Total Return", "terseLabel": "Total Return at Net Asset Value" } } }, "localname": "InvestmentCompanyTotalReturn", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.vts.com/role/ScheduleofshareoutstandingTable" ], "xbrltype": "percentItemType" }, "us-gaap_InvestmentIncomeNet": { "auth_ref": [ "r10", "r12" ], "calculation": { "http://www.vts.com/role/ConsolidatedIncomeStatement": { "order": 2.0, "parentTag": "us-gaap_NetInvestmentInLeaseAccruedInterestWriteoff", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities.", "label": "Investment Income, Net", "totalLabel": "Total Income" } } }, "localname": "InvestmentIncomeNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.vts.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentOwnedAtFairValue": { "auth_ref": [ "r74", "r207", "r208" ], "calculation": { "http://www.vts.com/role/ConsolidatedBalanceSheet": { "order": 6.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Value of the investment at close of period. For schedules of investments that are categorized, the value would be aggregated by category. For investment in and advances to affiliates, if operations of any controlled companies are different in character from those of the company, group such affiliates within divisions and by type of activities.", "label": "Investment Owned, at Fair Value", "terseLabel": "Investments in securities, at value", "verboseLabel": "Investments in securities, at cost" } } }, "localname": "InvestmentOwnedAtFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.vts.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentPolicyTextBlock": { "auth_ref": [ "r125", "r259" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for investment in financial asset.", "label": "Investment, Policy [Policy Text Block]", "terseLabel": "Investment Valuation" } } }, "localname": "InvestmentPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.vts.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_InvestmentTextBlock": { "auth_ref": [ "r241", "r242", "r243", "r244" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for investment.", "label": "Investment [Text Block]", "terseLabel": "INVESTMENTS" } } }, "localname": "InvestmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.vts.com/role/Investments" ], "xbrltype": "textBlockItemType" }, "us-gaap_InvestmentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investments [Abstract]" } } }, "localname": "InvestmentsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_LeaseExpirationDate1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Date which lease or group of leases is set to expire, in YYYY-MM-DD format.", "label": "Lease Expiration Date", "terseLabel": "Expiration Date" } } }, "localname": "LeaseExpirationDate1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.vts.com/role/ScheduleofInvestmentsTable" ], "xbrltype": "dateItemType" }, "us-gaap_LegalFees": { "auth_ref": [ "r8" ], "calculation": { "http://www.vts.com/role/ConsolidatedIncomeStatement": { "order": 4.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings.", "label": "Legal Fees", "terseLabel": "Licensing and registration fees" } } }, "localname": "LegalFees", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.vts.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r5", "r92", "r126", "r131", "r132", "r133", "r134", "r135", "r136", "r137", "r138", "r139", "r161", "r162", "r163", "r170", "r212", "r248", "r257", "r258" ], "calculation": { "http://www.vts.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_AssetsNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total Liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.vts.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities [Abstract]", "terseLabel": "LIABILITIES" } } }, "localname": "LiabilitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.vts.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "stringItemType" }, "us-gaap_ManagementFeeExpense": { "auth_ref": [ "r46" ], "calculation": { "http://www.vts.com/role/ConsolidatedIncomeStatement": { "order": 1.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expenses related to the managing member or general partner for management of the day-to-day business functions of the limited liability company (LLC) or limited partnership (LP).", "label": "Management Fee Expense", "terseLabel": "Management fees" } } }, "localname": "ManagementFeeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.vts.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_ManagementFeePayable": { "auth_ref": [], "calculation": { "http://www.vts.com/role/ConsolidatedBalanceSheet": { "order": 3.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount of the unpaid portion of the fee payable to the managing member or general partner for management of the fund or trust.", "label": "Management Fee Payable", "terseLabel": "Management fees payable" } } }, "localname": "ManagementFeePayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.vts.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_MoneyMarketFundsMember": { "auth_ref": [ "r252" ], "lang": { "en-us": { "role": { "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities.", "label": "Money Market Funds [Member]", "terseLabel": "Money Market Fund [Member]" } } }, "localname": "MoneyMarketFundsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.vts.com/role/ScheduleofvaluationofinvestmentsatusingthefairvaluehierarchyTable" ], "xbrltype": "domainItemType" }, "us-gaap_NetAssetValuePerShare": { "auth_ref": [ "r40", "r41", "r42", "r71", "r73" ], "lang": { "en-us": { "role": { "documentation": "Net asset value per share or per unit of investments in certain entities that calculate net asset value per share. Includes, but is not limited to, by unit, membership interest, or other ownership interest. Investment includes, but is not limited to, investment in certain hedge funds, venture capital funds, private equity funds, real estate partnerships or funds. Excludes fair value disclosure.", "label": "Net Asset Value Per Share", "periodEndLabel": "Net Asset Value, End of Period", "periodStartLabel": "Net Asset Value, Beginning of Period", "terseLabel": "Net Asset Value, Offering and Redemption Price per Share (in Dollars per share)" } } }, "localname": "NetAssetValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.vts.com/role/ConsolidatedBalanceSheet", "http://www.vts.com/role/ScheduleofshareoutstandingTable" ], "xbrltype": "perShareItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r91" ], "calculation": { "http://www.vts.com/role/ConsolidatedCashFlow": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash provided by (used in) financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.vts.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]", "terseLabel": "CASH FLOW FROM FINANCING ACTIVITIES" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.vts.com/role/ConsolidatedCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r14", "r15", "r18" ], "calculation": { "http://www.vts.com/role/ConsolidatedCashFlow": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash provided by (used in) operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.vts.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "CASH FLOW FROM OPERATING ACTIVITIES" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.vts.com/role/ConsolidatedCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r6", "r18", "r54", "r62", "r83", "r87", "r88", "r90", "r92", "r97", "r99", "r100", "r102", "r103", "r107", "r108", "r110", "r118", "r119", "r121", "r123", "r126", "r131", "r132", "r133", "r134", "r135", "r136", "r137", "r138", "r139", "r167", "r170", "r213", "r248" ], "calculation": { "http://www.vts.com/role/ConsolidatedCashFlow": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income (Loss) Attributable to Parent", "terseLabel": "Net increase (decrease) in net assets resulting from operations" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.vts.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetInvestmentInLeaseAccruedInterestWriteoff": { "auth_ref": [ "r130" ], "calculation": { "http://www.vts.com/role/ConsolidatedIncomeStatement": { "order": 2.0, "parentTag": "us-gaap_InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of writeoff of accrued interest on net investment in sales-type and direct financing leases recognized by reversing interest income.", "label": "Net Investment in Lease, Accrued Interest, Writeoff", "negatedTotalLabel": "Net Investment loss" } } }, "localname": "NetInvestmentInLeaseAccruedInterestWriteoff", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.vts.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": { "auth_ref": [ "r1", "r31" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.", "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]", "terseLabel": "ORGANIZATION" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.vts.com/role/Organization" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherAssets": { "auth_ref": [ "r48", "r57", "r85" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of assets classified as other.", "label": "Other Assets", "terseLabel": "Other assets in excess of liabilities - 89.6%" } } }, "localname": "OtherAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.vts.com/role/ScheduleofInvestmentsTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsMember": { "auth_ref": [ "r32", "r39" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing other assets.", "label": "Other Assets [Member]", "terseLabel": "Assets [Member]" } } }, "localname": "OtherAssetsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.vts.com/role/ScheduleofpledgedbyfundsfairvaluesofderivativeinstrumentsTable" ], "xbrltype": "domainItemType" }, "us-gaap_OtherIncome": { "auth_ref": [ "r63" ], "calculation": { "http://www.vts.com/role/ConsolidatedIncomeStatement": { "order": 3.0, "parentTag": "us-gaap_InvestmentIncomeNet", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue and income classified as other.", "label": "Other Income", "terseLabel": "Other income" } } }, "localname": "OtherIncome", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.vts.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherInterestAndDividendIncome": { "auth_ref": [ "r55" ], "calculation": { "http://www.vts.com/role/ConsolidatedIncomeStatement": { "order": 1.0, "parentTag": "us-gaap_InvestmentIncomeNet", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after discount, accretion and premium amortization, of interest income and dividend income classified as other.", "label": "Other Interest and Dividend Income", "terseLabel": "Dividends" } } }, "localname": "OtherInterestAndDividendIncome", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.vts.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherLiabilitiesMember": { "auth_ref": [ "r32", "r39" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing other liabilities.", "label": "Other Liabilities [Member]", "terseLabel": "Liabilities [Member]" } } }, "localname": "OtherLiabilitiesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.vts.com/role/ScheduleofpledgedbyfundsfairvaluesofderivativeinstrumentsTable" ], "xbrltype": "domainItemType" }, "us-gaap_OtherReceivablesNetCurrent": { "auth_ref": [], "calculation": { "http://www.vts.com/role/ConsolidatedBalanceSheet": { "order": 5.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.", "label": "Other Receivables, Net, Current", "terseLabel": "Other receivable" } } }, "localname": "OtherReceivablesNetCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.vts.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherShortTermInvestments": { "auth_ref": [ "r53", "r60", "r235" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of short-term investments classified as other.", "label": "Other Short-Term Investments", "terseLabel": "TOTAL SHORT TERM INVESTMENT (Cost $8,250,285)" } } }, "localname": "OtherShortTermInvestments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.vts.com/role/ScheduleofInvestmentsTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfStockIssuanceCosts": { "auth_ref": [ "r13" ], "calculation": { "http://www.vts.com/role/ConsolidatedCashFlow": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security.", "label": "Payments of Stock Issuance Costs", "negatedLabel": "Cost of shares redeemed" } } }, "localname": "PaymentsOfStockIssuanceCosts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.vts.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseAndOtherAssets": { "auth_ref": [], "calculation": { "http://www.vts.com/role/ConsolidatedBalanceSheet": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets.", "label": "Prepaid Expense and Other Assets", "terseLabel": "Prepaid expenses and other assets" } } }, "localname": "PrepaidExpenseAndOtherAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.vts.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProfessionalFees": { "auth_ref": [ "r76", "r78" ], "calculation": { "http://www.vts.com/role/ConsolidatedIncomeStatement": { "order": 3.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer.", "label": "Professional Fees", "terseLabel": "Professional fees" } } }, "localname": "ProfessionalFees", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.vts.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_QuarterlyFinancialInformationDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Financial Highlights Disclosure [Abstract]" } } }, "localname": "QuarterlyFinancialInformationDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_QuarterlyFinancialInformationTextBlock": { "auth_ref": [ "r22", "r112" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for quarterly financial data. Includes, but is not limited to, tabular presentation of financial information for fiscal quarters, effect of year-end adjustments, and an explanation of matters or transactions that affect comparability of the information.", "label": "Quarterly Financial Information [Text Block]", "terseLabel": "FINANCIAL HIGHLIGHTS" } } }, "localname": "QuarterlyFinancialInformationTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.vts.com/role/FinancialHighlights" ], "xbrltype": "textBlockItemType" }, "us-gaap_RelatedPartyDomain": { "auth_ref": [ "r147", "r174", "r175" ], "lang": { "en-us": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Domain]" } } }, "localname": "RelatedPartyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.vts.com/role/SignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionAxis": { "auth_ref": [ "r81", "r174", "r175", "r256" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party transaction.", "label": "Related Party Transaction [Axis]" } } }, "localname": "RelatedPartyTransactionAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.vts.com/role/AgreementsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionDomain": { "auth_ref": [ "r81" ], "lang": { "en-us": { "role": { "documentation": "Transaction between related party.", "label": "Related Party Transaction [Domain]" } } }, "localname": "RelatedPartyTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.vts.com/role/AgreementsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "auth_ref": [ "r147", "r174", "r183", "r184", "r185", "r186", "r187", "r188", "r189", "r190", "r191", "r192", "r193", "r194", "r256" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Axis]" } } }, "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.vts.com/role/SignificantAccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember": { "auth_ref": [ "r84" ], "lang": { "en-us": { "role": { "documentation": "Type of cash and cash equivalent. Cash is currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash and Cash Equivalents [Domain]" } } }, "localname": "RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.vts.com/role/ScheduleofvaluationofinvestmentsatusingthefairvaluehierarchyTable" ], "xbrltype": "domainItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r3", "r29", "r59", "r199", "r204", "r221" ], "calculation": { "http://www.vts.com/role/ConsolidatedBalanceSheetAlt0": { "order": 2.0, "parentTag": "us-gaap_AssetsNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings (Accumulated Deficit)", "negatedLabel": "Total distributable earnings (accumulated deficit)" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.vts.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_RisksAndUncertaintiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Risk [Abstract]" } } }, "localname": "RisksAndUncertaintiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_SaleOfTrustAssetsToPayExpenses": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of sale of trust assets (includes, but is not limited to, gold and silver) to pay trust expenses.", "label": "Sale of Trust Assets to Pay Expenses", "terseLabel": "Total Trust" } } }, "localname": "SaleOfTrustAssetsToPayExpenses", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.vts.com/role/ScheduleoftransactionfeesTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of supplemental cash flow information for the periods presented.", "label": "Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]", "terseLabel": "Schedule of gross amounts not offset in the statements of financial condition" } } }, "localname": "ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.vts.com/role/InvestmentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock": { "auth_ref": [ "r35" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.", "label": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]", "terseLabel": "Schedule of fair value of derivative instruments" } } }, "localname": "ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.vts.com/role/InvestmentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": { "auth_ref": [ "r168", "r169" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).", "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]", "terseLabel": "Schedule of valuation of investments at using the fair value hierarchy" } } }, "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.vts.com/role/SignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock": { "auth_ref": [ "r36" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure for fair value hedging instruments of (a) the location and amount of gains and losses reported in the statement of financial performance and (b) the location and fair value amounts of the instruments reported in the statement of financial position.", "label": "Schedule of Fair Value Hedging Instruments, Statements of Financial Performance and Financial Position, Location [Table Text Block]", "terseLabel": "Schedule of effect of derivative instruments on the statement of operations" } } }, "localname": "ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.vts.com/role/InvestmentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfInvestmentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of Investments [Abstract]" } } }, "localname": "ScheduleOfInvestmentsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_SharesIssued": { "auth_ref": [ "r28" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.", "label": "Shares, Issued", "terseLabel": "Shares of fund" } } }, "localname": "SharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.vts.com/role/CreationandRedemptionofCreationUnitsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_SharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.", "label": "Shares, Outstanding", "terseLabel": "Shares Outstanding (in Shares)" } } }, "localname": "SharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.vts.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "sharesItemType" }, "us-gaap_ShortTermInvestments": { "auth_ref": [ "r50", "r51", "r56", "r235" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.", "label": "Short-Term Investments", "terseLabel": "TOTAL INVESTMENTS (Cost $8,250,285) - 6.6%" } } }, "localname": "ShortTermInvestments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.vts.com/role/ScheduleofInvestmentsTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.vts.com/role/ConsolidatedBalanceSheet", "http://www.vts.com/role/ConsolidatedCashFlow", "http://www.vts.com/role/ConsolidatedIncomeStatement", "http://www.vts.com/role/ConsolidatedIncomeStatement0", "http://www.vts.com/role/ScheduleofInvestmentsTable", "http://www.vts.com/role/ScheduleofInvestmentsTable_Parentheticals" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r94", "r95", "r96", "r113", "r182" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.vts.com/role/ConsolidatedBalanceSheet", "http://www.vts.com/role/ConsolidatedCashFlow", "http://www.vts.com/role/ConsolidatedIncomeStatement", "http://www.vts.com/role/ConsolidatedIncomeStatement0", "http://www.vts.com/role/ScheduleofInvestmentsTable", "http://www.vts.com/role/ScheduleofInvestmentsTable_Parentheticals" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r177", "r178" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "Subsequent Events [Text Block]", "terseLabel": "SUBSEQUENT EVENTS" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.vts.com/role/SubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_UnrealizedGainLossOnDerivatives": { "auth_ref": [ "r17" ], "calculation": { "http://www.vts.com/role/ConsolidatedIncomeStatement": { "order": 1.0, "parentTag": "us-gaap_InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net change in the difference between the fair value and the carrying value, or in the comparative fair values, of derivative instruments, including options, swaps, futures, and forward contracts, held at each balance sheet date, that was included in earnings for the period.", "label": "Unrealized Gain (Loss) on Derivatives", "totalLabel": "Net realized and unrealized gain (loss) on investments and futures contracts" } } }, "localname": "UnrealizedGainLossOnDerivatives", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.vts.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnremittedEarningsInForeignInvestmentPolicy": { "auth_ref": [ "r30" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for tax treatment of unremitted earnings in a foreign investment.", "label": "Unremitted Earnings in Foreign Investment, Policy [Policy Text Block]", "terseLabel": "Investment Transactions and Related Income" } } }, "localname": "UnremittedEarningsInForeignInvestmentPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.vts.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r23", "r24", "r25", "r114", "r115", "r116", "r117" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates, Policy [Policy Text Block]", "terseLabel": "Use of Estimates & Indemnifications" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.vts.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" } }, "unitCount": 4 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=77885760&loc=SL35686385-199418", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "https://asc.fasb.org/topic&trid=2122149", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7(a),(b))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=SL124452830-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.M.Q2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7(c),9(a))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "270", "URI": "https://asc.fasb.org/extlink&oid=126900988&loc=SL124452896-108306", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.8)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=SL6953401-111524", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(3)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(4)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "3D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL120267969-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(A)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(B)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(C)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(03)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(l)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r152": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "718", "URI": "https://asc.fasb.org/topic&trid=2228938", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(b)(2)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(01)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124437977&loc=d3e55792-112764", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r178": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "https://asc.fasb.org/topic&trid=2122774", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(1)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(2)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(ii)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(iii)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(iv)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=118262064&loc=SL116631418-115840", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=118262064&loc=SL116631419-115840", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "5D", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13D(Column C))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 4))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r21": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "https://asc.fasb.org/topic&trid=2122369", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "80", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124267575&loc=SL82922355-210448", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r22": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "270", "URI": "https://asc.fasb.org/topic&trid=2126967", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r222": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r223": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r224": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r225": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r226": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r227": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r228": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r229": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r230": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r231": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3)(a)(4))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(8))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=SL124452830-107794", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r241": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "320", "URI": "https://asc.fasb.org/topic&trid=2196928", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r242": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "321", "URI": "https://asc.fasb.org/topic&trid=75115024", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r243": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "323", "URI": "https://asc.fasb.org/topic&trid=2196965", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r244": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "325", "URI": "https://asc.fasb.org/topic&trid=2197064", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(3)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(4)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(01)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(3)(b))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r26": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "https://asc.fasb.org/topic&trid=2134479", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27405-111563", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "25", "SubTopic": "30", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121829422&loc=d3e41263-109329", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r31": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "810", "URI": "https://asc.fasb.org/topic&trid=2197479", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "182", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=127000641&loc=SL5629052-113961", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "54B", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126972413&loc=SL7495116-110257", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "59", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126972413&loc=SL6740821-110257", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "60", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "940", "URI": "https://asc.fasb.org/extlink&oid=35710059&loc=d3e41357-110954", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(4))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(5))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.15(5))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.5)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.4)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(1)(g))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(10))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.1(g))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.15(a))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04.4)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "205", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=118262037&loc=d3e9915-115836", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "205", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=118262037&loc=d3e9915-115836", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=25866437&loc=d3e10328-115837", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=25866437&loc=d3e10342-115837", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=25866437&loc=d3e10396-115837", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=25866437&loc=d3e10403-115837", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=25866437&loc=d3e10411-115837", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=25866437&loc=d3e10246-115837", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(c)", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=25866437&loc=d3e10246-115837", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(h)", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=25866437&loc=d3e10246-115837", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(b)", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=99383244&loc=d3e12121-115841", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-05(4))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=120401414&loc=d3e604008-122996", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "220", "Subparagraph": "(k)", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=124433917&loc=SL114874205-224268", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "220", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=124433917&loc=SL114874234-224268", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07.2(a),(b),(c),(d))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=120401555&loc=SL114874292-224272", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(6))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=120401555&loc=SL114874367-224272", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.3)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(7))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=120401555&loc=SL114874367-224272", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" } }, "version": "2.2" } ZIP 56 0001213900-23-023646-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001213900-23-023646-xbrl.zip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

A38(L8O@4( MS'V;OX(PU _%EI,[1')M[!Y.Y=)1G77C0VQ@+BUD,5Y9Q4Y<:<"V[I[CTC@4 M(,JEDPLBMT75'45G-%$!8FV!:8W7*7_$@^8=P3/HL+N:P&;,A;Z:\OP1(Z.I ME8U[9-W;:OX%CU^8JF+].JC?6 ;=]0?*> _GH99B!0;,0UEKD%D!(9=D0LA^ MT)6+3,RAN3U!EWUKKB!"5-[)[]):_>^9V:"4$-0>1Y=OE,D$HBS1$3<4,JIN!?0 H+H,NG06,=; MLAL[T+R ,\NP5/L_C@&U.,9Z2:]@.L>ZFXHMFKV.OE,N+2B#Z$4?L3%_W%B@VT9/7ZJMR%2[? M39U()=,5G%8%6>5Q?'M*,2A9^GH2[=S8Y A$7:9="*(4ZW>0^!PJABE_C.ZN M,Q6RD<@H*#@;&7C^7Q<-/X&&1_QM^,3%QM,$$HMEIDB3L,IPTH,3 M92E!2V0YI$^>XUX=XV>ZMQBX5\ B352:E@S4?>,NDU*(WOOZZ*TA><02@4RZ M0$@TLM^ETF%KRTPXE/V'EM?#-!_'2@1_W!_!QSO:$XVUU$46J3SS4.ZY-&!6 MH'Y\#BN1CU !7AWLXDK%*QRL?OP(<5QDF)3K0=*QY*^ MT+]O.@ [U72 1[.:[C:P[S7P2GH-C!%\47_IO9BDGFBBQKWW$FEH"O/V-]\C M>'ANO@N8CFS>P(36EQLX![;/]Z;"KSG0^&Z.UT?T6X%;HS_$'BV/5C9'L6U,=HVCVVCDF8;\M>0.!AAENWQQ+91J]\-:HBA.,?@D MNX% [EE%>NHZ&_HTUSADIT](QY'(:PNBZ;+H*[]A4:<[0?*"1:N1RD>/+07C M6=1RQ!%<$[-TNFL*.7-6%9<(W?Z"P(&7+RLKN)EV05E770.9.T2GRU3+A:,X M<.'#:^<8]P$1:. YLKX%/P.;_70!*3]&<+8E:DL" W78T8F(3: :N>#F1!V M+[8/6'S$P56=0?#"@R".Q?0Z#%>)$ 3*)Q6@D@I<_/SZ%))EZG%#]>%<[CB] M<)@E8E)5VBA84=XXUT7LZR+V=1'[NHA]7<2^ M+F)?%_$7JXOHE.?@."9HZU4 EB._@\1@LIF+E@#O$.F,X'/#W]T9J_,%M;QU MG!$?H)9HCR.-28T!.K&\YF)51THZZA^F[-;SMBV$-&:%Y+IM4<52 MT-/VPK?PX,78@3/$-FN00G8[ ]5S;CG4.O+D3+&/RY. EE*(6XS@)K@8RYK' M2IM),;T.ISA+A*"V47L;29=DB#="],]P._DWH@>S.W0:RK 4C2)Q$7&?7NEF M>J5"H1I.K.SS*J\DK[)_VW+_MJ7V7%83;UO*7B*9/N//RK-9A12[#%"I)/;O M6[:SB,9G*,'"+]EEKY"<[K"&M_!E5PIZ\ER*L.@$ E4:%LB_&:D+%Z]$CRL. MD'EAK2V3[O("'INH8"D>3%-%1#%0O$+JRI.AT>.*C8!7,(B>5:<:LR*9**LL ME["VYDPK@J2#@.2AH.49M5T7K;[./V\$+6E'GM6H5"SJGB:L!57X6&Q!"15W M3) AHVV%J88A.V4]SV]%ZI!Z$BQD3K&9Y ZA":(BC2M\)6TK$F6+OPA*UQ"Q M0QNZR*5? 6L&L*K1="P\/,!52DGO=;/=Y[L4HY8AWU68LG+0ZP+]N\L- !+3 MU1(4\$"1F+K.&VA7-L;DG. G:KYS:J[& J Y>T-^:$- #)@ _!P#JHKP\ # M'Z_<%)XJBUT\QX[K4+:B.2E&,D->S\Z(/P;/RD/"^E(!N& C_R3S_HW'\,7) M:'?].[%M?N/KS[> TL-$;R+]$4T.MP(4Z) M$-2%)+5@R;N(%;$HB$PI26VOGI0K'P.G7!0*7ZVK!5!XJ"?;KB!#1M_;0-5( M9.>L[F6YFCYKZ$P18Z-7U):"D'SK#MF5:&K M2Q#5LA()*&V1]TO*IRO^+W].BKQB 7%MBY8(D+P"T^-2(W<2<\66@1OL.&,4 M=V)0O6&K&JT3Q8BE<7ZEO"2VW J>SXN=QA O5P!MME.DRJQF:*_R/WP@_'[BO\=_7^.]K_/]_#%T^(ABM4M5(>7+1%?Q^$Z&W][E;(!,16<:(B-I.O8H1U)( M9%H*SBMSDB9,YB>;@ETA#]VS:\4RUEOKMD\,=CXQV')H/P0KRP6V_Q3QE #D M4#55$%E5DNTNDM42T7&M)7XKVD+!S\*'I!E">F)>7LT+CD.SLU=Y!%KW\#KB MAAKW>!;\>@]-2)6*,GC!NBP1UOW*_Q=IG+@&T11)B8'()S9U1Z*UHZK(.X]0 MRGT7S58\=*H[D)8:ACH@BPA/76\XU5$1548+F]JBH8+A=1^UR$9"15)5504M ML$<.&),O']NAT]TH)V?.JJX)B)C@*WV+JU"SRI_@$L@2K7R;HI@35W*/N&7G MRW&C8'0>#C9_\4U9 ,@EVHE"VJ[88/T_KVS\_$;,+K=.9#R+*#7VXD794/N" MC5=7L,&C6ONJC6Z$$/NJC7W5QKYJHY^=&?>5&_O*C:Y4;B3NR?J-Z0EF+=;, M\\V#PXJ+P^,1-!\8KK4.8&PFV!1@0-.>I?8%Y-J"U5I"$N0+\1*RF@GU("=H MZXYWQ74^<\,\EI=6[ ;F?[SHF45\#PV,#,N&*0ZG6*^=-\*BUBOM:M2H&>CT M'&'?><18 H+P?"F@)C.75B39L9THDA^2@]8:P%*L &AZ9\:38!-&2.W M@(9L_@R4@,P_P*L&OH:8Q^O\G0(*BO5M YA:B2.ZCN38L^5Y*/@< 9M9*: MH&(^=]I[Q:K=1,/I6H._YM!%% ^!V_<*VVQDN?75.N91=0:$8\"_:*22%7RH M&N]:#TVRS.TLEW=@(Q&7<)-_U9K +^10#\[:OJF5LP0&+$WQ9,4..$1/;#@( MO_8P@T>V(>[O.[4TT-4,>U0J(;NLMWFPOB6>OFYGS>#BY%6[$"50A5KVH=4\ M2KP1VVV^KF9I*:;[NC>Z''*-\F8J+OZ*07YC&70'Q>:"S'LX#Y]%P$@E_#QC MO&K?4%/D*7L2"VBIC< $-?RO/.QK804-O,0>DD(;/R5;#R; MN-AX&CF.QQ[[\)^54&REI4/IWC7*HSF'\LG^N_SJ66OJ@?PW$*@J6T9XM<^PP-GHOZ)YJ MZ>5L!I6O\"TSWXOHH&U E5VM;EU[NZ2,W;B$TYQBR5R]SK]XVKZ^*+^M*JTQ MK]L9)6['"MP8S[L=V];UV#&9 V1]"QY>$-T_)XG$UT\8PLB\2_ ZGH5Q!;"W MH#2UI5;#DZBWEQK]PG(,&SL>@5,*YCD=Z:E+PLEC3W.\H50!4R^X*\=1W7:Y M)0\QL>;(FED&0&YXJD/#JSLJ"(-M"L0KS;+$FKKV4#R08-+X'#@6W6$E%8#J M0ZF@FK)D*58T6VVU!B1-44[HBEO.MF%XR9)SX5KQN %G4X^*9$<0KVR/:#5E M+7DC:#V**P$HOWU4$RK=DCX/Y@3"2)WKZ$?\Q7A%E>Q.54JR]CE23"VGK8H M3V+]4^+O9S8ZPIS<:.^0P@,^,Y4,!LI:HFB9;.;B>BZZ*GJ+R%IB@:^6,L7= M$$4G$KE9@PI!J'+-;24!9I1#&C<%IP2U4U:IK\N^0I%+JWX:+45'5D4+B&GI MSUXF:[_W2L'$>Z:20P)],H!EW4RX7+%?\"SZDTZN7KPR[%L.Z]YRGB36)/9U]A32 S(@<8&%&JPI+A^K M[LZ?49-97^+O"U@F^[+L"I*FH7?)X%(#9DX)J2MI(]O^E#-Z$TVK0PY_B"D. M*+S4P'AK_@">:T@=^85<4TO5R7 )JX?';1/OT8%?/4KM'!__W M^^VG'_[]?Y^-E??R!_KA@_GM;#W_8X,>+KSGZS/RX>RWT_\\3#>.?;8VOAW; MO[I'[@3^^NWL[=/+B7'C'O]Y=74Z^>UH_7(^_.-X;4X(P-/;WU;F[?C3PZU[ MO_+.W[N?WL';Z]^/CL_0Q_?D[/3[T1]_N+]X;Z_0R?MWUZ>WU^3R^C,RW[NG MSC^^.B?7O\W_F"#WXM>/G]8O?Y[]X^CLYCWXA#&9_?##]>_SV<,/-U\_?_CU MX?VW9_=/]_37CW?O__=V=.:>??WESW_WY]/[D^NOHVW^.;\].CT[@\-\'P\G]X:%H5_<= M\3;5.+]H&.%N]#L$F_((Q>/HKN6M "[55;=86+VK>\F6$YQO_)\VHGG''E:\ M7"XAZP MU+A5+M*]<*M\0I)X)T\"0);6LJ,7M#X!VX-7F%S1G1"P@XM)E$]Y+.N.HK7) M'1>FM>6FZAT^08<<%]XUZX.+Q^F%J7*(2Z#9H-(DSQ6PB*]PB5+]$:)3\7P7 M$T;V:E'E&U-S6Z!: '-*4:!]H+H&V0^(P*7ELN=O $%T8LX(42\#K3G:U4_5 M<7"-D?L53M62J;JF@4*&;F-,S@E^@@3,83-VG3=$KQQUOI $NOXI]=%!_ZDI M>&EZL2T8ID<;UV)1*6NJUXT;9M.@(ZW@2\K]R[A-C 4T/=9?9^BY>#:;6DO( MS@K]_[.-D&UX=G",[O?LE-TNB@[7"WXEAC#?@&)M::B M7,/$GF>$$H\W;S=%=^RY%]8C,=*4YLU1#7=]N ZI'!&M+P?FN)5?H,D.E!)S M2B9#XRE!XA?5(8-U6,[,](8-6Q$H-+$<-,J]SAQG;?5L"5!-IU;Q/.]L.C_6 M/>[*0Z:SG;538*"*(U>YT34'LA4ZI4S&J@ZZY#Q<=(XS\58KVU=_8,<%9&T% MKO6XZ+:"2,M8Z0%:5ZX&2@:H?^D;@K$F30F@8QE1KV_%;KN[6M-H:GAF^'E* ME^4GZ=S=5:FBD*0ANI"E'>FLZ(U>>KW12/#']:LN$J;;1^ MU"QL FVWF\[<.CK?9.5Q ]?0YDW\B%S>*A^T'R&VI-?+O0)6 8:&5%&&Q; 4 MUY]LEMD+O 06:DIMN,;67%M2S[!RM8!/Q(GME_AEW"WY$5IYKN/S=Y*7<%(' M8LY(>BO6%2"6)SW-?2_"]_5V7M5KP*F7#-3]';-")UXF<"69,:'NF+OO+>ZP ME__71AR %"N:G7JU,24U04[H.WY=!/5;C.#F%I GZ/JGF(W@63"(7E]>#Z@B M.2EN%JL2?MBA!:+$016IAX6(RCP M^BWFR<4[G64;O//9S&#))C2>3;$+["GQ'.'7-+.$^G!(J>!8PW\+,$>,/7MM M+9;)=LYX9FZO%5H[UPIKWZO*N1%;<&U1V0DD]T#2AQ).3-\Y!S:[O#M90+J. MA;=USS?Q!Z*MPI0.<+X);P5?0(?J;7RSMZEDIGI&Q3-^"5:V_!4<&LI?H"L= M2_,!8%V#R$WI-J""RI[/%=6+6 ;LE8D&P+6&1[8UC=H M#E94-H;E2T;*"Y>2U&RQ=:$H%X_:#<.K]V 524,E)RBU A#9@Y.= Y,.;'Q+ MLK%^H-' &4<85;1[S@%G,VBX!8<<5#\7T(D:=.(97L'@O5M'[D+6I3]H0:)W MC*8+F&A<.]X.JNQ,1';\V@:2N-*2.7V30D!,$HVQTP7!%)R>Z!1.ZI!%XQF+ M(KMC#K YC5;YP/L^=;BK#$U[HK9:Y^P3AKU(&+ZHSQ@6D]2S):J1-"R1AJ:+ M1]-G_%EYZK"08L=3A\62Z'FY8!M.O]E(3MM=K OXZ$[8\S6^TMR'.8QKZAMO ML*.^$J-T,$WWJ=J(T=/9C7*1ZWF2:K@ :$[CY?Q$U@6,?QZC1!KA'AIXCMC' M1RAXJT[0KZH;7\\RV986*<1):-WU5H6\SJ-%3-6O--#F6) M'-%QZR;WRY172-3J4Q-";&B40Y-I&F%6M-WG4&5)59&8F++N^QIK6AAE?$LK MF9A]_9!@*F#?P+B+P+3>P+C>9C3O0+F!DJ'"8;2ZI$K/D] 524E7H^,47\&SR,T!EZ+?,\S2LE&8_WY=+JJ9 M+5?;?3JN"7:X"J%CN)7D&G7P1EJ[>IB71*%PA Z] RW(S M9RHQ4GCOF[_7.'2WW+>F5Y*#]GS#F:M'LCBH/0IM-^\Z9S8$@MDCS'J_T_E; MJ0PVE>4LFK41S7J;@!7+OR9-]R-FKV7183F$K2P1*\V 0*15IL=R.*C/2,KQ MTQ'A-)FRE>=)]RMUJFRP*NB35.V6DW[[3*Y"A[1_EZ[3V<-]6K>CP+SF=^E: M<3H-1Q,:DJR%^]Q$*K'.MH7:OJ!1-<%)]TI\E,6<<: I3!BWONVD 21R M: Q):O;!S75:%MWKKZ\QNV7PO\NTO\NTW^7N MFQ_U!)C7W/"\$=^N.)C2=D=I H)0QG/<8!LTQ7=@<_FR@LB!JHO#*@;3=$>I MD;@X6;)2)6.EEY+:W3PZ"RI6[+ET(T[WPV@N>18Y8>3&,3EE^\="P@+IGVT. MX!=KOK#I?SGJD2\7L5F(CU=S.1092'9#*#>F)H_!K[#^"U?B^M*=/<)KW/1) M&W)+F[S]7F-_HO87VVMHN"C!V+^/3Q04.;Q=BGI.5Y1YNHR ]+3P3K"A+'F5 MI:GERDJ)&N: 4/@V>&V13@R( +'P'8%K"WN.O;F'*^H^HMV_A[Y!XGJ"(5ZN -I$/6#&*/ZGAB"O-[:F/:QR;:@I<2U/;E.- MC7H"#9 9MWG)8]6AG]A]G%HP4I<>5E?J7)F2R M>W7O@2MQ)KN\+NIB/D$&G MY\ +&/R_:>]2AY57ZVQJX2$>;DCXGM)5\\MQ6V'':T"_4(3BW>N#T.,2F:*! MQRT@3Z61)/=JD4>I]PM KGA"N'[HB$_W&_/?0[KRJ'XBI72HWF/+)] 0['=M M-U4HXRJAE8+&RDN]]R!SBS'$^:Q=H[YGPG2F>+"&!,QAM$(X[R2/D*OI]GQ- MY1!%21N_"N@F?[\&,CD#C._JOUAH.;#ML'M*T^^;B09?)_F M$[.RTA4EJA'_(6C#RG:6_@2:UH?B@?5X!S4J4").A8]NM5*P9,V1-;,,@-R! M8; +0-0=WF';,EB);^ WZU8M16++$LQ?9 %XZ#4 #UD E)WT=-U3UXQHVJ^X\KL3W<,U1,)I MLA0)+==V1<+&;6?#[>1U=8;]B.D.C&['B&M1[4F_[Z\)Z5.ZF1P8( M><"V-X(XE=/4]CZ(*& 5(E)YB-Y&#F@P)Q F&\S4?K,H0<%R#!L['H&2QPNE M)&L'D9DIRB1Q"HC5](,9*K*YF1*"FCPBCUKXG8<*T.E:QJ6]%(O&G$JYJ7 D M4+3U3*S@J_'L27:L+NXW>=(F.5+;N4>Q3Z$42W2?,VE;XJ\D25+M>LN"!@7I MCUKQ2Q#_7E NMC6F[!!4.*HJI*=% ZO#,Q^/8B&H[7S([VR]1V"N+0>3S16$ M$GCD$.J(5>0BD3=O+3HAPO?$#NNX]<$/P*'K8.;DJ=^I8-926;$6RTQFL[(<;S=3*!\8Z4D M:;UO>:F!.M4^*24W/2^X#SQW@0F[L<2"-,NP5H!R?0<)JXFCCD#4\U61U7%4 MHA[):NDI?L*M#<=Y;SE/DJ5CC(3CWX1(T@"P=G1K/A8=?-)V=OLI*V#;4]P(;_CM<=+J7K%'+9H1FF"R#NM[: M"WT9- J!*JZV[2*Q-7K;P-7 M 4I#G:8+0.FH;RU?TQ-2D/*9]W!NL343N1_!4BZHR278I24L-TM7+ I-:6O& MT)0 =AESLED^8EL*E#0E/1%;73AV9J\E=YWD>4H_IR2*]@GI\K=U$$C/7)7' MK2O_H4?8A*XLQP#V'Q"02V1>9(YQ:F)12%17[5U=;(JEHJS:3G M&>+E$J.) MBXVG(!^;:'JM8&4I)=\7]'@D)=ZA1@V.=]ZC;1E7-@9E"49>V)+4^N#[3\7UE SD+2E/J1QBP,WMEO6$$G1MD;>;L$3+ARV]PH\*?[5#L MUIZDRH/MBD-=2Q=AA(*%,6B[R^)'*CY/+B%72K@?5E0N&RUM6V*V/F';HV(C MFRO+IO048+5+L5=&E1%'",\'?4;E4<$Q5.+TVO7U';CBRB?:F.!$' MT._0MG]#^!E-(' P@J9? %'6AIT7IB+*_0*L4#X1=&UG=I/3N(NZ24IO:?,I M]L3S%8@C0JCUI$/$3[R_OJ)_47.*NDNS'Q%$H40BC#0D'-(\!;JC&JS+,9YX'Y5F%"6:+^<79Y4(JCD$P_UL1H9,S+P3(O^Z\!U_5>=*&?2*=82 MLCT)Q^DQ+A49F=%E/OB M$"OD$V&G(CLA!MW -*GTG/!_;!XG"F#+H]HCB\L52H25BER%,K!.&P'KM-]@ MG<9@M?Z@3H:O(?UQ3*;X6<7]C"S-/B4M8'8@M,%*Q]7-R M^CBU7,G+U!EB/<$C*X0(C]93$1$KER_& J YE+X+EDNP%]%TOB@B9#1F%T:( M4F)-_];P K@@K.A4DB'*)=RG$*U(-A%L&JY2A ,/:FM+AFMG&@=[H_HSK0[#3.V^4CLOW^SMO=E[IC[UVVIW>_<9OWY>P")A MH4G^9E1DOS[QYO@ZR.)FFIT]A0=/B_E4/X7/MK>V=[9V=Y[(-]'7HOZ;*(FC M1/_Q_O3@:6'V$18 "1ED=VMGUQMD*]?#TD#P=_,LO5@YSL[SK>U76\_L8N#- M+_6KV=W>?O84'P_"7)O71SJR;].;9DYX@*MTZ\O3O=V=ERN&EC?,!_@P6O5Z MDA=A,K0KD=.T7]2=K@/6LH%WGGG0LDO)RPNY?&:6L?/TC\.#WO!<3\*MZH)F M^18>>&X_'8?Y@#XT3TH RK-B\4WXL?32UW@%1/XX@,/QP3>JG(V\^>(I/_06 M>A:&T]IUXH/R"O)O ,4P^K(-;[Q\_6SO=1D%+@HZ&)IB9]>AX=<%/)29=EZ_ M?OV4GLJKRU_":_D$KZ<.1^\"A?_W2Q$5L7ZG?GG*_PB"7R:Z"-4P30J=P $4 M^FOQE#XD2K&E_SF++GY]TN;G6WTXMB?J*0SZE$?]99".YN]^&447*B_FL?[U MR1A>?:-VMJ>%ZD<3G:LC?:E.TTF8-/B'ANKI+!H_H:]P!4_Q?XGF[$XHN#-!OIC$=['X?#+VH7%IVG<32R#\W(_'S'/'_R[C_^;>?%]EM9 M^\(.GBYLP6UT6H;4((U':N?55> R>Z5-JNVW"D]J*XRC,_AI"&>C,]AM/@V3 MTG;'X22*YV^N&ML'#8SOMH<#POZF/W,/LJX]7->GHVZ_\T'U^JU^I_?+( -4 M['7:GTZ[_6ZGIUI''U3GC_;'UM%O'=4^/CSL]GK=XZ.;;>-*S+W6-GX/\W-@ MTD4*'W]HMIO +I_OO?ZA2S!G^ .G7)SL!M_6M=_]NE\5W?__X]%#]$GU]DZ3)T6P"HPZ9 M<7TM3O7XUR=#$(Z3< *?@O#UYD,ZA'>2@EC6NYWMK;__\K3T[;O%'2[N<7&5 M3"ROP^$L%J_B5]>^IM>9KVZUUUK#7^K>WBDD[\5IKKXCK/[\^@14IC?CZ*L> M;1793-?=G5:2S,+X5$_3K/AFZ0)A\OKEW@M'4,<3J8QF4M-9EL_" MI%!%"D,,45-CL.X\4VFF=IYOC#95.E;%N<;GLRPJ(IB_\W5X'B: *UA@8]W M0-S&S=)[XR@?P@QS#9JL3D:@)=\ 2B/0A+=9/0!/KO1:=3,4YZB/Y^SQ*9.X( ML!2'VN)?'RAI&8=Q7DM;R#(5X=V^'?JRMXJ^N,GNDL84;I8IT0 USM*)^G_R M?SB5^?=UK\D#UP?:Z602Y6B\! (<:Y7,D$:]N3XMZB1%5,SWX=LC^O3)N^WM MG:V]G=U7VXN4Z%&W6AL9[6>=U>[>[9S5S?#[5)]%.5*/X@B>K-"#2#_[W%/] M;)872^C=#T7*C<[7$"@A;@C)868WHL)-PF@,4S;^> M@ A19&;T"YT5$U( MCO.'X'+39>7=# M#S7/[G($KT#IJEMK?5R6\M]3X%H>4BS$;?8?Q:-L_NDW>]601T:&]O M;U'U_(Z]M.&?QUD_O4R>O#L)XXEZK\/AN?H-MJ&3_+9V0C3T.#L!*2'"P(1W M^P>+=I)O&ODD!?DC_N]HRL+$LV=[VZ\66OLWAU5A/<:UBJ6J YCJ,9RB= M!D"X,%#F+X(LGLV3E7J=@1Z_W&JZNS'8#,1>VAH6;W[H;A;@#U9M/0.S;R#?7>*]'8BVD@]7&HP+R,J ;_.+H30D&5ZHZO#&X M(;"OLRR=)2.\)6GV1F5G@XW=[;W&[K-7C=WGSS>?U *4#6][S6<(SHIT?W-E M?\=G@D)-YSN[ T+K%29>HTIL[7P%:1E=59^[?ZC]63%#P;G3W[^.9649"I2W M^J+Y[/GM[U4PF1'Y&AOMP?YN;T_/FKNWM:6JG0TQ=='$9H[6> :OL.";7;<' MJ5;O__L/ZU'\;LN,0?\?@=R[WXGXG:N_<4M4LF MD4>AFH3JLY)0K8Y -?F1:_[!X37?X3;C@>^GA^R>'\:3=]UDA"9+C9ECPW,- M@( 7OJB(,<]SZD:Y"M4EZ#-;7T ; "J@PQQ0<@0/\AFHRT&8JY$>1_130F?& MJ][;?EX330,XW52W%/:C_H1W;RE$\::FO-\!(G]'@/0$'ET"QY-W1^F-O?/? M<'SW S&2M(!?_CF+D*8!*:. 'XZVRH,KPJW*/_FQ5[>)(L$MHLA-K:6?TWB6 M%&%&L4Q9OK:H<7FNR4M7P8^-G4U>RCE0",2,D0KC.!#T*.'-0,L+,/#W1N:- MX"F(F?CJ---#32KVSBZ/1X&VN=I(LP C^/(9Z)XY:ERP?(G?*\[#HKJ5RS!? MQ'/Z6':SV5!A,E(;N]Z6!R!:P4N#?\"&\"-Z'[[$]CO6]#(@0@ N3J,!L M;1T#3F1I@KIZSW:9ES1$%:$TQ0"NXYL51WW-Q>/GT.3O0\";EFS\-T3V8 M(\@%[Q\1_7H"P2C*AW&:@RJ/V#320-K^.0/X$7W,QG%,3V&:V+?:"#6(5(.=%X$I7!%ZP%"N1:8 MSYE&UP_+LA'=PFF6?ITC XH26S] 4>@5$6[EPAZ8=65Z#.M)AAK'.0FS@G?6 M[7;M5O9A'&%MVUM_#V#L,)DKP,IDA&/R:A?>:]XDMV2@JTJP% M] -W ;O9C\.S.\OR60LT7T+/22N*802MPN$0Z#DA 9&S#-'1_U697P$[DZV: M!_D$V #,D1E^J["2 R!&0Q&"*, W7.N9.LO2R^+[KQM*'GMRA>6KD]>I.LG[U:6&E3>+&F(.[N#K5TCU_G"7/-' MHLX#\^ Y2T==/-)*0]T!X4/+.V[23-2RV"GC&]J^WE3?'L!5SN6I7P5MN&K: M?EEG\;T*##<&P.[V]TQ]BV"YID.@C# WA,X-(Y$UR5%$-I!ZGJ79O"X>F>#< MEA=0$TZV%HYA4>):D6EFU .^-YIOU=(X+.B];V?Y2 _ MY?FM W>%N/"#,+QC6-1OS$VO@OY=P=FL@Y0[TG+1,P1L]'FNR?2"A1^4X(J465.T$,!,1)TMCE0() M]A#6*0$SN +6CJ_VMOB8-FIQU^)Y7H< MDT'['*TL6:9-4@X1W2Q#6W8:3)'0I;,\GIN#JIDT]P[K09W2:A CN2=PIL M M&"(.4'2J0:8]*Q*AMC62XMT>IF00ABL/5$C/8Q KJ?'&I9,))O&FPR^<2W4\*TA6A'O[1&'!'DTFJED2\80YO?7D MWUMF[QDEO=.\2O(\X2X]N"JR6W,3; B\>K5 MZ\:SESL+O' I7.IV78_XWPG*E8,N@>=NX]5KX>W?N/QO2RZHCKGTBB^-][_& MU;I9/A/6;QJE@ 5ZR6*NA;ZW,?1U/ZB^W&WK,7C;WGSZ_$]6N#JQY% M;W9X=S%9+?SW&B]>U=Z-;UK!79'Q&N[13XLP-HM>!L9KX/)-/DSO;+ MQK/=YXU7NR^N1,JK$.+Z@*E'I!KH7/WB,KPH%_7X@0K1#RA3C;6=CMN?#CM' M_5[0/6H?GYX/S4[!W!M?Z5JKS?4_=M1^ M]ZAUU.ZV#KB] IZTZK4_=CY\.NCT5/OXJ-_J'L%Y=X^"D]9I7^+9/JOC?=7_ MV,7N"T>?X./3#B!&7QT?*2S8[N+6<(1>O]O_U.\HG*[\^N_=_D?X=^^DT^ZK M_C&]@1T M[P=U"JN76,/F[NY&^^KB@P_R +^KY."=-52Q#5.6Z&:[T[]WYEQ?>,>U0EMVF_6V4 *-G7K94@:9#K]L#31( M$;#R*>W$7]Z+FM7ADK]]>K_*X) M@9',[W6!F4!=66J0;^)UJY6\1HZ" O3-/MNYXY*@RU;#(7?;S9WZ,OWR\^JU MO]K^28N_'Z!@VZS@BWZ@MW'B#&_!#P'IOK\&/P:I[@;IW M6U5T<5W70\3KV: <($-UGJ&%YM_"_[>]O7/K]RDK5+=9NE+AP\'DOQC*P8'M M?!OU0P?!(_U[I'\/D/[=:AGH0D] >*G>H8> M"4VL'O+5,7DD=P;/O!(7\LH MVWKX./OLED_J-,J_J/UP6*39(]Z^VWGQK8C[LZGQ^X>/VGNW?)B?DDR#/UR]N^2P/ M]%D8*\#NH:;J2X_H?5^)\M[#1]Z7MWQ2AZ#FJ5XXUL5WHTO3THT]M2Q\*K.W$L/'H6'@A&(05\Z0OL M0H_^[R->?SM>WRG6OGSX6'O;T46'B_6MT.@PR_-(BF*UO.HY^[;X4#M-1ERO M#=\!U)_%!;UR/-7TG_7S]\M+[M$(TVU=3":H6$S$#[P[-,"WK_CE4W6UQ!,,0?@-RW M7$%!_,!="V>K?L3_W>J!:4Q9&C.U)Z?BZ-$A\WU8?K;I)/I9#LXTWX]IOPZ"YZ=!?=$W?1MV?L[=QV!(\X MUA\]ZP\$Z1Y)X",)O#_8^'"3]K8?OEQZVS%6'R+L5Y!F\%;'M@PXEI8!9%!H MF\Z7ZC=L%8#6M$<#VGVCQQ;%'WYBZLYMQXTXO&Y[O30>4?C9]@.U+^P\_$RI MW=L.[I"@I;DZODR $G5^W>=L2(07K"9S2@P67(2QA._>ZX)G'>$+]7!:-[0@(>*> :4\#;ET ??@;7[FT' MJG6^GD>#2,*2:^*556]XKD>S^%$*O7E[BV?/"B8_;]5_?D4H'"07NJ,IGNKCL*)9C@=I0B'J-2#PWQ)$+JS MGB$O:,$_JF7(M[6:6-[)@OX3JFCTZQ-3?IN(PFW.;6MPWTD;C6OO;?5V8A]V!8RP09V*\:,S=WMM_0+ M_7OG[::*0/Q3'W0<7F(3[!QDOUF19G-5X%N8W3_1(\SC.1X6*;;SW=W#5KT[ MKTEHA(^'LRR#B>.Y2K.S, &^@QVTBU3E>AI2G$(.BX;=;& ?[D80FF68YM^P M"AH+6Y\@?;_0\9Q;O7LOYF:]3<7=X7MZ"GB("S)-E?F;,8R27J(IM;A,S=32 MK9DVKL[#"QT,J?KFD-9ZH?."Q-W4IJ*"L+*LFZ_:D&7UX(&%(FY@2>-5^\$G M[X.FZ@ T J^-=*[B*$=O2#A(+S1 -I_!]](DGIN9P]L#YSF,D+O TMV"J+6\ MF:&A+L^CX;G*]!1^Q>W90<;2 !(&@8FCBVBD1T'=R)+DE?H^S#2!HZ;8:%QU M4V&;=YZYU-:=6JK+CE)NJ-X>I%J]_^\_5.?KD++([,K-$PL=*ZFL[]7LFW.7 M/.H@ G0D68>@;%!1788YMAX'L$J3[-TFS!Y1?H9#ZB3-/$PZ#P'^R=Q#:#7- M(GPEK8S54*F,!,+FA+W+04:>.KQ"J4*4&>$MQD7Q!0]M&C?.F$GM#[-RP@"Y M=[ 86:4KXJ%:PP+?VWG][-E?X9P[YD:8?/G HSCZZY22$ #2O#:D'6.A'=@I M%F]JKBZC.%;#<)9K!B^S%4^&_P#*2J< MI+N7\"T0JR?DS^S*7Q9ND'W@<"S>2,"- =7< M.>4!?J4Q'6O(IIDIZ"C#"!&2R?PPG<6XJ2'(\X FWE*&:2XFGDDX5^%X#"A! M"_"H SX=6P,0_$YY7[01CT/]%:[KYQ0A'@.&!<+5#@[:RA>?Y!Q] 0J?YG*\ M)5FC=-9EY [C/&6LI"HPB%CV.UM:P][L &^VG%B:\4B,0,AGRP0 8RB : ,W M3P"QKG7#2QOT[G3#[L"[&QY:FMW2=0F%Z]LK-IC[B&\PM>96E]=OM\FWTHS? MY-7V#9 "&"A)$<:^#(>(CZS/F\)!H.O>:\M[->1M;[NIUAK33W0".)HA3^M26)+AJ(?ARR[SL9/,3(RP=@2A.2L:. M$9<.X<9& ':U?WK(-W<4U$&C9F4ZNUI5_H83?G)5(\N[02)4?P ^@O*AQ'H M!-XES+B\3T.Q74F-M18.]A4#?G$BTB" _<*K0!Z(_R$,:UC/HA:&06%?RS29 MWJ'?+69A8;I0Y2![Q" KA:!3 K4(Z%<4C4GLA>FB%)283S? N\NV MA&IBL'I'I$F6-@2:KWGH-F44:*"%$V#\,Z1WXRR=T#0%G"F @.[-,(R'2+6Q M= >( XD&PIGGN@@NPGCF-+&CUF<+0#D2&L43 RQS2@ K%'Q@QP:.P)RI\B,/ MP>?!,NA\BF9PA'.N]MYL;P?3YJ2I-CHADNR$D''3J);V9,T.^;:Y<\I WMF( MFKH)RLP4A+*HT)M5J(? 6;)B#$)32AIPE.7%%IUBKD'.'FV!EEV$$-4<]A'5\24)(-6118P@$WS?GTY=3K=E)=:G"=I=9H";)4G%:] MUZPN+- E.S9+#J GA'%(AA &*!SZ1&L2$*,LB#6 -SR#IQLHCS.P-TLV$U8Q M+G3#$VI1T$36#/)V/HNXD>Y8!L@QNP5$@51-86*<#V.;\>,)O<-7,EG*&U'P9)IY)@7PK[S2_#*?P/H,!EF(V\^Z&1X3A?' L.0TW1,DG_P:<7KR.#XTE^"\!:CR#T&T!$M(1I4)=]&E7"3 M6*PCT[.Q%PMQM!73@B'0B8$F?CL475EHIH*1YFH4C6GF(IXWJY26)K6\F.9" M#%TYH5H^8; X80OEUN$YG *.?H.U.D9MN=C6SM=- Y<:N0$GP*2_ "48)I2L MH7WZMJD)+AN[UYI3N3F]^Q[@/8V263K+T0. $]""0 X!H=H8AN'R#>)T^(7T M11"58@!X 2C=V-[>-N]LL.$0(,GOPL:LX)YIEB,^)9%S7*#(Q;X'7!9KZ\(' MT-HY1-/-,?+FUJP +"3'Q GQCVA*Q>$ M+>*P1;/, )<)D[>2)5.3SR4!BEB@*$'"(\RGR%ULO"?ATH^MON+48V=LN+'Y MHFFV1IH[(0@9[$/E3E8-0JSG":M:!DIO]W1(.9X.2('-8-D7"&B&'N&,$?]G M@S@:-@0]46K$!_"_C?() "J6YL./YPIM7\C@"A3W=+;EHT1 *,&82U<",/%* M #L;-QOIEGS@:GRIC_#)($V_ '$AYYD<$!SL1&B9J8-JK.-L%%E^W"6,3#.# MD&$9 ,VE1T,F)J3?F1YJ9-D(P8!QN%&VSQC5:"R<-!R/ 9509VC0 ]!\\!UF MQD,O>1//'S:62'B&P4L8(@]CHB1R>J5C!N18N6NSX*&U'.E?A 85<=( MR%7$WSQ[C;@ *K0SDU^%B MS,W.VL?61>9$*)I &AI66V)R M3"HV<'6A"106XW_MY0_S4#ZJ91;>5W M\H67_JNAVBS/!+6OO-KZ.YO881TC7@N1TS1'!L4? +U&]@T$;I8E47ZNG<$4 M7Y9[+%,^VP@W\=V=YQLC*P$Z1VU@W?3.8[M'K@5: =H$/+&"O()D3#>> Q%' M 80ZS\DLI8D5P*#9F::!\I0]:NBS2I-P -"94FP".1J _P#$ A())P#_C&(3 M0$[",)$L3<2$A'LFEM,H;[Q(F;U]:O::OO\986BWYGLE?2&IT_;,;M8O%T2N M(")Z&*1NG!/!R,.&^L4 I0R4$HWSCP;Z58Z-VFQ*H)M'1>Z>'#E5]1ET]KE@1NBBBX1UN^=LGJ-WTFLH/?CPR MO3#2PY0=R&](E(U!DV(+PUI[SWZPXX/-&+XS@[<["N=-]C5&6E.$@94-\_3P;N*]\$^O=H%88,PG!,BP$6AF^"; MG SKB5A]\E!?X>CP\"18XM?P? 4LR*P(+4*%F ,8 %TI-\$;$#WU&)0Y(O^K M/7#R$8A\I4+4:'-TM:.((1H[<$BN?B(G6CNMV2S&D!J\,%X(N"+H%N(IR[XA MG(/=QJ3GL_O*#1!8U O9=<&V(+I M4N!JUI<:IVH9V_VGJ^><.62<$M&X8QR M-C?(&E!&F**-(,_Y<\+NW;?\1\EUA$BC?M>8,8'V!MG""0V&+IC^[ZV3&L^8 MBQVD6#V,&32N:YYD=[<18-1N4W51;HR&H/2J?#X!;@\' *K/Q^/3_N?C@^:/ M1?D?.UMWK(S]&X1*/([Q#*-=R>.%AT3QL=9G0#2*\8L,8F?P8V)OP2I_<'Y. MT5AG=$'0]?(U0@$6$1N(),JS-"#<9=15\839PB9(@%ZWN,0%@B[[6=HIDP&, MD/[>U<6H.-QL=4']ZI2LKA6#-F)<3D3PF4TBC<]0S;\&HRM1&N=3M"Y%_!S. M)YX';LB*]Y_X1FF:"XG_R4%SL79S&XWD+B".2-&269;>3;#&S[\$UY7C/JV[ M''?3F(]KR''.G[(B\./[);K 273JYTIT026LY%&B6Y#HED5],,Z5<22HB',8 M Z$HHH6,W\!-?HB %Y0$//6S!+R@5L!3/U[ "VH$/'7W IZ'.5:^"TB^@^E- M.A;G<>PLD^L.CH]^0[%.==U-O*[\A?HG>M9&U2/S<:91_^>5I M] [!A>X"8S->8[)I$!7A/])Y=)9P1 ,%IT7DK &^0#12LOW9W)%*D-D/#= MKT+DO."ZDFS!83+<$8TCJ*Z[\!9:RF%U(9K?8R(BF9?AQ\Z '"Y3""/EP26& M-< VSN=3=-HR^1]3!"9*+WQ=O.4"Y>28?KLN\A[S R=!HP]X5IC8$@F]E)<( MGW'EFS@PPRK@L3Q@8GRTTV1"?UOV)3B3=$1+&R+EDM";.WJ@AAH7G5U M:F%U=W"M0.Z.["V*[D"BOJ&#=^_1E\N^W-U'7^[/P-7HW95>H;N8^3YPMVY" MA%?R:XU$H:MIHK4,KE%)Y/(R:M2,LA%1-#_7*$L@422A2S)&>3R8MJD^Y>RV M1%%+WE@U\DAC_!(6>R!1JX +U5#_1*=H'Q14AH((2H"QTUE02FH?+/!\:2(@<%" MZ@F%7)H(>(:LY.$Z3<53$L*B9-8PUHY2[LLGBNA+4(R(32BJ"_CC"&&;!N[4 M<$[O!EDRBU#2(6NF/0H7X.MLFTN^+)L+&J@M+,D>L:>XF/'"NF6>AU^(1LD-3^,X\E:,F$+GY=:R MGA>ZR[(T=Q8D\BAQ1I(NP8GG#3$QQ-$$D*T1&#"9'V0F^=,%9EJ&)!-&%J$$"&@[T=D9 M+@2#TT%@06J$4DG#(+T:13D9B!I!01I]A/2R*% (IE!:%7+@U&_IB *MX/UL M)E HCQ@B#$B-/ _C@KY6XSC,X2YD\%_Z&K<4%3,AFTX+,F>$8<'H5T=-5(*H M8OZ.LD])N\7"$;,Y 5['<8VM;(,N( ;&SS*ZFZ*2PBX$A"Y\C@:'*_S/680B MP^::WE:'9(1@B&F4L3;$XT%NAO\+>D-T$<;(MP(#0@P\DYSUC"R_F--LP]#L M?3T'-1Y#UP&&*%0A9!O,!+90[ (2_E6/8%% YDGUSN%:QV'FCV5/+;>%>(#, MZWE@T!Y3-3;Q!2RRA'X!5)AAK'K&2SG96LP:3KP !*Q]?TW/W139,9:H4&I3 MP;<)I41B>0.\M1(;.-$@_HSTE1R X')/#*79#0V'PE1K\9R\!ML M#H5G_YB-SOAP_.(\R-'3"25,F(,)N-!'1?20^B;J(@* %"EEV#']=@SX0ANW MEV0FH(BX,))4KJK86S.-_@+ L]CZT33;[V&,@HYB&?:P_H#8:B;ST_R0.RXJ M#%(P8 GOJ6@,P3(IF9ZFLT(B.=FOL2"S%1F)W$2^,XZ?75.$KSE7BYX(0X>= M>\E&F6Y0^H+E"4U24@P*\S>VXO,TB8 ZJ]##;O=VS8.U]KP#+$&;7AU M 4G"18?\&744SP%MC0--)(J4ZP.:UEZM9D6*S>9 MDAE_!0(5ED%OZ9481 C+EA 9S$O(I9-$R]1K%! M5LJM8:FJ#-5,*52PIN=TW?#$0SC*,U:$.'BFR_[WDE5+RBL%;6/?H5)$,R_X)TI6#5ZD09*Z& > <6*9Z<;.]M]L M&J7W"0,'IJ,JQ[8PM "O <+"L.F51.W838L)#E)!Y;B'+9+!C/9CQPDEEZW]TXKWA SMTJ@'@R\,E:P4;(3!X@XZI(8* F# MH_+)+[=L>K;,:F&$>ERQ*B1?&EM9B(<.**9'RCO$'*"2EU"^7("+1>W05).I M'5/Y8UK+E!O#9PKK1+?N99&$YX\Q-!Q#\^PQAN8FE\;_[WT3JRJ)9>LO#%VO MO.2:9%W^-<[Q6OD&027\?TE6 8-RI;Q9GUUP=;[H7^,PSDDDK2:H EB7Y*>N M)U1N0GY=VL?:4]\;Y48M)D/]##)\&[E1?XD#?:3"]^:JM:;$Y/=WEU:B24>K[6S-%4Y#=8FQ:4R.XW"64.@AY6=*D)LX MU:BH.I#1W>WMO>:JVQUB3S>OW*.-9G>>C8+JE5-\BZ&[4DDZPDXXV@;%^/%K MXB7YCW R?7NBGF]O-\5U1Y.@#4S\@#<:,/ &9"NK;J+][^=8.*[$5VS2&252L$1B#M74&K8> MN96(Y&I.4+K[LVTK0$AD+5\H RM,1JMH *X=6S".(LQ"H.Q96X#:2GN-Y4/6@.-, M)SH3GS*5F/_G#.LZ^M6X?Q@W^1DM5V#25D*-QS),Y"#ATQC;Y.3R:5H\%:H0 MF/QA:MUH)*2; 'S#>O8ITWO9$*K%K@!QZEB:Q6YL[C%'N;;<*TMHEQ7MPN5+ M,$4D8W3.-C#*%F1TC#WGL%D3H. OJ*%="N6'$F+:P((D3%""A4XM MQJT!_,EK3;!J65CL;U2J^G,V>;ED 0L2E DO@MHUA =?9C!HS(A.T;*E>3U-NR0O M6"E##75&)HOIK)">&I@ :(+CDD5!N#H%$)_85%F09A&9GD2SB9J&$1$M1_A1 MUC<3FCG*M]G4\PBJ\][^R=%_]UZA#ZETA%N[>Q5G46E:+@$X!>OWCY^FWUN]II/RSXUD&5 M=&DD@!:@#3)B%*3>2#Q!4..-3W*3#\<2L[DZMA3,ZCOD]1@3[8N"W1I.:BI, MGW%[2X)Z9%T]+/81R6<3FVE+X@:P1'V!,II$U9D,"9R<9#>*/+M ]> ,8!@1 MKG%VR&8S0+,DMRR:94F#,^\62P.ZZTGZ,*^F2><$2%QD>-2(Q(_W:8WN$^OM MRZ^4=U."&]\4&/R:-V4)6:\=-C##WOY-43>\*2CFF=7<_4VY#Q+*C2):7CQ& MM'!$R]YC1,M]1&;7W2NH+! MF.G4)9.1I5H,&$[6;EA/H.9V8-37B)I/>-\Y_3V@82B77@)G,<;/9:AAICR1 M4EMP9='4@JZ<)/7ZRU/(.H=UDOM1UM"PN4J8%F"?GYOF2_1M@,4WZFT-%=D? M34Z\K?=QFJ+?_DRRI;0Z:)XTO>27.2Q*!KR"3 M&= Z_6-L";,U#*>!2YH'V0;XAF@#?G4VU>4.>FH2FYM&_ M^'I1X%]7K /:\RV--/C M7K;IQF6'&O67*0J-5X\K8H1P?9.MB482P"$'7#B4(6*$(!2 LHAZWMAZ EYT M,LEAC24[QHMO\\'5121:5%.=:A*JHF+&CH/A< 93 ?^1.IS_M#V**"LH.4O) M68G6&Z M=F&S%$KC<3]F1:B3F[/VSC67/'O;1IBC-NB-S(FQ;A(3AP B-Z:SR:3!U9.: M*@W>Y.4"0B2H6X=\G2L2P5E9?Z8IDZ_@)P%=F[P0DA[/3;)!"9/I"Y2W%\>* M([HX G"3DM"TRQB>IVFN<^\K[N(,6GLN;?\6_9W2\M KRCF6*FY+4MDOPI<;05[*&J:3BO8 MZ.XIIE05IO: VSIRSIHNE!&GPH,4D=8_*?=-Q%0Y9\-G[;B!G,R44DLDKZYT4E%NN@F?@S!K MA;S27:FUI,/K-;61-_=C7E3RZ7N\RP*A9X1PCV,$4"VID:RV. M=%KMCVK_T]$'U>VIH^.^ZIT<'_6.3SL?&JIS].'XM(?_ZAT??%#'I^KD]/CP MN-_Y$+S_T]ZM%G[;[ZG6_G[WH-OJ=WKXIB?D^R^2L'_8^GL'YE*GG9/33J]S MU&_UN\='#=4^/OK0Q7_B +^W3D];1_T_81E_X<:O?PY*"+"^H?J_['3G#\ M^U'G%)[LH[<5-P'OM([^5(>=P_>=4_P=WE(GG]X?=-LPW6^MTP_=H]_HQ]:' MS]U>ZSTLN?\GOM@]^MSI]?%I]P@[TWTZA:7 7G[KP!2M@X,_:?XC^I:F.FF= M]KOM3P>MTX,_ WA&@[KQ\,_NT8?.'[36TU;[[[#OT[]W^NJD<[I_?'K8.FIW M$"9/CVFAOYT>?SKAK?1ZG3YME_ZEV@?XOSWS+@P'9];M?.X0V'L O0YL_/U_ M=MK][N=.X%[#66@=[UN]KD"I]ZG=!F#N?SJ0'1\"_&&04QCE-P!V"^8Y 2"W M6^\/*@GZGWG8^M@G\#< M]R< 0)]V>6OJ\S%^3^#K?6S!B5.79E@W[@#>[QSU\'1@C';GM-_"HSAM?>@@ M4'D ^E,=M0YE0'@3L3O@4_C]8Q'(,*,Y[:AW@ M>2(X*_A-:/M[M__Q^%-?\ @!?(,M!LNW*+B#2-5;=F4^MC[3E3D&3/Z-P$QH MA1<)OSWJ=#[0 5]G1<&50)<5N=MEUP=( _/"1>UU/\"UH(7 21B0P@$9F-)9 MG5J8FFM'AU'>96!WB:>#-(CN)I >N>8R-;YFWH"5(IWJ(H#WZ=)_,##JR\WL MGM!)RI4U*^0E&\)P"F@E Q\>?SKJ!Z6]"ACZW4-!/-I K_>)KBX\[;5@^A+Q MJ9_- X.;O/-?G_AOP#5&3AJ$CR' C<+NWW<0V)\!X6DK"/M6[^,-L 3F!J(L M9 E6!Z,=(:& 1XC/0@KQZ(@&$!UF.H5G270-KI6W?T;3]62&/V&>-=G140>0 M"3BNH&2C*A$@Y7'-X\:A]\(@Q#'&ZHWSZUD/%W.DSY6VU@ MQ:WVGY;]?>P0A3F *W9$8@'$GAR_1^;)/&XINPANP*,;_.^/("-6V47# MG,@Q80=(/CU>/"R;H 7R)+W]J=>I.!G!M&>?4M$. 96>8 >!OQ9EJ G!Q(_[\= M$RN'6X, _4PR(F&\N4#!HLA_H_M#-PLW6,"&F^'@&# :5!4X@-ZF8#_^7L6VZT&L0?M7W7V4 M+;K[>"!&?#B&J\V+1\$!1.N/2I;S8#M6W\@U^O+1-=K[QJ]I^BZ:+]9 M7D_5U))$H^,AV<[NH"OYC^D34I.+M:Z=05J+(>/DYZ+8^3 ;1?\BV[Z))B=; M?T"UC#*_=A@Y3[""//56"!.O4!-90\,XSBOM\M!4'5'<,_E'I#XFS%;J\F$Z M 90<*&QAG&,0'Y4.Y+;,;@2RGY-S'(@=%; .8\R_#&TU97(7<3UJJC0(@Q0Q M%3EKUL2S4UZ)K:D4DKD8J_!$FJW U?7D7I@AW+UD1#]@]<&\4%BC#6M?$-A)LH9E@#211CCWU*)&=]&YSJ5]\%(>LN.SWPLZY5UX=Y)5 '@/S$:.X]XN4 MLJ0&HA8[ K3H)_H,9@^E$%9A\R@J[0%,CT,QPDM/""DC5:INY0?]#V9SJ5F$ M>64Z:TIZB)>^,]*4QYT'IK+DT[14SYRK52=JOWW('B?<_517&Y0L%BME3\2$ M"WE)3!B5S<3BK>1'-5.;BS*,=8@Q=N@/:<%;=][J.@IH$F(4:GDP)V& M<_('>_5!^5PKWPPTUFW/N?L*>EXE%9(*:%'3!YWAFO)<)@:2ZULPNRTA[C6(Z$B.1T0"]\+*K#^D!3+TT!:% M7GR/Z22%"L U$NPK$U!3:U2"]\F!%YC4EF$IH\LQENDL WZ1ZZ7/0&_732YA#/N&ZL*;2IA2'#>@B<)7]',DXEI##4$_"46)(]$&5T''G3*E: M6M^XQ/R)F5PN5DK<_TRAI F&S@*\)7YNHSW.B ML#[3K%LG?C.8F\^PF>-XC, AM$#8PG,#;.K^FWCD>T$42,L=&"7PUO+V@4L. MX^03J;O 69UFJ1*D48\!=)!8M=]57:\32,R21P3"U'/3,JY0/H@A"BNV#+1M M7'"?@?22(LGPHT&6?J&8"RS./8GRW):IM5O%CK,VT9?X+? D=@ M4D)_HKC%B@@OTC#>4!#0>Y4H D=R2'5M6@QQ6BYJE6(,^%!CI @%7 ;R5T. M9F%CBL;Q;"CM;TPZE W#"6M2EELCTYJ#=DFA"2EH2X7I@X2T4'H3U:M+(R9M4[Q4@,\!BQ"F%0#E1)""L('F$TR4I5[,>1M4BL&;M MYG<7YE&2BQKW!DX9JUB?RVDB/0Y#NFZ *)XZ1 MFIGX9 8I*%B,ZSBQE&)WR(P1-#X&3C% M^"XPD4J*7D2IH(K0O LEIA:$[I" M#7V/)0M6<)QGQ1C? :*8:=L5E25_3SI,4EXO=RD88*3,B/4\5SB.[AXCYT#/ M4]/]E^?RJG+("/DLGW(O/,2NLB*7>T5<2[L):#>+]$@ ,:1\6[PQ-@&09J<9 M] 6)H)1M,ISAP2X 2E0"N D%\Q#9MVG>3*7GIQD5KZ5T,B DTT(B)FW@ESDF MIT607NK5JA<]B0_-B,M>XT0BC:C!=<<6;-*DFB\KKRXR:F+(W/K!U&]&I,[]*U7J3>&R^(GHP9:UH23R6PE JXXX(HITYI- M(.12,"R=V9=A<,W24 I"), H!"XSA IN;(6HS8B?8M:R$89DKPJ>_1MSGMO2&' _;9;J) MT>\:4KD'^0"P=*GHC^X*&3+B38" M#CWWVZ> [*=#%/U)#JJ*/>(#05SG^REAXG*5?($O\MLB+!?)FNJ]Y@:YB[CN M&V'3!(]:Y9.0RL)%,H??8[/@NFX39J/&5DNXQ;HVO,!N$U'VX2WJ(7KE&I0@1HBK.:$/YB*(X;\%8-("L#P$B<'>28&R-1MCXSG< M"2O^W*@\6'(,/F5JF+;AB9:69=BA=HF+$SDQ$>%+1!:Z:VA=8I44V_*.,%$" M( #DR*HE4O^)7T*(Q;9*FC-PFF;%6E-O%$#Q MZC& @@,H7JQ] ,6#1.9#)DEPYR6MTQD #).P=3)0+ B 45".TF#N:EA<8?7" M#CHL+['%O_)XRTIAO%YJ^VTDXNJGHL]9]QSH;D&=P&<4GO;A9EV3'S$D.F/F M.+Q(,],L/#1M5U$:,\Q)Z/V%M ZFU%O4$V5V]"0'D1,I/6N%!T'BM20'@["' M&;K<1AA=MF*>QK%L/6BG.'Y,+Y&[-4PR)?EFQLP#Y'LQBMBZ*, &?9F2I05K MK_$5.\KZPS %FVO+;H8,N6/N>?6LT0@]*U*@"QFD"*A*S-NP?3WA#$]*\]6C MO!%PZW;9H5B/HLE$CU#VB^>R"T'"9(UUPYJ64WP,8Q 71,B>3.F^<>_@P'?E M29/J%:J\ZU?58)O!UQ"& ^4%QY<6VKZ?L7Q]//ASZ 4*'.@?Q'SHS4:PVHQ0 M)A:V8[6YS;0CSGPMZX %6N_P[HZHV2\W*C6&;!=IT)I@=6\R'L!",/'5.?TK M4UMEDZY9@]L8DVMN*!$MVEZ@D$"#0H\E@(VR;DP]53-I:%41B@*/0#B534 C M+A#%5S2<^32=F>ZN)9%6^[QJ90"-B9)-.;(-^I?=QYFDY@K-6@^(Z3X7 ,US6#9*2H_&O\EB=D< M6V:C,D-X'B.1SX,-Q'GCQ6H89FXF17?+% 8")+1F66*%-(H0 T3;81Q&$YAD M%$Y@'O@'^RSS[45=*$D"\$L1!8S#P7I G0I;Z)_ TI@JUJ4;,> MZ2^<)!S90TCV1FWL;/*YDX/-D1 ?HJ:\*NF1"W3SQ6/B5RYF,HQ;SH>'4QFV(E! T.7LBFC!627)L8>EU;M M_7[;Y#>1 <=]S:TR18QGZQB%^\;"[LAH#;]D%'F ]]\9AXSK$:C$KG@@IZ!B MH5L5:Q$ZH'G-S'UR1+8P5CX$Z%1/1TI^+Q@?U[4[@G,S2N&>F,J3Y>P_L2TV M,'0+'>[C""W;;*T%Q'K#BVU].+0--7#N"R0XE8ZWF)';,URNH5K&D2;ZCY)=$18CZ,)-7B%LK1\%=4'8:TB!D%RXD3% [%F2[".$]%Y\8KS'%7'#\969=$#@>D MW1EZ^G^E^K3UW8K2.PRQ@BLF";":?89EA5",0' &-"SCAK-W<)2?H0Y]+*K% MPHWXV;P06!/GF8PLZ?#>ST5QR3*.Y3%QAR =#&>V'):-9EXTS]9YC[PM- 93./Y5+_%BU7%"22"P MPRDS'&D9V*1X:S8E\7#1">6A1.X)%OZ9YOX).FRP? /I=H,34R;:9 3@@Z/] MEIRA!5;YA?;[XWY#M0\[#77TYV'G#_(B"O<))N$_X"]'GEWDL[9UJ8Y2LT0K M2AO?1F9/*H1M3Y'68)-S'V&<(2JO]'>FQ9GY@MYLL 6$!D1+>41?:\U_M$88 M.T<^./R47R[]U#<)!RT4_1O&B-?&( 70ZA.[#[OBA(7@2ZKK1*Y57IF)5D@Q MH$ ,7;1P4$60D%)I7) LD>&/G&*/5) M?U[G:ZH8#(^CW!NN_GN0.OXY"X<2 MUQSEP4F64OS"C/RJYBTT']BWD$^[_#1DDUP6$P7PR&U9U&-N4^Z.V)9S&B&+ M0 3$="<;A64N:U I^Q11*%:EW\A" Q*F?H!F7N,D.7HE[8_0"1:Z>-'*9<\Y M1I43F&#A =^?*B6I?/7 8ZN.N<#S^@92M4QO J9E?I>6@JBHA)5+M+J[C%,6 MATFY(GNSX3E^0X2&,[E1OY79W%YSSA#(M G!=\)K0YE:CWX&G21&S6T&VKP1 M1-S/Q*9!^&-8H[FA)_ZZ%_P(H?):06PRM1+;G+^(NN4&PKZO.0^VGI!IV(/K MY2FP.]T%EW(.7&E$YGK5IA-H[Y-\CC&'"HA9@@QNE/720..9L98JWUI::EQC M^VB)68&7)%LT94A+R3 EMV]0#N=>A<-<=AJ9$84.&^@>\D8^B8:E^9Z?M[J0?T6-&#KR1 M12=&D2'DT;V';E%$$NPJ*O%1+(*:?BPFWRXW?)8#VR@%AH3)-#L+$S2U!&Y; M)O@IO BCF*Q,U330!3&2'(DN\K&AO+-WUOA2;"IY4&K@:Q=B3NA3@JJ]V 4* MQOE,FTA20@0;]&\M&^8HVX8%M]-L*C4078 X?#\;&MRF' ?*9?42'VRFP/XL MPZ_0K]D@@P-E77!?X3 SY4*5U]_&STE>A408C@BSLV7M:1=9& M*4I=PA;+4>HFUEU7G2(2_D_)47*S4L]XFGE7TE!_LJ\$8DM>%@%5]1P3?;:M MP;#30X:&QX8Z=QY;6(O?M\W&N^NZBIYRCX(9"I8Z1T,^+0*S5Y"M4D"]QFYX M<.9DQ[>69-1(R1,;::LTKL(1V"0+O86VE>4%9<3S70I_='8Q3&M#'FGJ.(]( MA[-IR$R]D1$X_4GOT8.,2! M0R\? X=^3@F2WF4X_4ODEN!&A=VZ"@]$M"F& "DT,S9R[>@D*+%X8"X3IL34 M#,YZ#FR$JQ2V=VPMETAGIV:(!(C&/*2M["ERJ6QDG$^D?_(42>>G4+GO6.FH#"V!4_[X!#3K4@Z,@X($ M'\PKH^\X\(?4"58'1F"SJ4;AN4K4@EK[TB,11H MW@SX/(GS<(J,>\A6*60N> 3,L% ;@V,8HM]&N+M;XRB5'#9:;'F_7&)>8L8\ MX*WG+<$$#PMN.EI?.)9&62@<(XXAU:!TA:]>SQ>V&Z!$7J^;EM**IAA$)EF$ M)6. L9Y5=,0&1[Q@66])#R;=*LT"ZI=!NJE4!1#[Q0:NR88@>$.I6)\UQ$W9:OA<)Q+I42. M"W[!R0CB?D4+XSU=%*2*M"C'U]N@;M+4 S/<^F*J;X)9\")O<<,-4^'(=AIA MPE#V1!G;A;-J^(CBM47,U;]TEJ).B&V6J..).)1)6$:5!S%TK$E5<#0$^ 6B MUI1ZUS6#OKM29%ZPQ2 DL"4D]6DL;5A$27$Y])QE7ZIEX5U2G-GG78QO9QD6 M/C"7D[LDFWO+%-[KLUI5DHL:A#6&(KD!HQ8 M#R %$U.O, ZQH4 ^B9K8S"YZ)S&QEZG)^<54(1U.I'&(IDPW'(.BAD@WO41"P61K28(D@D/IH\*U$@'I;B%P$ MF?,)2-<;/\( 8RXX6&FSLA[<<6@'DF&9I9*]TY7*&+DOO53%%?USK!KL# ,F M>IT\^K8( \UL1R3_Z9S,X8F- L4+A.BQIE2S9^5'XG.$.WK!TH(R$=J0FD'+ M$3KKLK=!MUY N!=$R]CG65T;(%\1?4S9)642L_S8-!%>0;3"Z^.=!5 H[ /4 M#*HUP#*^^'*!BYMEC_! MODADD:$B3UC&:-D:F^I38B1FEHD=_3>UZKB##$F36(!F2DFF86U,IZ$\@K8X M(@OZ3A)/4D%MK_!0)GF%\TH;/=Z7\<'@*I@.K3.:KRH8I+R"0<&W%@PRP;!'DN,V"7Z4+AG*_.1@^4@+O@=*F+6 ^D(VU]Z0A65HW,J^ #XE4D,113W)^Q=JW'TBY2@L6U#(T,0\.["M!+\VD M[Z&_CH:'UI@C2!8\*7AG*G8X]]^:$I7V0N96.7&VBM1!)7,$P%+)8,A*0SF)N#*C5FDH^CFLO4.B'E!=9M,5/)#TJX"("YU$VD@=#$Z"G MJF6 _8&O+ +<7;BZAJ\ZV%A+<%!>-)9!HG1:O#5" V8EB;EL:I0Z)O[50R-* MKO47@N\H"R_#V,3Q^63 !@DY& 4"F37%U1LY'7>V'[V.['5\]>AUO(_87$MY M%XB5#>''A'QGHUU%14W _VKJJ993SQ44,*A;H_.*\=0WI8'VRYN0OJ!,^LRV M) _#*0[ O[U:W,CB)7*&XJE-UF&M,=C-N*8$]2@M<-_62N3IVQZT?3&_82)& MQ6'#0> .D;V@M=!B0ZFJD(D+Y$(_MO0"%N#*<[,(7ZP+/=R@D$0T<8V"LM0^ M%PL"YLSEPRP:F*;+?B%W6S#"30M*-B:14=B2E#P.770>.<2<'BT%(-##]T"C M=J)WAW0I.:O)K\BTOB$1O&,;[N?5H,)X371P;E$4[T@/2L\#%S<1>A&_D[ @ M]RWBQK/7+VUD _GC*;F<;6OGT2#B6#ELP4)V)M&W19D![7+ITH1TH7>V/M_1 MZ24-/T0QRO,9,Q+W+NDT4@\376KIE'K0 *YGIK]\IFT1>VM?>K@H[@#VP=-( M.B9<=GTQW=^NEU#L=;(@+X )6PS&X=!$6-J*AC:(QOFU/J2CT=8^\( OJH5Q M-J9 !@JN0*$I(L54,WQ$DKQ'F5%2I=7,X)*HR"=Y2"EMIK>22=(.9*H1QW3XMD5KKR**4=^F MB2'H$MVXO L'=1O/HXO87AHI'9@"_-0D8:A06A)<5^:KP[M5S)O8.8MA;CDY2'?8]5UW'^?CL>.]OZX M;X)4KF#6-5;1=^MGF(Y %E$OC4^Z/35#@A$G/I,Q\,&$/ MTSF'FYPAYPQ,B?[<5,_G*@FV+8.]GZ769T0>J*@^'#\F/7,N >72F!!!DAVO MW[XI<)VNR(7.W61J^V.)-=*1@DI3)S,-OL3,UNIO-#2G<+CX<#_"WV0+F+06 MBL*GSBJ-BFL_-+T-TO2+N&0J7;!DUU2;R&\NU5]\QS/JFU+<@"?42R+'L"_T MNDFL&M)?F[-!J=(N_H6KV)32A:V;RZ5,8+HW 34:P!'@>J*?$;4LT@:&\H6R]Y.N&QV%3 M,90I2A5E%M0V^T>B-\>S&,1+Q2\MZ:)D G/,&-*0H\*JJXGLH9=^9(\V,/=/ M.B1A;/"206!-F8195 Y.:H@/3$RL<9DRW>"#<7G*$@X@-="F7",E,&=I8VK? M&AAX-(EBM&QD+P?9D,Z/838RC\LXB3(OPUG*!M@^6F6R6;I@W'+-$%A[<:Q3 M:NS?3:$K8#S20W(O>F+C,FP.#"9*1\$:N;DFA(#XA"0+89PD5JWR9V4>@,8RJBCF MU4[PFS$X*3#-@K)$[LG/-=,[,YE7YGJ)+.J17O1B>;-<:#/+O.%'=@0#OL$+ M/9=@0BQX)^MJE#NNE-XWV9"V(-O#UB-/7<6COYC.>(5^XJ&=JPKE*8SM3JMA MC-E<:P3_Y2P2B#;$YDT-6J3!Z( 5O6],49)V8&I^5[/*P"AOUEN,M,[+L]TW MQ8U8JQQ)?JM_WHH[N/V-PW-($Z-7V%^YTC RT1!EL#PZ-,QC-G MJ=/8!.(/E_451)%?7!?"R-DRNU!UC^F'C(KJ(CG092I63B\P5VO%JCCNI M=IJFF/BOJ?*1J55JA5R[=R*>NKR>JLO,EON24L1>_5,L4.I7_#GQB@N2:F0 MZI%A6]0U5$N6ZXJMX$>N%E2JOF@]E?)&F$YE8OBQ!";1"LHU'Z;8+["Z"U:X M<9JHD)E,PV]:%@=W4X,]T)]@56/2CEUH."L59UQ-RF2')W/[6T)-\P(3#5:I MD"P%H?2DL(25(,25$6\E%Y\ M (4&L/8B,K7(L,#(!H>L;MKB;:7!O9@PK!R%#=31-L,FV3 )SSBM!#VTY'HM M9^C7;$6BE1>_)KO;S:"M#<.8J:F,%0O^R3EIH(7 M^*;U\3!4ZF#MUY"O65?-HM1EF'O0HFIHIF 5%>HQ%,5LGYIOUMX*UP5GG!+@ M*(8QE-(+\M3K![ $WNLIGO19//6("[:HD8909#LBO)0>4('+GAI'16(.WH4\ ME]O?V&@$U\Z.JPH2ZG,I&5U@\1%7;-!$8^1Z&F;)](P[/!-%$VG$TP=F1HRA8C M9,^0PV'A/M 4L>@ZIA:P24\*J9DT 7:K$]:;@D<27>%W0F>QQNN>8 C@1K54 MZ1)RN&E:^#4"[/E(5=%,?JRU\GE&0%OX'9L/E%VBAJ?9*4LJKZF$[&W?1&4F[%)=01?]#VG\*K81!2F=L$U M]INJ%!R4%UO2.AK$@1MLIASI,"8OAQN4I5(*S%3X%)INU/4 M$0+-.$XQ18J_Y!T:NK*D+.Z&MN6T@1< "IB^/V7J0 ;@BA,,/M_DHF\)#<6/ M.?G8F]6SJN%;]@!L-6AR[H21B828HO+(Y;B=0#(TB78-XV[*9RB'N&R5-24= MEK'#KD5]=*P9=L_A6.)?"P?8Y[&49FJ]=AP)XS7'L?WL.3?;(./ WD/.K:<; MQ(T:6*6DB^L[R>M\X5Y>IC1:#Z7"OVF00YY/:?"81%.V0?*[S<6=$G)7%F[, M"53R8T()PM(S5EQH>?0O;6JC>NY(;N;[&U27+RNW329LN3;K+59>;>SS,*8BK*2@4T@>M:FW MAACJ5!]+E3RC13<6/@ODL[(-A]S$(RD.+BY]&8I(^R76XQ,0FU6"B)-FA=14 MF"RV=UO3^VB[#]3TOR7_0FU?T, XLZ_A8G"Q6^5F%1:9O*XK[BIX!I6'ZI?Z M0*U8#^@*KZ]CBMJ.NU#.1:JP,0 *Z9<)*!9\+;E)A*9_B&1AY$DL:&)+@GEQ MKYO*W7V7PCB.9QA%(:4F.2QCH9\QUGN7&I6NS0B3=5LG%V/<8^T*HE&)2L_* M!\0Q+RN6K-%CFH6-T1SK3$0.H+UBT^4.O31=X*^6:;V7$$M>:)*N4)PM?B-I4^'YUI23;QPR2I8&EC"06*\3.E4%&"DK"E:P@9ZGIKD M8YH%6)MI6M+@D$=A6;02AM[G[A\UQO0"!5K>(PG:S[<;V]O;R,:PUEUT)]GA M]ZW@YL[NHU^-_6H[VX^.M9^4:$*_K"]_,M'&G%*^6&] FJ69)Z:SKU@2J"## M; +J=XPDTQ2*8I%[,0&P+L7:FUX<:35&UIC&D6>,]! - M&<8R>*[-KKGWJQ>%)"O)B37ZAO%RC!T6O.!7 P,ZB@W\HDUA-3]$;Y"2!ZK MO,MISO&8S!F]IC_^VDOQ?>/2FXY5G;O>%%1^!<./UU4?Z'M([Z2JLCXT*G>F M#!:KO"Q(7&@WT39]W\6\F2032:]W;XO"('4W/#7#Q'4O]%&P7DE7I8"'<_UD M/5=^9IP_4D<7HPS9J923]IS(GD6_!NU0#(YAN1 .WZ,SXU R>$)H$L9D68P< M;MDEK2?RO"<*AH#A9F>3T-EKI!J]R=ZT2!64S*P&]SP!V^NP[K5H,Z:7RY#L MK6L*T,-%.X04C9Y,*4,"17NKHTAI*+@YK*^$B\S%.<2DN:B7"24E.&+QN+BA M;7I8.%?>%)+T0/2Z>N$Q"Y[L92,7+B]M"2)Q0IT1L<^DW%92LFKAG?[7ZP>58FCW[^?:3]#@J0G-JB4>[JQ MQ#M84ZG7:RJ*@+!1:B.M@2XS!%R;RT#:7#;4@.K>@A-#C4DH*_W" MWIA!G XI'02M X"/!>P&E7K/X8H-'[G4Y"5>5LLX4:0(RI-(YT!>JBE9R3L@ M-%_[DD\DBH4@965('5A.*H-(TATR)W=PI3*&DB;1B5V2KFJ)U*1GJM)R':%/ M7.YMI1WXDI=.7!>6C_ :1K&P,PM(%->W]OJTX!JE(2"Z.S-=$P+75._G"B.I MV !G4]U)&Z+H@"4K(9M@SC&>3)5),4BSH-9X[7F=;1TJ6]!<;9C(,:^UDW,: M$! !JJY/XR9%2;)R8"_91*R+0MJ#^H7G7B,'HNVPZ"QTOF>3_!(E6U\B2IPA M+6I>KMGI[:R!N2YX3=+Q6,3MT,^GP>;S%)#ABF\,=)Q>;C:81X2S4OG=FJ(L M?O3\P$I[7*\%'2SA5[J;0^G*2_$@ALES]$E8!*(H(LMRY6@L,Z>2FUA9DOGW MFE[N[M@K[BM7TSJ9N=DO*"+^;0FJ$;"F6OSRBV'#6NB&5,J%HO^/*\:P+] 3 MPKD,8E5$XG0/DLBLO&"SN3O[[=,3FTF.YGQB!NP"=YW0;4DVV?*2A5^Z;J(V M9=F/P@Q5,D/G/*>6S*>GJP8;J/B2+@TO%1_B(ZT M^$:1UE<9]'I>FI8!!8D;MG3JXDTBKS6%L@CQ6G1+(26BHODS;"SYKU)!1?$\ M5<.%W2$V+(8"]71HB2@:DF7**3))4'>5J-O.LI.GOB)GE %8YS99\=U")U#' MC!I!B;484N!;O*JI3^0O'W"T*L4F>]9'>Q38@8@#;<@G3$%*/(J."IM?[U/W M@$N%&@A-L( 496J" *"9!_FKLB^*U=6+"'=\.=':@3_RKH?-,Z^+$@^P=^= MRR:U"^B8H6T+I #AS9-IR%G7M"[+>5-GZ#(0XXBJB/H8#"E^GJ"$VFSB!;' MG!>1ON2VWZ6$5ZX11\-[! \%;I^@5O"?(,.7(/?XMYQ=N A*L\^SE'?%&@)5)3"XF3.J6/[OS[>W MR[94Y@EL5S$HS!H'[V@9TC";)+AV_&:V%I%,;&54Z M$+%S.:W,'1Y%(XN796%6ZCT64C%YTY,3J5L0COXQRQ<%Q7) I&WX3K1ZF6"% MZ(5QJU/JZAE1>R$,V#0>$#2JTP"T#HJ:XMDIN\65;?"775X' I<^]AIB+86S MB)YSD>>X519:LDJ:1BEO@H6M@!$#59^AB1)FY"\BP@6/WE]HT)VID-LRK)#F M]+%O6)F0N;HCOP7W"Y>&?&M* &\6\/#L,>!! AYV'@,> M[B,Z(R6C+B) B:YC'0O$FT(VS.M;RL@;"O.8QE[N#=NDX.:&Z;">*\47-1JP25@ MP<4(NAA@CW^+XC7W\YX0/O7+XDU?=^FF;Q_C@CO2("P*CL!#AJ!)@QNMLG[4 MX8L$Y $5H?):%8N1V:;XF',CLY4W&JS8Z#+.B,E5EL'5(9[/]*05#@;VC:FM MD>LEF+LNXP:>5E25Y.@(H_1M4R)<.UD]:0+1)?T]"[(;&QAVMO3SV>LZ3Z59 M)07&B'DU8Y;,+7-RYLOW(3>X$'_&>G)U\A\MLRIB1$\IP2X@'9#MP5L2]RX[I<+ E*N+EQ=WXO;K(I:-H,A) MJH&97?UCED7Y*)+C*!V'EPL5*YKJRN.FHHZ4BG*9$.]"0=U6OW"T3CKD)ISB MA-DG_$:44)@5J<"#,,LBR@3+N3"7]*:E!B3AE/.OB;%@4+1D7)JY2\6KS@"M MU_0"KCIP8XQG2Q-"14+P".D0-\^(O8]M[MR6R]8S'#/WVKAYE:E-DI,_)ZFS MEQB%6&>-^$M8GD^D]K'IQ!'"85'':$HBC6>R,[%B M% SGKHX5#I=@1U.5LII-8C22/O=%4+:'9)(N:PIKR*DR;HDJ;.M!+B-$ZWKJ M7KK2==SE9?\/.7G$D0IR=(*Y(2L.SV;/&Y]%J9J?,X9X/Y>9[#.NCR8V-%?$ MU:S>=/M=N0C+4!RGG(A-W;@>R0C$V8EV)6N* "S^F^IT[#4O%:!O9ZCF!T&TG;!]I,]]>L2E7J3FM[=I9@+]G\@CWJ@ M24)>?)I3]M8W!^.8>UN_-R+N!PP>7-(#BT5=58P?E7NV],\-VT.6D&&YT0M9N$8OVD^>-P5FREXS$'T@OQ MQY[2$>HS8_;OZ*_A9!I+3&G'JU?+TJ/G-F9/KKG5Z"&QBC=7D9 *$U;)IK#4 MW"\DXR](RBA7@BZBW/7 "4MLHR_1%2I-<&5HW M"BPD_2@SLJ=4PS*77ESKY/^ F=V2%606SFW)F6E@1T=@9X 59\0^4=',VTE MW?)2'RBYOY&+9._112(NDMU'%\E/JER@*]4&3XTZ<,(ZQ/J**L@3BQ1C5XT7 MQ5>%1-2@^ Q#%@,3 ']%4,#R"$*@S+.\RL$JCO('7 ;#XR?M,#]?7]QI4P!W MR:?F(DN)#[K&H ,=F,C6S!7I<2(=&-7Q*Q MWDA@QH9)$*$6F]CMU:$25H["TX]!62^Y?0-,@#:PC,=82 M&1]-!K,L9PF;E!M;()9"E;P2=Z3-RG1F'[(,UYN /N*135R;W7.:%0"%*&T& MK:(NR+Q1,C:[B'/*&K (3;#R:AT"N)JJY5+TD>WPQ].IU+LUU;+<81&&E%.W MK,PO,SGZM@2FLZF@OT47KQPVX,S4]DQV_2\G=]1 _<XVN:M\_,_/\182=[/.1K*1<\CT*LST M>^8M!N/[Y") MQKJ< '-#A=\W%O<3+*/'QK+D2RS<.\DUMBOE<'F]RY$Z[;)3P=6$:4C4QY0*B$E MMM6AX>%P$&^X^8J]=PDWJF$M)DMUVYYOMZ%Y21B0E,"B(B1+K M3PR@KROB]=7K>:DAY/4/UURB7 M5J*FOX7GZ-/2&-/& =;0668;4O!B;BHLH]F$5<]GWI*8^A. 967)/ZY0IDNZK,!CA^V?QR:*S-@ANP@YRC*@0PN8ETI!\N29EAJ'$5%&1< MD]"D)TK]'(*0"UREJM\E>F!PFL3Q];_\-H4G(SI8@R'C-[>_+OKOWBLT&=\$ M' 6[HX!-3['X67+VZY/M)_1W/B5W#/W]C4M;:71_"Z@X*LYQO.V_ 1UDW9+,8%6FJ\G YQR-D7Q/,TF/ ' OLAPC0C[1S1X6&C +_KW M?0!2H[Y8@0J<#$SZ73B"7>4Z*,*O' C//J/#QH!_Z0?.+;;^M$18VH[[B)G 6VQZ4JPM)&&/1"(Q2;<3& M&.D)]@( J%%U8TM*4)E(LW5ET=D!B44F!N%I!XY?*;I8J$Y>B]PRGNX_H M7(K,K=*056'R?ME+=O@M!)V9,B72$%,*T)ATK@_]MO6K8)+Y%BPKFYN:3XLT MFE@ 2LCHCA:/3Y*FB0LL[PM+6A;,HJ()+" R_7-]!UX]]=SH_Z^=S;*!=540 M2K 0A.+*L?C1)W5 ^J9@E*6;"*I^R$H(=MU!>]RQ$O;@O2WM5U?%8;,L<0F; M"6KBRE:%7ZMJ^/7"J1@COZR"7G8.34S@MXYY4?J/A(($3@\8D$7*'@NG%-84'R MLEHB+]?)E]<1F'U9$TU XD2X+LA81[?(X8W%N^2G^)W'F+=6IV@R0T8O_;[ MNE^IC6!I6P*DI+D/M!MF21+$4:\NK2$HI36HGY+6$'!:P^<33E<0@]@JP$FH MR +PJ/EQ31I1O4;GGW@CJ)SC"$WQ2*_PCRA?C,(CW0D[/R^03/%_)7*PL)[00<072=96'01U!"$ZC50JA:,A46!V9+NI>%(Q8E<)=]P&KW&^U//)WHIT%4X-L,5N M/8TA%*E)'L8#'<\R4JG0D88]PDE+M?W?:BF#":8MY8HL:77QS4&OWY0V$5P5 M]+J^+,L*G=5V[*.JH6C9C06"A("V6&"C+JZ)IU0!_KJX6N:'P>WP0U7BAZL8 M\CD5#8[)GA5R%X (JVBYDH'7L:Y=RYQF[A_WW^$8Q$H]32$6BWV9UA1?Z[,V MEAP5)7$$Q,NM^M"PH=XK4SW4=5,]C(GPJDR/@$3\OQ\8./GU<^,GP]L_+RZ*GY^A>C_O8'SI?IV M/RUP/K@,Y^HQW26WT=T7B 8-@=D,8*'#<0KL@463.AD M(;ANF<343%%)6'):Z82XZ !901Q>PEL/5HI:YD3H>Z;R?:W76( J=5;:ATM- MX<8D/?2D_5%#'1RT2PV1@MMHB*1<0Z0\G5 8GV<<])T5TJ%S=6'%2G'7)7VJ MR% &CU?MM-S&:DK! =>W#7N?O!VE?L:V>,M1Z[,M;N6J:P=.*YUH MK-)/1)X*TM$@N>_9=G9O[MQ.L7G11"RO#;:BHU&*^S?"/Y#RPS*DN(6H=R,] M*/S26/^?O7=O3EO+\H;_UZ=09>9,.5,RX68NZ=.I(HY]CKN3V!,[YTR_;[W5 M)4#8ZH#$2!#'_>G?==DW"0$"(PR$I^8Y'=L@[;W6VFNOZV]A%MSB=YI@X\:+ M'5D; 0\:NJ#'"W+Q0T3RV M91J AJ60+"*4#7PRN-C9"]")#S(B9R>XS_F3L>&QKQV5S>>]+SD3 M$WFX3&2(C0<]@?682$%P\4D]NRN#4Q@).#Y\WKE1FH*?D"7Q\+'T/\2$XNBCF\4.P&^3#5 M"PU[H*LE=&'LCCPE,U3_K!]K:*>95UCF*V!+\R9"X QVFKP,+\Z:#H-4%93K MS]F .<(DO>H#C;O!%:?*T;3>T_>!T>/TQ]7_6AFSZB.AX>%:5=XC+L/^T\.X M HX;_ YG#@[F#0VM/[G[LW/S6K)9/E"$D?%70]!0V \#JIAT'2*!_N/VPJBR M(Q5IR=AW[-'D-LC$V/T&5FX?\'IW!*(LI)^' O4JDK?))4@VX39'TA5!HG M9S-J!ZV,%69;&@8UVB5>Z9[M$WB(2,%1!-PC%\7]3,#VXO*H? MDB'EHBKC='[D#8:>F),T1;S?!+\LJOH2:'))HT>@VJDM43;"F%$L M,RY&>R"YB^DWQ0+4(#&)W3P'')4 /?L=;C$*J/@!V#8QUO;*"9%\+*R$V9DG M747WJ0)54*^"A<$Q& ]-B Z=)/+@1-$N\,OH?U#=[($>$V7BD.TU14PZBFQY M$\H+CL+ >Y*RZ!M*P_HTYR\&HV4)5>)6D#\<*<&#C95>7T+: H@*R$?#VN? M0IZ2@/*H1P*%\PJ>X,<\98H^$T89X=3D%:W=4K-M:")61->Q<#*V :D^3(AK?P 7AI%=K\^_ MHZE2,2N@)XN/C1A_1\&$4/F&LOP,C2/AJ*J]D$>%D=^$=8=G+J\[94["7+E0 M8=:?DA36:L+PG;7A2(Z+(HYBJG":K&3,05:VTY!3PM6$GZ;COC1EJ=Q-7B8) M;AB5$#-QC6Q[[L$;RB"*I7TRVI4H"!==3C"ZA!$B)C>M3KT* M+>VNUW-1_V9%%*1O+P297K$2; M <)HT%XIU?_Y ^J!DQW\=,XMP3Q>K,+.4+/AY%AH42T18S6:".>X7$C-E5'D0/*5,EV3^(778ET&\\ MJ]F5_<+)LI: M4W%%CKMK5TB6:H,S3P@!9F!*)NW9-0.U_GX8AA@BOQ=7EV=]+-V4\*%OJ)1T M.L&LWE*Z=4.X,]:P@'.R9=W'7\K.1AGIW]=T]"ZS43D(:M+G=LE M7F)7 <9MN9Y,YT1=RI+Z 0:V+94.*-FIK]_^ESL:_^5&/$&F#E2.Q9VX'/D$ M\551T41V1$KC-!;NH1_U*8WV!-X0 D/$$#1Y?P6)$DE2,0FM2/8+1.*/& <9A@&D\ES)'YJ+T5 MFEO1SGL>CD8^I1P/5C*^>*!HABI\PUD"/;X&41","([P5C@A*PH#NU'XC4T9 M46Z#( /J<1A+0GGHB=Y;8]:1:_<0!&R$[3D]16EQ(_N1>' L;MY =.U0R[5< M8&SI8B%2=Y21^$X-/QBU4E$I>+/\]\SJ E@UKE]@LF$4;2;UJI9C[I/C108 M)Y=(.O$G3A:RW.:75&61+ ME'O+E!^_E\:"):N5]_7TOE>,TN>7%1,J_(,]R?-UO"CDQ+25%F)]XF+'TBV- M!A2%*K-"Q>[8GR\[6L7?P\-.IV/QI[$_,9ZL/B3JXHP*]DC,#9RY*J12R)1: M:5'C%KCPTZR9RDC"D\XXO[P[%Q4DC.ND_LIHR^Q_.:+V4)8WT\F:A-;E^:=, MY:5CSO_9+(DF ]")0?\4+"_NTL3@]A".)(9U,NG-MI?8E:ID-%+FA-DB4]RG MW:=3^6]+@+AH7G?116JHP'F-YE'[8*?W[KAD^D%C%#C=\H1"UO/Z)[%R'D M*.,9V9[<9B&7VKS-T7]-QJ20)HK)JHW<:"+CH(K%U0%\"8PZ473C$WH#;B3L8D%E44&'@ M2PP!>7'VG17&OFH)<0W'./1FR[JK*'9-# OSQ1G7*(QQM9+]$><[25A*JK4_ M!/X%WDLSK5D8T^HE^Q,&M6[= 59'?E!="X?!NM6.WB8VE*<\I'4L#Q'E(8UC M>^>+=T\ T _0:[4:P MH2^H8-6!3W!DY782]KXQ@)+UR9U,:&P0IO?B> JFNQP'3OXV?Q=6(9WR A01 MCSMLEQIG,TCSI]5FJ<;X]HO+Q5>:?6@,*_R+O=%!B,MF'V:..:Q62S7Z:O:D M0Y,$KJA,YP\RMH"*C>A: @JM,S(E>@Z]1#A-EP5S'&OHFSCJ&"LGAXW"/SQK M U_35P56R1=:(JIU[RK(,T<$X..G$3H MZWG#\/$M[S+'3$0E3!L:C2GN)D+U',>@FN6_$F,N\TO.*U3""^2"Y>:Y=4[9$Y:K 0%U%/I>7IKV0^2A,4YE6LOLI[U M[*Q;^]6[G;V>/1NS\UQ/*S] .85P M[6.]Q*4HK;BXNU3Z<@'1LO9<;9W"!7M:K:[[ *RX6_>[Y]W0L]__/_^K:E-7 M)6H>DE5_V!]#4,2[0K"OQ1$L>8?LJU>(5S%XA5'XP\?6'Z-<4,YU3+2.),T" M@FVP/GB@5N%+O/!:Q;&KY6K5?G0)$)01L>.WVW2@]^!VGCU,&7ISN5.;=1]G M/"CS1LC6^;![3 +]]57UU8('9CG&RU?[60G7[RQ<.6^NQ==5P?>"$()6ZY>L MX>!+[XBTC_#+PJO6N*.S!I'K/<]\I9WZ"N$EOWI7N9]F;-GE! MS)7$)??&0OEXINV2E\ZK/4F0OUIQZF>9])\CZIOBQ3J2ON2<9S.04ME@77>I M<('R<6^7[;6^#M/@2W8_G!(P]+-X-N]!DF5UIU'-Q;)Z?H8=CK$@H03Z.%8C M@>9-T("WYDAH ^EEX,<@I?:3YT860Y=GFPT&)!//3("7)&=?C-QOGH#_]GN+ M%W (L:7-AI/8I/GK*S1IBHXM=9.QI9G\0\YHS-$Z)/H^^!/O%!=(]3N/D3M> M;G%EZ>\,6^K.G_ L4AV5%=%?[7NO='%)BW#388:<[TA'\L21F#T0K]YUJ*?+ MTKL%ET6-AIS14+]VHS?O+%13G!0IFC 9MOC&B"3\N5M,&%R*:LJ[A\CS>)/V M)VP) R-L@:XNC #[2U0*X*2;G#1XN\D8RG(WE'\QZX'$Q>["88GUU>=;PO>B?5<%!2_LC MY5*%?RV-\T9FL$=D]6GF .J"]U[@#7Q1SH]&43QY5C"+<^!Y, MC-F>NF1_1Z)H%:>9'1)8_TW/V<)_KK9Z6'JCWG9J[;/=6/Y:'&@X[=;^LJ#2 M:CO-5L.IU&9NS1<)Q*Z5J=M=77MNQ&==@ZN1=*6+KB!N59I.JY:I M/E](?"KUAM.$2^FL/:,07VA%M0;U)QFN75G=S7.^#?5DKUUHMXMO.X7#&X7'E3*[]9O8AT17L-N%?-#E$L M8%E1YG6UU&CLLG,FV50UV%1-'L:BV-3.+LAZ 2;52_5F44S:8K7V,8RQC9.R MX-HJ3J$U\WK$A9^56JE]_O_WTGW863-4P/?(&P13D/4.CW3VJ&A8"_1Z!61V+=B]_AV,/4KY@?Z=\R)F/Z MM^,AB('XG25^YP:,ASKQTI\6@R!G'AU/J!-NYN$(/)CQSA 'C@.+TW_P _A# M/[V<<13^*V/EL>=]D[\2-6V!AR7OW^7HIEC!T9""JX2 $L8Y.'T=&(A $PNBZ<3P=>8PH MBF#X-,C[2<%Q\NC,WA-^&=,=B+!K:+ MR;;SCP5"NX>D7_@ )/^DAH8)/8LXQ99KRW'A@0 ?%> *. 6 I5#HX<(0=(O4 MQ:N.CVH?\8$$/E#S@/&!#HQJBH'S//X&R/BZH&$R;'%/-(<@8#]P<#O@49@($LZ\6(L M!.L<@2B.@R*G$YQ((A21E1CV3IC!X3!CR/V"C>)#$4OS?NHB](_'+=_"/I!Z MBH%]A:7(/_HCM%VPNF' (*2.A3N.Q8 @Q02&$;.N\2[0QM*YIQ9-;F7V\$$ MM'+&UR6J]/@!+")L,^L)=8^4M\07A@3'A\L1F- XFP4A)E""#-1KP>/$]4$+ M<-3(C 0QQ1P7B3@:B<^)MW:CT,7K P>)AB.<\HGC,.7LQ<2#4INV,$0T:W))Q&O6+F@VU7 M^USA7%64#[(3ABC&8./X_T8T\,C_3A9@;(_#F(^:@X,]$0=7CQ_ZW/G#2H R M^&*"*>H7-WZ0P^$09MO.0-B&1][#-9+\E3(RYV)ND\UIFYC;UC,PMQV[ZP;? M8,^T4_ECXG-RYH*CAK[C$&LZL3BL_13GU$C_R^)3KJ=8W$>>=%-,(I-=>1]^ M]Z* <('TLE_C5-\DI6,O 3 OYC3 @B<\A(8%7IZD#I-L!/-[:$+M:SCT!&N,C5F(%R]U7&STRDHMQ-.( MDS@?-"X\9N7#G;=T,_&_Q(AG.;,5Q\TJT! ]P9T(H+=MJ6TR\GQZ\^*6+-D? M= LQ]@[;BWJ''5ZR'.Y+EP9\)R!$Z GQA03UA5!)MC6+]5B$LYME)UR$>:P>3 MKUVZ8N'V5P:R'"ZOQZ=K#PU\,>WR)(98FL8#&A485Z*V6N^'B^$[A[DID0>[$),I= B<1\/22^.2 M#!1_F'T:ACC5VXG6ROST?H!E1P:H6D[7>PJ%GVJ\ $<>]3QC@AA&9&>WA!BO M8"6A*'A]M.C[GO@!MY0Q!#?U&D?[*FJX[ P#,%=@!YY/4@>;F+C?O "'TM@L MSN3+3P,Q:&-:&:0,Q2(BG&4F" '@ 2@DTM_G;5_.X1I)9=@#*:$I M=K"!4?A=#V$U]D0AAMC#HM&A19('),?(/(W0)>L>_"*"T(B04P*UMF3?TFC= M]&%$:07W#)QW3+\ $\C$9ML:_C.>T'N9#KA3&M(H-J&(6_R,HA=1MN: ]<2< M9AKKAUD20@#R ^#+OWFXBZ"O/QHCB /!XBERECR*Q2Z,R0=\+7\H1\9[T6^;91&./!@3^GJ$=!@!] <7!M M_ !),:O,,$5F6"'^HG.DKF;2?%8BO&NPD4/$QI+M]))U4!:C// .'2[VQ0A0 M,!_\ ?/N0H&"BVOQ]N)<#;],2 ]&!N(0Y0&G%\!G% %0/*EPEYT5X*)8^& : MD1D@]/>L/Z;$;( MA9T*-6ND.TH6%:.H@@)0DD.JYA#U*&"1@R7:=2?:2*$#,J%1D=H EM/07&IE MY9E?>*;@Z(!Y?Z"BA\IPB ,\P6S^MZH&2-BB0E=SRQPRR>T1CY6]RW%,RM.E M?:LG]-[1EOLFSC'.'M <#]-).V7'"L^&7B!5P!!L$M)QY ;V+5@8IIVB)V'7 M@ML4AR6[ W?2Y&E,F^G[<30=#!NX+> ]X)CJ N?)%RE%0S1)D(__YA2#XG MQLDP4-\_4 F4260=-4<9X^M7J<18I'&?V*=15V2F>^V0Z=\322^?7!R23L%3 M(Y&,#*7(N\Y5&-:KN+7QNZ]E60^PEVMW+#*SE/KPN7I-5(*)VI?T,&SSX2(Y M1 _??DWEAAZ_4D5*M7RL2!$5*:T#KDC9:8$5"B[0B5,J.!#A-.G+QS+G4,"I(#8]4S!3+[M.^1FZ4)I;2L3.+-8 MI2B/="?6BL1U)XE+1D13A/<6F(G]Q,.!_"K8B/:^U;VZLI!@F!/N18^+2"E:@0$ *::6$-.$:!)CS/(E^28Y M##W[7;%@A_=CC+5!0AA8:D"W3MB^TZN@^_I +3%,7Y!);M3U.Q@\E/X;-TET M2O;_3+$\?$*GC6I&_H=*7/CT&=,_[4X7,P^&TI7.']E>.2KX]]4P.F?K[G#O MF3]1HYBZ,\X,8&05KF3%-(S(E!^+TTCGT#"3M0^6<-N%BE?J3(:Q[)&'X4M\ MH<+!/]3X_UV:* /5G)(9H[:2(0YRKC":*1.M\JLZS>>"IJ2[+U9Y/7;,?';_ M>T//)1L";E54I'$<@A<\T>TZ(G@$GKZKPSDEZTIE+YW4,SA*A<440AD[,F]4JM&2/IZND^U.P7L(1+$HO@L32)00"<+ Z./! M-^K^"'BQ?!V&OG0<6E@B,1 -3!6XN";4?0%7B\<*SI!?"N.RA_^(H;,,NEDB M!I78M?Z,7,.)7_)*#K<9298I5LF8 M.$RMB,*EU)$&+P:S)(!/'T.UW*UF$1 MWW2$!,"B0J.!)EET[$^FAWRRS@UA3X0;4M%4>2!(ZV7I?$L3)V39CU0#MVF M0N:B>D)HE>&3]'A,1X"B-X8O @S FGB16A>W#/8(>!.V8*FBPNW)2.)TC"V/ M9!CC2TMVI]>C9,_]$-.+L]455, 0V-=WYZD;TNI[ Q?KUO4-J IF9$@5 Y\Z MV,B%*/%$!94"SX1&'+M/&5T J*8-KV9($38<7T&Z$F35 [(XED_M9F#CXQH3 MZZ>UP$,T6:5%+.Y?O0(4WVD0>:)4^!Z.#Y:J#+$,Y?Y!:B#.X@OWP'@1*AN, MV?:>1(9!1_(IL"^+8) 6;<,["643I116BSJC?$D>T#[>P['1OXIOU562=L& MS91?VIO&$W K\+C"X@[T&%W.ZC5QDN:='W%HY&D)L@X+IP!E,18=&-UN0F],3\4C1%Y]LF:*ZO.Q@N7'V.+D>J= EG 7:6>0>,, MSS^V,]:JK<^LFY24Q(DEE:S/BSBVFS^UMCRUOX>/6&U#Q]B@L22[)((F);S< M'QK4M$]$4GC(N?[(XZ28C1W"(L6"5@W8#6*5E/0C0%9-1U>%\;&Q60;?9:OK M8"JRS%@]E B^9Q3*];VQ%U \2Q2(R,2.?A]Z\CTPN-!\B:'F65RT2&)?L_4%MJ(Y3J9P(TU)O'\$:_[A*66(.EBW(0&6M;LAQ$R421>(AWJ4E6W*2J)H#FW; MB1F"O!X/3]Z+)X/8!\P^=*,(\E(;V.S>J::YU8N(PPZ@=!H;TNM'4C9[X MW=46X2S4#$P<.:-]8F',RJ$F/@JN>4\"NXP0T^)4PL[AHBB,9T\CJEBA@* H M/AW I41E&!@B&YS*WH^8V"*R=JA$TPS"M5C8IA&Z@08P2GX.LW\SSTQ^@B/_ MWWS5&$LE_$8\F;0 !>$)[XG#H!2*0I4>4&N&9@AOD^P=Q+7(%*^5)#&GXSYQ9:1/NYR<3N!:9K;L$&>FY F5]XE$!2Y':=V+-D>Z\D3?HQ M^DYET6$RD(2Y"@1)=?H%J:"UD<^5I?D'FN+0X*[VP/-TS'V$)>5)^"KJ/@/S M A,+ J?&96@8$UG&!'M1Y/S<^:-D=\Q&-?E,P6(-K2G*(F@9*@Q#IA/E#HR* M!DL5E,>I@ZDK/53[F4N+T%+Q+0@? Q'LE[W+5%/)S7#JA.HDFERQ2-R($6R8 MW.X^R2PIQP@H$UHKBY[>R)],J"5Y(LH!*=:D/[[']5P^F=V4Z$5*@KZX >.H MYQ>!IK4+A^4F\A FU83,RH3E9<@H.B56WRC](RRGT7CHTWU!DN5JVHW!2X S M,/3,C#+\W1N++"V^+UFD!(OHC&#Y/5>>"JX\$L4MZQPRC ,F*CIHG\#$X:2O4K@*0(YE0=[DPDN]0*9&,;2XW?:YJE M4.OPI G8.H%5IR^"[26V7A(GA# 4C$(J?8&"'M%(VU=&YY]&:.1"<#?Q_20, MF1_)A+4L73/P1V8SCURDN QUQ,(6^02P))8?1!+4@Q,Q7+[>=1%TFCB/6(^P M',Y]SE2HZ;/EB R.[E MHA%/28S#H'+26$Q7J2#719/4S@ U+%9\R0;@65W@.S^-DIF!.%I>23Q)]QJZXMF@AQ=;GLI MB9<)'%8^EG3%L8<6FUX?L=4RX1 91H.L*"[U#&-Q/_:D;L">V0@N H4C$*?J MS;@O43Z37N*J]EV^C;+$S9J]<]"CG,;Z!I86L%"CTK-*@N+Z6,B!G;KXL32@KZ0/1K_=B5>Z+SE9&%H*ZFRV4R*CLC@7^-EK8J&V MHP4S)=NXB(IP6AG^5T*GZA=9&67*NN#;J+!:5# RBQD%F_)X.@&K 1&PTD$@ M\8#?P'@#2OM#JE[K3'&( #H.]@?,/3/$"^,?7DRC4.64LS8M+J.A&T]TO2&C M"@6FNX Y"85M% :J;PV-,]H%=YK'&9M:OH7#E.]+K8/D*<<;1#AC,O-+ %]R M:#M7H+M=B3^GS9K 4$'S8VCD1!$R!X\%D86/Z#.1M9*^H69JJ%%',E=A]<,G M*_(&0T_TP9H7)LNV>(*L:A3;-&]P$<.A1)>GGRR?,?=PD.U%2"((KS4AP">A M;$6S ,W)X994F@9"A15BN1PHXA[+1($HI\+"+@/MA5&2L%@9BAVG'CM1X)Y3 MS%BTEQH?M.;NW3[!IV*C!_O,1'3X50]='%PZG%5&4X_=X<':>'>2_.R*\[6G MP"K2?CM;>6FC7#@:HLK8O(")/S$YL!* D)[H$1B;RG:J2.Z"*4D'3'\^?R+$ MQ*'3I*O$A\D@K$7"^N###1'U'IY8Z*GTVT=K*Q:,&$^YE%;9S;"$WD/@_]]4 MLMMP*_4K#Y34V+[+@6B>ZB4M1@.:7G9]]RE*KHQ7$0HDA<4A\RN1,A'@S=*K M^,E"%5^2,883CC"\3@\UT<$("S_(GWN-7 C!?INQV(V;AD)- BVAIR:)B8"D MCCLE0QJ+&"'^;@F@.S\PVOHUN$),WBK? _07L9<0KR^'1EVQ/3#,$???2\[J MV.48TQ_^)#9VC2-,O@%%[SW&*J 1=#16!9.9E(C-,$4''B[A\V5'_ O1%>WI M6/PT]B<:^XB#V_07 XW8C-K(.)?Z".8' PQOP=NB>Y"TQ,0%D?\1""+XC.]\ MX F!;<8X,^V,@ "3GB@02X)?$4,ETR7J?12Z4[=D^9AEH%=), M\O_@#@>G\$$A\7N;:5JM JAZK #B"J!J^5@!]#("FSGL5,7]]*2&.<-'[*4+ M0Q@WN-?6.4M=M?GN\EE.SWK/@A$-.5Z]0]-28#;G>]M&.BSC!K%$4\LZQA1*-[$BC!#HT+P&5DK3_2; M3L';Y<=@@V3;JTDW<^9P[.Z\FM1PFCFS:79^-,T[#)UU/9"G@!IP!R+IN=XP ME9FQ,AES5$[7FZ"RSN@8/6_G%>W3"_JS.TQ]>(M3=>H-I]9L.8UR;0N#==:9 M5S3[[AM=%J?'\ )I"YZ] [IGN=3\LK[ O+L5X_>,ALF-'8KD-3<+$X,K6K_[*66DKO$UN<0/:*]?FZJ7&S$6^ M![?WV"16T3=QN#H"",RGLJ@"G$7A[+8H=0AMOL1S=&E-W>@RUZS:HE M>+LONK!$02HUF:G*@0>W3_U:H8[9*52LY*,C> M#?Q_\W)D&ANGQ&,MCUPPY1!BCX8BZPD)MSJSV.%19)5VK58J+)RT"YFCQ>.9 M;3V9F5/4/&A%INT2$H'W&!?$<*43O-S7 ^^-+P-=E06=L.&%O=/72Y(0Z7=+ M7DZ7J#N,0TNM *\--YKH]_>F(ZK/^>[)P8-&F0Z-IN.!3SXC->':VT>&I[0PORK M78_5SH8UL\*#J! 227LZ(EQG\O(QSY-FK>G4SV:LX87O6-DASF/V)ON$"[9R MZZVV4VNW=ML]S*[->*/RG&8M2M'TJCB51OLE0X"?P^ T0IN5[*49PZ3H*"@0 MH-'(X3.^I+R@IDFTUJ6T3'%APK-FS6E5"SM.>39_KH((B/%K]!AB1P^B=S#4 M;M_3/Q5.&*=RUG JY3T0F\Q;J<"P LYZUSK7P_GY>[99^L0,]LI=J]VK%V3]3N50Z^=J\(39#% MHXVB$%)AFS3Q;M387I?&PV=[R[_&T_&[DPHH;OQ'JO9M=@MJRP?B$2]P@9>? M4XF3MEE_>M/531_#X)[?$T8<6-OM]5ZHZ0:%QRDVMF8I"7%ZR>O%'/9ARW^H MYJL;M!U^GHU+7MN?<"#9>.A[T<^S^<]B#@A'V3J,9N).^$<;96)#DK"5L%NM MGAFC.G]_?<%5X5_OOGZY,(U0_N_?W* ZO] O5P"N_$L6"P3\1#&/AE6?/G?9 M2ZL89T.;0Y9]756JFR6KQS(6VV3?1*5M'2RRQ_1<*? M5!M.HU9?>?V%A)N7ZH=+KZL/6MY02*8&6/7+\.;3U5^]:@5,8B@[#S8]TSFE 5%'+Y%0Z,==580 C].V( M;?0G&=4,ICR.=6 T)_-< UJP! .1H%F$WZ+^HCKI1\KRYY*;]#H(#%C6X5@G M,@+[&JL>!,@E02!1^[;\7&RK#\:O9?&.0$)*!FOE.DIV!\Z,>'4:JV!VTB8L M16]:XA6K04!86D:0U_&T&U- ;S)_::D-JZ(? [\5ZS7B,7RG3\!41I>[I7'/ MX',T&%0#@Z:',(K1>;3"/IX1*EX;J]@6@MME 4?:O_KOJ'JM[S[]^L9_1Y @ M[D1@(A@E1U9&R9%(DXJR*CORL$U]86E3!ABX'?LCD#R$GA&_DT+(STO4.EDY M:YWVHK6V^L/&H-.QL7:/-GMLK-W]8/7>18N.C;7'QMIG%IE5JF=.O=5RFK,5 M-,?.VA2IRN72L;?V)^FMK5:<^MFQN?:G;*ZM-9Q:^U";:^M.NWYLKCW@YMJS M4BM'X^C.W=];[:UM5 J^R5?<_+:::T]KY5+EA77Y_-<>0G?MOD8BCNVUQ_;: MC;?7:B,Z=W\M(=N+)U#!-H$AU.!C@R!Y&D;>VV46;#FG+5V$0=B:P?$!" MLUKU=OU8O2VJMZO'ZNT=:3\X-H9OLS'\F%AXX<3"MOK"13EJ=KK!VOE\PVQH M?@^;PRM.I5UQ:FV5:Q[^XUAY^TG6JYYIS-WF);CI$O%I=M-H:? M-)M.HUUSFGDZYE^ZZ'6+K>%(^YR-X6(*VJ8:PXMQDL@>B^'\\:,TC>=X1'ME MAALF"_Q/]G%>VSB?7ZG+5X$!81@5FKYS&<8R)Y@XVI_ MZ<[0=1I;&TZU.E,WL!>-K<>.XA=\K-EE-KK+_^?6HK-G72IIWP?+I& M]B9GZIH7:I:M.[6S%:O1"EO+L:%YSEK*35A-%3BU9DUD*L"S --JO5B#=<#M MS%QGD:D?Y[6ED2OCIW5Q\[J M_>^LIE[@%VBL-MZ[K[/%_P>KC"=<1OC!CWL@@T"^PRC\X8S$$W[\&R87_?A; MS,6-LK2'U0[(0AA[5.?8]\;4I!!0Y:PU;[A]V/V7UR.:N70QR%));E<3-=P@ MBW!:O!\NR)+G2)607A$OZ!:M&3 M%87#(?Z!=,[,0_?V+*Q6[7EVK/84U9ZU@Z_VW+3 TG]UT#-H)?T:]],&=N 5 ;\/V?$4+?VMF M*+Q4[1;UV;5NO) EG9.'R//L$;SU0:BX6&2>R:I7QJO%O0%_FP:>^%U9]@O< M>N.):>FJ/R!YYUC!LEU#9[JM.9_$A9(MA%>1@_K:!8:!'@:'HI2+F.O)3W:H MMU %G.7GG59^"-R<&:B7'=CV?N7^4XD6)# >E8KA8\L#="I^77#ZJ5)/4V?N M/9BSBA<-/SS1G_!$QV*&T\G7P)V"L^7U9\I6=RX/EW=!V9LW"I2WFE[+2)UE M%6*O(GJ+3V(J7)2SZKN VO*-R6WROC&RIYF3QA:2=UUA/@0R)F[H(_U6II^R M9NPC_=:AWYR.D",-GT_#S*Z:#1*QV%J2U>Z^S&T),[&>+@K9DVZ=9GM^,K?IJ!2L[L>Y&U2G7]T].7FA0Z?H&]72:D]2ED#MS*DV9^J0YAAM.?3]WI&@!11H ME6?D.#<%LI>R=V0X:8 Y XK4(\7)6 MU4*=OM KVP[+9DS;-;4X3EVOKZ_#]GOW-:?=*COEV?:.GV/_%>>LT7(:LY " M>Z&T-D2#MG-6/\.ZX9^9"'/'I1>LM;=OJRL%SBWM1F6H0&YP8T3GX^'G"LMU M/:& %_TL*3C=%OMHSV2,25B?@35Y\43<-C]5Y_,9IQVOJJ@TBH[CUM_D@<\N>A5-)VS:LNIUPN.'^6G M2K7J-%H-IU[9 >*YFDW67%3/ M&DZ[/G/"=SUON4E)*#MGS;K3K/WT)1Q]Y GGJ3X2U[##@I(N_" .KH_$G\0L:L4K#$A8" M3574P4[=\P*3ZG,X22(X;1DJ+R4']8+EH ."@+B X9#AQFZBL.?UL3AN;U$" MM3C.V]K^2^E7-2H^GH)E^=V/Y9!Y"4C+8\E[_EB-FA>HDP'^;FA[/[S>%#$I MK7 P\'OP-$*15'\?J.,M_RX><1=-XXG#_P-+57,U']S8]AC?UV/P-)YZ#J\( MO#A.?%U!=DJ<-<+Z%+^U^IJ!/9.!8\5 1WTQ8T-VW@T]N-_I#;WAM$]+%L"C M^OW6G/7L!/P#_$;EK"]^FBIF MWN($2G_B8VGJCQZ/'>ST)@BC6VG7Z@PO-V+\NQ/\ I*L"D^&/_([X-/TN\I? M7K^V'[W(X(*S<-P7 9.*R91C12'NECF3.8([C1_8AQ6;N* M;+QM!BI%/&8#T97)-?"''L$6Q]/N" &']?YQ'[AAQ'?M>@_N<)!):8LI[W&N1#1" M!M*#<.=*]( 6A*YJ$L2GH:G3$4-D"^C9T6@:P&4R83KI ^.@YPB2)Y&+GR') MCI6D$F$01B%\ UY+Z,XX8)OVC-/_8+,\ZS7R[MV(%J!8V5_A+M]1_:]G_2H> M=H( D;B_D"2@<%VA[8L8V^*&L*^_ YF526/Q)WV8ZE/8'TQN$M\>&?5HZ75HSY,K/N& M/KA%0W_RA!3(>HV^PCRXJ]4UK3\::R188LP/L8'Q-$+H:3;=>Z@ "6N=;GX# MW+W7PXK-OHD;+W0(D+FDC\!R>O -B8H<7FN/P?_L^=[,G8@Z\:UU4GG-+!P+ M7&N!=TU2Y 5$*M@E*V[^$FI"\\KI>_#%H4.Z%.B".HO4K^M'\,_(&PSA0F,M MKH'O>3F@OA1\O52*%(5;=&7_Q3ZIRD4ONP!3KXP\=06A, <>R@P"]:*T>!%< M;U8>]B88::_$2'T?Y36O8,&>/YX8,/M]7TS\ANUT/7S^" XZZ$EX>\;2S,O% MG8)0P%TK8'MA@X9V29 \?:5;F9S 'T]J>;BASQM0&&Q,)G"D;[F)UY-$GP9R MG41&N.M81AQ[&GLX,L&0FVQ#5< 1)S2*$"RB/7 &;BNR*%V:&4)QP'XU.^]G@N$1LKZ).T/8)B"? S]$8TV"'$ Q!+];&E]-'*?<$B& MY#M2DKEMXQ1[33B[,XQ#L@S_Y?64?.(L#D_/(8'?)/T4.+D#C" \A!P55V/$KFP9GE/=O76>SK@TL-1!&+?) ?2\_ P!,,35$9CN$'4 MF:.+0BK>,+(,O8LOQOW#8E%;'H"\?'J^D6PM\U_Q\,;Q\SS5_#:%MOXTP5;;FI84I*H24)!2O/30R*=$_0L225C9!36Q;ZL<+2>K*'_#=THGNR6_$+65;UH8\NM@GU5 MT.=8BS3 Z"[:% P\DP9A)5%O7@.^ZS@'/;[ MDGT-Q(C@SE&YF /P@E>M1-C0:W,RM5$P4\]+1ET)'%09[/L;W'IQWQ?Q'+K6 M;C@.9%T%/&<1_O 3LK_@0]PL@M\W;C3A]U]=7;WX%EO%BG2EC"(=@82&$7Q\ MYEY@+_L\C,84Q[-_0W.)$B9[:Q^A/2$B,(4?FVH]Y6IM\&79)_2/<.A..,5W MBY7=L?WQX[F#Z<.)WG?B-K<2<922W:$QVVBC=,/O8@2M_![5T_SH#:>Q3U:[ M"H5Q68&PJ >8VX>K'Q6?"FIUX3MF)%.\325*/<_"IX.STI]B?C*R=;(2# M9 M4N2EQSDK4XR7Z, 3(IXI/=&/%DF0X,EXJ)SF2"-MD28BU*9R=.*)Q5]RVY>2 M3B+:91OU-@:S8R"X1]-^9V-O6$(2]I&,XQ!93N'8PZ35+1?BT!!C+M>1PY,3 M!F^"=F\W3P?Z;[TUL\K3Q119"=IOU:4MC),EX #A%IO?+0-/24;C<.P[^!:O MWEFSL!1R3&LV:$6Y-*\MYK_^H]UHMA^B0LW283,LG!#A2'L0A2,N"D9# _[W*"Z' M)"Z)J^'\4ZJ!2=L1-E78>1$U3R!U_ 'X;$]4EW84B ,2"*SWCCTO5A4C[&'= M3KNGG3[ZOE%6%8JH7,QAF]HKV::&25HJ7,Q>W,NCJ! '3%S*F4[LOD?EEQP< M($J%7>"8.\D($CB): -F+H,G78HD_$6,F<33;NSW?3 )N-_$'0S\(=L)\EOT MJJX;?'/44NZG;N2"#N 4E?E>JX#WDFS(5_L!!KO5>R^]/I8 VQ^8."A27/MJ MR2 A52L9?4"7'Z[.9?M/\EWW%$Q$<80'@C@'O:>2W0F2D*"\6^:,$3K"HB$/ MUX5Y;EB;SQTSV.6"_6.X WA,.*0(AOW@WS\8A8Q8*7F(H8J[1 $6EU6EXF-( MJ&'(K3]@>%3+Y;)]\UO'?A].AQY8JGUXV]2?>':]7B\[]HT['-GO*6WW&_S1 MP^+0RX\B.5JKEULM1D,45%<;E=-R MM5G;VX#R:A51K6-%E*B(:APKHEY&8-\K5)IDVK^ 8I$75XF=A>VE1K;D5P0, M-Q=P.G!'_O#I[>(EO'K'=Y-%:9:$14 M6]1. +I6YQVPBA[O0'05N/21U1L W&Y8,?3\+H"=0]4KRX63LO;$L*PE!=7# 9/B73*:D$ MBB43* LZPI)R0$V2]T!*,H*HS&9.3D;W:IQ?WIW3,TDR1YS[ ?F[#T-T3. O M*#AB!9\O.R4FFO%:[7_0E^,'?ZP?#]\@\03Y _IP;1YV97WGPO+KWB141[!2 ME\)]-7A>EF 9QNY4^K)I'(W[B\RT!327^BG&C^XE?&; MYXV-GG#NI;+NA-0I%B9L3B3W[:,[CN'2CD8+1#!UKN B#&5OE>B9](%//5"@ M<",$R1I$I ]Y&[@..$.# 8N+-L/'8)N1&)$"AM-!O['I&"2#Z='U1OLGU49Y/+J!ZJKC+\!%8!H!<'PE0"=Q' M!H.=N8JRD':-[KM??76+^.^*&M'&[\FHPYFY&+39QB6J8+53FCJ86!>@$\(G M3WO,JMZEN(5O.1*8W=R3=NK/EEB-,BO?7VAAC7,]T%--=8O_?'N^9N(]N M$O-(F$<9T'MS "L736"I+IXLD7O#9^EQ$FIFXB:)<"/ZGM.$R &]":Z?YN<& M5_4WC-(&]C_ ;;K_[T7,R>!")NG%/YY_\FZ,B$]";Y_ ?0-73Z7\IOX&;[K7 M>#HW]=9.'(<]G^)(-Z"?9F\-^?;J&_B_C;]^4>V_>'/]30O>6ZT4]-[9&OGM MO-> O,LLSL]:Q4L?GMO)U(TF]GOX3QCLW>DI0'QSGY[RFTH!A_?\P?<&]I6. MLV>)\&Z(#K7OV7_W1WLF-F^J#3Q_U0+X=JYQ&%)\2[[UI5GWR0W^C;[)QX_G M&^'=YE:VC'MP9U6D]ES?^LAK7"V>^963.@MMP^RI@<45#&#,[:V\2/@;VU\#'TA]_\E2R;^D"ZH X"0@7,/Z:COW@ M45R,D@@4[Z<:=60 ]JL%[ 2P08=P-G^$0[QV[9.0:XJ(4Y)-L#*46\NHLW"Y MONCU7[CHL#.]IVX/\?XS#(-F+0E#Z7]@D<%-Y,5^7Y0C??%^&,U'B36,H[ _ M[6%MS7>0\#&^VZ+%V!=WES)]I5:1>&.%%I%>F%C$[YZ+)2'VN3OVL9KDDQM] M\P1&X6_#L.N*Y_ROK7&"R/__C]L*^F$9@+?T #P[1>2@5 P?O(M>&(0COV?_SDE'/GFHE?218[$9 M=2._?X]XQ(']"8[MG _>8F+GB?,4<+Q+MSU\#6A'N#X\@KZ8^X8QW!APV,4) MMT!">P\%GW![_@E/34Z')3001RZU*BFO<_W%Y&DWUZ)?+1>3<<)G5U''5?[F!B#@6J6TD#BSRQ+OGP;"T."R M#N/*AKL:U*U\*'Q./;&)>YIYC7SBK1=@YO_B_Z:XR \@X-^IO"ZV[K"$@(C_ M^^U[C4O]>QC<\V/^'A)8&U6@G8B"@[Y^P*Q\8N'A7+$HUVF=R94_>-;"1=IZ MD: A>D/WR9 1$ T@#&@??N _" ]MSCKM;A1^ P>N[[E#+Z'PD]=1N9(IO&4E M(6NM\6,8] O!CM@A1:Y,V SKZ=(?CJ3EQ ?S'\"&A,UT:1P6K.PA4T%UM^(O M2+UJUJ7%:M4[I>QD!&I<>@XSHFM+$\!< M1SFU#E 9JE*;#1.=LSV_OL;7L?5BYS)<9A9JJMS#EJ!$K ED"#%.1XA[.R_4 M@\;5I=>-M.:K<%E8I60;#Z,[V07/*J:6=[C 5Q$4$Q N-L#'_QP'R^]/E.%:T ?"3*,?[3]6Q_- XU M-JR.E)M?&+G?/"H*4C=0*DA&,PMZD=\5'1N(8SL:1XA9WV-\_:DGX13B2>3W M)F;%F"77T'WBWDJQ9@1+YRD$+IK8A!D[&/H"=41IZ 3*NVML7:#IHET'UV?, MA4[XFRY0"82!VV5>.P*'D"JY^I:H_(*'CU*QP([L\ 53,I15M?0Q!$2A29MH MVW@(M4-;Z1)-*)P6&HTN_,(^/HMF/,"V8GCJUJ[P;0MEFGJB)]Z8TF,<5L9H MUNU+0%8@+@&\P&V; (W1G.'Z9;29#"Z(:,Z3C3.N@1NBHTCP5T+=^3'9@-.) M!&KG00N(T.\';B^K8 [_E%PDQT*3+5E]C;LD0\M.2DC&PI5U9+6=A%Z.Z)$J ML&R9#5=R%5\\'OESPWVCL@<+^T<3JTU]SE$EP0,7SH/#..XC&HA"_* 3V NG MD8"0!_\$0WK@X%C"%NJR7<3'+XGXP\'Q["> PTPM9RCN$W\R!>?Y/D+6!-X] M7,X[G,)EB(65+1:'J-EX'IYJ[H#_<3"6(*^6(3L3?"?AA(@I12@GHH@'CPBY M'J;",DGV&K$"'%'4W1.#;7I^U)N.L):_QR=9LGOHW6.3I5!7YH7X %+E#0<< MT@1-2I>_%?LC?^CB;!MPL7E\7GKE.%9.ZAP0SC@6CU?-GL!\K.-%5Z?OC@A1 M!\7TNQ\:1>9I0X1P?]4"K21U;$$=]5X=JLGSZ-:B&GR>2H\RX1)4\KJ5+P6:3[)0 'HCV7%2N]!@/X4=I3A#= M/O@:LQ% ?M[('8"<:FS][-X V/YH.KQ'J;"(=OQ J84OSD40]/W,IC%I39M6 MMZU09SR )!!=!'J\R#3J 5^($S&&?51OLT%0I5(LGG=BDT69YHMXD8K/ZSRZ M$ 'Y"=:\4EJ4M*8N&7D6L<7A5/4X\-!+U1T^A[R'J^WFZ"'3JN'^"A0"2TF^ MG3A=V"4CQU/%QEFSV>@17:/.4BZSN M>9W!1P%V==N*O.&,5Z[499-]DJCE[CLF#\2!12W()\/E :1P=@Q3%5XD3MR5 M:,EA93 5([3XHD[2(N;K@UZ*5'6H7_X;,T4W],2V,E.,]1V@_'+%"/ F1$F3 M]2'":Q5FF'2>R:=CZ447C6S$[W!E2+V3$'>6!ZD)X/BC7::,1;[:<*%:0'0- MA:NLI+[(%!-2^ W8;BB:T[AD=6+^'=6X1.[8[].@,4JORQXJ2@;3#V"CR2>2 M/9)8*)0423Z%EH:>, @I0&O@110H0 ,4E2N?,*Q] MP&)FL#\T?CC\?G:Z$)%)$4-#$!,]I4\R 8[O+8K >=@GHEX -WO%=V(O =8N M>.PGNV']D$<(@@SPWCW:NWTBC#LDB:5(HBT[%$T2 2^679#]O!_%S40VAS^^#A9QQJY6/&060< M6L>,P\MD'.X>Y@!Y'6B&X0:4#%BFKJIA,..2#[#((1:,^Z?0V_ M[;OVGVBTQM0I72F73UU'_,&QSSLENUT_:]2<%-1" ADM M8&6M/F-EAVN-9[-*PZ9@M25566#'O:5R!NF:-^2&1.%T""0,+G__W\*DIPH) MD\LL.QPRSEZ!+"T(N.&=60DV@"K]L+#.@R9<<9E@IC\JZZ<%$Q,/L.4#2C1' M!$$=$'O/%%*:@LCV[VB9$@R;(381Q7^L3F.X5_F4+!Q)Y0;IS'Y^' M!Z\?N8^!HZ*][KR%AI%1FFM7:LD7VMDOM!+@ HE7_ERR2Y$/):A2*"V)D)"N MU>12?'7.\?9D!.IA-Z':'>R*F [=R%SI?>@.*49+N157X">E-0$K#='? M@1$!2S)#6/A((7SO%.Z/(4V"IWHK'WU3V0'!0*]J[#>8D\.G=(FL_.P@,;$K M6XPX!1A;@B0R_8-?D! P@XR9X&:"*DT)@0=*T6=?W)W@Y PIZX<5SDAFZ=R; MSR;9P-JS?MB;%C4;_,6/],)Y&9E,L@23J*LLD;=)JZ?QOU$ MA>'RO+B$S X8X+)%8YZ;&KNG9N=^]".WJONN#T 9X3EA(3B8AH7'R M3\:Z'7OD!U.V2>+I2,Y-=WN]:&K@FV&]!.^)T[W]D+%4*=<]?++&[M-\HAVB MZ&RN$\WH,%.ABBPBVA?&81VG6\ML:BU;J57,RM,J9A];Q?+4J7:"R4,8/(&# M!,P HY^*5?\5BNJ*>D;F-X=S/;'Q9W'G@4T4AEDS! M.T.).]W3WZ=$A1]_,XJ?+633')'[%(D$Q-^]X3>7,=84:!-7T&JOSK1TVP6- MV)[+@!?@^0=N#^R P138'SU,-ST% G_0**G4FINJ"D;/;DEQ-,-7C MI@.>T"69IVKCQ-DT."@7:+TX#W?JX'*[)E"^'_F8!<&7KW1NRVTDHFZ4Y-9= M/+;7"AM3A:1GSNC(&$D4FCCQ1LW_PEO!^MV3F5=3<20:-U7XYE;GJ[$&GI6( MTD/$=;E-\_'IHZ\TK+&87?6/.U*$Z699Z68 M)R6X+8U>$0!)X8\BTI\"M1D+4)NLH(819C EAJ,:ZAE61F!%QT7V-44[%*X2MZ"AU[N2RF8G2%:>&R@?D:[M MEK,T1#P@[<>7[,]86"MN[DR$$4=BHXJP+;E1J0_*J "\U$,&] P&Z(JW@ZVT MO?WCZG_A4#\E1VRY9NL=!D;,M(WNIK0N/4_'*$>PJHP>7K!8 12"!JV=_8(7'05B=$!D3F2E9'^=L\KD4E9;0F.U)8C-=^9\0)#! M0@1K=TC#5%AB@7,^N? DA[B^4P_DVH@;8?6&C#))&=?(%3V<(]1W14MT'VD M.Z*B'7K:(0HEW%P<[#8:=X&_& (R WH:V]V:\T$NC44K/1.>6<7T4HF:)V/V MG @GIT;2ZSE6GEH-[!Z! /_ZJJHHE&4!K[7:#JGU]'KG@#QG?#\+VV\9 MH6&I:@H,,AFDTX[NNR?5SL]2PS!.=;K10(- /;G580"2:,)C;> M=)>B^OCB[G+.U+S*8DQJ]:FL=_WGG&>FX:FI@/K5NWJK[=3:K;D+R1[=MPY9 M9XDV^^3J#T3UN)]'ID5$6;S,[,\)&E2<,C"W>59?]-GY6T\"!;Z(%U,M%^S% M5$LR]/5D7RNH!T3G$7T-1D<+_YUF/QC:'W^4_8.WD[#W371N?6+,KD+J+K?K M^7P.)T8!]O8C,2F1J!0L$K628C[Q%2.M(!1Q@M-WD0O>%C=,."02,E9'T )C MM"J"7@YB';F_&O>K!7._7K(SD=?)R*.Q&\*8+H"U]-]Z&WR\###=)GB?/QF> M[GH#>$\0PSD'WB[X0"?UUR7F+&8ZM9O$8[W9G+]S_8EC_PET!*7^7^YH_!?K MO?O-BQS[X\<;5;Z$GQ(?4FT+H@VAYSV"RHC.0TS/Y:Y4 7^J"V(_8 MK$@SX- +B=_FA_)-L&Z6<5*4#LIYR)R(DC6])-N(ROGU#*/\N;Y%CGDL:Z_M MU;M_H)A=H)C]VHW>P$)FA8W_@"*W-E&*=6!FF9WQ8 P,+K2J#=*G9&!GO*K. MM.]S5.'EW:A*TVDW9B7B9;PH(LRI-,%, A7D0)VNYS@5(S2S[[YS?SR#"CGV MWZXX[?)94418OL6Y2K4S!'>,8IM9QV0%39Q;^^:5HM6>-$_.YFC2EQ2_])+J MX[DT6/;17-2'+]G]< HV2"XUMM(SI'(KMYU6HYEC^47JN8Q;[.NR6^SYJFWY M!U]>O\U>A*L18T9(X5MO*Q\9P0JEJLCDNSS<-2E^E4J2GJ[1G;UV0L8Y5KH&CFVI2$\(VQGSG(>+5KN!PHY!/")&X[/]H#><]L6@#7A>AS_[A:;8 M$\I\&,ET0OGT[_FWY*B/8@\XT%/V7RY;!1=BF6_]'TY*)?8OT!<7/8L@&1+- MV_I3)1LM,V*2^+P$?[,F\(=T*Q%1@Y"U9JJ/ND]&7/PAG,:>"HZ+&K,,'$R26N9>/T8Q.==N#'VTA,RJR=AI^ !"G2.* V;T*L> M@])0_1?< MF-J0H99UD-<10%M?!%PFXWWS8)J9[JZLMM2:6+N!5#$@Z'"S!6 MGD ^3+R;Z3?[W"EMUK4?O>XI]_;B]\1*TY.VB,X6$%)@$DS"X?!T$'E>XDOQ M=(QOM1^\X=C&YM\"TUJ96:UC2BM/2NLL7TKKSBPS5:T60S4)(_,HFOJ24E8@ M,AJ[W>W"0[A:T=[X_U,5AY%W*M;+R.FLKP5 ;?CH(4QT<,J_59LP:Z953:2O MLN\3LU]E##>_W\/F99G0'?C1R"E@3UI!X4:X-U86) MM@F""*X_D/(C^ENJQ MOX7[6VKE8W_+\PI!:D44@B O,!5_>/%2UWJ!9>ZG&$'#TW<8+VD@1)OI=%G MW_8>O#[BE"ZG!L)_@8HM3D6M_X*%.]O_$JU;CR&2L?+L!UJW&?N5PT.'PF6: MYU=878]OQR%W:2)LA(*A37@Z]HRG4])$U2"R!+ >CA MLR_ZB@EE%G&-/9^" MG8@7(N&5'?I)%YPYEG!A3$,8.YK5R!I^@W1AMEIQ5Y"!FJB8F5M9LVZ)S&SX M1[[O[!?Y:46RU%7;S2YO7_V"Y1?GNUZ[[X2:HK5]#DNJM7M!]4,U5XU$JS:[ MY;6/YC):,30$6=9CZ71^$"!*B2WE" F2V[&9?,NO6 ^3B.H-W)$_?'J[;/OT MV=C_M\?4>O6N5JK\]Z]O\'%)UF0Q8H.OA2OS(?(&?WWU,)F,W[YY\_CX6(J] M7ND^_/ZF$_4>$-[JC=>_=Z,W?7?BOJDTV[5ZN_FF7"Y7JI5:NURN(KQNNU%Y MX[F5L]I9H^W]J)U6_OD])G2STL,$CM$7CY1DGXJ#>7 8M7&2^\'WM-YY7@YN MES]UX,\*#'H^6>'_:JUR$\E:/6N7J]Z/>IJLF]M=:J:4VJ>[WX>J7JJ^/-.J M13$-#0@\11T>E/EO.80)ZZ^##7 S#Z_JI=I__S?2.#=Q!Y7R-PS8(FEJ2=*D M]#MC?.^]$%;*+Z\ZP,(L3'=(,90!J:W(W4;9\^)* MA3N):@KIN!A_SQ@MZ3 M#JX?G-8'CM9V@*.UHCEZ#L\.^SX\=?^.7'T'&%0OFD&?W.B;1P%S/',':%\! M(\]V@)%G13-2MAV+GK8]/&^-'6!3HW!#N#_R YU^YQN.C]_A';RF9.@JQO>& M.=HLW*8DP+^BN+IUGK5V@&>MXI5ET#>[?P_[&+852[?#TVKYK-5H--^,P]@= ML1\-3&T7Q=1E UOVX^C5*NB"KW(%;C[ JN,>M4K:&==A43$Z==&$-K-TP[[1 MLWCL+].A)W$8W--*_<1];W5G6)[-3?;9P;O[3#;M\S4ZDZ=Y6HQ9[G2XJU\+=V6S@EGA^=U,YO/RH[= M 7=$S(0TOYCX9+O<4/AW;M1U R\^O?XQ])ZD"*")<#"GO;I3I[U:S&E_<<&P M=DL=5,J5TM7GVQ=B_%6 =;_V_[[_\M&^"D15LLQ+EP[A5"%];\]_WP'ZWKD_ MPB =[YN)OD/!OD#T^:/UQ< M[B;Y/W@#/_ W2/WMT_9CY_UNTO:CV_6&!RS4-U\N=I/P-PSZNTFELFWJUNT7 M(NTY#BJAPGY/($R0_NQ 63<>C9)US6.>%R4Y,3/-(DX#'L-+J5RP#A MR977V53/ XCV=J,5G<9F<]0S8GM/,9U%"_N*YK05_7>NIJ*KH!=&XS"2T/#@ M)'@1-2N8G7FJ >>+V3VHRH\=BRN*X7=_1MA#/[][)Q[&=;) MP4#,NO)2SOUD/'D9IJAA28YD3(XS];-Q)C=KN _Z 3B"C;D+"+G.[9)J\#E; MU."S3B]>UVSO:932C>BW/'FT5,1HM-T')M[$AO+T.-:./8ZBQ[%R\#V.ZQU2 MN8X@QUG_>GPR>ZY4P)>F&V'@Y5T/5L,HX=[&=LJN]Z#.QS( MJ3"4T>(/T LB;QK M_"YEJL*X O19(6.Q=R00;[-YCC0'X8+;H("S[J^B2Q) M]]T?M_;=EZ^W=TS)Q0YUOG# 7(#@^B_+UB/?-;N,U*-JC5P-<8WR+ZNB4\TE MI5+CRZ^RA7M\$[^Q_\83E?\13H/[31-]R>O?/[W-?./B;Q6YX"PBST%06[S( M!6G=+1/Y _@UZY#YDQOU'NQJB_R>VI87/?_P90;5CLXF"PI_BE.6<)AWWM!<%U^>/6$C:N..I[ MN8O4_;R7>U WB&5 N;CDXV:#2.[W=@^!903#DW<+ZUQ3VZ+V"WOPIM63_^F9 M]I%I6>:;V+K25MKE3$=][5+,[CM97!"GHPQ+;61-WZ0G7S0)?M'XSQ'C(-?2 MV->;/VI *;R_TT0B"W1CXI.O6L:D;_[729)AH@J^49N%2,7?&=6Y_X&)H\8F M:2C1O ;&Y,J)2#L2=N8-8V>:PQ#]:&2?W)QWKM^+F>]O[5_]'V^#,/@,8AO! MI[%P _;Q!=?< RT1@-'XUU=]SW]+8,]AA,^X O,6*/CKF\1WW[U.=^2D/8SG MT7I[XGEY6BU2+ L7NHT1PK!=L+M.><7G8="G:D%'0<>Q('[WX@E]WK&3W[T> M>YP+G_G+.47Q$0&645=X#J\"^K[XORFV@-$(S^3WW/C!OA2S%9.*=A]E;C8H M=>C:L+E)\BT8:?Z2.NGRM+:?*B3!J=8F.35WIOK+\JGU4YRY]B8Y^3D4J/Q9 MN*6'8PM4FAE:N9@8:?$N8IX(Z=E?X+JFN_HMOE'DY \Q;'IYND[@]/#K8S89 MH"FXP"19>K^M6$B^N=E4"IF_@)+W8"UL+U#//S,R_OX(IQ9,_OH*=A+U_OK* M'P&3_UDN5TK_&M^_>J-2/K-U _24YQXY4L8SNFSB^I-'&D]1ZH6C%$CNVF3) M2*AFZO]Y)*D22>17'\3HITIS_$-1MGE6'O\ JLVDQI:4N6]2CF?N 3FD*L"N MB^'2$&"J8K6Q04CZ)0-8LKCQY>+F^LN=?7UI7WW^<'%S ?_Y?&=_N?CMZO;N MXLO%!_OFZ_N/5^=VY_S\^NOGNZO/OUF75U\^;36.7/"\C;O0_N0&WN*1M7GE_>HS7 M3T-V/)YYA>-R1J 8GC#HUY/S -6P "LQ3ZPG8SDHE5)$4JDJ6X\ZDW.UY*"K MV1'^M$&ORSURVS&B08_^9F\',Q@DE@=/!Z$ M$/L),=)'@]7TP"=KS%4Y.)SBW@M@E<2S?WT!N#0>8?]KDQ,^+PG#B-?6(<$#62$0^"P_,,79STY3,7I#IQ M+#U>BP::J7DC\"%?1XWSJYU5M0W)J<5R*I^ER?( QM40#:SMJ"$K0PW9\]70 MZMIG TIGOJXAIJ^A:^8SR3*99&LFK<&@-;6,K;6,==0R9%2]=V.?J2W,JVV8 M4-O?Z=T#G(HEUW5"%BWS#Y$G91V-=[_K#U&XQ$$9+3'X8S;X2_8UG-_4(WP* MK'H_\-#B N3YEC9NXDG6\N7/#-#-_"1/)PU9H_#PV9(--P[NTYTSC-$8UVCQ M4%1XE<@]G_.-E*B@_4Z]- \3^WWH1GW[)'&H7NM1LIBE5L-D::1DI/J%^J)K MQYP:*6;@D@ZSS);X%<$V>T*>$G5*L20EKZ,8%3R$?2/HG(=*W#W?F=(174_-\P!S* /0J7X((A[]Q#"&==_%5($'W%! M;N J&;K,$+A3\((P9R^#)(5=Q+* ;[EQ&!#SX;Z:1CPSN1M.X1D/'DU$,ZUU M:[DJL5.JA,;\PM+5E8S"HEK'U5OZ4^HY!VL!12."K\%::=9KEH18^&1S5!M^ M%V4-1[9%L'WX,]" )Y[2'P45\"I/3."&.]S'8$G AN0D"HE#[*@+[R-.^V03Z@JR#;,^3['[@(?<)O*/IA&8V0[/$6H M4?0F9C6I-QBP#1:@ILU4U#1ET52>JY"!Y!3^B287TIG7 B:@'4_!VV>5]&@+T1+S0'ODUM!%F^,5*'+U(^_Q7./@>30"C>V\89,@:<%78^Q"="T.E^M M]/:R&( VOR\'4,([C*L=9\[WYSDRN!LXN8+A7L)6Z*GI)TB1;A1^ ZU%=WC7 M&_K>=W&S&!>6&-P- F#<(EUE81L.7.&*8,M12AVG/8#<7([.V]7J=3/2:+*' M.$=^KV;F]]9-K"TJS,A.K:U6,(K9Q;[P@B)^&W]W =V<9N+T4D @#-66KXXLBY6RTOV6EYL;&L4I'5ND< M?G?C;K91K5:9T-PHEM86^E9.*S^LV]^QG($2(U_OOGZYN.4"5J.9I5C%5\C& M;N\Z=Q>?+C[?6=>7]N75Y\[G\ZO.1_O\^O.'J[NKZ\_[OK\/%^<7G]Y??%%M MEQ:W71:XJUWM^?O)EMWI'VRAKEY[]:YS>WMQ M=RLQ C-QA#,JVU4#KEO@0> 72YS>9[5\RC%9E+5X2#' 8),W%YBN[[_7 )QG&)&0,# Q>RH_)VV Z.NV'DU/Q M 6E83N/3>]<=O\7==8(^_@_V^7QWA^C,=R;G;A1A'OL/=SCU0&R!#1X]>QKX M_-9I#.P_ Z(WRF5I=\KES0.:S";%>E+P7![/KH-@EC$Z%'D]#T@!YWFA8,\I M$$U+>=;G"N:JW,D7M9'Y+*Q4G7:YO92#FV);\8=W=J4WD3=V?0P%CKT@%DFC MD(*0G/?>4S:+?5WPMN 87^.>.K2E!0PO.]7VV=88OGEV?O"H(,)V)_9[BOQ1 M!$]4R.PI*]6HO7/,9\##B8OGTR@"*%BV1GCS6/ M;-511.["B3NT.XG+(;,;@)^:^8Q5Q0R^9/?#*? GU\HS3,CG/K9@*5QV,8$R M:S3!&JDNMT8R")Z3:+NI]!9Y1AN\O99_<*>.ZZMW'Z\Z[Z\^7MU=72SV,7>= M-"]A]?[A1CXG73DD EKJ:7V?9D;9;%-Q<$(\ON$-++VZ*JVF4ZXM]TIW0_!? MO:.AV3%";V!E5!^'*_?WS([M^=]P3C6/K'Z+&R(HD?B+V,X"9H'[67/*E=8! M6[ (!*HJ40>>%S_O++ZXMZ)W<^EYXE0NL"3K3JVY/0=E\\SK]+&"B&?)8-6> M4:!#G3BJ&&6/69L\P,D=Z^)A#!7*W0+KXZ6\KYPYK<:A1Y?"@4 R[+$$ M&+=M-/7ZYK:0U>+6!0GX' :]I5=P]B%D"N.7WST76IF\;UU@AB;$-%< M+OGJ\OJR<0R#K/.%M.I4VV#W5!OK"FJ!T8R7BZM]]B9SHFH;#Z%M(EZV]> 8 MT&=!?*P!=G3+:91KZ\7']D7U'8-A^+.YLK,+!*Z/;J%B%>WNXUW5[$ M@G?]_BEV)[MC'^[-/0R0]1E3P!WB5JZ"<]Z(J4JP:^2OKTYGKJFV4VLU'"#- MX9GJ; 3UT;CTNU.NS_+<"'N!8OL$G/CI:,I8!GUOX/?\R>NCU3Y'P+YX/$S\ M0I"OHXGW@6F70]8J#:?=KCKUYO)0W\]IO"\QD8Z)Q]VUK7;66C\(8^H%SJMA M7-E_=#Y^O=AOLVKS1M/YT(UC^\H^F09#?T0($B*%I2>ROMYOHKV$+3JK_O?( M#-VHGMT-T7_UCA.9]O5T(G$1_NL_?IQY16O4_$RZ^GRYA$W8Z^/_^&?YGP-X M6)IKO#]C>YG!%1=YZR@;]+H:W42XU#,^SR MB^TG-_HF958+I7V"TP/LZHS3>Y3.-:6S,Z7G,;EO))J@1J*ZG82];[<$S7CC M1NO(\.K)A.?)<++IO_@N[H+P*'+!9B>0*58!<5!-\);!!_$T>E:*1?)/I7DF MX"9;%ME0,89G9-_/NI%_@[-)K+$;V8@[XR4&'Y-T_5H(GL3+#=3X>8#;?[OJT70&?8PJ[,<1C;W<4^ D2L%VS1: F9<70: M$WIJ+_2Z*A73[:JM45&(;P%O"EZ@C5,X]0+HR&^IG3:M:=\AKIZ.++1]>Y(Y[1BGU]U_EH&Y5NA9\QJAN2 MH>:<)PINX]*LXOOE&%M=_Q3M3PU'0;&LC4='E@0'?H9X+..\/CL@:WH9=&NN M$&$%T1R$X02#19R+DM"(GWMILLEXU@7/\:^Z&_] '?,9A>;,4MZ8PO_/*5I M$G!C2D(O[3F;YSK-/,AMX/8'1IE@E!Y?W B]F>AP-<@\N!7_P8+J3,> M1^!4L!"??/#T3_D:/I;2HUC7.=/@E=/CJYF(JN?OKR\, \#^FQL@)/^<*-SB M6.:#/_%.44M[./O\,7+UVRMI/-<\$RHJJ:*:/FB5TQ%\X@$=OM.^^W3ZY+G1 MJ1?,]-UZ;NQI?83JJ/+J'>QMZD9/=J4E)P]D#;%8>=MY 6LS@[89CO')8L^X M^MR.>E9WUP.E[/(TY#B5LV=B]\X/FF\-&GD)96O/I>P'$*/OA(,BM2HKU47- MWPVG4:OGJI+==>H63-PK-7KX&F=!H=;NA?@VDF14$>0G-W&#,NCZ4! M\_*>K][I5B#[ZO/Y]:>+A?@@&QZ*J5?X[BH 2\9;#+RSRR,YS=F;'_SO?M\+ M^C.9^QW+@U17\L-%T5]C?GFXG-_8"?J2!,S6!2FGW:F=PS&"<8N9AKE5K=:5;V=WA?_LZ9))L/,ZZ\EB"U%JF!Q=+S\BCX MZX2"$^BL5T>QR!:+]AS](N-.3+B%_1"D7)K-EY:1573.(8!5&KL1DWGC(PQB MWL%8>V<'5+)!]1(3LH08+)I\V79J[>U-0'L&OU::A;5_W*QDS>E:,LIOR+X=A&#$5 MX=J^^-%[<(-[#Z<=#CTWMUC&ZA6GDF/,X:Y[8])>/0K.K."<90.BA/$D M!CF1E%LPM:Y9!0VP-I[#WH$W"!E!S&3MM=K#,-Y_Z5I<^K.>>&5'@X%ZILM/ ME=%B/J<,-?X9^1,O' SF2UZSUG3J9QLL+'S]#)?X !S\@H[0JW=?+CH?K_Z? MBP]VY_,'^^MG]>-OG:O/]O5G$VV./I+1([W'9%U^>[$V47U]]ZX?V&%P#*[, M=0)N'\)H8M]YT3+=DY*MWEPS@ ML7]\:BW@D]C42H7&#>>L67-:E>5WURY5O[.:8A<"H>*FNA79-5N1P\%^JZZ] M4TQ&J=UI[/5._1^G#WZ_[\%'^']/47Q/*Z_>G8KBE!V2LCFTG6,\IU3(WIK: M!2BI]@I*2A=SFR "A=9R%QX3>*XWIY59T#=UFS#'0..I TT?F8&C2E-@-P!/ M7AQCMW)YV_GOG\V^PKX29O^\[ M/':J/6NI!]RI)IS:$Q &^M?KI.!OM7DLUY)G/>P][FO+\DXPL.8O+I/8-63% MM;S[L^SZ*QVE,M(!.<*L>4L;\J L;B7QD97 SA\QW9M,X-G9@B [T."+$9T< MIOG>"?J+DH79.<+J]JKGGZ,44L'2E>0F3T9Q]>C[,27TS[/&8FD])\)?!=G9 MH+X!\W,]6%N.#S=AY(N0+$IN #^+(6I E^F0&D<&43@R E-'"9V5T'GMQCL4 M%#^V#19][EZ].^_<7.$XM-O?.U\N[+LOG<^WG?/E=O&N[WUC9C96EKAXW<'A M[.^?U;2H?HHW=@O[\@/^=YXRA%;;:;;@7JGM7)G;W"M#<##R^IXW\OI[?QL4 MX44MJF'1@@*WP?6 ?_PBJ.D''S .$>%80_K+HJN@[-3+9:=\#3?I*%UD#'3<\<^-M3$2&(;;+\@9LK%R?5!>#AE!=;X=*(N0H2 M5LXYDYJ$^V-O=P98OFR\C;KDK:JB4FH"S]L)_? MBG[&)-*C%;W]$\6U7C+IL\>[WUADZM6[]]Z]'P3HG8<#F^5_GW5(SM+O^MS2 M[ZW?!)EU@HLMDXN@K[EE4V+O/V1:+Y?5L9=HWLV='BI]+ D\E@3F*@D\.Y8$ M[F6EP+$0,*L0,$>%7KU\K-"3%7J-8X7>407,7?[IK]UW/T<97N?V=_ORX_6? M>U][QS5WUB[4W&W$!MSA,B6C?25]$ MI5ZOFV8_!$SU9C9L+D>/PY&'-68;27YO!4Q]]LF=/OH07-T#YA].G0+S#XYQ MX$DD=?L$"ZI>XY_QESWW_V?O79O;1I)TX>_X%0CO](8T :EYE:CN64?0NKAU MCBWI2'+/OONE R2+$M8DP,%%,N?7OYE9%Q1 $ 1)@")E1NQ.6Q()U"4K*R]/ M/AD\FQ/?0Q;Y@=F;F@=1 /]PW$,I"D@1")-\<4*GG@E1A)R^K(F<9)'!+.9F31LLZJ9U9C^5Z?L4' E5X MTP'GUH>K,8Q\$O0T5NZ9[2!@H%//VURQ!)@D>\ %N/6_JNEO9,/?'',].R29 MNS$/9#:'[LL+-O$"!R&3H=GC9)JP_AL'XE9Q_K,Y;].YK&OWTO9=$(BOGLNF M7-H^\VJJW6E:[0$_0M]4)<_;^SF<3VQE(TE0.F_6H:44R=[I# MFYY-ECN[Z6+NDKV2ND[DV$>"5<6<%_2.=G#GL^LK9G<^ MQ2)YK^:*ZS26AG=Y<.?<+LYJMY?Z5IW_%9YQSJSJE5 M:R[N&;UQ@&CAG1931)_W8>*Y@>?OWA[G<5QF7-Q\QH^>F&\!+'"[935/WT6K ML;ERL%1SDMU5!]DMP^;< EV^!H&0&.QAPJ_^+X[=;HAK;5*4!LO\6J M(=VU9'>W/0_T'8-CT]U,%JO_1MMJO _%,!<:.TTT^,X$YE@:^N;[HWYTMD@;=] M6:IN[:9G2^(22HMRB-X0#FP0)OXZ$:FCW4N:G#662)K<#K^!2L@SD'>PPA*; M%N&F!OM*RX7"DAU)!]N%,F>WPX?0ZW^_#H((FX11-Z@\9ZICM*[FHV29/RM*I6PU09/4R+9UU==M[,&8V MWFTMQ5F.5M'^),V>I#G-_. 8X?]?_BMR7N"@4"<@*5DB> M[BLD?Z8*R;548OD:;E]2N2^I+%Y2>;(OJ=S74_U4)97U?4FE+*D\W9=45JD" M_M%3,\JI7J/_L4D?VW_5&AV\4>R/NZ(F>A\;/XPOMS>?WW71I4B5=+]@'^F+ M:V23W/7YR8)++J'-NF50U>6^SG*=.LL"_$AO6DKY$;V/U4(4,R[8&@YRK?+N ML;.[E5\GJE7Z(.@%QBZ*@"PL=P%?+6+FW^=8^NM4@V9')]8H">VL[L?&:W#[ MZK)!-[RR'?]/G'H>_J31KA4J?:J@&K2<1M37&Z]IJ&X#TX4*>=$%J]59G,G8 M9.'N6Q<95;4MR0*BKCO@F%.:4BZJ].1DUYJZQY)'M8'!=A!-K[!W2<1#/*TK MSX^Y@_,Z%9R!157;8,.-(KLC2A;Q1OL4%W"FVJ#OR :IX*LW'GL#)YS*_A%T MKLXCWX=[+&>#ZBVKTZA;C=/-05+*.6(S%3L[>VTESUBJ(J?('=9IUJQ.:QN* MGM%FM.5FZ'O80@K(((^?/QRW?UT_67W8BDYA/)$KQA;799V>6)WF=K>UFWWWSI5@KFW<)6?<5?,%9_A< MSK98(=Z9==9>W&MELV&+4JLGW_#LB:+7='6DL+]@KVX\M[_(&&O4FE:KO@IA MPAMCUK)NXWWQ8QFG?ZT*QWK=JG>VN,0Q]<(E['>MN+S@;$HPXQ.2L+1%6N+# M*]9EA2KW04]9S<[*K;LJ-.@WZT]B[FZS FUQ %-6V6AVLX%Z^H>W>H=R" M$A.])Q("0QZN'Q[-VZO?=GJM"IF\MC,XPH?/9\Y]]L<+C;"U5D&685Z X96.5JJC?10*+)ND;P_9__\:/-JM9)Q;?D M^N:J6"UW-@\4G]\B_G)^\L#PK5NM-G8ZWR:\Q3S+01T=D_"KEGD['#)?QG&Q MT?MX0HM[YSM]9DZ8;])J["V5N<+66.K\R[;0M/QWC(/FYND"^+N4LO9Q 2CQ M-MLMRTK.5]O_+L4TED/SX 9K-!L+?:V]0!:]D**^ )?!M/Q[?J$'4KCMGK%5;>%&L0W<4PF\!95 TB#- MVC'URAO/G-@^+V7B,OV/C$+Z,K>NU&)T*0<;KS'_V4OJJUWXW]I7[ MLG*_LZ_;8Y;+18!=K8W'R_NOVJZ81^;)\7:($V,)<-BM$.T!FLYE!I1=PK >XR2]P+/$DX4)K3DOFT\L8U M]TE%2OU/3S**W.<^[\KQ@]#LCF'O^B">GSW8,)>0_+<]^+J@R,)38IFMXWK] M%_/ GHD+E3%L_/(JF?F\CM8KY>L<$3&W2#<]2>8#8ET3Q%@Q]O!&[9 M2A!WHB3SX=GSPT?FCPOU1"X>7=K"NLP-AT"S(XWO(62[!4N; [S(6=%B('[2 M>YJ7)+6=$OY#,&N74'W-%50?6=+S[8P!'>B-V/UE++L/UG]D<#: M9+=-*$;Y5#^E@]Q:O=YM(^GDW(3VJHIEYLM+J96E7EU NA=QV*^D4EJQNZ05 MCE2M.PC@+_$X!35%O58[GL5Y+;81EE_(]X)&>4= [JI2^3]U%#\^=X&! "_* M\@[ L#!MA'WAW]"HP%:"W-@XKG9Z[>,YK4"V(23^;O$:);9^L-=N_=#<3.N' M>S;Q68#>E6&[;@0C^S<"^MD+O&E@3\TI9H41?'7!^FS< VM;IA97[ *Q%[62 M1:VWMJ@U\D3M;QH9HX%]5+$+HA.8$Q[211W95T%=HJP<@J="%B)@L:4JK8+>KH1%E_COS\]N;QOGN.3.N[,O[UP1.E MC;442.76DO 7 7A)KMCM#'M(V,_ECXDCR(8N0/F5.UBM#4%!GU:>G,7+>Q/1 M->X-.6[(E,M=#LW-;BR!Q^D%Q ITQTAX!D:.^/E/A<+]*5;CF^LS;O?)]9B M3=CG?+_B5P<7+/Y=L33LPK6I-K(N]%R[D=G2X/S3[:5^W?)QZ?_[?VRWT9P+ M<2B$V$AW4U"(01XP@(.(J))4TNDT&:H8@&XY&L,GGC%&@2;YT939_A%S9SB5 M>+=6J950*=4_?(1I1+8_Y:.M=RS^#[C=%$VJ&,;\EA!;U#^COD(CR&2\C6N_ MVZ'2>O-C/"=6H[$XU+OZ JRSLGFHGJ47=6T*N0L0H!T\NZN]8D^OJ.C=OVJJ?6&>G:S:( M*8')I'#*;['FOF*]6@P.U_3Z.TE-/K.40'EGZ2S M#=X%+:O9K@@N]5[WIU%[TVNE=FK5:@W8MHJZT._PMN7?4.OO6YDWU&GGQ&JW M5B8!+>&N*HE?8(E<^=K74HFO6Z$=_!*2NDY/^/61R4OH_WK-:I^NF.I= W-1 M]M8LGXG?0-J]/*7?:->M6J=FG=:75_KOV6ZLR-2Q4-&G M*^EW.5V_[<6X.U%+OS$"A"+%\\U]\;PLGC_;%\_O,#IKW]*^E);VMW>7]UUL M9%\PB;Z]T[JZO3<>_[@T84+7MQ?FYG/V'CUK-Z/7-^>W7R]S"-RU7F5,G5]@#UXC2KETP*%@^MVS);U_/_T=+ M%&%@=8X#B[O [VM. M$.@M^M<7WM79%ZJF]0Y-K.(RT0JVKYFY?=K.B9W,W[9F[<2J%4BA;D,!WH(] M75"!EMSGG0T,5R!)K3Q%D"\^]?:;-PY>(T_).W=<[P5CCF!D5^+%$26^_N[=U9YMY]84^+-NVT99T4 MP$CLP!F<:TY_\KWOY&@)SYIQO;2WK&?$J%G+%*.KD>?Y?!7AXK[\T7^VW2>& M+=Y'S/9MM\_R9:S5M$Z:G;>VM==VR*3%NA><6<');D2$M%D!R(E/G[O6->?#E]N'AT+R]27#WX2'6+MAB4*"KSR79<\P!5RZ'IN?N MRURW@)@#3:0.U'3R[GD#S60.)@F\RV)'O!>24@ G6<".V[!_]^'C%6>-J'B? MJKC56CD;)695I-KPU&J<=:S.Z2H='#<":L]64-R/0/+%2$$^35NK(#8/!GKM ML.D-=UMY[9QJTK!Q1P'K'SD_CIZ=P8#!1_A_CU!^CQH?/AX)W,KVJ_UY;/U) M);(WOC4UU5Y"3<7H;9T+H KP=A76=UDN7:S.W(&NW9*F&*B^N&DA?G*&_ZC@ M&I30*'3;^%NKD./L?%0LL9]A=[[ WMRZ<2E)D>*1TQ.K306#BY-4Z]"[;N2J M7DOR+Q\1GPENV<,E.&$Z&2JX7]^^/%XCU]/][=<$2'5[);Q8(>(QU)@/34\<)+_>OMM]_-AN=-.=E M6"V%X;[B8[>*R1;23):[N$LU9FWM:\MD;5F]MB\NVTJ!7L"!NK%1J"(L[+%Z M_D?WYC,,(V$$;WA 5[?WYFKE4W*(;R(F[Z?R23A"!](E.DR*PT:+D0H->=8K MV^$ZJ2RS$T,S3GZV?>M8WY;B*A'.X$EVNCR.;\QIC36/$:EPAKQJKK?"\?*< M!&CQJ-N;9))6V_"\E!^LQ;T6X1JE):#K#O*237.$0F:=FHNEXHU"6>L"!POE MJ'3ZP)ET54D!WMW--ZPFS'EI4=B4<]J3:S<[U:#OP>UP;3%_G_F)@0CSH6#' MK6E 8P;1B,H5AKXWUN(9>S'-$--%=6A;&''=L"9^#V"V0I;S>??NFG?+[MY? MFH_WW9N'[OEB2WK;YU[:K8L !ALO/CBA@[<$5*UVTD]R 54XL0>8E^/R?Q>! M49V=P5$^L1HGFZM_6AB]5TW N, M7/C8QY'^DH-7!KEIU^$:.-M5;M.4O*UCS&3TY\%__V:ZN%VCU,/Y+\D$HK$Y M;J891,9/WYXX6/81X&Z88"^Z 5_D8$Z^:><.0 7RW\FWW*7-<^TFC*)SOM0D M]X_:0L\_ VB3USL-JW5:HEU>F7VPA#SS4J-LN7P;@=M649QO?8-B=;Q! MGM5=7I_6/4W$YH\4AQ_)3,L.S[X,UG!9^LJ>'-=%?]X;FOP [+(2*0A';L^% M(V_\*LAD>\[O*7CI#N+=,BD]]Q\R.5?([MA61NE=[KE=3$*J:;!=-4IF#UC; M ];V@+6M.(I[P-J:@+7V'K"F &OU/6#M#4BK4XS^N\W _3/PI9]W'_XPK[[< M_G/G^=(YT,_XJ7C22QCJNT4@*LE.U%S!<<;4Y)_7C]>7[QOG)V*H!Q+L<+@J MVN%=8 +/LJL?>53>&S,$!I:+0=ATXU?DWT2_B<.MP&+&GE)@,<-A=IED5)037Y@]J;F013 /QR$;W%Y0)) F-^+$SJ5^UV=L(%*= M 4PG,#T?KL8P\DG0T^#%9[:#N(VSO'2D7 ),0#[@ MSZ7]7T"V]XS6ITZE;M M='/TQ)4R(,FTF'D@$V5T:5ZPB1RJ5R.VR@,0MO%I+CEC-3SH_U/'^[^3)GM>/*BT =)3C;<\Q^MJGVV[= M7ZO0QX4>^KBSIQ39 M?W8>*Y@>?OG$5?K^75!F7H:S[E1T],N$BQX^F)U=D@ MS66E)WN.)"S5I\2<\$7<06&95Z&3>?B[?!$"(3/8SX1?"E\,R"_,0V5; M9^W--5*H0#ND.YCL\+[GU6O$MGVZM8G8^'S4<:O^OKL2SI&.!1U3TK*R673A M5F/BZ[6\$&,LC6J%0?'<:^M;2#+K=:O>62R8;X9_E-*X2@7V:A'ZG97 2JS@ M[-Y.6$L-JWLG%O?3]%N +M"M7-:N6M4"=E.C5@>55+=:K959,/?5J9N"RJ=2 MPU?7-]V;\R52P]N^+%7W>M.3)W%AJT4I16\(1S8($W^=B$S2[N50ZK6S)9(H MM\-OH!3R,B9GI];I2=MJ;&.CN#EW!;8QPET-]@6P"Z6EGMU"# P82J7=#A]" MK__].@@B[!M&#:)^ADK7@01^7W9/%<*8'=:?8_9 M@T'S%ISEBJKO^H;@H+M_E@I6RG7>OE+N9Y79;:_8? -I/'M[:9SWPM9,9>:B M(6YM%6;!S:C7"N_&JA62>[3YINHKT?A,5Q9I*.J2ZROG%E%2]<%\%:P>^OC, MS.4J%WA\/S,ZO_WZZ?KF\L)(T/B+N'CW"[8.OKA&0L<- MEM%M= %DO2 7U6;=,JAH\"WG-^^N>"_U>06XBK:B!"^NM?OP$0-G:1MN\^5Q MN;'"L]6I9'!V77> _[G\5^2\V",BC@[/;=]'V^E/>Q3E9.';L(PGM<7([]RE M*,N%S0+^Q/4\#B@.UA?5+A;6=;S@W,R_OV6":HV=B^=V^^JR03>\LAU_P7:A MO&/]3GNK 3U9^[AI:'9UNY:&6^=TN6Y:S;-52FBJ.U!O70I1U;8DJQQ (7)\ M)$TI)R72MLY.MAL<-_ON6/*HHBW8#I;J%?8NF9>/IW7E^3'Q<$ZJU3H#FZ_6 MV!SNN>5LT$D# MCE?;ZC16*2AZRR/V=O6#U9ZQC98&5G7&YN9%;U/%/[N?A:KH/*<+AVZ*'&:K MWEXL!5O$*KQ6IKT5$UMW"Q%9MTKJ^*VGPDIL^+W$8RN6O44F6?VT9;5/FU:M MLSQ->O8F["$ %1ZF#Q^_7'<_77_9??SM2G;!6O5&,T=WD\$J\SH&Z[J2=AA-*-EO)=8-JH"[KV^4&?;5=^XGRLUM3F+?&:8EG M<\78XIH[<$L;]7:NP';M4Y:<<5?-%\/IPMW5^"]$R-*S36MLZK2\FZ2FZ%;L:@,&:HGWX MI8+P2W[GF=.ZU3DYM9H%&GWN(S!;>)KTMF*( GNX?D!HV&\[O5:%C%[;&1PY MKNR#N8-1&3A-(1FW.)5K5W29+$)ET&Q8[9..U2Y0=[H3YBVW0P9HD#F]B./G MF.UCG5%@'H!S&HVCD1VR 2SVT.D[X0Q.?^A=\\7(P+#4P1^I6HT":O;IZYC*-BOQ6=O_H:59'JI6=ABO=6R-[:V3/W)*9 M#U*VA_EG]\NWR]VV.LH)K9Z/[" PK\V#R!TY8P[IO&PH5JNE3O)%RKIUH M,+Q$%^%2.P.GNOV:PWDU],9,#7W19K_[S5),$?RV+VN_;CSPL'U>A;5P,[:_ M'O\G(S;8O4[)IWL"!$6 T-P3(&SZ_%9,M/->.!#>C/E -(N]O=GYKLA7M_?& MXQ^7)N^.;/Y4W9'?"U/"]B5C8'>2'1:33>O"YS;9S']5XNLN5B7I=/&9'E"Y>;ET+5NV-U"MA:;WT^%Q2&[=R^97=$_<*>%FU8O=FV6AM4J!OWJ03!E.I[+DC= M]F;TC R=9,K0U=CYCM8[>G? 'KM*Q.K<0^3V_D M?$GS="\W,W)SFBDWU ,,Q$0N7%XM7_/DS#H]??,BT95+C>C?OYDNKM8HA::6 MORPL;QEX@H6/)]PH#2WV>LV1%P0%P?A;+[7Y91\KB>W?7O\=G])E8./]]WS!73?V[ZZ18'I/H-?_9L- MS"?;<'YB/SQYI:WCW?(J]1+$T19ZA-\%Y(28&* MS )LB=7)>-:6;8:#MOS;K%W+V20Q*4E,F^>^UZS31MNJM1='PDNXHLHI'**F MJN24()@\_4' Q;_!$IKN-M*:[=44L'>=,VYK>G>4MD. M=.69M/! L\8E._C)(=\R$@S:LSF.9L8BE.KVIH!R*QVE8BQ*)0VOS)%)];K2 MT"HXX]DIOO@T?P:9^@(2=>M>@+2^4'(H*&(E=C Z9+4R\PK%XQN5[G2RQ.?- M'=MY9%&7CXB155VQ-0X<\&:_?7F\OOEL7MW??DT A9<^TFLWR7U3(H<*3D9V MPC2VP,YYM0LH95Y#?>5[XUM5UG7M]GV,0UTP_M\"1V8-1I+BA!"I2W+3M4P_ M48+]LIW>T^S"W;B,)"6@BC@TQ9'5>0N2PFAW>*[ MO$8\=<0E*>=FCWFVLK:UV_'#6HVB$9473/TO;$6\MKC'^>*^2[%I,L3YI^WPC+'VC[OWET_=K^8 M#W]T[R_-Q_ONS4/W?+'UO>US7^?&3H)FMJ)[_$JGO)4+WI,-Y!V7_[M0,O;, M:G4:5JNVN8J]M4 Y#]D]+_=702PD[4)" C?![3#9<=-Q+S#$X@=WS*>_Y/7_ M.['.ZDWPWTJLLM^($;^ZM9,MD.L5>#CBXDU90&3WB)XNG#C=!"/3#?@*OQL[ MJ'S9/\FW]J6=<^TF#"'1=(9D_E%;Y[R&I\6;S^Q4,[S5Q)FJZG($^DT%=DM% M-;O0;K[%#DK9\09YEGIY;43V1"B;/Y)Z#[.=GGUIH;4/'S^Q)\?%!DX8_N(' M8)=U2$'D_,EG8)ZB8:/A7; M_SVB;X_HV^-V]K#!C<(&S_:P004;;.]A@ULIT'N47Q&4WP/!_+H/?YA77V[_ MN/UY0[@VE)3/:YS6S8/ M[B:A;2*B=R!3]H?%\_79SHNVW,60<7E?+.0ASG_ QO!S]7IV124/2WMCABBZ M:A+O19>M!#!)QBMGW],=H$?$@4Q@1_L,%K?O@/IPF23%E^@Z^#/^LF\'S^;$ M][ ;P,#L3G#A0BPK;46#;0N^FAM_6_JU;Z P M/GR\B\!!1760!*1M^8I7<9R;.;DFN4I! C660]72:5KU5LTZ:17/I^8N5OE' M6=X8L^^Z\[T^8P.1M@Q@AH'I^6 RA*(3:!J\^,Q&<^.&6R(P%% ?(;HG05:&ELKF$TVG$:_?2]EV0L:^>RZ9R.1[5R M.90_S9K5:17OZ5*N^+R%PKKSV<1V!I*_FN/Y/6H8)!$3/YV8S0-$I#656#M) M14P=@W*0.FW03HO!C;NBF13S^4^MD;)3K;.BDN+ZC751;C[VI&DUSXKS5^^^ M-N**)Y:HGU'[S&MJEQ8I4C>Q(.4U8[#J!1A1MT[Q7*MXWP7+,XDF]G0'M$_Y MDM+((V>=E9>4.73'5RU':CJG5JU9DMQLH0ME2[@+2K1F"?Z2TK^CK:JO-8\%,U/4263!U?*VH@4@.GJ^J9[ M<[X$@&G;U[*\W'7,#6 1[L0;PGD-PL1?)R*WOW/T ; (2Z2@;X??0$7D8A9. MK7:[;C5/FUO=<'2.+,RY2;#3(6Y[L"<:6"A.V3U&P0@BI,+M\"'T^M^O@R#" MQJ+40C+/:6Q;M7K-.NUL%SM264:.#EX3A2/OR]#9L)US)=;-FT/QWH$55):-,__\73Z:BC'U^H8*&-[FJ&W9(5-*?$[#7SAR^/^7_XJ< M%SA4U D07%VG'[(!_H&\7_T7VB>SJ0HN?_1'$2ZT;#M];X?L#ID?VJWY=3N2_JUDOYZ_:UJ^DOR,_=$ $NHU&QXREHJM7P-N3)SP)XX MP-T3!^Q2N>*>)&"[20+:M3U)@"().-F3!/P<'"7(%6 ^^J#A>5EY^K7T/S89 M%?9?M<89'BK[8]5CNKE]O(1AW?'3=B@R[8BG_=^D^VZ_R;[NISQ&J!,J(?P."[\UD M;Q0,\U?RLGA0=\6%$_1'7A#Y[!'>\&GD];\?]6M_X1O^JG\P&9B%$[0:_(BE M#=\) MWQN566(',\Z>OM5B/VWE(&Q@JI:9JG8S(,0[%;)8: 5+4;!\8'>:,0P MA,Q&4\O0QDOFMASOL=FE*M89E629^)4A/,1[1;LO?/7DF^'C^#>^$L_V"]-L M=ZU?4&S&_V8>U7^8#\^>'QI_7O^W*3I,F)>/5^:!&-4#_$$M(HZ_\YC>"[YF8$!G^XQEPT=,F)5 M_8D:$.7)Y!LL\_79@5?XV#@#19,_!%\Y%(XI/ 1>[(AD2,:3'9=70[VZS ^> MG0E^V7-'4]@<.Z11'YOH#PDJI2C3+?+Z>]()\$FM'@H1O*LF:]VP%UF M0[G,\%Z'"F'B4^MZOG94GFT0,'>J.]X3W\&/>"GWVQ(E-2"Q6"\1@F1C*GG$ MT4WP<3H3VNH:*/'XI@323XJV4"@P"#&Z!]:7I?7=/J6KZV?-YEZ I7RUJA;@ M9F4"?"EUF1#@0+\KV(\)#0A$B&\(*'=CILK=?'5&([-O1P'C\@,"UV,F!S+ M34CJ?>"$4W/B>2.ZP7S6FYI!U/M?O I!1&.-2OPL3]&([U\L@N?J(5*Q\A&! M//)_>$/^7Y#,EJ%T[F4W<7O%3Y%WUZ-O8\B/_N(0.CA6V%>/Y^K;?C1B@;@( M> $$F@7\^,!T8)YH8<3/OX.I&AP/P! M8AG@S^$S=NX:.7T*5N+0Y)!T4*@8Q=VMZ8QAZ[#0=P##H6O0P'#1R*'G>3WP M/N)@7JC-2A^64"*,MB5^D@EF% A9O$^\GIBY8$?U29AAIV&H#HHBOZ#[7C0: M*&XG?2B(=^+?']M3TZ;\' U 4WO4?4P%MN#W%!>GB6BVQ0[HHVJU1*LZ"]O# MC1ZA8 LSZ,N7\X2Y+<1'2K 5BMA=3- $P,[1JJW9<1/Q+\=C+BH1\L@,GN!WJAPK.V(/SY#K@!=ANV%7% M6W="82T=]5CG':5&.!HJPO%P_?GF^NKZO'OS:';/SV^_W1!]X-WME^MSPM[N M6M"CE'V4 8Z2A*)R@XQB%EFG6%=DJ$W4+6'&(SH^ M?%(F2.;GST'GX$*$NBW4?8A-H4=O B?OK'6B0A=R 9,\\7IPPJ0*#9^G]4M ML)K',A[2#< &Q&A);&_PR ;](D-]I6HMP>OW?/KI*7+(4*(KP(C#(Q3V":(Q MK/N44+;Q+NL/D]:*>#U'32J;E-8[UO06VF83G\=]A-N$_E5FYLV \8!9K%Z M-X%#XHTF#.IV;MII8_'!2G(F2&KVQ%Q0^:,131R\2FX6XMH@5!I^(K. KILN MG3!;[=?G;O=N9P,-I9S09IG'O=H 0B*3&[EV-*#=S1(HXQ4N;R%]V5X"[CRQ MD5& RQEKCW%N,/<=5YPF6$G[B>8+1P],01@RS 0F M8,=$GA;*#.PL[IN!X3K\(N\/A^3EICYPH#L*Y>!D@I0*>!L;7-H.WZ\ MRM)^DRLX(JY><>S3+Y8@<&#)) :O:%W!CY M23&@:#0ZFC+;%P\JYPQG&5=;=FQ;91[;YH>E[,5$@-2UL)"9+7HH\L2R34+[+?**7R2OT[6R_+9.S=IERUOJP8,QK2)8P6]>2 MS2HO+^5U@JTJU#O+ECU+Z'Q#\\.%/?-_HO$$E*H?FK>1;WZ* OAC$*!]XX?1 M))CU1QNU>@.NCI#'"GPVMBF-8\YYM8D[.*)7@4X=.0PC$L9!_9 _#7_?TX'" ME&1S?$P-.@B$-$D5:VDW^OL0+3?XS@OS V%@HB$(]UA(<:JH!QL"OQTRO(PL M\Z"1]3YC[OOL88@$?2Z(U @G%&",X(6!4.%Z_ZTX./_HM% )3%);?<87WO/W M*3CHV4R%^7%MML:%S[('6T.WO@CT\B"BO)"%C3+DIL0A,?AZ/EC7!\UXE8P! MIE8Q?T)!$A4N?;9!3@>1+_<"#*(7QXLP6.0S1A:1S0&WB69)G5 MZZRP>C>>"T\D&"?X#!>L%\;V4>YJ+EA,I,+WW"/MV?SO WB#$21-L(.66$E; MA:08AU#CD= ES=%7& [^=Q::+_8H8KPBE=*S[%\1^BM(IHSN$8["'@Z=D8,^ M"'\/^X$EG>"5+K.Z)ZNM;OSN2_%6M:PGZ64]S< K\Q&/Q;+.K! %+Y$H?F#^ M*P(MQ$0,TTX3T9IG&ON>Y.UZOH%9ZX"+3'(*L /C,XL/Q&M6DL>T ?; M[]E@*1S=_ABQJ8K;8VIJ$"'N9:"R)8F4%[BPMD]I/UC2?D0N&(Z+N4&<'L]T M]Y V))).&5SN?-FYNIWXWH^I]F&>)LC:M/3\GKT1C<9&K=IS7/[#X,4)/']J MO'@A;1ILH8^HF>PQT\NHBAR?AG8#?1R&+_3]$_X:>11! SY'\,B)*)RFC9(W M* :;^'L$[(5+,YI9QJQDAA3=BF5/FRRWN!R1D* #0L;, B-1!@=W0;%6,[SE ML.SU/99=8=E/]UCVI4_ IBV%TS(MA9/EXCM_?0O8[? R"!V,* 9%,WS);Y45 MH/G&>]JHYYK_:8\GF# 9L+&K$C#!/F C-JE3IN"<+@K8S!,5F42<*TE5AEI2 M2:=Y!DJ<7#+BC( P.0(MN(XVQ1BO=*9DD, *X"K+2YR;A3$FA]_T"% 8$V$G MV1:\*QM^=133==+/L?E%J0*^PD_XZGE?XJ_A7K\,BV3,,H8OSHY'A$@$)DDV M/.#! B/^$N7:>&P=PTL1Y0UX")Z#E08.!FZDT>8%VCKMW3XN[F=EGLG.'+=O M_E&L:@M$1DIDDV#D/M?5/1&7M#0WC\R:P*!:@!@12><&?Z2P)#EI+)QRZ9QH MJQ2(L(M@ZY$97TP-)6X!S117**BQ_<,91^,8I$F('H.;Y+;O8_*-GQ;8 >Z+ MF=]=[]7]'?R-5S@D?F(><%#Z=+*FIN\$WW&LV!)/@#G!60$O9)-9J"T3]7JM M3%D_6])P$2]-/7K9;%0*LK3@:649.O0VXFW0EFQOULBMJI<*2ZK-4Z)+2U!5 M6W,'VC2RN?61"2I0P9W+U P *7?RF&GCN\3"A"Q U7N!A4A\EI%HIEZ'&DA(7AN%0D-K#4/2"&A?^' MF/=7!VV('QRSP -@,/R)S(Q@9"9T^K ,/A]/\&QS4+@ 5E/PCJ .]A.&%D.R M9H0EA>"F2)4EP?\3")1_SDQ^+EZF&&!$P.^I*"/A-4]= I; 4$=3*_6$>,WX MXPR1!*1XH!@C-YF&'(V;ZC85AQNI*Q4&"V5: 08RP#UR>I' GM[^XY(Z5"K"K-PHE?9:4J2J=<6+9Y&XG:&HPJR66859R#!JF*4HBQ'=B MUS7@S\K\>HSM/?=<7G]#WO$@JS188&+Y1HBG8F)FX#$>Y)<*.L":WR-P7,9Z MG]R?66^6"CNKKX4[PRT?W;"PBU?EGYB$O_+\*\HY<^8S>/'**G3)AY>E3>FU M)I+3THM->C-'FO)DNN1TVRM7OI>EPM/J2^+35I7 3*C:ZN)< X2=9RMU$W+<13B=("H<>@*Q5",!0!R]!S ,LZDL;"[Q< M5=!!Z_/;/F#)A:I4H$J]O99]W']F@PB)[\^C$&21%AX&0?]%\T:)WR,U7EO1 M9E[Q+9O1&,TR-0::D!5Q.6HTC2I9CDPN]B1@OYGR7Q\*<:3&_*=%R7C3G'H% M/UXBXV#OXSGJ-/;K/?4GX/>TX"_;@<'?=/\T-4G?P>&GAUR8D7>6;5?(!^RAS(GA_+EI\>=1^R>>5S/EFJ\#$*N?HA!/#38R_'UP^/![^-+/& M3Y@_UY0US6)>@))<^:RNQI[]^NR$[ BO-QB4Z[WZ]J3,"2J.L!G*+QL/<\[^ MSHYK^9TN^HP\,ZQ1U[BRSW):$O$[CE]QW%JZ /+=\AZ+W--&[_5:N;D>'RL MUB_MCF[[>F:"\KM_ZN8D+ &H@8I6L+7S*ZC7/&!$[X@<0%S7HX$]I1*6(^86 M66G4.66N;08/ZOPU7JN-0\6J:PY7X4XH+>FIHM)JYK6 WRNMPNNY5UKKKN![ M4UJR54&5D;&%\;$"<>BW"I>5BM:NGQ3+\:T?%]M([*I59NRJN9'8U8>/>?=T MZ$WH S/M1"8_1/NBC#\V6O37TL[QW_7;F8)DN)=#SPNQQ86\$D__DK_Y8/X8 MCWX;V;@ZS#WZ]E#F8+JC\-F+GIYG@_^B72?6ZTG1(JR*;Q/^192.8E$XKZ9% MIJ->0!4IH02U: D&'>P\,D%3"N23B.O'],;QA[P)YH^QSG4JWNP&8"00 %SF M'SQ?3S]P:N1EL@Z)BTJNN*9"RU*@:?69+IXID%;8,L59:K5"?6&Y0CE*J%VF M1JN.C/*K7I\^ 7&E?!K"*P8,,0U$+"$J";#\@&'Z3O%R2Z;1'C.1VE20)K\^ M,W?VE&/<./$">61922"S=Y!1*[4&H#ZO"* L :^R##Q&J6H5)I%//+PZQQT) MKB$5-@%)>]C?VXPF@HN7:WB47<$(UV<"'N3X^.-8NU@R@)H:4!2K2N"7_E&*^1Q!)Z2FUKJ"155>PK+Q(;'(1R:IJ Q\R MD8\$G"&U3(:#/4;M_6_01TA.+DJTB!7AAZB3)+[ &/ SL)'/CZP%H>^/S<4W M0C8*,S46TOF&H.3A-T%$MX).YJ@W>[?A*XX_.,)J@BE] S\=<&)68EGBS_I7 MY(D:-*)@9'&G%M#[@1.*:\/2KA #AQ9CD/JP%$^>3[UP[,#\PE[8R+R6UX6V M1,\.\[%?Q71O-(F34"I,O[$PX%'@R#4+'\[JZBXQ3C_;74([#USRJ> $T\S_ MI![M\/ON"PC8$S/OZ'PW>H7&KQ0(TM;&3#J:ZW3? 4(L&?>_/_/5RJ MRDI>C.23-\\/#]&76J9OJS8K1N"-&!P"Q>FB#5X%"5@8CD0_!!P9+RI2O%IV MLN\&$FHQ09IZ1(&$@0;_OB:*5D'J(X^@D?1Y>L3=,IK*><+_NT>BU3@6@*0#/V18 A\7Z&9=W@B-S!'NS[DX*N62$&?52"Q[SEN%SWEU M/6?@NI'>0]_Q^]$8_!"W3\W3CI^.+=,9)CJ2]-C( 7D-9F\N<^#Q.K<^2#D( M]@@[' Q'DJT KR!CWG&+KUR+JM_4:7^V1R&/&Q!YEQ1X[>I$"LGIH948)/A/ M1 R.(394#<1]X#,9 M^:CB3_/V\#OTNX$]/38?\%_:&M!+ O.5V WBTC]JU1/K$/)$$;O\ D8-1:0= M=Q*A'NYYD0BJ")6BQH&_I.ISKGNR]#A1:O%7]UC\%HWMG&H"]27%C*8PM:C0 M$OD'<4![[2+T0:E%*XUF"=JE75B[5!<>C)O 8$P#FU(E"!C&GLMD\$00GPNJ M_J]S_J*=%=FF*6&/Z,9Y0+I$+=#@:[2[!IH!#T4T] P,SG+D7IA+;B$$Z4(YO5)X/ M9E[QWV+.ED:O(/ATF,M[(\HGRV(_/3"28B(4;/T#XX=^;F 6?J MYD:ZQ5>?""D&BJT!'&3X*;!'[) [N>(RI/P!M7J4:Y?*,QBQ>-" E(4(RFO$ MNRS+7AQQA(QF YI\H KW^!,9.1%]^0C5-D0XMID->LK*+\Q@#CB.X%1@Q/7D M@TBI[X2)66J]7&/)>KF_4/50>D]KA:B%&;@N+)J/*/2PT@J>41_\*=5>9I"D MM%3%.M*WS1F,4L%GC2SPV3K2)D.XR\IH]6Z/8%UDZ3 \5^^.K^M2@[2Y"M!S M)4Q=IAUT7P*A>RD &I4Y0)@"/UGU_E7))4\:<0XE;2>G>IT$S'RW>!9=Q$ EFU8 MA)TR9Z>,>$N(2E[5GI=35OY^;\]246"-Q:2UR^FBYDH:K(ST#_]?KK=DVE V M+_U_D8<9"F% @B#SEC%L<,B[W9%Y+[ O!EFF>%8Q'Z((ROP$IZR**VHT]? % M;&4B J[\LP2CQ$:+@>*A%1J-[&.$N^^MQ7P)+14+ULC"@JTC[ZV5Y+V,-$B& MO,<"?\UO5T^E%BG!$1\!0=HT(#)G. +RP"@./4W3RX0>9R31#L+4,IE#;^". M)J?\0\9#_M.QJ<8E3I'DBB(C0C:^^DV,S1!CHX2#,W8P6YI]^F;.K)6:7O(( M%WF>1%03X9_L6<)?8DE;9>YJ+KMJ-A%#E3S(9P! 4D:AQP! XX!\]2CQ,WN)['93;\K%4U%SC MK&0=U%Y)!Y61+,G20;$2^J;;BS+P0Q*7<1?RKFSS3\UQ\G'B^"@ZT_G^@HS4 MP#[P8@=X]^R#Q)$WE!F\/Q+Y1Z)4*&!S,11P.>$^6>E(5!?OO@81\,9,13P# M2W>"LX17Y-?'B$:"7XR0OUV%)$/I:TD\4A8NCCPS^EP>?,X4%D#.#Y.'A\.$BT3)>!U,RWFJFW[D]E_CDJ M%0/87(P!7.Y\G:YT*D\VD8729 XN@U'@J5P4EDWBS.V1H84R5&W/BS>"4?.F M(R3CF)%"NQ&=O_G7&>_QK9T#,)X'#*L; F3[MC$A,1K1?_%-B4B,(9I\JYR- M5O;!.Z/ANP@YLS\O^1)>*I:NN1A+MYSD=U8Z+Z>5AH.U?L5D/P71&+ZIPKIQ M,-<;&@D$>IA!0*FPMYE74UF1P%W"7S7+[56_)&FP5B>O9([JX;!6_DOL,7_E MVG)PZ]YC=V $0=-XER.5E$FT4E]:\A$\6^D(=I:MO)]+_YBBB2QZ!I9EC92? M$T-5V!T"."5H0+0/TSWP2GAY?.)H\+NY^/OJC3!#O"G^ZT,CO0IS,5:BFC[Y MRBS*$?)%^4OK_#]'8@@]_]>/!@\'\W\3O#](3RUS'AFOW^FE:8BEX0MQB[$B M_D]34S/BC['#S'_! XQE+]MZ:S3G[0MX;9:3_M4I,A?LSX@-"Z$,.=WEKD@; MP5^%4(D2^ZP)O-_C)BG"^!J<>Z( Z>];OP*%YE=$8!^]T!Z5,]V*.2_Y17O2 M^F7A[N)AS6&Q3,]6L9(68B#])>M=?YOSS+/4IWT<\H<$9O&230Q]S8FCUZ,_'1S$=FL3AW\EBS!@\4^'O+GB#'=4$/?9E?UUA>CA%ZZUYK?F+78M5VQ)]E0QQ2!Y!'\E M7VW$;:BG"DA6L?CL#<#!>IIRZ"+"G!"[P?&]<1V@Q-&[# M@ M0.*QR:AK"OB2$U.4^T[P'4%2'IX\<0#$D_@S!75L@!J;M/@>V)0O4Z76N39/ MEH21?'-]-G9"V,I+VT>FJ>#:O?)\L+?<-.M$49#($H^L@ OV42=61JS?/2/& M;M#V?6_,*F:(?9>EV,U2"QF;BPL95Q%*B:==3:"K0Y,KP4PP?MM48XO$W3$* MFR@5J;B"-W4FUHR%W^+%4T-'<$T)^CA.<^]_%VAU67KDC*@Z0[%KY%A4AK1+ M-'.*7D]L))I!M=#LP;%P$CW)0@[^89$AR')O8T*L[H4&< N?I6]7RD+Y7N^B M4BLXF_/8_%<\W]6=T9#YO/ZA3Y4? 1TRF.N_!1S;)^<$QHL&.B\8$11PRGB:X)2CL>#,H=43Y86!)M/@L:CA7(OAI,2\"BE_ MMQ+=*K4>L+DLB_[5R//\3[[WG0B*ER2LR?AN6?:2>BRHZ?'8(7YC?FG(U+98 M#O.*L?*H:GXBFZE5:M5=*ZOJCCN>^1)6U9Y=VI+1:V)/@S3]6D^)5S\6+\O@ M*I-XSY2RC EVAPR'<&/S"IY8$(6O2>8!!F4:M=]OKKKTK_KOA^)K3_#:HV@B M?IHXH38&_!W)-M58ZYU73%_X!NHC[ >8/$C]"X/RG[B1 4OI2G(V]'8E4["H M'7)$%3N32Y+!,8R/^7;\<$S'S0.[:&K(^3V*I\4'44WS_.KQ7,V3LY)SNT<+ M6Z&_SX9#XK-#%UUREL-U8P]@*03K&?P*KA;?)VH M (27 $XB'Q8HH"@:S>O1IUCM5//[]6+^9^?I&1O"P,S-?\$]BF557@$'W2%K?#Q8L?2%D!JHA,/AK_+E=A8!Z@I8P<)9*1CC> RWU2JA2,.)L&A\?& MH\:!C+_G(F'K+4IX>- MZ2P86-3 +1)8>K!DJ(#-%9HX%\EWHF>66BMDEFB@@M)?-GD*NBYHO=%HJI), M1PTMRP0;P3Y\K!W76C,YIE]P2XJ,^_0MQSV;&_O%HIU[P$U%H?H&_[ T'8O- MGN#PS2H=6S1#<%DH.31L,8B?@H=X6<[AYIYS6'$.G^TYAXOT#MNX+5EJK7BK MOG0K,+R7'^T?*W<"R_Y^:62;<&_Y9+N0_0 OVK<8 MVG,4/\'OHB^1Q8V!'ABBL*5HS'NO,*",WB(8 %VA9>/4Q=4SK5MI/P<'!4X8;8#^P%V+&S'@ TB+0G#Z:V\M@-$BU=\DW@PUJ2/3T[1?*M?W\G[)Q,;[ZL0S^71W[AZ:RN M:Z\+][.,7\8.R3-A-%X<]HH':33B.0?830-W4B8R_A>DX'_!KPP&CA"J ^>8 M'5MQ/Z^A!V<%SX44H$#Y8D@A[SMC?OHHDP!^J=OG#;*(P",.1QP*IU>0[G&2 MN9 "O$37D3QZ@I$>994(X#"MH1P]_"07UY0#';FR_9&N%KS X3/#B,7>;AX"BS8=B4R\#D']"\/-"7F(98E9L*EW9[ PG"Y3S1=%-+RCIRQPS?(,CSWB(\>1CV: M8EP!Y1REQ7ZU9/3&P39R/'N@CY((.7SF#8]74RR;,')7Z!R[@J4X\]6RC,2; MV\=+LQFS;M[\>?GP^/7RYO&A3"+VS#;#NGVXJC68MZBSC56KL:9H?KR#ZB-V M+=7@Q1CM$[CH4R,.NUJ:O85A MUZ.Y85>3PJ[R$M*BM5H,5YA@SA.U]!Z#&2R#NT/0C<)<0[8LT)K'1M2;.'KS:$YB?SYB(1XO@)LWP5^ROZ_EPOPWB M8.&O8V#(W<61XLKU2LM]D1.TI\4 ^,VP+0/SGV*(:GT6^HT!D'IO?!'.7 M$ZA/))^E["/."Q9.)PQ9FL%V0WU!!KCS XT^+9^E["\KMHLX,3(7(>WO,5WE M3$=/.O3CGF@912VQ,?<#@P3GD4GK%K_3Z+@&K,K_@GL5WR&:R&JWFI,XAV/&9!LN[>-*JA*]H_FT]=9E M@E42[T-L99)DQBFUN9(DFHBAZ;&J1@)= M2]5 $\1DHD(;+QF+ANU)O.CI67:.BWLVB(5_3R?\M, )KY!15;%#HD2"\ 5] MWYGH4/_L8V;(IFYQ#$<['^D-TZ\'T)T"FUX&+2C/C @TP+G4)N_-G#LKL)J=#?EIE)_E ?19% ;\$J/CAJZI M4YAHV:6+]R.G7$34 QLNC 3;?EQEHYIXP%0"?#F@4J*MLNNRI43O]:_(\#M+K!:UI-?Q MO6C#3N6C,' Y',*<:&NP"2;^74=(82&5:G&2W@6)XP]L[H2/'/<[+(B"Q?%L MNE#(&%G\>S"C!:D7(ML3RCK-XR%!20:3!Y, 4?BY-'+Y1T9]/0'![CE MJ6*UPHGE)?@?'[WJP>#Y8SHRF1,_-N\B/XCTO@CS=UQ33130"G@[8ZP%9J;L M'32QIX9X%!_(07!(M0>4=E$C81C)D^_D;L5P%*&:E$7&>K_'F5$=FP\16?#P M\@FO$H47"^9O4#3?7>_5->R,NF>;^WIQ!1+(6CQ#^(96U8.7'6_>Y 64[(Z3 M[I0@$A^$;P0N:=LO1$@W7Z-F;@X5(-I_*9, ([%'E_^,"A+!B0!KU! M*@RT&>*K ]7Q)U;?:8W*[ZTA&+R\=9PP"$6:/='XG?&66+)%.Z7CU:MC)0P6 MIR%N+]YE-L)\3G^$-C<-2'/DP250_5)H0L%,73^5:G(;-AM:[XS!S4HY$# MNS@PQ$/1,)DUSH[-?^)\,RP6A?T8@WTTQ@K *.0-HBA[PGQ<9RX0\D[FA@B' MF,P\D9@6I"@>4I.KH8? M9R#-JID&PWVP!OVX&H!60_SJV<,M ].( MC8;'YE=$?LA1R/?R"L:>9_L#537".)HA);*Z93'!+$$H*F]GW!C18%'$@FR< M_].(J8*4@3U%F$>?:68+O=! !% /Q 5M HP-4\_(A/@J>PKQ-SA4E4H70U?JK891!;\-L,^+R8*(%-2 )[J)K@ M(3Q?-P&+<8(30\E6KIW<$BU.CPZUAYK#(1481#P03!O$H\\>CS+8]!%EK5T/ M#3D\T:5(8H+(T70DI%#/'>&G,*I!O]:Q8ZY."?:*4%?FM%)5#KYY("&.D'/XQ MCN&1&0>?E?&[[* AQ?GB.UXUR=4R GH4L<]#H:'O?&>'7*7(GLGZXT7B$F\] M!T'+&.'P!R/-8!.6@F:L8"M$]5)2*0BR1*/OU:.X)L?#T (%X E1OT52OE%( ML)@^1[;*37]ATT!>$N*W:N4X?2/^5840$[?AS,7+UR"T59=C^@WB/3&F&E]C MQL@9*G.*OQ6CPMCR<=F1B3U;951&:E1FUJCX:89;T4=[PT6%*^X;<76_/GLC MWL.:QD"76Q^N#[PA#K"),G^Z2$MRT]@;$298"]8:4L!BNFQ()?D_DOK$XZI9Z"IXNNF'I^.08P&Y(:8F([& "/$M$.48D< M'$I_@)\TUZ;(NSX:GC1XM7F.@(?9:0WXHHGB6C]\)F%7=:CBRQ0FAKO?^">7 M;OW RWV 57J"D>&>BN$'L*J'\=)9>B9![-7(D=?FV+SCKPS4.WG#>/P[13JEOB.YXR>1WR]QA5$RM)KQ2#/GD=SI MY$(\X,XBAN#)&853* J :&T\K VGT"U7E*9-+XS#$J2E/,GCI+QR!(CB$%GX(.KC(SSI D]">$PSK,N?8JDIZO1/((S)S1Y@&=.J&9\%#J2IG8D M8W,A?F""2<7!Z!*&-MC[ FG5B^ PZ]4!,24J4DI,(LHPME5,A_:&KD'?.."V MT2$O-I-2FC!314"6(DK*9N4]K3.#M;'#1ZPL,?,)X8?)N))Y9'EPC31,-V,& M'%GA@ITE[3B9DP:;W\(K!P\+>7WHR#W!%^:@9M*@8$U,%0AF!MG(G44^T\23 M'3$;J56G) JV_,'8YF[3),2I//@MX1HO)'FMX+A#+C MR"!WJH.F5>588NT37Q:H:G3#>TQ5%1J\PIAO.>VB^+=PF@B/0JD287 K^&W. MY$QM;[GG]L2&=/N@OHG(B@&'+.F+)8DHN!GH#O MIIA/1. _%%'B6,L*V1HPBO>ZZO;"/\!(7'BE0=@8%=%W>(J>/X?">_'#M'@\ MN8IV8LQ:GD%\Q=*=5VHFCVX".LXP6)7LACM&S-00UF,";XW8'U\%IRFV0&%G MN0H<@O8#HQN4$M7]K('WZF(R@5N(*EPR^QJ\XQ+ZQHC_*)Z/=ZIR(L%3AX-_ M!*MQ)-9.+9,&>!#4TG#!(GI)<'XQ4'F]:5S>(Y-&<>Z*1Q-@/."7692P<#V3 M9ULT?)5/%<1X*.+P$OF:E*S@6\??K!%F>>E1SVX:=PJXND"@G4@C648<]$#@ M!7Q!^U0P1@M!5W#\?2*'EJG#*8M'OHL,R/,WR32C*$C6@(.21'[!D&MY65-_=.T%$T=!8CGE>C8(\<>A;)EF7$1UW N^EB,9_( M[O)UW8@/3+STY\)RM/=8#H7EJ.^Q'"63#>6:J$6J#>IEE!OP,F$, G15[>:[ M2\<4@?'7R\#Q+XD\3]7,2K^3KA@T<2:(612A][GU3JOCSU/P@QODTE%Z6H>3";\-Q.( M7,(3H#U A2>8,Q9U87QF] 5#ANMYM57:.)!TG+<:&R(/!T15\^;OY3S0E'D(?R[GN&6%1 M\?(\AUL8R03,.]\+1;5T%_RR [S@Q4"UI\"?U)@GOO="D!)"),1Q:PR_P.-5 M_@OF:6BU/V*J>B6/+?/Q/)C@2==?F2$DAK,)<20T/8J)3(75):"UE(?'N-,"182O#+,APKD+'DXJV^/^F+OZ!R*"5%=27H*RCW6'7CU MZ'A8M*].8/#*B5GE,>!<. )"*"HIXJJ/1(0L1L>]J^NJ2)U4O;I"J<_2&;1F M+JB$DN;%"P:_V92H""\$L5$I'(%26;K+CO$9Y572(15J$>M8J0!7:$2!QI%( M-0$C.B85*\/5EC%;G2\S/OHX\!:D]'AP*+B([-14>10B4:+$D?P>-A[32VVY M\(M &X_T&BK)$Q,=::ZSI"KB&DO$N"@61"O$XQ=S1JM?'/'KY:4A=&@XG2"* MUDA-*;UYG*26(BL4K ,\>&(4X&=HN^4(3&,X!!ME&B@1>"*6!<:7)]J $/!OBVW)*W7PH3U-D%4 MH;[*:<%)K_*#6F6>^Q1K852Z%HGU7[2]QM+;6W"IS267VIA=ZO>DUQM%ZM[J MU16^/295EMA5#G^/0_M9--5&0HF_,,X(*:2)BT[:/J!G@&V:/AX(2,/N+-(D M2S M8&'23 753"V7 2Z$*.6TGT3-FXBEJ\([57;%0XKBC0+J[\1E94)PA7@C M)UZ<0]&">!R5IA78<38>0R^LEV#ODP>.N[C,Y_78HER/_K.;-LJD?02[9O'$ M+VVB$Q<0#'B[A,2\U=L2KN Z&S^C2PH"R0];99.[)\TOS/%D$Z7=L5I4$Z>8Q*K81@QSYQ*#XJ&Q%_X \PA580[T!) MDQ_ MTGOP8@U6U_T'AEYK\*YYZ:Y&!M"_4+"AP?_8LS7[(UK&/B8B,US[[K=$5)-J(XTFBJN ZH13<:]SA;=?Q@ MO4.MEXA6AJS_[#JXRN_K#!>IFFA41XV>/L-Y99>F++LT4F67J;)(,[LL,E4L M_JNX0T0\2E@ZR9MN84FDH4E(=G6D=HR2EXZ.5Q#]N&Y=@(\8)%;S( FBU@=O$=X MA4B@7QDS8T>#E;-8*Y8.0Q B\E=)=D240)0?>6_&JHX<>U&%EJ@5C2/SC& ) M^EUJD: MV&X44 MZR<[.L,8$5Q"VOHPV5H TS'$14X%2QR)9*A/\8.-")T)F".(VD&SW"$\DIAZ M7'$#S@.26&A;H,5JG"!9J( 5$913X$P@6B@N5H]&GO6N3'4>]-^^N["BEI%+ MH2Y.]J@+A;IH[%$72\M[6<9=(5;Q#="*IWI>6)J&QILEI3LQ)"7#)X)$31*1 MD7;7XCLJ_1O'>>R [HN^'<8IBL4MP['SG>")#=)$L4:7:LW1A^]Y+XG1RYLE M@TP: OARLX\.U7 M>Z387;4AJ5(W;5G48@AD*N]EI%"*%/8BEX"J'BCWBN8]%9BF []A8@60G(#J M@K55Y,6-@3(?5:WPJQ,P8V@[(]W&G8E[HG6#5&%*$!4^E_CTDSD$'6.K82@& M8,E/.7ZD%PHP-YH$& G#3+-!@J/;M[*DH/N-Z\5_P1&((-0$.W4);80W56J06L5%=+6*\31S*'U=E> E#/1UA MUQPI^.=4>%,SY'!),SV)&5)]E.## 4930NXFA&1EXB<")CS5;+5(2=T E4&6 M\:Z*J%,N8Z+C<0R>0060:"]0-\% MH7K(?XI07\$V4$WXC(8T[!D_-*DBZ3#%OJ> ]",DCLA1@V!6:Z6J-&?5KH:7 M5W') 0&J'8Z-HE54P\+:8Q[Q"R5!D4U>#"'-L(AD9#\E,/6)7) ,4 X)&!33 M((I8@0Z/P)62) M)#KJ7GS)*Q>7$@^J0U6L=H6V([TKHD4$8N0MNG FVJ;&*O:=Z<$BQ::-ZHI- M'U-R_:NN_(:2I KY:Y4I9J1-L?@DC. X^QPOB=]-FG"284L[.-DP0&4=Q'#6 M0:R^]-$:%+>9':+&:N$2H[GHN ZG-K*)#T%H':$<9=Y6V!MXW6IQQ_AAH@V M%C.B>B-CY'G?@P0N*'MB!.[5WH$<4,J&T0P<#B\92#;5C DF]D#H:EZBSG.[ MJ)_A]>#B'<6@30WP88F?A9<@PDY2U_;MB1.2#E2@4=W_X/U*,&""R1)LO_F^ MSF21"M)&B16DB6@"YX&W'=_\4]8&9G?Z$??.!=Q3E(AIUBVS46LTRH;NIT:W M^>TH4@C1.%FR1[+T5F^'\>IJBWOM*I_W=J@R:^%28=T M(OML-)J@QG"?_NL#3A9^#B9V7_XL@T$\)$97_R1@OYGR7XBM'(3/*"6U7WXW MBTK,!XS\_"/TY?/A/B?2="DT/*#T0<2'PH'\7%8030Q?!:$H4A?+6SCXJ#U@ M\8?3KUSJ\3C_HU>&WBU.8C0H,CSU1EA46'OWOSZ/7U2WUXTLTZ^AO^(I6&[&(S;, M'HPV2SZN&R_D_Q =X[CYQ']EB\_\P098[\)_2/2/JWKKEWOPXB ^^BD;%-A& M[IE>:09*Y_,7>\-_]/Q?X=7J N _JVBK^/,7KT]WZ8YK@ H6])O*Q8FEZFH9 MN?URK2A_9DH :6Q[(2PLA!=LOA!6>_7 <&%X3SYQ8C7;[.?U_]M9K2K2DY+&I6_Y%X%\E,GF2\ZJO_@ MWZ5.QOR?\'+^#S$"_L/EX]5Z \A\_YQ'GJ4^3*D0^9;5_G?NX+.&M> KJ\_W M;\M-6'A=5[Y"2&MN5[/U 2M%D(<](#^$0A_@?SD_PM_<:'PT\,(C\0'I*O6= M[[5:K7YZUFR=G?[VB#"Q1S\*0CBA(-B,'A.Y#G]#%,"1J%OU]HE5KYW([MUR M,//V;L,KN@D)^GEFNO[_KKQ6Q?7MK#9]"_-+Z+ZQ,*QS5$LN0 M(THK?'_IU^_G^Q//=WF/?=Z[EWN26(6#W,OVM)J[%D$3__7A*'WIGEF-6M-J M8[QYP:5;>)<.J[1JBT;Z^8]5:IU:KOMC,+K0BJ=/^*R4R-I2UBM-$\[-8I>>Q MBE!0-4X_S+Z#OE5=PFK)'%+Q?=%22A\^YNGST)O0!](6>6WR0_@4&7]LM.BO M&+])R-W0'CNCZ6^+!D>?#9Q_,SZ7#Q___H]?\5FS[]/E"9D.G.&4;]+0\T($ MMM(&.3_^.OM+_N:#^6,\^FUDX\HQ]^C;0YD#O>;TWLAK,HX$=XA>!A' M8*%H_BJJJX_5%FFK_S'6(^5ID05Y[CDZHV2%480$J%$B"= L#@'A09<$G*96QI$U=%$+QX:/<9E1* MGVU'YDX/OE"3!/B]CA'@?[MG?>_)Y>E1=?;]@9V;+21GLO:\L_4P^+K.U);1NS$RMTSKDG8>9Q9C&1 MV#8/+I)VWZ96;W4$3(8CL'2N,>^$%7S^#3(A9#51R6)/_U5O+C&/LR=M@J>? M4VSX&0JB4/Q$$\.N%#ZJJ5&IW5.ZHVG-RN2=6^[1I=0I$F=Y! M>GR%!4X&\/BE<.W&5X)^(^CWP:VK70;Q77#M\IM@H]GU76[&J>;$(WS8F$GYQ:C;..U3FME9[\VF_89G7=^\QN9DE) M*;FNXOIK,ZG2F=MX>;E<(6U>FB)IUZS31MNJM5L+Y2Q'8^S"DKW=42Z>MMS! M'.4V],@ZW;,U*;:FYIZM*3>55@4/5+5IJ\V,6":0D.5",-LA 7A^&FD#0YNW M=6LDC8HPIC;+8$REA;VECLM$?$6EDYR96)8(.JR\3F=OD8 K0E#6K(Z@+*8> M=0*=NV5L!\CIZ8J%UZC)J)'5V,'V2[://;<$+(!8:SB-,V6:!"$(D49*4A2- MO4;0GB282#A5);X3V4PG1&DP2Z])#$V&^ 9O1B:ZY<)TB1Z2\[AC;W6-JE_R MX(A/2;;\%TE-"Y;.*/Z](('P8L))3@R57!=#9SJ=LRZB%1)R+W#&"7UA0N]7 M3ODPAQ[T&$1^EI@EYG:)L,?GOYG>.TQKJ*030H=SF\^9@\B7_*.\/]JCHDBB M3L:OKED4!6*(V8;8"X4(84& L0\NU\E\.TBMTQ-&[$D0R(+(]!EMVUS)F[?" M;]S/=(VS7X1!JUD=@Q;>6#%Y"4?]X)++YH6ZH T\[($ >X:Z6*J#S+:<.@,-KUI@M,<;$$: M>V^:5$5(Q(LT5)+6Z,4&NY(XO[*G)@C3OJU MRT]=QW0VP2I\-JOEF*NE]JC7RE\F;J"6C6C8X@DGS/"W12(LF)/ _:Z*NRF] M2KVT+?B,'4 )^&1V^77%1R!( #34B/@0EU'ZM[@TY9_X#KOM<0;[^6\S3$ MKLCK1D!VCEJ$:KP=AA?W]Q2 MNI/:[]I]?&:9135*O>7@!3NG5JVY&!FU$_NQE\"]!*Z'5\V\5Q=@-BLB1S546^XTFL \Z,'WXRRB[ 449T"/ M9#)2:_2,_=-F,XT( PAB( #OT)GL6S? 1G74C2Z12M8@");6H2RO,Y%J')YJ MCXJ=-QGO+XK]DYX9 3*22551U6=0JU_>QTA"47F"557R89MZ43R.M0./]H$[$;G*13$JL4XOQH6@.I?+* MR4%DKGCD'J6>)YJGA^O8D]H3<4"B9IS!,C@<[.3A6+MWCBAO6FD;6>/M%5(V]8>:5L< M:9O)*+7@6BN'M>,<]/L5W#H/T63"6P_9HPLGZ(^HU_N[04W43RO* ZBK!>DX M1 :@,*M2R8B*XM5AJS!;<(,Q*WM>]&GKY1RJ9>.0VZC(]5.Y,T/"DW]5#"5Q MJCV-]ZX\X31NM^4HGPH<+.H%=3[E\8+O-^)C>R$3+(:XK*J<.$VD@]M M-W:-QB._7K-17S?@-S>JJUU2RX0 ;]TBE9NEQ/%GZNIW*XGTOI)+/_?L]Z=T MT2DM*]$F6UUL79:MOC8+1L6;O$_([/ X]J*W*.>T=)JHTIAS^_G^\O+KY*,,V"B1USJT. ?$:$HY2=]GM@\#$?E) M7F3._A79(S/TQ(;T\K5_JZ9K_]8JVA],,1CIA>V,I@@ (Q#C]J:$I\ M DL/QN%QLYVAPGL??\'4)J*\Z_ M\03Y1/*$X&Y/;"=9+,X9,>9\T'%3' P"=2'.H"J2#WV;A,8>O#CP^ZD9,/_% M05"!+&/GXU&_GO@>R!F'GJ:5_=?S0.AN\Z]\=@#5V%J/D2]HRZ*%O/E#4F@$U2!4J0,&\G!,[[!*4DR M_Y0^$.K&=DG-PET1P(>54./=[0V%_.3='&?K7APP1OE6.(Z+;HS:<6/VQOC% M[-D!0IC<65(+8]Z] :8)43+&JEYNH87 GXC?P(%V ?7[X%T,=,Z.0[[@?;7@ M,VL(J_YJ(X&%(4%=0\IJ>T[2CFR& 22FB3+/>Q_-O\91-TL2%2+'D=H0SPTM7;;,5^I7 MO9G*/%E=998!P>3NK.<>W2/I)_$>74DU=OECPMQ@Z_G$5EFZT]57_60#W&-T M@=BC$>DC.&9'OMH=W)@(M!9H',/%=9>DF?AO'@&PT#OB%CT84N&&. M#284G,>905ED!S-B49*'55E[0R)-Y+AJFW#9NIAQ%TU*FDV2-M'<@#[S0^R) MHS\%)\L-;_B7)?X4/Q2E0?TY\7R#/U_[H]K>X_22W="#8-' Q/($'S2,?=%2 M"*]"$"*.)Z#B"2"9V#7# 9L0S2J8(*UI'KO=J;HUY;_>HHHS.HNL"_4N$,T0VCHGN'EW2]OD9ZJU8E'RG# M.&7&[9S*MX@-,FB#5#@I>7VFMC%I IO7(08P'1>-Y9$YB(BIU,;C>^ <\GV" M:^+5\[^;V 59A,<2IAS\W6#9H0NZ(=*/PV?.I;NL. M4:GX1E!<3X5@0<6F_SR8A-E<-Z#4S[PG9B$V>/=?I@WE@ M]XE[E]A2?_7XMP.Z>X5U@_=T!*K:P*A1Y HG!OP@Q_T>S%O$WVEH!\Z+>#=? M4%-;4 NW"4-,GAD%\!-ZB12G-,=J@Z5_),O8QA/PM6!>U,":F)=A-%B4\G!Y M3L^^NKZY[V*D&Z%) 3["CT9LJYF$5SJKZZ2QR\AC9Y_S#"4+THDBQX, &1MK M! S,0?@)?%P9<$@6^0C[Q6*1(HR5N/C/;;1 [T;VOVT89N2$ M#(N*S#O/#T(Z1FQ5Q.]G/*!6PTU: MG=NKJ\O[ZYO/YOGM0ZF@G9SR_76$?.$"5Z6:Y(M%4.[5 774HXILN"C^G>;H MQB08"';XRD8O(M,NR[GQTC71D498W]$(]4O/#IP G@9C<'D]>Y_QS F:.WAK M\AKN.#_"LS RHT6#P?Q!_QE;&%"L- D]D66%/!6#7/YH).CYEJ',M&1B*GB6 M-[$$&#L% V.DHJ$8^8SCD&! 8>Q19IE=1MD10]WV8I^]*(B?"X-X@!DP?3CV M,)2EY&(=9#\7G*5,36LSD3N3D?K;D%99[!\552Y_Q9K\=GBNZ=M[7LU/IX"6 M[!.F ^_L*:V-V;R[,^\N+RZ]W]./M M5?RG;S?7VZ>VJME#V5NG/)G81.N8(!()$_0RV!AI-.B$\_L>GHR,%/A?R^Q% M<*Y=#O'R7'280'/Z+.FZ8..3E#,#NM,V>S@WTANA.6)V$"Z;R5^N.R#74]LV"ZVM.ECBM[8Y3>.J SCR/FS@ M;/AX,W(H1%*7$C)"'ED":J@+%8[K$_IM&DP$82,*(I%]T6K@2125.1^Z\[T^ M&U"1XA_PL9[G?3\V/TTI&$S=XG05.4!M"C[8G&=17A)5TV_F0?T0*ZJW& MN_BYV#V/6OWB @U%":;D7*//2,XQQ:P&O^-V&OIM+!ZM4I'H\!JO>&.) L',X,FUC4/^W79/D&5 M4=QY-CP,.<$1QIS[? 7H9?%710^[Y#Z: UB +8L<5J,D3DI6$A6R*LY)NZ"M MC;A+'H^,)BA0N>[#^E4W:B3Z0.Z8CZEM^VD!++C6G(4%2VOH!?MQ*9 M%T7X M/5*)+L82<:%RWMUD*QQ@)30I&OUNH=DZ$[&R+DVF:?M<+O@ MDS!-M"A1 6&4;O"B#&-WRA] X_!)5]/;9:PL-6S$2Q[/S3_B02 K/78[<+5& MT4!9U.E;E+34IM/:@N,Z[OC-(GSF1%7:Z>W$G?41OH-W9'\"S:L M2SP%XM_R+/ !X8'@?XCY&'>B55 GW2IHZZFQ\BM\&VN$=VU^4.$*Y25 CQYH M!UD&DM.=HM:V:AGU6F_>G0*?/)=H;@&73J[HYN[U8C+1HH0HRSVID'@TWT \ M3CM6IW:V4#SF*(FR1&45'5& X'56OEHH'X]4=$B+M4)ON=8J(@9?,@=>!-=H M06;:&;VS[F,+]>HXW;P$-CI-J]-L+2V!KU!])5"TO_Y?!&X\\T=3E>2ZCK-B2X-"BCVM5.S'J<)^7/W_[3UI;]M6 MMM_Y*X@ !1*,[)A:O&3F!7 <)W6;I6,[F78>'@I*HF0V%*ERL:W^^G>VNW"Q M+2N2%]7 >U-').]R[KEG7XX^[7\Z.-K_X/YX]/['#_#_#SW,XY; 5]$_&OE_@'DV\V?Z ^#-Q%QOV*OMV6^\:D"XQ<,4T_;(-LNV1Q:]]@[T >'U[^[G6Z MOX]@M*IVHHHS$31@^\1!K[)[P',=C]O;; C'?90EYZ\'=G,K 7,8;? M0$L^4*ZGS?II' W,>ZW7BLIDG< 9?2 M>.^'\0< P>?8/&HZ[L9N =:Y;VUZNPL4]WYQKZ MUU"?&[0[=P[:F]U+5X)V MM?QJ;H?3S7?R.)".IAC!\R5.U3\1C.YS!.0+C+@[LEO58OJV2*X'.BR/KW"G M^0H_6L_62HC$;@F3:UW!U9'LQT-S($UHG<$;R&'OS2,AW/:P[\1KCF3JB(,( _?Y6PX@#%Y@;%M%6 =JEA41Y;Y3:-QG MG:VZYKBY&"'J;LW'4ANE4M:$U+FH4[D=^>GL/)&?U9*?KG>O1[PWCQ"U.J*S MB&S5&!=1,PH<@@QTI3E@Z:$5RXBCN'78SD)Z;;>]7+VVN[E=C[Z?*X9BWJNZ M'H?56^BP.DL]K-[F[NTO^QQGM0)K!-?($:$!ML#>5ZID5/.LBF;3789QHH8) MMSWHG87.N7N-#,J@6.1B;M]Q1[OO!M[N0L#K+1UX<%':2VK)=F\QB'/X#C@> M\3@ G27&FU45UOE>]6YV&QS&ETO.VQ;'M-VOAWG\E M)OMTV2VLNLX >!UN6>QFSMO??KK]WW'[K[/=+?.<@!RT[XT_ M>(?M@!=9S/W3XF,T>U)&L#1:,M)7]DJ(\?;5Q/@!P?)!+>9NW7HWG;-DH;AD MXY9#W;E3'_H*F&-O3J.T;)X0?1]K5Q[%&/<4G@?[$=4?AO5<5]G#7@)$%W$)+ $^;4^*/N,=+@).M,>4#C)?#5,KCPH\P.<4#() M<'=T:G,*A0T%36JRQMUC_C(EN)4"T-O][7) EBOHZ5<8 KN9*,PBAEE,'Z->%H M!F2U'BNXA4D_5\018L-4G2A4PG2* [[Z.N@)\51'29+'21YH=@7\7WYZYEY. MHE>1CV +XHTO)\]>OTGR,ZEVH\I4#TOEM6,T.PS.W/8N6^\W"=W5B+P5A^[@ MO^QDV?)]N"&U::EWHK?8G>BN^$YTEG(GVD]W0M^)]APLHO%">-==B.OC:M-@ MF@891>W%]1>=8)?=\U["QZ#=O77<.W!95VSL.))(H, M_&F(YG"^AU9). "FN9_<_8'+CU-?"91/4ZD;* ^Q>U+@TPT+HBR@HIWT@JZY MW%1J^<%?P9W%KN#VBJ]@;RE7L/MT!:^Y@MU%KV#GNBLH[B:JR,GEAZUVU+X4 MI02V%Z@ZC:8KF3--06],9VX49A0]J@K8MJ2VL;0'P&)V6*+/C[F8O"Z]*+U. M3=-Y*0P:@ICJ1X."JN ]^"NYN]B5W%GQE6SL5[_ Q7ZZDE=?R=ZB5[)[W94T M%78SU2G=]6/ $I:/BKQ[\M=E;[-KLKOC:["SEVFP_79MKKLWVHM>F M=YMK8Z[,7=R%17!YKP&7EX!\.T_(=PWR[2R*?-O7(1\6S0Y*CD7N 0#B3WNS MO?<#I?^U-SOP5QIDV(TN/ ^B6#*CW MW0AK'U^@5@-B%Q6_7@6:WVTAGNM*U'E/)>ITB;J=IQ)U*^UK>)"0#Y?-X\=A M]NW:EK77UZF;9ZRE5JG;U57JCH].?EYB5;KF+D[+*$YW*WBKTG2W/*0E0> @ M2:EOC.KO@+Y1C%=!_1<7\="[+MT*:IU%0+VZCG2GNF?#,"&M* N";VA ] =G M87 >2#_M+)=&=Y MG[F3P,>=#CD[]M/^5VV=0/!*D\C&WU]P-XV4PAL=TS66:Q?*(J(D'C?.'6;2 M?0BSI?*3(3[%/L. M]@Z.!V?80Z.BO&XZ^PP06AI9F29)',RP&11NUGP'[Y,@C6P.BS]&V J)]DJ] M.;E#"SZ1K4@7*!X=3L<:6W_&NPUIO8X]05*=79JQF): Y\-8E^P'MESTZ"E M_L8)O/&BA7W[?.LDV6>4!GT_0CTA'G,313VC@IQSGB Z16$.HN+ D!K>,;@EX]@:$@N+A$Y0PKSH ZH M>&0I_#N<8DMEQAS^7",=0'23"F!DB" R#,K$:2@.9[Y[XQ#!+OA)!Z_ *^U] M"FDO79W0T1,27K*-D1HT%OV,9*!*-$$L^NGV,:2;DSYLI0Q33>J!QE"71)K MM97%.OT 3RCC1K33-(GA 8+:M\I9$M%$Y 05\GB:<3/W:-')*_(BH M#OEA<"#L(480 .!',V<8@ K$+:]CFPPI0@LDSD(Z)$*J$:][%D1#W8W)6K+0 M$[,=RV]:V0JU&K+I?FB,S9M4/Q"66_X&^,]9.,9KU 2OEB9\@,?$[FB%BEU$ M@3A]"28^GU!^%12=1&VWBIZ;[ENB!S;(-9+IERW *;0>P':'J8_VA0&1>%R= M/Z0EX[]X18AAS&0VT+)?(G4"3 $&SHK@L$"PZ7XU9R$&?=7#&-$,6XVFN?0/ M;=Q>F=OY-OX[3B"LYD54B/8(O 4LQ]*Q*VC;==RBS7/H3H(0M*W+"D$+B MIC)KGSQ-:7(9 G8C,AN)P]=L,7#I3O$X?3_#5MN9D9O4N#XU;A3W,/QBI,$1 MP"@'X5'H"5%=:\6G#8M$AHY3# .,= R&#O?-Q:<-DM+(7@K!1=N%D#521>OO M6*'@,Z@<(4K'#DO'VFF 0NBHWPZ!)&=NMC$OPXSH6"-L,1$!$D+H",F?I> M7'VF21HVJ\RXI29,I1;P,J1\""V@.\@W2\A$<34P=*C@.4CAL^PW^(Y)!55<0F M^%J,*K17U#,H9(=P0 5 MONKWF1VKJ9'.-DVLVB)R)U[4G' M]O56-T+JW=ER1_PUD MNYNEG63((21'0'86+[.JM45=0XPG@46#VW@LMNR(U M /K(.ESM:"B@@X[FC/0 4N( R\(_BY!I5IBEQ106!*-NOZ@>&;=4H$;"&2@8 M.$DJU@7I-X\-B)&"#:2M]$L8$R,W^"@G07Z6#),H&<]@_)T7+E-TP0XC9A_! MD)=&CD#:#@O+@@D A>TWJH?H/YWGNR]D9EX%7'0\YNK2410=)5&8*$AEJATL MF3\ ^&4"G<,F)0(ZA8\!3<(@8RUTC*IBDLX(UOZE&_D7#I+:, T4.NR] ,$_ M%:F[@)/D'J6X=NG,K)MS\Z$0AAFU5:_14BB1Z[6$=_#QBE2A;FHR9=.#VL%>W:'+(]4CUM6]8 MTL]!M^*]1^,?G'7[9[:3[XT[4O;??*EW:K=T[)D MN^U%9+L5MEUWXX(*6*%J(V+8C1*88_D>?+:<#(-Q&@1L^C'B#?,>6QUN*9&% M+),H %5E0U_-RB+B//-L.N] 5#D;YZ%45?Y% WA>C8R9?+'Q(&N$"XW@8&; MENOER9QKH,!R;,"QT$C+K@#O9G#0MY;)0>)Q M1413LHEE8!\ 3)V0F!_P_H447NJ$Z+:AEB3*.+?&@$)NC+*,$1MOJ M67,N" I6+8MFXRJ4UU(HN,5[B2.3 )6%>>"@#AUE;&')<4^Y\BK ZHT,HS\. M,S&J8@>P6>Q/Q. I.3@&A]1")G!\+!6+B5-YRS;=SVS(0)N*$G!A77[48EN6 M;0M1HR@YC..3:U;[8DIB=7(1,Z!$4*R/9]K>-RA+CMXWXB7['N@L0S@M]FX5 ML7@FB#R8VT*S]EG]@8-!3YX@[O-P,]AL 8_P+N%_VY?LBM(JT0M<1FDSC@P< M<*U.!39-K]@W$IXE;'#OSWF!T,+/AG; ?!@O,['@!HZ,%2BL&0L?*AOU*'2E M_N"!KHVY8V<1EKA]![9A),99F1HCSIA[BF98QS+#RL5FE\]0F0M"I?T(I]&C M997AD+B>8V8!D5-T<:.G#?YC_$O%E+@7D2Z PS#,5=2787N3P[ MRPL+*E!5F?HI,+^UBP/:6P2VNW= F/"&(9L$! _/R?:0L5 "=S*[\*>NCX*7 M,:N!DG;AIT."!3?@>([-!U4X+MRS49"F+.^A:(XW*Z-XNO;6/ZU)Z!?OGR^4 M7" $;A@ >0G[\+WYV,?XH3BSA&2'*8B) [Y*.#TUED)[@\8FP\PU]9=WU4GDIPL]A '(]+>(5$]LP#IZ]/C9&Q%.,&,#SU06F MUH@Z>-Y"$9E;*Z,/;ZW+@H:_<0"7DX13\2K"S?Q\>J"LLD09SGSTML9$ P;L M3Q/+N<6^T0B9!B"W9GAK1;.BK TF U_B$%DXY1-C0):?G6V >I9'@28]U17) M(,'0,80&*9,2:&19M76.I]7HM/0S9"@[(1F;Y1\ M'/+-#HH4S<#P*P7[66/AQZ-@B!/!*N ]_C;R+[+:X.8YQD&&L&+WZ]&1$KS> M)L/AQKO4C[^Y^S#V<]D[O>? >YK$#BC:9DA69GVAX$\4+D<4>J=/NV4\+ ?O MX("1Q*(U0,4#LB]>0P/7B*#6JLW)8>D;I_D;=4J\O=E&GP0Z&FE35DVDFTL_H>@#V-_('$;=7>Y(TTJ+4LY\VU=@Q/2*?AG$8W\E-6^>,CG,8@DV=Z/C1-? M";EHA$!95@ ]9-!9*.)'6:+//09*,("_QDD:\FK-G1$% )D=^5[( M*ZX$ .LV 9+X49!F+74^5Y_A5:]._#\0>OA&:3IYC8A(^=6&L>TOU?@8$D!E M].$;T>-;]I6S[0<,"ZJ10):=,!-JB_\"'C1$4QB"V;$@/M14&'$K ]Z49:0S M%8/<,O64;I=!)!7"W/A0W#7FY!0;8=1VAJC0)]-@:%D[12L:%2E-B_0'=\>X M)QYEC(6P; KEL#:)KK-L7+:+K:ID$LEG&L_.*"T>(381O2ACN^ Y1_):]V)] M[ S>8BD4R\BAN,+X3O%&P;!ET3TB6*K"!X4LDP@-]T- L M,$3V0'CLS#U4=)$8'CX3@G%PN&]K%+#Z6*8C_-06!1-87-E[DCJUK?/%):>< MH9E&6,G,E>'[QLJ$%2!6H3T2TLH&<.0RQ#+]/@88 MLY$.?AB)TP*.QR:0ZZ>W+)1/XRTCH>96BDO)F'$ MR?,Q::QALK+0@&YWNHB MH [4T$?2BA2,9W*'.)G]I!$9%#D4YG,%J6JK Z%PNM6=A50' %*E=//U&MV MN);*D@0A6$7/J^RK/FHE)1*%858AD'=TLKK[)IFG964PF"4YQLYKPX^(N9A] MU(I4+DTN\0^;O^N%6P%/F<:@IPJN,&B!,E0.D=$J-97(B&3(8S^ 8 M,+*F!#>58((008>&!44)&3ABB%$X MP. F/%:!'?.?K*!,F@:6DRB&9=BZ3A11#CG?! (W94R$L>,;DR&0/:1T:R31 M+10IZZTN5-90,:(B65*,SPCG)V&.V!'(B7*P>7_FV!81U"\XX%T5H"I? 9W\ MR*&?Y%M')$PP)C&)J-X4BA4BF'$AQI)?O.5*O#GY4-CCCBZ7EF-;>T3&F81Q M."DPO0ON+@;M <'Z,;G *'"1'"6\S(V _N6"^B8!2JJ26-[ZH&3 -O'@59,U MDJ":1,M) B(I%4AN[1L+4A\3%C@4#L^-XQWC.E.FVT,@PB] MLTC/!R#3(444'J.^;R+'5IQ$S0!-@>G:,N[W$S1R&"."SM@T,Z,N"] E>5&5 M\P,5SDJ@5/1H@%$8R2 (*)*215Y>F2'K1!Z9.);L'&3M(VBRPCZ.DCZB31/1 MOV_M[ZXC!#M/$8(Z0G#O*4+P7B($O85"!+W5Q0A6Y2[+BFI2-H 8%AA']5

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end